"","query","baseMean","log2FoldChange","lfcSE","pvalue","padj","blast_hit","evalue","ProteinNames","BiologicalProcess","GeneOntologyIDs"
"1","Pocillopora_acuta_HIv2___RNAseq.g6351.t1",1780.06230928926,-6.55617592440502,0.680641849792378,2.76863968827508e-24,4.00456044512108e-20,"B3EWY8",8.79e-09,"Skeletal aspartic acid-rich protein 2","","GO:0016020"
"2","Pocillopora_acuta_HIv2___RNAseq.g28575.t1a",2844.3905409903,17.5525503314959,3.97246411802524,4.35406812870942e-20,3.14886207068265e-16,"G5EBQ8",7.13e-107,"Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)","cell wall chitin biosynthetic process [GO:0006038]; chitin biosynthetic process [GO:0006031]; positive regulation of nematode larval development [GO:0061063]","GO:0004100; GO:0005886; GO:0006031; GO:0006038; GO:0030428; GO:0061063; GO:0071944"
"3","Pocillopora_acuta_HIv2___RNAseq.g27038.t1",1882.71411858623,16.7964263086784,3.76680294480794,1.66847362198095e-19,8.04426748944418e-16,"P24383",4.23e-13,"Protein Wnt-7a","angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; asymmetric protein localization involved in cell fate determination [GO:0045167]; canonical Wnt signaling pathway [GO:0060070]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cell proliferation in forebrain [GO:0021846]; cell-cell signaling [GO:0007267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system vasculogenesis [GO:0022009]; cerebellar granule cell differentiation [GO:0021707]; chondrocyte differentiation [GO:0002062]; dendritic spine morphogenesis [GO:0060997]; dorsal/ventral pattern formation [GO:0009953]; embryonic axis specification [GO:0000578]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; establishment of blood-brain barrier [GO:0060856]; establishment of cell polarity [GO:0030010]; limb development [GO:0060173]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neurogenesis [GO:0050768]; neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; non-canonical Wnt signaling pathway [GO:0035567]; oviduct development [GO:0060066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of excitatory synapse assembly [GO:1904891]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of synapse assembly [GO:0051965]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of axon diameter [GO:0031133]; regulation of axonogenesis [GO:0050770]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of postsynapse organization [GO:0099175]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; secondary palate development [GO:0062009]; signal transduction [GO:0007165]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]; stem cell development [GO:0048864]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; uterus development [GO:0060065]; uterus morphogenesis [GO:0061038]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing, spreading of epidermal cells [GO:0035313]","GO:0000578; GO:0001502; GO:0001525; GO:0002062; GO:0005102; GO:0005109; GO:0005125; GO:0005615; GO:0005788; GO:0006915; GO:0007165; GO:0007267; GO:0007269; GO:0007416; GO:0008284; GO:0009887; GO:0009953; GO:0009986; GO:0010595; GO:0010628; GO:0014719; GO:0014834; GO:0016055; GO:0021707; GO:0021846; GO:0022009; GO:0030010; GO:0030182; GO:0030326; GO:0031012; GO:0031133; GO:0032355; GO:0035019; GO:0035115; GO:0035116; GO:0035313; GO:0035567; GO:0042127; GO:0042733; GO:0043066; GO:0043627; GO:0045165; GO:0045167; GO:0045893; GO:0045944; GO:0046330; GO:0048103; GO:0048864; GO:0050678; GO:0050768; GO:0050770; GO:0050808; GO:0051216; GO:0051247; GO:0051965; GO:0060054; GO:0060065; GO:0060066; GO:0060070; GO:0060071; GO:0060173; GO:0060856; GO:0060997; GO:0061038; GO:0062009; GO:0071560; GO:0098685; GO:0098793; GO:0098978; GO:0099175; GO:1904891; GO:1905606; GO:2000300; GO:2000463"
"4","Pocillopora_acuta_HIv2___RNAseq.g2165.t1",1608.73918294661,16.5688340887259,3.75190701948851,3.9071483380673e-19,1.22204437986412e-15,"Q9CXI3",9.57e-14,"DBH-like monooxygenase protein 1 (EC 1.14.17.-) (DBH-related protein) (Monooxygenase X)","dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]","GO:0004500; GO:0005507; GO:0005615; GO:0005789; GO:0006589; GO:0030667; GO:0042420; GO:0042421"
"5","Pocillopora_acuta_HIv2___TS.g18104.t1",1967.6090074664,16.8137638454139,3.79636568074966,4.22443438835771e-19,1.22204437986412e-15,"P51029",7.78e-22,"Protein Wnt-8b","canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]; Wnt signaling pathway [GO:0016055]","GO:0001654; GO:0005109; GO:0005125; GO:0005615; GO:0009880; GO:0016055; GO:0021854; GO:0021879; GO:0030182; GO:0030900; GO:0043049; GO:0045165; GO:0060070; GO:0060898; GO:0070654; GO:0071679"
"6","Pocillopora_acuta_HIv2___RNAseq.g14330.t3",2168.32101516159,-16.5174777038239,3.9256044314038,6.66109003173888e-19,1.60576677031785e-15,"B8V7S0",6.57e-97,"CUB and peptidase domain-containing protein 1","acrosome reaction [GO:0007340]; proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508; GO:0007340"
"7","Pocillopora_acuta_HIv2___RNAseq.g14090.t1",2027.22358063107,-16.4360779665545,3.92208641830554,1.09543012804369e-18,2.11271333763091e-15,"G8HTB6",3.49e-20,"ZP domain-containing protein","","GO:0016020"
"8","Pocillopora_acuta_HIv2___RNAseq.g14025.t1",2533.20105807112,-16.6012727225841,3.96216821588213,1.16853613807019e-18,2.11271333763091e-15,NA,NA,NA,NA,NA
"9","Pocillopora_acuta_HIv2___RNAseq.g3832.t1",4681.36281946371,12.4923076415858,2.34800449451893,5.39932632588341e-18,8.28049105849486e-15,"Q566X8",1.47e-36,"Diencephalon/mesencephalon homeobox protein 1-B","midbrain development [GO:0030901]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007346; GO:0030901; GO:0050767; GO:0051726; GO:0060041; GO:0061074"
"10","Pocillopora_acuta_HIv2___RNAseq.g8006.t1",1858.29368115358,-16.1656027241107,3.91968160307518,5.74180077044122e-18,8.28049105849486e-15,NA,NA,NA,NA,NA
"11","Pocillopora_acuta_HIv2___RNAseq.g10378.t1",1200.09323446445,16.1580082923622,3.7327526613979,6.29738672866728e-18,8.28049105849486e-15,"P22897",1.35e-39,"Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206)","cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898]","GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353"
"12","Pocillopora_acuta_HIv2___RNAseq.g14253.t1",1084.62610850225,15.9449806203823,3.72600215228243,1.43614754593446e-17,1.73103650869967e-14,"Q96RW7",2.16e-33,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711"
"13","Pocillopora_acuta_HIv2___RNAseq.g25431.t1",3378.81007684284,-11.7349380030129,1.97733030305288,1.70268411528234e-17,1.8106919873551e-14,NA,NA,NA,NA,NA
"14","Pocillopora_acuta_HIv2___RNAseq.11056_t",1574.73889068724,-15.9358651320797,3.89078629777836,1.75260562935366e-17,1.8106919873551e-14,NA,NA,NA,NA,NA
"15","Pocillopora_acuta_HIv2___RNAseq.g9588.t1",10129.8808156182,13.0019191011354,2.91590220115698,2.00134721875055e-17,1.9298324114672e-14,"Q9PT61",6.33e-42,"Homeobox protein otx5-B (Orthodenticle homolog 5-B) (XOtx5b)","anterior/posterior pattern specification [GO:0009952]; eye photoreceptor cell fate commitment [GO:0042706]; positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0000981; GO:0003677; GO:0005634; GO:0009952; GO:0042706; GO:0045944"
"16","Pocillopora_acuta_HIv2___TS.g30765.t1",1392.70364464146,16.3447584332851,3.80868578569036,2.47296616482107e-17,2.23556141299825e-14,NA,NA,NA,NA,NA
"17","Pocillopora_acuta_HIv2___RNAseq.g14021.t1",1390.28685695327,-15.7443142439334,3.85317969026011,3.14334444562964e-17,2.67443141538748e-14,"G8HTB6",2.38e-12,"ZP domain-containing protein","","GO:0016020"
"18","Pocillopora_acuta_HIv2___RNAseq.g19082.t1",922.112612153853,15.7395547637724,3.70510612057295,5.04384777531586e-17,4.05301190123159e-14,NA,NA,NA,NA,NA
"19","Pocillopora_acuta_HIv2___RNAseq.g16202.t1",815.958547797283,11.135166154603,1.74229028680281,8.59803846655988e-17,6.54536991475379e-14,"Q9GZX3",1.09e-27,"Carbohydrate sulfotransferase 6 (Corneal N-acetylglucosamine-6-O-sulfotransferase) (C-GlcNAc6ST) (hCGn6ST) (EC 2.8.2.21) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 4-beta) (GST4-beta) (N-acetylglucosamine 6-O-sulfotransferase 5) (GlcNAc6ST-5) (Gn6st-5)","carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]","GO:0000139; GO:0001517; GO:0005794; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0018146; GO:0045130"
"20","Pocillopora_acuta_HIv2___TS.g19991.t2",950.24838269187,15.739017006898,3.72381145194001,1.16154272214417e-16,8.40027696654667e-14,NA,NA,NA,NA,NA
"21","Pocillopora_acuta_HIv2___RNAseq.g20860.t1",1265.2742161805,-15.5762447772559,3.87381005283364,1.35817286920059e-16,9.35457732386536e-14,"Q01528",3.72e-11,"Hemagglutinin/amebocyte aggregation factor (18K-LAF)","collagen fibril organization [GO:0030199]","GO:0005615; GO:0030199; GO:0031012"
"22","Pocillopora_acuta_HIv2___RNAseq.g8588.t1",783.119333561871,15.4774117501853,3.69354649776281,2.18853875389073e-16,1.43886475164889e-13,"B3EWZ3",3.14e-104,"Coadhesin","","GO:0016020"
"23","Pocillopora_acuta_HIv2___RNAseq.g26604.t1",3789.9648726559,12.3051226483064,2.53307531075201,2.56133742617023e-16,1.6107471535707e-13,"Q9GLK0",3.7e-171,"Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1)","keratinization [GO:0031424]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]","GO:0003810; GO:0010838; GO:0016020; GO:0031424; GO:0045787; GO:0046872"
"24","Pocillopora_acuta_HIv2___TS.g27642.t1b",1146.75164624353,-15.3843570127424,3.83971613953649,2.7425318068115e-16,1.61468308910218e-13,"P15535",1.41e-89,"Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1]","acute inflammatory response [GO:0002526]; angiogenesis involved in wound healing [GO:0060055]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; development of secondary sexual characteristics [GO:0045136]; epithelial cell development [GO:0002064]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]; galactose metabolic process [GO:0006012]; glycoprotein biosynthetic process [GO:0009101]; lactose biosynthetic process [GO:0005989]; lipid metabolic process [GO:0006629]; macrophage migration [GO:1905517]; negative regulation of epithelial cell proliferation [GO:0050680]; oligosaccharide biosynthetic process [GO:0009312]; penetration of zona pellucida [GO:0007341]; positive regulation of apoptotic process [GO:0043065]; positive regulation of circulating fibrinogen levels [GO:0061755]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; regulation of acrosome reaction [GO:0060046]; wound healing [GO:0042060]","GO:0000138; GO:0002064; GO:0002526; GO:0003831; GO:0003945; GO:0004461; GO:0005576; GO:0005794; GO:0005886; GO:0005989; GO:0006012; GO:0006486; GO:0006487; GO:0006629; GO:0007155; GO:0007339; GO:0007341; GO:0008092; GO:0008283; GO:0008378; GO:0009101; GO:0009312; GO:0009897; GO:0009986; GO:0016323; GO:0030057; GO:0030145; GO:0030175; GO:0030198; GO:0031526; GO:0032580; GO:0032991; GO:0042060; GO:0043065; GO:0045136; GO:0050673; GO:0050680; GO:0060046; GO:0060054; GO:0060055; GO:0061755; GO:1905517"
"25","Pocillopora_acuta_HIv2___TS.g18100.t1",8027.26641448667,10.6172019278843,1.8763792779783,2.7908654056661e-16,1.61468308910218e-13,"P51029",2.52e-27,"Protein Wnt-8b","canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]; Wnt signaling pathway [GO:0016055]","GO:0001654; GO:0005109; GO:0005125; GO:0005615; GO:0009880; GO:0016055; GO:0021854; GO:0021879; GO:0030182; GO:0030900; GO:0043049; GO:0045165; GO:0060070; GO:0060898; GO:0070654; GO:0071679"
"26","Pocillopora_acuta_HIv2___RNAseq.g11588.t1",1254.25173047322,-15.4699309222934,3.89022465385711,3.01703869785162e-16,1.67840183560484e-13,"B3EWY9",3.43e-26,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020"
"27","Pocillopora_acuta_HIv2___RNAseq.g25327.t1",1008.53047685861,-11.8549816922529,1.97447473382116,3.84323231076912e-16,2.05883378307276e-13,"Q13887",2.02e-24,"Krueppel-like factor 5 (Basic transcription element-binding protein 2) (BTE-binding protein 2) (Colon krueppel-like factor) (GC-box-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2)","angiogenesis [GO:0001525]; cell-cell signaling via exosome [GO:0099156]; cellular response to leukemia inhibitory factor [GO:1990830]; intestinal epithelial cell development [GO:0060576]; microvillus assembly [GO:0030033]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; regulation of microvillus assembly [GO:0032534]; regulation of transcription by RNA polymerase II [GO:0006357]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell differentiation [GO:0014816]","GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0005654; GO:0005667; GO:0005794; GO:0006357; GO:0014816; GO:0014901; GO:0014908; GO:0030033; GO:0032534; GO:0043231; GO:0043426; GO:0045600; GO:0045944; GO:0046872; GO:0060576; GO:0061586; GO:0099156; GO:1902895; GO:1990830; GO:1990837"
"28","Pocillopora_acuta_HIv2___RNAseq.g12281.t1",740.060962879886,15.4019456150839,3.72097169211652,4.02937321358851e-16,2.08145907719087e-13,"P10586",7.23e-48,"Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR)","cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell surface receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; negative regulation of receptor binding [GO:1900121]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of axon regeneration [GO:0048679]; synaptic membrane adhesion [GO:0099560]","GO:0004721; GO:0004725; GO:0005001; GO:0005886; GO:0007155; GO:0007185; GO:0008201; GO:0016477; GO:0031102; GO:0035335; GO:0035373; GO:0043005; GO:0043025; GO:0044877; GO:0048679; GO:0050839; GO:0070062; GO:0099560; GO:1900121"
"29","Pocillopora_acuta_HIv2___RNAseq.g19284.t1",5809.18872335367,15.6933024622459,3.62338862970703,4.58299617747811e-16,2.22136984539083e-13,"Q9WTR0",1.41e-46,"Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP)","bone development [GO:0060348]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; protein processing [GO:0016485]; skeletal system development [GO:0001501]","GO:0001501; GO:0001503; GO:0001958; GO:0004222; GO:0005615; GO:0005886; GO:0008270; GO:0016485; GO:0030198; GO:0030574; GO:0031012; GO:0035988; GO:0048701; GO:0060348; GO:0070006; GO:0097094"
"30","Pocillopora_acuta_HIv2___RNAseq.g19085.t1",6069.90203768671,11.1262619215748,2.10206430176727,4.60737661516351e-16,2.22136984539083e-13,"Q18DN4",2.43e-08,"Halomucin","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0005509; GO:0005576; GO:0007156; GO:0016020; GO:0030246"
"31","Pocillopora_acuta_HIv2___TS.g11360.t1",727.48293499131,11.3112024014355,1.83306883267603,4.91236544960691e-16,2.29201464074562e-13,NA,NA,NA,NA,NA
"32","Pocillopora_acuta_HIv2___RNAseq.g7803.t1",953.479854409614,-15.1821578705503,3.81260026304841,5.715961285974e-16,2.58361450126025e-13,"Q21305",1.37e-40,"Transcription factor sox-2","neuron differentiation [GO:0030182]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0000977; GO:0000978; GO:0001228; GO:0005634; GO:0030182; GO:0045944; GO:0048665"
"33","Pocillopora_acuta_HIv2___TS.g16008.t2",945.362231842888,-15.1356859473163,3.79729136104194,6.03941798624965e-16,2.64709520463985e-13,"Q40778",1.37e-29,"Allene oxide synthase (EC 4.2.1.92) (Cytochrome P450 74A2) (Rubber particle protein) (RPP)","fatty acid biosynthetic process [GO:0006633]; oxylipin biosynthetic process [GO:0031408]","GO:0004497; GO:0005506; GO:0006633; GO:0009978; GO:0016705; GO:0020037; GO:0031408"
"34","Pocillopora_acuta_HIv2___RNAseq.g22978.t3b",946.258537376439,-15.1544248500445,3.8140489650611,7.3502531683953e-16,3.12688417140205e-13,NA,NA,NA,NA,NA
"35","Pocillopora_acuta_HIv2___RNAseq.g2406.t1",916.583525243243,-15.1306366517088,3.81606191192764,8.13181016645971e-16,3.36052863564781e-13,NA,NA,NA,NA,NA
"36","Pocillopora_acuta_HIv2___RNAseq.g8119.t1",933.904971969952,-15.1807514948259,3.83576795462561,8.57027740224448e-16,3.44334700961289e-13,NA,NA,NA,NA,NA
"37","Pocillopora_acuta_HIv2___TS.g9414.t1",1170.47134434928,-15.5408802566191,3.97764821538116,9.66668777052303e-16,3.7788911327796e-13,"Q8BFR2",2.36e-58,"Follistatin-related protein 5 (Follistatin-like protein 5) (m-D/Bsp120I 1-2)","cell differentiation [GO:0030154]; regulation of BMP signaling pathway [GO:0030510]","GO:0005509; GO:0005576; GO:0030154; GO:0030510"
"38","Pocillopora_acuta_HIv2___RNAseq.g21374.t1",755.981336839023,-10.2047254547067,1.62040625750153,1.62837464642277e-15,6.19810812785761e-13,NA,NA,NA,NA,NA
"39","Pocillopora_acuta_HIv2___RNAseq.g21000.t1",1227.75708253182,-15.5945081085334,3.9631230877074,1.74185867663675e-15,6.4600625381728e-13,"G8HTB6",7.06e-32,"ZP domain-containing protein","","GO:0016020"
"40","Pocillopora_acuta_HIv2___RNAseq.g5252.t1",685.237729174062,-11.5318852987869,1.91703616232947,1.84758088939598e-15,6.68085249605585e-13,"Q00168",4.64e-72,"Calcium/calmodulin-dependent protein kinase type II alpha chain (CaM-kinase II alpha chain) (EC 2.7.11.17)","cellular response to starvation [GO:0009267]; chemical synaptic transmission [GO:0007268]; courtship behavior [GO:0007619]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cytokine production [GO:0001818]; negative regulation of lipid storage [GO:0010888]; neuromuscular junction development [GO:0007528]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; regulation of filopodium assembly [GO:0051489]; regulation of ovulation [GO:0060278]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]","GO:0001818; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005737; GO:0007268; GO:0007528; GO:0007611; GO:0007616; GO:0007619; GO:0008049; GO:0008582; GO:0009267; GO:0010888; GO:0030424; GO:0030425; GO:0032226; GO:0043005; GO:0045211; GO:0048786; GO:0051489; GO:0060278; GO:0106310; GO:2001234"
"41","Pocillopora_acuta_HIv2___RNAseq.g22853.t1",8612.30390232864,-11.1329375109481,2.15130725801366,1.9046364512493e-15,6.71918576362681e-13,NA,NA,NA,NA,NA
"42","Pocillopora_acuta_HIv2___RNAseq.g17117.t1",1037.72978148286,-15.1578340719951,3.85908239440274,2.19017396969699e-15,7.54254197564221e-13,"O19132",0,"Nitric oxide synthase 1 (EC 1.14.13.39) (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS) (N-NOS) (nNOS) (Nitric oxide synthase, brain) (bNOS) (Peptidyl-cysteine S-nitrosylase NOS1)","nitric oxide biosynthetic process [GO:0006809]","GO:0004517; GO:0005516; GO:0006809; GO:0010181; GO:0020037; GO:0042383; GO:0043197; GO:0046872; GO:0050660; GO:0050661"
"43","Pocillopora_acuta_HIv2___TS.g16802.t1",3444.71837581509,-10.7029757939764,1.99183805886875,2.39520092444236e-15,7.88997550901037e-13,NA,NA,NA,NA,NA
"44","Pocillopora_acuta_HIv2___RNAseq.g25759.t1",808.98861100082,-14.89459268006,3.79393441085278,2.4001584789578e-15,7.88997550901037e-13,"Q27128",0,"Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase (PAPS synthase) (PAPS synthetase) (PAPSS) (Sulfurylase kinase) (SK) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)]","3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; sulfate assimilation [GO:0000103]","GO:0000103; GO:0004020; GO:0004781; GO:0005524; GO:0016779; GO:0050428"
"45","Pocillopora_acuta_HIv2___RNAseq.30415_t",893.176357470135,-15.1484622018048,3.88439129416118,3.0993510589749e-15,9.89043486027918e-13,"Q6XYQ8",9.54e-39,"Synaptotagmin-10 (Synaptotagmin X) (SytX)","calcium-ion regulated exocytosis [GO:0017156]; chemical synaptic transmission [GO:0007268]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; sensory perception of smell [GO:0007608]","GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0007268; GO:0007608; GO:0017156; GO:0030276; GO:0030658; GO:0042803; GO:0045956; GO:0046982; GO:0070382; GO:0098793; GO:0098978"
"46","Pocillopora_acuta_HIv2___RNAseq.g24120.t1",770.649944734318,-14.8749741751358,3.80361623449667,3.14546462647153e-15,9.89043486027918e-13,"Q862Z3",4.51e-46,"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829]; neutrophil migration [GO:1990266]","GO:0000922; GO:0005509; GO:0005615; GO:0005929; GO:0009986; GO:0016020; GO:0016323; GO:0016324; GO:0050829; GO:0060170; GO:0098552; GO:0140367; GO:1990266"
"47","Pocillopora_acuta_HIv2___RNAseq.g14336.t1",765.622505305614,-14.8579821159918,3.79621481937334,3.97574978507373e-15,1.2235158487512e-12,"B8V7S0",9.84e-94,"CUB and peptidase domain-containing protein 1","acrosome reaction [GO:0007340]; proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508; GO:0007340"
"48","Pocillopora_acuta_HIv2___RNAseq.g26594.t2",3371.39523172936,-13.876443132684,3.29865167810793,4.81724214404903e-15,1.45159563274011e-12,"Q90632",4.11e-37,"Monocarboxylate transporter 3 (MCT 3) (Retinal epithelial membrane protein) (Solute carrier family 16 member 8)","monocarboxylic acid transport [GO:0015718]","GO:0005886; GO:0008028; GO:0015293; GO:0015718; GO:0016323"
"49","Pocillopora_acuta_HIv2___TS.g4983.t1",908.847886315208,15.6677967496912,3.87045338562334,6.21386535163676e-15,1.81798857257218e-12,"Q9CZV8",7e-18,"F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like)","behavioral fear response [GO:0001662]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of synaptic vesicle exocytosis [GO:2000300]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]","GO:0001662; GO:0005737; GO:0019005; GO:0031146; GO:0045202; GO:0098685; GO:0098793; GO:0098978; GO:0099575; GO:2000300"
"50","Pocillopora_acuta_HIv2___RNAseq.g19115.t1",990.626313025877,-10.4520572559079,1.82367707827171,6.28452908107088e-15,1.81798857257218e-12,"Q8NB59",7.09e-20,"Synaptotagmin-14 (Synaptotagmin XIV) (SytXIV)","","GO:0005543; GO:0016020"
"51","Pocillopora_acuta_HIv2___RNAseq.g28635.t1",3721.66147975373,-13.7972964429873,3.41135912342529,7.81342503225726e-15,2.18881340422377e-12,"Q6P832",0,"Glycine amidinotransferase, mitochondrial (EC 2.1.4.1) (L-arginine:glycine amidinotransferase) (Transamidinase)","creatine biosynthetic process [GO:0006601]","GO:0005743; GO:0006601; GO:0015068"
"52","Pocillopora_acuta_HIv2___RNAseq.g25317.t1",2252.95465312817,-10.9676173799993,2.31449225069005,7.98166741539946e-15,2.18881340422377e-12,"Q03146",4.64e-09,"Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (Protein-tyrosine kinase MPK-6) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a)","axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell population proliferation [GO:0008283]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell migration [GO:0014909]; smooth muscle cell-matrix adhesion [GO:0061302]; wound healing, spreading of cells [GO:0044319]","GO:0001558; GO:0001952; GO:0005518; GO:0005524; GO:0005886; GO:0005903; GO:0007566; GO:0007595; GO:0008283; GO:0008285; GO:0010715; GO:0010976; GO:0014909; GO:0016323; GO:0038062; GO:0038063; GO:0038083; GO:0043235; GO:0043583; GO:0044319; GO:0046872; GO:0051897; GO:0060444; GO:0060749; GO:0061302; GO:0061564; GO:1990138"
"53","Pocillopora_acuta_HIv2___RNAseq.g21373.t1",662.832864169878,-14.6187376320666,3.75855430690229,8.02040309899472e-15,2.18881340422377e-12,NA,NA,NA,NA,NA
"54","Pocillopora_acuta_HIv2___RNAseq.g7627.t1",764.189970591372,-14.7549733634802,3.8071151290367,8.43939620507203e-15,2.26050790204004e-12,"Q6T752",6.86e-13,"Toll-like receptor 2 (CD antigen CD282)","cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; toll-like receptor signaling pathway [GO:0002224]","GO:0002224; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0030670; GO:0038023; GO:0042497; GO:0045087; GO:0045121; GO:0061809; GO:0071726; GO:0071727"
"55","Pocillopora_acuta_HIv2___RNAseq.g9210.t1",701.432652665035,-14.5150882807768,3.77441461653343,1.70601873062281e-14,4.48651907631424e-12,NA,NA,NA,NA,NA
"56","Pocillopora_acuta_HIv2___TS.g16384.t1",645.704218748475,-14.5974074873698,3.79876994415303,1.93746953386085e-14,5.0042070246006e-12,NA,NA,NA,NA,NA
"57","Pocillopora_acuta_HIv2___RNAseq.g27377.t1",735.340145124758,-10.2369611763518,1.77616837401578,2.13977437221085e-14,5.42977131923819e-12,NA,NA,NA,NA,NA
"58","Pocillopora_acuta_HIv2___RNAseq.g13561.t1",640.62448814426,-14.5819947469844,3.80007930531092,2.2606152935214e-14,5.52042908030029e-12,NA,NA,NA,NA,NA
"59","Pocillopora_acuta_HIv2___RNAseq.g1102.t1",682.410091221503,-14.6756718347684,3.81713157232385,2.27847804856332e-14,5.52042908030029e-12,"Q9EQD2",2.11e-45,"Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor)","cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of MAPK cascade [GO:0043408]","GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0042277; GO:0043408"
"60","Pocillopora_acuta_HIv2___RNAseq.g1234.t1",3320.09020492918,10.0171634865863,2.0723308301562,2.32585783139001e-14,5.52042908030029e-12,NA,NA,NA,NA,NA
"61","Pocillopora_acuta_HIv2___RNAseq.g9631.t1",5786.08667327334,-14.7559785945729,3.16630469660707,2.32816768458461e-14,5.52042908030029e-12,"Q40375",3.73e-56,"Repetitive proline-rich cell wall protein 2","","GO:0005199; GO:0005576"
"62","Pocillopora_acuta_HIv2___RNAseq.g11659.t1",606.94528410354,-14.4456197017505,3.78220724617351,2.65919510107599e-14,6.20364482934889e-12,NA,NA,NA,NA,NA
"63","Pocillopora_acuta_HIv2___TS.g1968.t2",570.15481360313,-14.3835703143355,3.76819015916754,3.18874792947424e-14,7.32096032570086e-12,NA,NA,NA,NA,NA
"64","Pocillopora_acuta_HIv2___RNAseq.g1126.t1",3758.53930256433,14.5774795798716,3.15720134877493,3.83075249892931e-14,8.65750064758024e-12,"B3EWZ3",7.33e-54,"Coadhesin","","GO:0016020"
"65","Pocillopora_acuta_HIv2___TS.g21863.t2",714.499186910933,-11.5870231763242,2.25752154264054,3.94089513301514e-14,8.76940110829708e-12,NA,NA,NA,NA,NA
"66","Pocillopora_acuta_HIv2___RNAseq.g14484.t1",670.562029806778,-14.6541637867891,3.85555189570815,4.67053029774861e-14,1.02355379131267e-11,"Q9JKM7",4.74e-106,"Ras-related protein Rab-37","protein transport [GO:0015031]","GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0015031; GO:0030141"
"67","Pocillopora_acuta_HIv2___RNAseq.g18517.t1",291.865888857358,-9.43443938347121,1.47306216981511,5.36788746872411e-14,1.1588227514571e-11,NA,NA,NA,NA,NA
"68","Pocillopora_acuta_HIv2___RNAseq.g27621.t1",1470.664505119,12.6387842115714,2.73278931373397,6.34629445352604e-14,1.34989416140883e-11,NA,NA,NA,NA,NA
"69","Pocillopora_acuta_HIv2___RNAseq.22067_t",613.52482329882,-14.2404358993999,3.77774669843241,6.53523055586136e-14,1.36993586608665e-11,"Q98SN7",6.5e-110,"Protein Wnt-2b","camera-type eye photoreceptor cell differentiation [GO:0060219]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell population proliferation [GO:0008283]; cornea development in camera-type eye [GO:0061303]; embryonic camera-type eye formation [GO:0060900]; embryonic forelimb morphogenesis [GO:0035115]; iris morphogenesis [GO:0061072]; lens development in camera-type eye [GO:0002088]; limb development [GO:0060173]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of glial cell differentiation [GO:0045686]; negative regulation of neuron differentiation [GO:0045665]; neural retina development [GO:0003407]; neuron differentiation [GO:0030182]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of fibroblast growth factor production [GO:0090270]; retina layer formation [GO:0010842]; Wnt signaling pathway [GO:0016055]","GO:0002011; GO:0002088; GO:0003407; GO:0005109; GO:0005125; GO:0005615; GO:0008283; GO:0010842; GO:0016055; GO:0030182; GO:0035115; GO:0045165; GO:0045665; GO:0045686; GO:0045743; GO:0060070; GO:0060173; GO:0060219; GO:0060828; GO:0060900; GO:0061072; GO:0061303; GO:0090270; GO:0090271"
"70","Pocillopora_acuta_HIv2___RNAseq.g27681.t1b",674.169731150683,-14.3970677012828,3.80580445584366,7.01436468437021e-14,1.44936815421044e-11,NA,NA,NA,NA,NA
"71","Pocillopora_acuta_HIv2___RNAseq.g28202.t1",2285.1584368848,-1.3318538696491,3.13168218468487,7.84045237564535e-14,1.59724370649767e-11,"P12391",1.25e-61,"Neuronal acetylcholine receptor subunit beta-3","acetylcholine receptor signaling pathway [GO:0095500]; membrane depolarization [GO:0051899]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; response to nicotine [GO:0035094]; synaptic transmission, cholinergic [GO:0007271]","GO:0004888; GO:0005886; GO:0005892; GO:0007271; GO:0022848; GO:0032991; GO:0035094; GO:0042166; GO:0043005; GO:0045202; GO:0045211; GO:0051899; GO:0095500; GO:0098691; GO:0098793; GO:0099171"
"72","Pocillopora_acuta_HIv2___RNAseq.g8732.t1",507.240463637248,-14.1287231168046,3.72576372876118,8.63273832957586e-14,1.73422121109702e-11,"Q8BGN2",3.01e-48,"UPF0462 protein C4orf33 homolog","",""
"73","Pocillopora_acuta_HIv2___RNAseq.g11810.t1",633.244866387664,-14.3290763069553,3.79401898956783,1.06418191491406e-13,2.10853797497493e-11,"P15508",2.41e-37,"Spectrin beta chain, erythrocytic (Beta-I spectrin)","actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; hemopoiesis [GO:0030097]; plasma membrane organization [GO:0007009]; porphyrin-containing compound biosynthetic process [GO:0006779]","GO:0003779; GO:0005200; GO:0005886; GO:0006779; GO:0007009; GO:0008091; GO:0014731; GO:0016020; GO:0030036; GO:0030054; GO:0030097; GO:0030863; GO:0030864; GO:0042995; GO:0051015; GO:0051693; GO:0098794; GO:0098978"
"74","Pocillopora_acuta_HIv2___RNAseq.g13.t1",493.162696204997,-14.1602003034474,3.76373524965138,1.08601393079659e-13,2.12271695878945e-11,"Q3V1M1",5.17e-10,"Immunoglobulin superfamily member 10 (IgSF10)","ossification [GO:0001503]; regulation of neuron migration [GO:2001222]; tissue regeneration [GO:0042246]","GO:0001503; GO:0005576; GO:0042246; GO:2001222"
"75","Pocillopora_acuta_HIv2___RNAseq.g5007.t1",484.02351264286,-14.1056450623185,3.73402567954359,1.13066241084229e-13,2.18052014805639e-11,NA,NA,NA,NA,NA
"76","Pocillopora_acuta_HIv2___RNAseq.g8062.t1",492.934930950537,14.7202756704439,3.75719718357189,1.16569200374965e-13,2.21469293889272e-11,"Q9PVY8",6.3e-66,"Forkhead box protein C2-B (FoxC2-B) (FoxC2b) (Fork head domain-related protein 4') (FD-4') (xFD-4') (xFD4 B)","mesoderm development [GO:0007498]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]","GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0007498; GO:0043565; GO:0045893; GO:0045944; GO:1990841"
"77","Pocillopora_acuta_HIv2___RNAseq.g13400.t1",533.223747836275,-14.2540822831637,3.7840255625664,1.17900550535633e-13,2.21469293889272e-11,"P51400",0,"Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase)","adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of mRNA processing [GO:0050685]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965]","GO:0003723; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0006397; GO:0007274; GO:0008251; GO:0008285; GO:0016553; GO:0016556; GO:0021610; GO:0021618; GO:0021965; GO:0030336; GO:0035264; GO:0042802; GO:0044387; GO:0045070; GO:0045202; GO:0046872; GO:0050685; GO:0050884; GO:0051726; GO:0060384; GO:0060415; GO:0061744; GO:0097049"
"78","Pocillopora_acuta_HIv2___RNAseq.g7514.t1",496.362437442143,-14.0517874949237,3.72055291281536,1.30031034195209e-13,2.41124215205065e-11,NA,NA,NA,NA,NA
"79","Pocillopora_acuta_HIv2___RNAseq.g9231.t1",1272.97552268526,11.0117940003162,2.78609057854299,1.36187884194451e-13,2.4528626789505e-11,NA,NA,NA,NA,NA
"80","Pocillopora_acuta_HIv2___RNAseq.g23883.t2",638.102436356512,-11.7250240512866,2.34846475679245,1.36354125222061e-13,2.4528626789505e-11,"Q5VU97",8.26e-146,"VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1)","","GO:0005245; GO:0005891"
"81","Pocillopora_acuta_HIv2___RNAseq.g3939.t1",610.379215541957,11.7790085610348,2.42993105057754,1.37363023364899e-13,2.4528626789505e-11,"Q9W770",1.17e-71,"Spondin-1 (F-spondin)","cell adhesion [GO:0007155]","GO:0005576; GO:0007155; GO:0031012; GO:0046872"
"82","Pocillopora_acuta_HIv2___RNAseq.g17085.t1",542.201890374515,-14.1797781084664,3.78198923384709,1.41414791310121e-13,2.49441895306047e-11,"G5EG78",2.82e-87,"Peroxidasin homolog pxn-2 (EC 1.11.2.-)","axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; embryonic body morphogenesis [GO:0010172]; muscle attachment [GO:0016203]; negative regulation of axon regeneration [GO:0048681]; regulation of basement membrane organization [GO:0110011]; response to oxidative stress [GO:0006979]","GO:0004601; GO:0005604; GO:0005615; GO:0006979; GO:0007411; GO:0010172; GO:0016203; GO:0020037; GO:0046872; GO:0048681; GO:0071711; GO:0110011; GO:0140825"
"83","Pocillopora_acuta_HIv2___RNAseq.g3222.t1",584.314671432432,-14.2009468635482,3.79712522148022,1.65827329586618e-13,2.87606469873934e-11,"P49013",1.81e-28,"Fibropellin-3 (Epidermal growth factor-related protein 3) (Fibropellin III) (Fibropellin-c) (SpEGF III)","","GO:0005509; GO:0005576; GO:0009374"
"84","Pocillopora_acuta_HIv2___RNAseq.g17946.t1",517.195459073916,-14.1220294914196,3.77762854709702,1.67028093676787e-13,2.87606469873934e-11,NA,NA,NA,NA,NA
"85","Pocillopora_acuta_HIv2___RNAseq.g30104.t1",700.233000546774,-9.79009571334673,1.79067988770514,1.86999497637871e-13,3.18207145156961e-11,"Q80VF6",3.22e-10,"Protein FAM181B","",""
"86","Pocillopora_acuta_HIv2___TS.g22105.t1",586.4538651294,-14.3735188119337,3.83991242520682,2.0016291444927e-13,3.35763046186465e-11,"F1PZV2",2.55e-32,"Major facilitator superfamily domain-containing protein 12","carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021]","GO:0005764; GO:0005765; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0043474; GO:0048021; GO:1903712"
"87","Pocillopora_acuta_HIv2___RNAseq.g21722.t1",389.219325198085,-9.91709445185523,1.69752879199195,2.01959243765365e-13,3.35763046186465e-11,"Q8VCR7",7.68e-44,"Putative protein-lysine deacylase ABHD14B (EC 2.3.1.-) (Alpha/beta hydrolase domain-containing protein 14B) (Abhydrolase domain-containing protein 14B)","positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0005634; GO:0005737; GO:0016787; GO:0045944; GO:0061733"
"88","Pocillopora_acuta_HIv2___RNAseq.g14933.t1",451.503456323017,-13.9466582083892,3.70889975316372,2.15449830303057e-13,3.54121175625389e-11,"Q3UZD5",2.42e-88,"Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.361) (PR domain zinc finger protein 6) (PR domain-containing protein 6) (PR domain-containing protein in smooth muscle)","methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of gene expression [GO:0010468]","GO:0000122; GO:0005634; GO:0010468; GO:0022008; GO:0032259; GO:0042802; GO:0045892; GO:0046872; GO:0051151; GO:0140944"
"89","Pocillopora_acuta_HIv2___RNAseq.g16988.t1",376.1632002207,-11.0459394646824,2.06633961195377,2.28780837165495e-13,3.71807418961991e-11,NA,NA,NA,NA,NA
"90","Pocillopora_acuta_HIv2___RNAseq.g13796.t1",522.094512369359,-14.2365534727542,3.7964061678665,2.43790179570422e-13,3.91797906367399e-11,"Q9D1E6",3.96e-86,"Tubulin-folding cofactor B (Cytoskeleton-associated protein 1) (Cytoskeleton-associated protein CKAPI) (Tubulin-specific chaperone B)","cell differentiation [GO:0030154]; cytoplasmic microtubule organization [GO:0031122]; nervous system development [GO:0007399]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021]","GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0007021; GO:0007023; GO:0007399; GO:0030154; GO:0031122; GO:0035371; GO:0043014; GO:0051010"
"91","Pocillopora_acuta_HIv2___RNAseq.g10163.t1",764.295436626259,-10.2054239525006,2.036319193599,2.65977410750337e-13,4.22757941658558e-11,NA,NA,NA,NA,NA
"92","Pocillopora_acuta_HIv2___RNAseq.g12.t1",573.90599235064,-14.126272837492,3.79880139575566,2.91518090858468e-13,4.55922511391013e-11,"Q9NR99",8.15e-10,"Matrix-remodeling-associated protein 5 (Adhesion protein with leucine-rich repeats and immunoglobulin domains related to perlecan) (Adlican)","response to transforming growth factor beta [GO:0071559]","GO:0005201; GO:0005576; GO:0062023; GO:0070062; GO:0071559"
"93","Pocillopora_acuta_HIv2___RNAseq.g18187.t1",361.132994907348,-7.55690659176975,1.18459732552624,2.93147079365074e-13,4.55922511391013e-11,"Q6DBY9",1.7e-30,"Carbohydrate sulfotransferase 1 (EC 2.8.2.21) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST)","carbohydrate metabolic process [GO:0005975]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]","GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0042339; GO:0045130"
"94","Pocillopora_acuta_HIv2___RNAseq.g11522.t1",426.990692656728,-9.35469308219403,1.62896784319225,2.99428555874314e-13,4.60737726826179e-11,NA,NA,NA,NA,NA
"95","Pocillopora_acuta_HIv2___RNAseq.g31136.t1",426.941973838769,-13.8759516495436,3.71250047099748,3.15358028416213e-13,4.80140897159168e-11,"Q1L8G7",6.83e-50,"GATA zinc finger domain-containing protein 1","chromatin organization [GO:0006325]; regulation of DNA-templated transcription [GO:0006355]","GO:0005634; GO:0006325; GO:0006355; GO:0031674; GO:0043565; GO:0046872"
"96","Pocillopora_acuta_HIv2___RNAseq.g7672.t1",429.596418846362,-13.8271196876451,3.69885970983568,3.26290326089361e-13,4.91610757974637e-11,NA,NA,NA,NA,NA
"97","Pocillopora_acuta_HIv2___TS.g28528.t1b",5194.87777708238,9.85366553584021,2.89846206784376,3.68608732999121e-13,5.49645022072092e-11,"P18460",4.35e-37,"Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (Tyrosine kinase receptor CEK2)","apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; regulation of macromolecule metabolic process [GO:0060255]","GO:0005007; GO:0005524; GO:0005886; GO:0006915; GO:0008284; GO:0017134; GO:0030154; GO:0043235; GO:0043410; GO:0060255"
"98","Pocillopora_acuta_HIv2___RNAseq.g2813.t4",1653.40829342614,-1.17478950087872,2.37215679410957,3.83425428687377e-13,5.65904632707574e-11,"Q3UP38",3.52e-55,"EF-hand calcium-binding domain-containing protein 4B (Calcium release-activated channel regulator 2A) (Ras-related protein Rab-46)","activation of store-operated calcium channel activity [GO:0032237]; adaptive immune response [GO:0002250]; endosomal transport [GO:0016197]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of JNK cascade [GO:0046330]; response to histamine [GO:0034776]; store-operated calcium entry [GO:0002115]; T-helper 1 cell differentiation [GO:0045063]","GO:0000139; GO:0001772; GO:0002115; GO:0002250; GO:0003924; GO:0005509; GO:0005525; GO:0005737; GO:0005815; GO:0005886; GO:0016197; GO:0031982; GO:0032237; GO:0032588; GO:0033093; GO:0034776; GO:0045063; GO:0046330; GO:0051928"
"99","Pocillopora_acuta_HIv2___TS.g10041.t1",413.393721368022,-13.7851723236533,3.69622808497353,4.1576228885714e-13,6.07432903639361e-11,"V6CLA2",4.93e-12,"E3 ubiquitin-protein ligase hecd-1 (EC 2.3.2.26)","determination of adult lifespan [GO:0008340]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; regulation of cell fate specification [GO:0042659]; regulation of germ cell proliferation [GO:1905936]; regulation of response to oxidative stress [GO:1902882]; regulation of vulval development [GO:0040028]","GO:0008340; GO:0016607; GO:0032436; GO:0040028; GO:0042659; GO:0043161; GO:0045746; GO:0045747; GO:0046872; GO:0061630; GO:0070534; GO:1902882; GO:1905936"
"100","Pocillopora_acuta_HIv2___RNAseq.g18278.t1",406.840971288858,-13.7874890986546,3.70321016624047,4.39220375188896e-13,6.3528835067322e-11,NA,NA,NA,NA,NA
"101","Pocillopora_acuta_HIv2___RNAseq.g13582.t1",398.602250368532,-13.7711609844583,3.69699448614936,4.67851841426942e-13,6.70000894494979e-11,NA,NA,NA,NA,NA
"102","Pocillopora_acuta_HIv2___RNAseq.g14640.t1",409.087856433782,-13.7881252559652,3.70940851131495,5.16209234217881e-13,7.32004937620337e-11,"Q6V0K7",4.43e-23,"Oncoprotein-induced transcript 3 protein (Liver-specific zona pellucida domain-containing protein)","renal system process [GO:0003014]","GO:0003014; GO:0005509; GO:0005635"
"103","Pocillopora_acuta_HIv2___TS.g20007.t1",530.728095558458,-14.2635343086158,3.8537952431928,5.41220126752743e-13,7.60020185762299e-11,"P49746",0,"Thrombospondin-3","bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931]","GO:0003417; GO:0005509; GO:0005576; GO:0007160; GO:0008201; GO:0043931; GO:0048471; GO:0060346; GO:0062023"
"104","Pocillopora_acuta_HIv2___RNAseq.g30663.t1",487.435148214201,-10.6690421451935,2.09681902694566,5.88748975239777e-13,8.18813959410397e-11,"P25035",1.3e-37,"Cellular tumor antigen p53 (Tumor suppressor p53)","apoptotic process [GO:0006915]; DNA damage response [GO:0006974]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein tetramerization [GO:0051262]","GO:0000976; GO:0003700; GO:0005634; GO:0005737; GO:0005739; GO:0006915; GO:0006974; GO:0043066; GO:0045944; GO:0046872; GO:0051262; GO:0140693; GO:1990841"
"105","Pocillopora_acuta_HIv2___RNAseq.g28971.t1a",1603.2281279156,12.4836724115879,2.91505518091902,5.96341388419078e-13,8.21474461151766e-11,"Q91X17",8.41e-23,"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; calcium ion homeostasis [GO:0055074]; cellular response to unfolded protein [GO:0034620]; chaperone-mediated protein folding [GO:0061077]; chemical homeostasis [GO:0048878]; chloride ion homeostasis [GO:0055064]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; ERAD pathway [GO:0036503]; gene expression [GO:0010467]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; intracellular calcium ion homeostasis [GO:0006874]; intracellular chloride ion homeostasis [GO:0030644]; intracellular phosphate ion homeostasis [GO:0030643]; intracellular sodium ion homeostasis [GO:0006883]; juxtaglomerular apparatus development [GO:0072051]; kidney development [GO:0001822]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; loop of Henle development [GO:0072070]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; monoatomic ion homeostasis [GO:0050801]; multicellular organismal response to stress [GO:0033555]; multicellular organismal-level homeostasis [GO:0048871]; multicellular organismal-level water homeostasis [GO:0050891]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; phosphate ion homeostasis [GO:0055062]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; response to unfolded protein [GO:0006986]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; sodium ion homeostasis [GO:0055078]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918]","GO:0000922; GO:0001822; GO:0002251; GO:0003091; GO:0003094; GO:0005509; GO:0005615; GO:0005783; GO:0005886; GO:0005929; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006915; GO:0006954; GO:0006986; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008380; GO:0009410; GO:0009414; GO:0009986; GO:0010467; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0019864; GO:0030643; GO:0030644; GO:0032496; GO:0033209; GO:0033555; GO:0034620; GO:0034976; GO:0035809; GO:0036503; GO:0044861; GO:0045177; GO:0046720; GO:0048871; GO:0048878; GO:0050801; GO:0050829; GO:0050891; GO:0051223; GO:0055062; GO:0055064; GO:0055074; GO:0055075; GO:0055078; GO:0060073; GO:0060170; GO:0061077; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072070; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097709; GO:0097744; GO:0098552; GO:0140367; GO:1990266"
"106","Pocillopora_acuta_HIv2___RNAseq.g829.t1",2530.87772725239,14.3264800898888,3.30124927021753,6.45877071629718e-13,8.81317543778514e-11,"P63253",6.37e-87,"Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1) (IRK-1) (Potassium channel, inwardly rectifying subfamily J member 2)","cardiac muscle cell action potential involved in contraction [GO:0086002]; magnesium ion transport [GO:0015693]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of skeletal muscle contraction via regulation of action potential [GO:0014861]; relaxation of cardiac muscle [GO:0055119]; relaxation of skeletal muscle [GO:0090076]","GO:0005242; GO:0005546; GO:0005886; GO:0006813; GO:0008076; GO:0014861; GO:0015693; GO:0016020; GO:0034765; GO:0042802; GO:0051289; GO:0055119; GO:0060306; GO:0086002; GO:0086008; GO:0086091; GO:0090076; GO:1990573"
"107","Pocillopora_acuta_HIv2___TS.g6907.t1",2839.24667072626,-9.38615985394496,2.37136527850434,6.54535927476237e-13,8.84785762151055e-11,NA,NA,NA,NA,NA
"108","Pocillopora_acuta_HIv2___RNAseq.g2437.t1",2337.698638039,-13.2418895257597,3.00343190605414,6.96196874720066e-13,9.32388110736207e-11,"A2R9H9",2.3e-06,"Chromatin-remodeling ATPase INO80 (EC 3.6.4.-)","CENP-A containing chromatin assembly [GO:0034080]; DNA repair [GO:0006281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of TOR signaling [GO:0032006]; subtelomeric heterochromatin formation [GO:0031509]; telomere maintenance via recombination [GO:0000722]; transcription by RNA polymerase II [GO:0006366]","GO:0000722; GO:0000781; GO:0003677; GO:0005524; GO:0006281; GO:0006366; GO:0016887; GO:0031011; GO:0031509; GO:0032006; GO:0034080; GO:0043138; GO:0045944; GO:0140658"
"109","Pocillopora_acuta_HIv2___RNAseq.g19042.t1",916.621468361507,-11.477262005831,2.53057192048296,7.40883147609873e-13,9.78615132170322e-11,"Q6IWH7",0,"Anoctamin-7 (Dresden transmembrane protein of the prostate) (D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G)","calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220]","GO:0005229; GO:0005254; GO:0005783; GO:0005829; GO:0005886; GO:0034220; GO:0046983; GO:0061588; GO:0070161; GO:1902476"
"110","Pocillopora_acuta_HIv2___RNAseq.g2959.t1",461.103525953368,-11.1507652600138,2.22458646138477,7.44245468326434e-13,9.78615132170322e-11,NA,NA,NA,NA,NA
"111","Pocillopora_acuta_HIv2___RNAseq.g16527.t1",431.570197991471,-13.8144505819052,3.74241035351929,9.16031746496493e-13,1.19364713345273e-10,NA,NA,NA,NA,NA
"112","Pocillopora_acuta_HIv2___RNAseq.g25686.t1",380.659258700191,-10.8384262135432,2.16689079635747,9.75165257126585e-13,1.25935627491776e-10,"Q32PP9",2.3e-38,"Transcription factor Sox-14","brain development [GO:0007420]; hypothalamus development [GO:0021854]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0000122; GO:0000978; GO:0001228; GO:0005634; GO:0007420; GO:0021854; GO:0030182; GO:0045944"
"113","Pocillopora_acuta_HIv2___TS.g14372.t1b",364.331645999331,-13.6055957220904,3.69236471482213,9.99430138177254e-13,1.26804890513998e-10,NA,NA,NA,NA,NA
"114","Pocillopora_acuta_HIv2___RNAseq.g26783.t1",361.906669694196,-13.5999506272471,3.70105374317102,1.19319302894126e-12,1.50072556266143e-10,"Q0KHY3",1.47e-58,"Protein mesh","cell-matrix adhesion [GO:0007160]; smooth septate junction assembly [GO:0090528]","GO:0005615; GO:0005920; GO:0007160; GO:0016327; GO:0090528"
"115","Pocillopora_acuta_HIv2___RNAseq.g299.t1",382.035799448043,-13.6026371780005,3.70602855079907,1.25548226802591e-12,1.56278007698963e-10,"Q9NZJ4",0,"Sacsin (DnaJ homolog subfamily C member 29)","negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]","GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084"
"116","Pocillopora_acuta_HIv2___RNAseq.g26596.t1",503.322440157317,-13.9368775954657,3.80363453569741,1.26414041072861e-12,1.56278007698963e-10,"Q8NDA2",5.33e-26,"Hemicentin-2","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808]","GO:0005509; GO:0005576; GO:0005886; GO:0007156; GO:0008046; GO:0030424; GO:0032154; GO:0043025; GO:0050808; GO:0062023"
"117","Pocillopora_acuta_HIv2___RNAseq.g8688.t1",10616.8423315086,-8.7936115982651,2.11856206254869,1.3692962241014e-12,1.67843225300023e-10,NA,NA,NA,NA,NA
"118","Pocillopora_acuta_HIv2___RNAseq.g24649.t1",769.933878983184,-14.5027261547526,3.9021892238898,1.50698701797806e-12,1.82838690482379e-10,"Q9NZJ4",0,"Sacsin (DnaJ homolog subfamily C member 29)","negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]","GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084"
"119","Pocillopora_acuta_HIv2___RNAseq.g18982.t1",470.704900766149,-13.8779884172653,3.84294728193499,1.52157744764568e-12,1.82838690482379e-10,NA,NA,NA,NA,NA
"120","Pocillopora_acuta_HIv2___RNAseq.g2567.t1",363.961123913796,-13.5037175528493,3.67728355424626,1.52955486368694e-12,1.82838690482379e-10,"P0C7M7",9.38e-55,"Acyl-coenzyme A synthetase ACSM4, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 4)","acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]","GO:0004321; GO:0005524; GO:0005759; GO:0006633; GO:0006637; GO:0015645; GO:0046872; GO:0102391"
"121","Pocillopora_acuta_HIv2___TS.g1253.t1",528.009635951326,-13.8273597276618,3.81408051269581,1.64841749120792e-12,1.95432054039602e-10,"Q91175",1.6e-45,"Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (MAR1)","adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; cell-cell signaling [GO:0007267]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of MAPK cascade [GO:0043410]","GO:0004937; GO:0005886; GO:0007200; GO:0007204; GO:0007267; GO:0043410; GO:0071880"
"122","Pocillopora_acuta_HIv2___RNAseq.5883_t",372.245882521794,-13.5429822997793,3.69869554364732,1.77106219761105e-12,2.08265395335335e-10,"Q5RCC4",2.53e-65,"Calcium/calmodulin-dependent protein kinase type II subunit alpha (CaM kinase II subunit alpha) (CaMK-II subunit alpha) (EC 2.7.11.17)","cellular response to interferon-beta [GO:0035458]; dendritic spine development [GO:0060996]; negative regulation of hydrolase activity [GO:0051346]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of neuron migration [GO:2001222]","GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005954; GO:0014069; GO:0035458; GO:0043197; GO:0046427; GO:0046872; GO:0051346; GO:0060996; GO:0106310; GO:1990443; GO:2000124; GO:2001222"
"123","Pocillopora_acuta_HIv2___RNAseq.g3739.t1",353.363753142325,-13.6172547321152,3.72108002722477,1.96770045888225e-12,2.29522737397361e-10,NA,NA,NA,NA,NA
"124","Pocillopora_acuta_HIv2___RNAseq.g15990.t1",372.608312007925,-13.5994791984925,3.72220503393831,1.98515855063304e-12,2.2970666621085e-10,NA,NA,NA,NA,NA
"125","Pocillopora_acuta_HIv2___RNAseq.g26586.t1",381.247139568541,-13.7468056008106,3.76496147885094,2.01677859548392e-12,2.3151337781809e-10,"Q7TM99",4.51e-38,"Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9)","carnitine transmembrane transport [GO:1902603]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]; urate metabolic process [GO:0046415]","GO:0005308; GO:0005886; GO:0008028; GO:0015226; GO:0015718; GO:0015881; GO:0046415; GO:1902603"
"126","Pocillopora_acuta_HIv2___RNAseq.g13044.t1",735.671212256975,-11.5629589999316,2.62249052307267,2.43220555764648e-12,2.77003316423612e-10,"Q9UGM3",2.37e-79,"Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)","defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031]","GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062"
"127","Pocillopora_acuta_HIv2___RNAseq.g30675.t1",961.143021798293,9.70737332231069,2.11231759042649,2.81128171153389e-12,3.15325120463904e-10,"P32029",5.44e-27,"Fork head domain-containing protein FD5","anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009653; GO:0030154"
"128","Pocillopora_acuta_HIv2___RNAseq.g10988.t1",1437.01770911377,-12.3304213075196,2.88742138115584,2.8195805311193e-12,3.15325120463904e-10,NA,NA,NA,NA,NA
"129","Pocillopora_acuta_HIv2___RNAseq.11917_t",416.64625142896,-13.6001172865798,3.78170396039298,2.83408916346152e-12,3.15325120463904e-10,"Q805E5",1.13e-45,"Carbohydrate sulfotransferase 14 (EC 2.8.2.-) (Dermatan 4-sulfotransferase 1) (D4ST-1) (zD4ST-1)","carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate proteoglycan metabolic process [GO:0050655]","GO:0000139; GO:0001537; GO:0008146; GO:0016051; GO:0050655"
"130","Pocillopora_acuta_HIv2___RNAseq.g10339.t1",392.049430458694,-13.6104233739039,3.7681507542242,2.97399138268922e-12,3.28364972207763e-10,"Q32ZE2",1.08e-33,"Adenosine receptor A2b","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cGMP-mediated signaling [GO:0019934]; mast cell degranulation [GO:0043303]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemokine production [GO:0032722]; positive regulation of chronic inflammatory response to non-antigenic stimulus [GO:0002882]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of vascular endothelial growth factor production [GO:0010575]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; relaxation of vascular associated smooth muscle [GO:0060087]","GO:0001609; GO:0002882; GO:0005886; GO:0007189; GO:0010575; GO:0010753; GO:0019934; GO:0032722; GO:0032755; GO:0043303; GO:0043306; GO:0060087; GO:0098685; GO:0098793; GO:0098978; GO:0099171"
"131","Pocillopora_acuta_HIv2___RNAseq.g5003.t1",327.196984667357,-13.431157330553,3.70387147691152,3.00007462134013e-12,3.28735449417149e-10,NA,NA,NA,NA,NA
"132","Pocillopora_acuta_HIv2___RNAseq.g15838.t1",947.248888807,-1.01461325178895,1.90474686115853,3.10063744832533e-12,3.3720015077126e-10,"A0JP86",5.07e-08,"Laminin subunit gamma-1","cell adhesion [GO:0007155]","GO:0005576; GO:0005604; GO:0007155"
"133","Pocillopora_acuta_HIv2___RNAseq.g22261.t1",1251.45084902703,15.9238331848865,4.19119276665777,3.16396184787707e-12,3.40818088944317e-10,"B3EWY8",1.14e-104,"Skeletal aspartic acid-rich protein 2","","GO:0016020"
"134","Pocillopora_acuta_HIv2___TS.g5308.t2",759.035885685081,12.4310654655339,3.01233472419247,3.18103166534035e-12,3.40818088944317e-10,"Q9VBW3",7.83e-67,"Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303"
"135","Pocillopora_acuta_HIv2___RNAseq.g26798.t1",364.94746280198,-13.4911543311833,3.71989483017572,3.27342255074669e-12,3.48138115985295e-10,NA,NA,NA,NA,NA
"136","Pocillopora_acuta_HIv2___RNAseq.g29539.t1",4459.14029207164,-10.1825247936247,4.40508550940885,3.35183545493173e-12,3.53875532993668e-10,NA,NA,NA,NA,NA
"137","Pocillopora_acuta_HIv2___RNAseq.g2220.t1",4540.85774542795,-8.54374371152647,2.11842028354186,3.43146188621997e-12,3.596569907412e-10,NA,NA,NA,NA,NA
"138","Pocillopora_acuta_HIv2___RNAseq.g4369.t1",689.301300641021,-9.45232308526084,2.1061942528058,3.51028570943061e-12,3.64409775583172e-10,"O75096",0,"Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)","amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395"
"139","Pocillopora_acuta_HIv2___RNAseq.g14366.t1",250.602068410561,13.3452216370358,3.5373604361707,3.52719638977075e-12,3.64409775583172e-10,"Q5RFW0",7.91e-07,"Scavenger receptor class A member 5","endocytosis [GO:0006897]; intracellular iron ion homeostasis [GO:0006879]; iron ion transmembrane transport [GO:0034755]; protein homotrimerization [GO:0070207]","GO:0005886; GO:0006879; GO:0006897; GO:0034755; GO:0070207; GO:0070287"
"140","Pocillopora_acuta_HIv2___RNAseq.g14347.t1",3739.22928222091,9.62610416816493,2.39824238395586,3.7544566919172e-12,3.851380254744e-10,"A2AX52",3.5e-14,"Collagen alpha-4(VI) chain","cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]","GO:0005518; GO:0005576; GO:0005581; GO:0007155; GO:0030198; GO:0031012; GO:0032991; GO:0062023"
"141","Pocillopora_acuta_HIv2___RNAseq.g2995.t1",1190.36858098257,-12.3930355481766,2.90788893515022,3.85585455175971e-12,3.92754086173609e-10,"Q90Z12",2.22e-42,"Transcription factor HES-4-A (Hairy and enhancer of split 4-A) (Protein hairy-2) (Xhairy2) (Protein hairy-2a) (Xhairy2a)","BMP signaling pathway [GO:0030509]; floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest formation [GO:0014029]; prechordal plate formation [GO:0021501]","GO:0000122; GO:0002088; GO:0005634; GO:0014029; GO:0021501; GO:0030509; GO:0033504; GO:0043066; GO:0043425; GO:0043565; GO:0045892; GO:0046983"
"142","Pocillopora_acuta_HIv2___RNAseq.g16699.t1",328.73878308999,-13.4918076891221,3.75157874430389,4.39235012214043e-12,4.41187167823883e-10,"P19440",5.01e-149,"Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]","amino acid metabolic process [GO:0006520]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638]","GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006691; GO:0006750; GO:0006751; GO:0007283; GO:0019344; GO:0031179; GO:0031638; GO:0036374; GO:0050727; GO:0070062; GO:0103068; GO:1901750"
"143","Pocillopora_acuta_HIv2___RNAseq.g26267.t1",338.990367495423,-13.4165757048994,3.72881320207358,4.5620349699133e-12,4.55070853826386e-10,"Q3MHX6",1.06e-31,"Protein OS-9","endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; protein retention in ER lumen [GO:0006621]; response to endoplasmic reticulum stress [GO:0034976]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005788; GO:0006511; GO:0006621; GO:0030246; GO:0030968; GO:0030970; GO:0034976; GO:0036503"
"144","Pocillopora_acuta_HIv2___RNAseq.g16486.t1",2676.39145640268,-13.4145832238622,3.22927861299136,4.89675133548287e-12,4.85113776139892e-10,"B3EWY9",3.19e-114,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020"
"145","Pocillopora_acuta_HIv2___RNAseq.g7678.t1",349.961710497645,-13.5161483246751,3.75407966505785,5.0853008064697e-12,5.00365924250189e-10,"Q60631",4.98e-85,"Growth factor receptor-bound protein 2 (Adapter protein GRB2) (SH2/SH3 adapter GRB2)","actin cytoskeleton organization [GO:0030036]; anatomical structure formation involved in morphogenesis [GO:0048646]; B cell receptor signaling pathway [GO:0050853]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cellular response to ionizing radiation [GO:0071479]; endodermal cell differentiation [GO:0035987]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2-ERBB3 signaling pathway [GO:0038133]; fibroblast growth factor receptor signaling pathway [GO:0008543]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; myelination [GO:0042552]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; Schwann cell development [GO:0014044]; signal transduction [GO:0007165]; signal transduction in response to DNA damage [GO:0042770]","GO:0001784; GO:0005068; GO:0005091; GO:0005154; GO:0005168; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005768; GO:0005794; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0007165; GO:0007173; GO:0007265; GO:0008180; GO:0008286; GO:0008543; GO:0012506; GO:0014044; GO:0016020; GO:0017124; GO:0019899; GO:0019903; GO:0019904; GO:0030036; GO:0030674; GO:0030838; GO:0031623; GO:0032991; GO:0035987; GO:0038133; GO:0042552; GO:0042770; GO:0042802; GO:0043408; GO:0043560; GO:0044877; GO:0046875; GO:0048009; GO:0048646; GO:0050853; GO:0051219; GO:0060090; GO:0060670; GO:0070436; GO:0071479; GO:2000379"
"146","Pocillopora_acuta_HIv2___RNAseq.g13102.t1",1328.68064326278,12.6365099275022,3.30125945914911,5.34917159732321e-12,5.22773094484344e-10,NA,NA,NA,NA,NA
"147","Pocillopora_acuta_HIv2___RNAseq.g21444.t1",338.570538120978,-13.3295976024447,3.71289780681284,5.40155381342314e-12,5.24349492331223e-10,NA,NA,NA,NA,NA
"148","Pocillopora_acuta_HIv2___RNAseq.g14763.t1",411.149002352806,-13.5681467270309,3.79130546629572,6.55775172319948e-12,6.32342139495715e-10,"Q90YK3",8.96e-06,"L-gulonolactone oxidase (LGO) (EC 1.1.3.8) (L-gulono-gamma-lactone oxidase) (GLO)","L-ascorbic acid biosynthetic process [GO:0019853]","GO:0003885; GO:0005789; GO:0019853; GO:0050105; GO:0050660; GO:0071949"
"149","Pocillopora_acuta_HIv2___RNAseq.g4770.t1",383.96335456763,-13.4647952974886,3.80366863764477,7.43305647491364e-12,7.07314005612835e-10,"Q8TE73",0,"Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5)","cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158]","GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097728; GO:0097729"
"150","Pocillopora_acuta_HIv2___RNAseq.g17965.t1",339.145514157385,-13.1858787356913,3.69536164384396,7.52016729958653e-12,7.10539299022564e-10,"O02824",5.16e-62,"Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor)","adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adult heart development [GO:0007512]; cell growth involved in cardiac muscle cell development [GO:0061049]; MAPK cascade [GO:0000165]; negative regulation of autophagy [GO:0010507]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; positive regulation of vasoconstriction [GO:0045907]; regulation of cardiac muscle contraction [GO:0055117]","GO:0000165; GO:0001985; GO:0001994; GO:0001996; GO:0001997; GO:0004937; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005901; GO:0007200; GO:0007204; GO:0007512; GO:0010507; GO:0010613; GO:0031965; GO:0043410; GO:0045907; GO:0045987; GO:0046982; GO:0055117; GO:0061049; GO:0071880; GO:0097195; GO:0150099"
"151","Pocillopora_acuta_HIv2___RNAseq.g21169.t1",384.726198752394,-13.5212108355061,3.78236243477297,7.56519994811082e-12,7.10539299022564e-10,"P79218",7.24e-24,"Substance-K receptor (SKR) (NK-2 receptor) (NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2)","positive regulation of flagellated sperm motility [GO:1902093]; regulation of uterine smooth muscle contraction [GO:0070472]","GO:0005886; GO:0016497; GO:0061827; GO:0070472; GO:0097225; GO:1902093"
"152","Pocillopora_acuta_HIv2___TS.g1310.t1",377.334204249079,-13.4490588457573,3.75321780810974,7.70463151572859e-12,7.18966388667731e-10,NA,NA,NA,NA,NA
"153","Pocillopora_acuta_HIv2___RNAseq.g9466.t1",3868.10737894307,-8.73779242586273,5.46350065581124,7.82097272152185e-12,7.25144547718539e-10,"Q6RI86",1.07e-142,"Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor)","calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to caffeine [GO:0071313]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of monoatomic anion transport [GO:1903793]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832]","GO:0005216; GO:0005245; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014070; GO:0014832; GO:0015267; GO:0015278; GO:0016324; GO:0019233; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042542; GO:0042802; GO:0046872; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0050974; GO:0051289; GO:0070301; GO:0070417; GO:0070588; GO:0071244; GO:0071313; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1990760"
"154","Pocillopora_acuta_HIv2___RNAseq.g14817.t1",308.277930305083,-13.218221034609,3.68839112203118,8.2240820512859e-12,7.49052939614694e-10,"E7F6F9",7.72e-39,"Kelch-like protein 3","distal tubule morphogenesis [GO:0072156]; monoatomic ion homeostasis [GO:0050801]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; renal sodium ion absorption [GO:0070294]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0003779; GO:0005829; GO:0005856; GO:0006511; GO:0016567; GO:0031463; GO:0050801; GO:0070294; GO:0070936; GO:0072156; GO:1990756"
"155","Pocillopora_acuta_HIv2___RNAseq.g29834.t1",364.43583865093,-13.3533766234616,3.74844004369742,8.23419644626219e-12,7.49052939614694e-10,NA,NA,NA,NA,NA
"156","Pocillopora_acuta_HIv2___RNAseq.g17943.t1",393.527067993985,-13.6987650046603,3.82930416674791,8.61004841412957e-12,7.78348376637313e-10,NA,NA,NA,NA,NA
"157","Pocillopora_acuta_HIv2___RNAseq.g14014.t1",1371.2473120555,-10.1938825601781,2.60695589672664,9.42563316064238e-12,8.44446199117777e-10,"G8HTB6",1.54e-16,"ZP domain-containing protein","","GO:0016020"
"158","Pocillopora_acuta_HIv2___RNAseq.g15827.t1",2147.21458205249,-12.8929478504619,3.17571594029191,9.45798425449943e-12,8.44446199117777e-10,NA,NA,NA,NA,NA
"159","Pocillopora_acuta_HIv2___RNAseq.g28815.t1",448.847439035537,-13.5182617835901,3.83568638430077,9.60331015892504e-12,8.52161215574796e-10,"Q5R4J5",7.65e-31,"Synaptotagmin-1 (Synaptotagmin I) (SytI)","calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903235]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]","GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0019905; GO:0030154; GO:0030276; GO:0030424; GO:0030672; GO:0031045; GO:0042584; GO:0048488; GO:0048791; GO:0071277; GO:1903235"
"160","Pocillopora_acuta_HIv2___RNAseq.g3653.t1",1313.49523169237,-12.3179792384906,3.02749038011501,1.00487127143437e-11,8.86247443294316e-10,"P29145",1.58e-161,"PC3-like endoprotease variant B (EC 3.4.21.-) (SPC3)","proteolysis [GO:0006508]","GO:0004252; GO:0006508"
"161","Pocillopora_acuta_HIv2___RNAseq.g30781.t1",4420.15094556839,-5.24816191003824,0.917675157972243,1.04425575659736e-11,9.14953956125453e-10,NA,NA,NA,NA,NA
"162","Pocillopora_acuta_HIv2___RNAseq.g22605.t1",3203.60822977716,-13.6487275012174,3.38471797585897,1.05007160340725e-11,9.14953956125453e-10,"G8HTB6",6.89e-38,"ZP domain-containing protein","","GO:0016020"
"163","Pocillopora_acuta_HIv2___RNAseq.g17429.t1",270.985949703192,-13.0546814356321,3.6395904438308,1.12366497921259e-11,9.64939971728847e-10,NA,NA,NA,NA,NA
"164","Pocillopora_acuta_HIv2___RNAseq.g20365.t1",286.998914749484,-13.1149862893431,3.66633168043707,1.12745336851614e-11,9.64939971728847e-10,NA,NA,NA,NA,NA
"165","Pocillopora_acuta_HIv2___RNAseq.5910_t",434.904133567734,-10.9751399221779,2.46249783799018,1.15729431491084e-11,9.84653233580614e-10,"G8HTB6",3.21e-12,"ZP domain-containing protein","","GO:0016020"
"166","Pocillopora_acuta_HIv2___RNAseq.g7692.t1",381.610015450429,-13.3302368490409,3.77591975616354,1.18186776021989e-11,9.99680425954418e-10,"O09118",0,"Netrin-1","animal organ morphogenesis [GO:0009887]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; Cdc42 protein signal transduction [GO:0032488]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; dendrite development [GO:0016358]; glial cell proliferation [GO:0014009]; inner ear morphogenesis [GO:0042472]; mammary gland development [GO:0030879]; mammary gland duct morphogenesis [GO:0060603]; motor neuron axon guidance [GO:0008045]; motor neuron migration [GO:0097475]; negative regulation of axon extension [GO:0030517]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of glial cell proliferation [GO:0060252]; Ras protein signal transduction [GO:0007265]; regulation of cell migration [GO:0030334]; regulation of glial cell migration [GO:1903975]; regulation of synapse assembly [GO:0051963]; substrate-dependent cell migration, cell extension [GO:0006930]; tissue development [GO:0009888]","GO:0001764; GO:0005576; GO:0005604; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0006930; GO:0007097; GO:0007265; GO:0007409; GO:0007411; GO:0008045; GO:0008283; GO:0009887; GO:0009888; GO:0014009; GO:0015629; GO:0016358; GO:0030334; GO:0030517; GO:0030879; GO:0032488; GO:0033564; GO:0042472; GO:0045202; GO:0045773; GO:0051963; GO:0060252; GO:0060603; GO:0061643; GO:0062023; GO:0071944; GO:0097475; GO:0098609; GO:0098978; GO:1903975; GO:2000147"
"167","Pocillopora_acuta_HIv2___RNAseq.g18342.t1",1995.30398268793,-12.515968457083,3.11655590449696,1.28261023748201e-11,1.07858572528719e-09,NA,NA,NA,NA,NA
"168","Pocillopora_acuta_HIv2___RNAseq.g31286.t1c",336.709257994196,-13.2592061896841,3.76835901605392,1.31932992464255e-11,1.1030513312156e-09,"B8VIU6",2.62e-24,"Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","","GO:0005576"
"169","Pocillopora_acuta_HIv2___TS.g27807.t1",791.766086285611,-1.01248086185269,1.8634243776278,1.38961734597492e-11,1.15513938460812e-09,"Q86UK0",0,"Glucosylceramide transporter ABCA12 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 12) (ATP-binding cassette transporter 12) (ATP-binding cassette 12)","cellular homeostasis [GO:0019725]; ceramide metabolic process [GO:0006672]; ceramide transport [GO:0035627]; cholesterol efflux [GO:0033344]; corneocyte desquamation [GO:0003336]; establishment of skin barrier [GO:0061436]; intracellular protein transport [GO:0006886]; keratinization [GO:0031424]; lipid homeostasis [GO:0055088]; lipid transport [GO:0006869]; lung alveolus development [GO:0048286]; phospholipid efflux [GO:0033700]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of intracellular lipid transport [GO:0032379]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to plasma membrane [GO:0072659]; regulated exocytosis [GO:0045055]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of keratinocyte differentiation [GO:0045616]; secretion by cell [GO:0032940]; surfactant homeostasis [GO:0043129]","GO:0000139; GO:0003336; GO:0005102; GO:0005319; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006672; GO:0006869; GO:0006886; GO:0010875; GO:0016020; GO:0016887; GO:0019725; GO:0030658; GO:0031424; GO:0032379; GO:0032940; GO:0033344; GO:0033700; GO:0034040; GO:0034191; GO:0035627; GO:0042626; GO:0043129; GO:0043231; GO:0045055; GO:0045616; GO:0048286; GO:0055088; GO:0061178; GO:0061436; GO:0072659; GO:0097209; GO:0097234; GO:0140326; GO:0140359; GO:2000010"
"170","Pocillopora_acuta_HIv2___RNAseq.g21255.t1",942.435162478306,11.9977776422186,4.13531308294035,1.52016438727021e-11,1.25643758271293e-09,NA,NA,NA,NA,NA
"171","Pocillopora_acuta_HIv2___RNAseq.g30046.t1",2980.31198903644,8.58192239268404,5.69786410913527,1.70561786471129e-11,1.40170777245364e-09,NA,NA,NA,NA,NA
"172","Pocillopora_acuta_HIv2___RNAseq.g13339.t1",286.202190123045,-13.0752016237068,3.70180576055785,1.73297011992547e-11,1.41614010251989e-09,"P86854",1.96e-20,"Perlucin-like protein","","GO:0005576; GO:0030246; GO:0038023"
"173","Pocillopora_acuta_HIv2___TS.g26248.t1",501.539228602979,-14.0001178479833,3.89944480630589,1.74753828785877e-11,1.42002212334771e-09,NA,NA,NA,NA,NA
"174","Pocillopora_acuta_HIv2___TS.g29848.t1",292.521544072173,-13.0607821173317,3.68225864085331,1.78120612468082e-11,1.43929415571975e-09,"O77775",5.75e-29,"Neutrophil cytosol factor 2 (NCF-2) (67 kDa neutrophil oxidase factor) (Neutrophil NADPH oxidase factor 2) (p67-phox)","phagocytosis [GO:0006909]; respiratory burst [GO:0045730]; superoxide anion generation [GO:0042554]","GO:0005737; GO:0006909; GO:0016176; GO:0042554; GO:0043020; GO:0045730"
"175","Pocillopora_acuta_HIv2___TS.g28126.t1",1512.9378096092,12.929109809701,3.46196080968917,1.85049746227984e-11,1.48075276254721e-09,NA,NA,NA,NA,NA
"176","Pocillopora_acuta_HIv2___RNAseq.g11198.t1",3305.3903417023,-8.71181109307375,2.91403028439554,1.85298845423843e-11,1.48075276254721e-09,NA,NA,NA,NA,NA
"177","Pocillopora_acuta_HIv2___TS.g16172.t3",491.815198073264,-10.5417770706884,2.39237961317866,2.0601320371816e-11,1.63723899921949e-09,"Q05973",0,"Sodium channel protein 1 brain (Sodium channel protein I brain)","membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]","GO:0001518; GO:0005248; GO:0019228; GO:0086010"
"178","Pocillopora_acuta_HIv2___TS.7324_t",804.567793162316,12.3187461670855,3.19161668112553,2.1318096769364e-11,1.68494509110427e-09,"Q9W7E8",1.48e-11,"Homeobox protein koza (Homeodomain transcription factor koza)","positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]","GO:0000981; GO:0003677; GO:0005634; GO:0042127; GO:0045944"
"179","Pocillopora_acuta_HIv2___RNAseq.g25168.t1",347.73098464024,-13.5180508936186,3.81570196783257,2.27515249060421e-11,1.78846769696192e-09,"Q9DAJ5",9.74e-37,"Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic)","microtubule-based movement [GO:0007018]","GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045505"
"180","Pocillopora_acuta_HIv2___RNAseq.g16.t1",248.537159781759,-12.941189554276,3.65489283386847,2.31325997074287e-11,1.80859417388242e-09,"Q61006",2.7e-08,"Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor)","cell differentiation [GO:0030154]; enzyme-linked receptor protein signaling pathway [GO:0007167]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; motor neuron apoptotic process [GO:0097049]; negative regulation of gene expression [GO:0010629]; neuromuscular junction development [GO:0007528]; positive regulation of gene expression [GO:0010628]; positive regulation of motor neuron apoptotic process [GO:2000673]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; receptor clustering [GO:0043113]; regulation of DNA-templated transcription [GO:0006355]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; response to electrical stimulus [GO:0051602]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]","GO:0001934; GO:0004713; GO:0004714; GO:0005524; GO:0005886; GO:0006355; GO:0007167; GO:0007528; GO:0007613; GO:0008582; GO:0009897; GO:0010628; GO:0010629; GO:0010976; GO:0016020; GO:0017147; GO:0019901; GO:0030154; GO:0030165; GO:0031594; GO:0032224; GO:0035022; GO:0042995; GO:0043113; GO:0043235; GO:0045202; GO:0045211; GO:0045887; GO:0046872; GO:0050731; GO:0051602; GO:0051897; GO:0060291; GO:0071340; GO:0097049; GO:1904395; GO:2000541; GO:2000673"
"181","Pocillopora_acuta_HIv2___RNAseq.g13056.t1",308.242236055202,-13.1119054455891,3.72751713165122,2.38265441140611e-11,1.85283405411709e-09,"Q18775",7.71e-07,"Dopamine receptor 4","adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]","GO:0004952; GO:0004993; GO:0005886; GO:0007186; GO:0007187; GO:0007191; GO:0007268; GO:0030425; GO:0030594; GO:0045211"
"182","Pocillopora_acuta_HIv2___RNAseq.g27458.t1",269.761135860062,-13.149861912594,3.72519649228952,2.45773993620828e-11,1.8824120161527e-09,NA,NA,NA,NA,NA
"183","Pocillopora_acuta_HIv2___RNAseq.g24787.t1",282.087472281966,-13.1712934420179,3.74422798977434,2.66492031568301e-11,2.01832501130311e-09,"E7FAM5",1.26e-34,"E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177"
"184","Pocillopora_acuta_HIv2___RNAseq.g1516.t1",374.092272868744,-10.7121035510984,2.42965050078765,2.66523836531315e-11,2.01832501130311e-09,NA,NA,NA,NA,NA
"185","Pocillopora_acuta_HIv2___TS.g12860.t1",867.113858485982,12.4403039108797,3.30036394282147,2.70427808495563e-11,2.03722282399991e-09,"Q801S8",1.54e-10,"Collagen alpha-1(VI) chain","cell adhesion [GO:0007155]","GO:0005576; GO:0005581; GO:0007155; GO:0062023"
"186","Pocillopora_acuta_HIv2___RNAseq.g10896.t1",275.587057410985,-13.0556060478084,3.70975016570992,2.8014795762423e-11,2.09951298397765e-09,"Q6XD76",1.39e-17,"Achaete-scute homolog 4 (ASH-4) (hASH4) (Achaete-scute-like protein 4) (Class A basic helix-loop-helix protein 44) (bHLHa44)","regulation of transcription by RNA polymerase II [GO:0006357]; skin development [GO:0043588]","GO:0000785; GO:0000977; GO:0000981; GO:0006357; GO:0043588; GO:0046983; GO:0090575"
"187","Pocillopora_acuta_HIv2___RNAseq.g9054.t1",818.346861337894,11.9534081435043,3.18660283846916,3.16059073926246e-11,2.35643218828311e-09,"Q68CP4",2.88e-135,"Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76)","heparan sulfate proteoglycan catabolic process [GO:0030200]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259]","GO:0005765; GO:0005886; GO:0007041; GO:0015019; GO:0016746; GO:0030200; GO:0035579; GO:0043202; GO:0051259; GO:0070821"
"188","Pocillopora_acuta_HIv2___TS.g9777.t1",344.16556752033,-13.5056745429223,3.83307147870221,3.20959585223291e-11,2.37049281344524e-09,"Q29RU2",4.18e-35,"Oncoprotein-induced transcript 3 protein","","GO:0005509; GO:0005635"
"189","Pocillopora_acuta_HIv2___RNAseq.g10991.t1",264.602602943548,-13.0756229962782,3.71776322394298,3.23371465413371e-11,2.37049281344524e-09,"Q9UGM3",6.87e-86,"Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)","defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031]","GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062"
"190","Pocillopora_acuta_HIv2___RNAseq.g30235.t1",499.633037389693,11.6857740726603,2.85719912699997,3.24279837407293e-11,2.37049281344524e-09,"P55115",1.2e-54,"Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15)","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"191","Pocillopora_acuta_HIv2___RNAseq.g14358.t1",241.294677966493,13.3659725169819,3.63375610374475,3.2450053723877e-11,2.37049281344524e-09,NA,NA,NA,NA,NA
"192","Pocillopora_acuta_HIv2___RNAseq.g22572.t1",587.18442038473,9.22779492786164,2.46277583642893,3.33020819608899e-11,2.40959196312831e-09,"P55115",9.29e-54,"Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15)","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"193","Pocillopora_acuta_HIv2___RNAseq.g14871.t1",360.811884576937,-7.61355623089259,1.46860722141223,3.33184729414865e-11,2.40959196312831e-09,"P48442",1.34e-110,"Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; bile acid secretion [GO:0032782]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion import [GO:0070509]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to peptide [GO:1901653]; cellular response to vitamin D [GO:0071305]; chloride transmembrane transport [GO:1902476]; detection of calcium ion [GO:0005513]; fat pad development [GO:0060613]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular calcium ion homeostasis [GO:0006874]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of vasoconstriction [GO:0045907]; regulation of calcium ion transport [GO:0051924]; regulation of presynaptic membrane potential [GO:0099505]; response to calcium ion [GO:0051592]; response to fibroblast growth factor [GO:0071774]; response to ischemia [GO:0002931]; response to metal ion [GO:0010038]; response to organic cyclic compound [GO:0014070]; vasodilation [GO:0042311]","GO:0001503; GO:0002931; GO:0004930; GO:0005178; GO:0005509; GO:0005513; GO:0005886; GO:0006874; GO:0007186; GO:0007193; GO:0007200; GO:0007254; GO:0008284; GO:0009986; GO:0010038; GO:0010628; GO:0014070; GO:0016323; GO:0016324; GO:0016597; GO:0019901; GO:0030424; GO:0032024; GO:0032782; GO:0035729; GO:0042311; GO:0042734; GO:0042803; GO:0043025; GO:0043679; GO:0044325; GO:0045907; GO:0048754; GO:0050927; GO:0051592; GO:0051924; GO:0060613; GO:0070374; GO:0070509; GO:0071305; GO:0071333; GO:0071404; GO:0071456; GO:0071774; GO:0090280; GO:0098978; GO:0099505; GO:1901653; GO:1902476"
"194","Pocillopora_acuta_HIv2___TS.g902.t1",264.583491307625,-12.9322149676017,3.6925145543724,3.6558928661117e-11,2.61776407997226e-09,NA,NA,NA,NA,NA
"195","Pocillopora_acuta_HIv2___RNAseq.g3322.t1",1641.02979850087,-12.6389455914522,3.22039851712137,3.69024257393347e-11,2.62934328026472e-09,"Q98879",1.66e-38,"Homeobox protein Dlx4a (DLX-8) (Distal-less homeobox protein 4a)","cell differentiation [GO:0030154]; chordate embryonic development [GO:0043009]; embryonic morphogenesis [GO:0048598]; negative regulation of transcription by RNA polymerase II [GO:0000122]","GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0030154; GO:0043009; GO:0048598"
"196","Pocillopora_acuta_HIv2___TS.g12050.t1",195.857715805126,12.9757844228997,3.53976545615581,3.81866214485704e-11,2.70638762235619e-09,NA,NA,NA,NA,NA
"197","Pocillopora_acuta_HIv2___RNAseq.g14348.t1",242.989419613007,-12.9275976953571,3.70018387765334,4.03292793337771e-11,2.80734731334184e-09,"A2AX52",1.61e-13,"Collagen alpha-4(VI) chain","cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]","GO:0005518; GO:0005576; GO:0005581; GO:0007155; GO:0030198; GO:0031012; GO:0032991; GO:0062023"
"198","Pocillopora_acuta_HIv2___RNAseq.g1018.t1",314.664717169831,-13.1724224363217,3.7988285101334,4.03711449927477e-11,2.80734731334184e-09,"Q0VA40",2.36e-89,"Transcription factor Sp9","","GO:0003677; GO:0005634; GO:0046872"
"199","Pocillopora_acuta_HIv2___TS.g28528.t1a",661.572430165367,11.4279085420748,2.93074603990777,4.11538105130205e-11,2.84807997732215e-09,"Q9UBG0",1.2e-39,"C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280)","collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]; osteoblast differentiation [GO:0001649]","GO:0001649; GO:0005518; GO:0005925; GO:0006897; GO:0016020; GO:0030246; GO:0030574; GO:0038023"
"200","Pocillopora_acuta_HIv2___RNAseq.g5325.t1",1851.39599504816,-12.8550773806347,3.31550965872661,4.22128980725287e-11,2.88672720218757e-09,NA,NA,NA,NA,NA
"201","Pocillopora_acuta_HIv2___RNAseq.g6468.t1",936.242664635455,-9.40702038798822,2.8133157124525,4.22716237295165e-11,2.88672720218757e-09,"P11617",5.42e-18,"Adenosine receptor A2a","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic signaling pathway [GO:0097190]; eating behavior [GO:0042755]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of inflammatory response [GO:0050728]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; response to amphetamine [GO:0001975]; response to purine-containing compound [GO:0014074]; synaptic transmission, dopaminergic [GO:0001963]","GO:0001609; GO:0001963; GO:0001973; GO:0001975; GO:0005516; GO:0005886; GO:0007189; GO:0007626; GO:0008289; GO:0014074; GO:0019899; GO:0032230; GO:0042755; GO:0042802; GO:0046636; GO:0050728; GO:0060080; GO:0097190; GO:0098794; GO:2001235"
"202","Pocillopora_acuta_HIv2___RNAseq.g14932.t2",321.144066743527,-13.2779203617806,3.81869379185273,4.23984293854962e-11,2.88672720218757e-09,"P0C6Y7",5.95e-49,"Histone-lysine N-methyltransferase PRDM9 (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361)","chromatin remodeling [GO:0006338]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiosis I [GO:0007127]; meiotic gene conversion [GO:0006311]; methylation [GO:0032259]; negative regulation of apoptotic process [GO:0043066]; positive regulation of fertilization [GO:1905516]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]","GO:0000785; GO:0000976; GO:0005634; GO:0006311; GO:0006338; GO:0007127; GO:0007129; GO:0007283; GO:0007292; GO:0008270; GO:0010468; GO:0010844; GO:0010845; GO:0032259; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0045944; GO:0046975; GO:0048232; GO:0060903; GO:0140941; GO:0140944; GO:0140949; GO:0140955; GO:0140999; GO:1905516; GO:1990918"
"203","Pocillopora_acuta_HIv2___RNAseq.g3439.t1",237.035201069787,-12.7778919950398,3.63442803291475,4.25105706627456e-11,2.88672720218757e-09,NA,NA,NA,NA,NA
"204","Pocillopora_acuta_HIv2___RNAseq.g23400.t1",225.381549575393,-12.7754171075021,3.63715132629186,4.41296876679854e-11,2.98267197397075e-09,NA,NA,NA,NA,NA
"205","Pocillopora_acuta_HIv2___RNAseq.g15331.t1",302.46734295645,-10.2834288132364,2.32218836913525,4.57076232062692e-11,3.07495377700222e-09,"Q03046",1.06e-18,"Isopenicillin N epimerase (EC 5.1.1.17)","antibiotic biosynthetic process [GO:0017000]","GO:0017000; GO:0045439"
"206","Pocillopora_acuta_HIv2___RNAseq.g7759.t1",254.520370342243,-12.9615533283529,3.70946871434442,4.80593017794302e-11,3.19003810822651e-09,"Q9WYX8",2e-50,"Uncharacterized protein TM_0508","DNA recombination [GO:0006310]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]","GO:0000731; GO:0003677; GO:0005524; GO:0006261; GO:0006310; GO:0008047; GO:0009378; GO:0016887; GO:0017116"
"207","Pocillopora_acuta_HIv2___TS.g13571.t1",264.733380063895,-13.0135690311161,3.76290348502399,4.81171928922072e-11,3.19003810822651e-09,"Q7RTR2",5.88e-31,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223"
"208","Pocillopora_acuta_HIv2___RNAseq.g8685.t1",253.737824638808,-12.7850677831587,3.66046065003153,4.83004940335735e-11,3.19003810822651e-09,NA,NA,NA,NA,NA
"209","Pocillopora_acuta_HIv2___RNAseq.g21265.t1",347.296729007003,-13.0248147039231,3.78225795300218,4.91411173069454e-11,3.23080509421663e-09,"Q9N126",8.65e-67,"Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase)","estrogen biosynthetic process [GO:0006703]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]","GO:0004303; GO:0004745; GO:0005829; GO:0006703; GO:0007601; GO:0042572; GO:0042622; GO:0052650"
"210","Pocillopora_acuta_HIv2___RNAseq.g28641.t1",1378.32284485933,-12.2884281415432,3.25269787550324,5.09867096218379e-11,3.3369763256573e-09,"P31851",1.07e-85,"Protein TabA","lysine biosynthetic process via diaminopimelate [GO:0009089]","GO:0008836; GO:0009089"
"211","Pocillopora_acuta_HIv2___RNAseq.g26781.t1",215.555654916289,-12.6978574580073,3.60943071652707,5.21173587461858e-11,3.39561025632807e-09,NA,NA,NA,NA,NA
"212","Pocillopora_acuta_HIv2___TS.g25577.t1a",635.713658056637,-14.4221066454453,4.02854215022082,5.42866434152301e-11,3.50703454471285e-09,NA,NA,NA,NA,NA
"213","Pocillopora_acuta_HIv2___RNAseq.g18273.t1",936.232722120782,-11.9192591881192,2.97944918262866,5.4312481887146e-11,3.50703454471285e-09,"Q8IS64",0,"Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-)","proteolysis [GO:0006508]","GO:0004175; GO:0004222; GO:0005886; GO:0006508; GO:0008270"
"214","Pocillopora_acuta_HIv2___RNAseq.g1841.t1",225.001535912449,-12.8329853634268,3.66747654655616,5.47868569842343e-11,3.52194266408873e-09,"Q8N3E9",8.21e-102,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-3) (Phospholipase C-delta-3) (PLC-delta-3)","angiogenesis [GO:0001525]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipid catabolic process [GO:0016042]; regulation of cell population proliferation [GO:0042127]","GO:0001525; GO:0004435; GO:0005654; GO:0005737; GO:0005886; GO:0016042; GO:0032154; GO:0035556; GO:0042127; GO:0046872; GO:0060716"
"215","Pocillopora_acuta_HIv2___RNAseq.g25839.t1",417.103348683199,-13.4598536536592,3.82287936511623,5.51073155962331e-11,3.52686819815892e-09,"Q9UDY8",8.87e-39,"Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase)","B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]","GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006952; GO:0008233; GO:0009620; GO:0031398; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0032991; GO:0036094; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043066; GO:0043123; GO:0043280; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0051092; GO:0051168; GO:0051603; GO:2000321"
"216","Pocillopora_acuta_HIv2___RNAseq.g19355.t1",356.045024497617,-10.6419036202634,2.5244635712364,5.80111950654202e-11,3.6963609049614e-09,NA,NA,NA,NA,NA
"217","Pocillopora_acuta_HIv2___RNAseq.g7975.t1",465.593153266525,-9.8450458649366,2.23316768012884,6.01262775744727e-11,3.79110263007967e-09,NA,NA,NA,NA,NA
"218","Pocillopora_acuta_HIv2___TS.g12304.t1",114980.255845133,5.93217094830069,1.20542525432642,6.27188609279069e-11,3.92712382883656e-09,"P00918",2.04e-48,"Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69)","angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; neuron cellular homeostasis [GO:0070050]; one-carbon metabolic process [GO:0006730]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of monoatomic anion transport [GO:0044070]; secretion [GO:0046903]","GO:0002009; GO:0004064; GO:0004089; GO:0005737; GO:0005829; GO:0005886; GO:0006730; GO:0008270; GO:0015670; GO:0018820; GO:0032230; GO:0032849; GO:0038166; GO:0043209; GO:0044070; GO:0045177; GO:0046903; GO:0051453; GO:0070050; GO:0070062; GO:2001150; GO:2001225"
"219","Pocillopora_acuta_HIv2___RNAseq.g12018.t1",4250.42387939196,-3.56246658266729,0.585198519982448,6.62630876105197e-11,4.12010512146268e-09,NA,NA,NA,NA,NA
"220","Pocillopora_acuta_HIv2___RNAseq.g27022.t1",1176.16342223307,10.2036646312793,3.27314159987936,6.63706093266596e-11,4.12010512146268e-09,NA,NA,NA,NA,NA
"221","Pocillopora_acuta_HIv2___TS.6598_t",238.194855496312,-12.8447226670456,3.6818834558516,6.74140253836715e-11,4.15320130706226e-09,"Q6L8S8",2.41e-71,"Beta-1,4-N-acetylgalactosaminyltransferase 3 (Beta4GalNAc-T3) (Beta4GalNAcT3) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase III) (N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2) (NGalNAc-T2)","chondroitin sulfate biosynthetic process [GO:0030206]","GO:0008376; GO:0030206; GO:0032580; GO:0033842; GO:0047238"
"222","Pocillopora_acuta_HIv2___RNAseq.g9089.t1",319.56517136315,-10.0963792152029,2.12058657232375,6.7478035616678e-11,4.15320130706226e-09,"A0A2K5X3B6",1.25e-51,"Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1)","3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; flavonoid metabolic process [GO:0009812]","GO:0004062; GO:0005829; GO:0008146; GO:0009812; GO:0050427"
"223","Pocillopora_acuta_HIv2___TS.g4109.t3",319.818971445215,-9.83734777531025,2.19087201155639,6.7931465109289e-11,4.16339284466422e-09,"Q0ZLH3",8.77e-14,"Pejvakin (Autosomal recessive deafness type 59 protein)","detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; pexophagy [GO:0000425]; programmed cell death in response to reactive oxygen species [GO:0097468]; regulation of peroxisome organization [GO:1900063]; response to reactive oxygen species [GO:0000302]; sensory perception of sound [GO:0007605]; stereocilium maintenance [GO:0120045]","GO:0000302; GO:0000425; GO:0005737; GO:0005778; GO:0007605; GO:0030864; GO:0035253; GO:0043025; GO:0050910; GO:0097468; GO:0120044; GO:0120045; GO:1900063"
"224","Pocillopora_acuta_HIv2___RNAseq.g26032.t1",1243.05244410442,-12.4053793010218,3.21627845635221,6.97422175281725e-11,4.25633516593876e-09,"Q85WU2",2.86e-10,"Protein TIC 214 (Translocon at the inner envelope membrane of chloroplasts 214) (AtTIC214)","protein transport [GO:0015031]","GO:0009706; GO:0015031"
"225","Pocillopora_acuta_HIv2___TS.g6104.t1",847.604023362473,-11.395630384939,2.89324084650418,7.13078758060371e-11,4.3336013262963e-09,"Q5HY64",3.55e-18,"Putative protein FAM47C","",""
"226","Pocillopora_acuta_HIv2___RNAseq.g29835.t1",632.036613902695,-10.8027525828133,2.72271440752901,7.3005770160502e-11,4.41683045299291e-09,NA,NA,NA,NA,NA
"227","Pocillopora_acuta_HIv2___RNAseq.g3837.t1a",978.541972025751,-12.0459299713117,3.09652498924719,7.32881159235549e-11,4.41683045299291e-09,"Q90268",1.29e-63,"Paired box protein Pax-2a (No isthmus protein) (Pax[Zf-b])","anterior/posterior pattern specification [GO:0009952]; anterior/posterior pattern specification involved in pronephros development [GO:0034672]; cell fate specification [GO:0001708]; cerebellum development [GO:0021549]; cerebellum formation [GO:0021588]; cilium assembly [GO:0060271]; closure of optic fissure [GO:0061386]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic pattern specification [GO:0009880]; hindbrain development [GO:0030902]; inner ear receptor cell differentiation [GO:0060113]; kidney development [GO:0001822]; locus ceruleus development [GO:0021703]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; nervous system development [GO:0007399]; otic placode formation [GO:0043049]; peripheral nervous system development [GO:0007422]; pronephric glomerulus morphogenesis [GO:0035775]; pronephros development [GO:0048793]; pronephros morphogenesis [GO:0072114]; regulation of transcription by RNA polymerase II [GO:0006357]; thyroid gland development [GO:0030878]; vestibular receptor cell development [GO:0060118]","GO:0000978; GO:0000981; GO:0001708; GO:0001822; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007399; GO:0007422; GO:0009880; GO:0009952; GO:0021549; GO:0021588; GO:0021703; GO:0030878; GO:0030901; GO:0030902; GO:0030917; GO:0034672; GO:0035775; GO:0043049; GO:0043565; GO:0048596; GO:0048793; GO:0060113; GO:0060118; GO:0060271; GO:0061386; GO:0072114"
"228","Pocillopora_acuta_HIv2___RNAseq.7335_t",1155.23121310386,11.6367071335351,3.09222342162807,7.40387077204878e-11,4.42810594423803e-09,"Q91619",1.16e-10,"Nodal homolog (Nodal-related protein 1) (Xnr-1) (Xnr1) (nr-1)","axial mesoderm development [GO:0048318]; axial mesoderm formation [GO:0048320]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; nodal signaling pathway [GO:0038092]; paraxial mesoderm development [GO:0048339]","GO:0003140; GO:0005125; GO:0005576; GO:0005615; GO:0007368; GO:0007507; GO:0008083; GO:0016015; GO:0038092; GO:0048318; GO:0048320; GO:0048339"
"229","Pocillopora_acuta_HIv2___RNAseq.g14712.t1",259.163273632328,-7.36033976954607,1.40617238406799,7.41005749372778e-11,4.42810594423803e-09,NA,NA,NA,NA,NA
"230","Pocillopora_acuta_HIv2___RNAseq.g14576.t1",352.944013763663,-13.4205963635468,3.93534936153199,7.43936493673839e-11,4.42810594423803e-09,"P46023",9.55e-52,"G-protein coupled receptor GRL101","","GO:0004930; GO:0005886"
"231","Pocillopora_acuta_HIv2___RNAseq.g23688.t1",747.922168689888,-11.1010569310447,2.90893057457668,7.57715188770528e-11,4.49163626654792e-09,NA,NA,NA,NA,NA
"232","Pocillopora_acuta_HIv2___RNAseq.g8579.t1",237.302808985398,-12.7240919681913,3.66097652808303,7.63520634236152e-11,4.50757651167008e-09,NA,NA,NA,NA,NA
"233","Pocillopora_acuta_HIv2___TS.g15672.t1",261.983130716057,-10.1969377833642,2.32611901132807,7.95259007870656e-11,4.67586434546389e-09,"Q91VN0",1.9e-41,"Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7)","adipose tissue development [GO:0060612]; amino acid transport [GO:0006865]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; blood vessel morphogenesis [GO:0048514]; bone development [GO:0060348]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cell-cell signaling involved in mammary gland development [GO:0060764]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; glucose catabolic process [GO:0006007]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mesodermal cell migration [GO:0008078]; negative regulation of osteoblast differentiation [GO:0045668]; nervous system development [GO:0007399]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; osteoblast proliferation [GO:0033687]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; retina morphogenesis in camera-type eye [GO:0060042]; retina vasculature development in camera-type eye [GO:0061298]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055]","GO:0001702; GO:0001944; GO:0002053; GO:0002076; GO:0005739; GO:0005783; GO:0005886; GO:0006007; GO:0006865; GO:0006897; GO:0007399; GO:0008078; GO:0008203; GO:0008217; GO:0009952; GO:0010467; GO:0015026; GO:0016055; GO:0017147; GO:0033687; GO:0033690; GO:0035019; GO:0035108; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0043434; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048514; GO:0048539; GO:0051091; GO:0060033; GO:0060042; GO:0060070; GO:0060348; GO:0060349; GO:0060444; GO:0060603; GO:0060612; GO:0060764; GO:0060856; GO:0061178; GO:0061298; GO:0061299; GO:0061304; GO:0098609; GO:0110135; GO:1902262; GO:1990963"
"234","Pocillopora_acuta_HIv2___RNAseq.g21915.t1",239.410855885202,-12.660871521048,3.65206415889139,7.99187129250739e-11,4.67993629047882e-09,"Q6IND7",3.85e-110,"LRP2-binding protein","","GO:0005737"
"235","Pocillopora_acuta_HIv2___RNAseq.g18413.t1",302.638732308369,11.4020013966571,2.81808679143853,8.63668131651256e-11,5.03713542588862e-09,"Q8AWC7",4.91e-29,"Alpha-(1,3)-fucosyltransferase 11 (EC 2.4.1.-) (Fucosyltransferase XI) (Fuc-TXI) (FucT-XI) (Galactoside 3-L-fucosyltransferase 11) (Fucosyltransferase 11)","fucosylation [GO:0036065]; protein glycosylation [GO:0006486]","GO:0000139; GO:0006486; GO:0032580; GO:0036065; GO:0046920"
"236","Pocillopora_acuta_HIv2___TS.g23308.t1",433.336818344534,-8.16305110073433,1.81079387434817,9.03924854172243e-11,5.24224138787413e-09,"B8EIZ7",1.29e-173,"Trimethylamine monooxygenase (TMA monooxygenase) (Tmm) (EC 1.14.13.148)","","GO:0004499; GO:0034899; GO:0047822; GO:0050660; GO:0050661"
"237","Pocillopora_acuta_HIv2___RNAseq.7853_t",1313.27373726846,-12.5599440290299,3.27758300366746,9.06089363708415e-11,5.24224138787413e-09,NA,NA,NA,NA,NA
"238","Pocillopora_acuta_HIv2___RNAseq.g2416.t1",191.354281203994,-8.47648869493022,1.67256038606835,9.09708647923401e-11,5.24224138787413e-09,NA,NA,NA,NA,NA
"239","Pocillopora_acuta_HIv2___RNAseq.g25532.t1",344.325732515914,-10.562662206619,2.57570300762809,9.3713243516847e-11,5.37884267550665e-09,"Q5REJ1",1.31e-61,"Small ribosomal subunit protein uS5m (28S ribosomal protein S5, mitochondrial) (MRP-S5) (S5mt)","translation [GO:0006412]","GO:0003723; GO:0003735; GO:0005763; GO:0006412"
"240","Pocillopora_acuta_HIv2___RNAseq.g26092.t1",435.119893250857,-9.04698340097953,2.07275783453971,9.41411522217455e-11,5.38204595152303e-09,NA,NA,NA,NA,NA
"241","Pocillopora_acuta_HIv2___RNAseq.1261_t",305.429133816307,-12.9853549239705,3.7662653418995,9.4860263725037e-11,5.40180651385408e-09,"Q58116",2.27e-71,"3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34)","coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; sterol biosynthetic process [GO:0016126]","GO:0004420; GO:0008299; GO:0015936; GO:0016126"
"242","Pocillopora_acuta_HIv2___RNAseq.g12660.t1",293.90661207509,-12.9532495234309,3.75528344883728,1.02073269319043e-10,5.78975595070839e-09,NA,NA,NA,NA,NA
"243","Pocillopora_acuta_HIv2___RNAseq.g9609.t1",210.694268716008,-12.6386449381456,3.66172669042093,1.0471496625109e-10,5.91639559318656e-09,"G8XYX6",3.32e-69,"Monocarboxylate transporter 8 (MCT 8) (Solute carrier family 16 member 2)","brain development [GO:0007420]; central nervous system development [GO:0007417]; chordate embryonic development [GO:0043009]; locomotion [GO:0040011]; neuron differentiation [GO:0030182]; oligodendrocyte differentiation [GO:0048709]; optomotor response [GO:0071632]; regulation of thyroid hormone generation [GO:2000609]; Schwann cell differentiation [GO:0014037]; spinal cord development [GO:0021510]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; thyroid gland development [GO:0030878]; transmission of nerve impulse [GO:0019226]","GO:0007417; GO:0007420; GO:0014037; GO:0015349; GO:0016324; GO:0019226; GO:0021510; GO:0021529; GO:0030182; GO:0030878; GO:0040011; GO:0043009; GO:0048709; GO:0070324; GO:0071632; GO:2000609"
"244","Pocillopora_acuta_HIv2___TS.g4148.t1b",261.243744564734,-12.8845156548217,3.74585759188049,1.05268268566597e-10,5.92451453909439e-09,NA,NA,NA,NA,NA
"245","Pocillopora_acuta_HIv2___RNAseq.6257_t",1225.63410570247,-12.3523647667985,3.21334536104265,1.09427492115288e-10,6.13472575951752e-09,"A6H584",2.93e-15,"Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain)","cell adhesion [GO:0007155]","GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023"
"246","Pocillopora_acuta_HIv2___RNAseq.g5054.t1",255.372150994561,-12.6509230546493,3.6964711089977,1.10845130381153e-10,6.19020836228957e-09,NA,NA,NA,NA,NA
"247","Pocillopora_acuta_HIv2___TS.g4148.t1c",2544.66451385655,-6.33432788104256,1.32676145996642,1.12817000384496e-10,6.27609651369752e-09,"P98088",4.18e-06,"Mucin-5AC (MUC-5AC) (Gastric mucin) (Major airway glycoprotein) (Mucin-5 subtype AC, tracheobronchial) (Tracheobronchial mucin) (TBM)","","GO:0005201; GO:0005615; GO:0005796; GO:0005886; GO:0031012; GO:0046872; GO:0070062; GO:0070701"
"248","Pocillopora_acuta_HIv2___TS.g8934.t1",1086.976965865,-5.59884644518564,1.09522645214074,1.17635184032769e-10,6.51906245919527e-09,NA,NA,NA,NA,NA
"249","Pocillopora_acuta_HIv2___RNAseq.g13682.t1",211.268369190467,-12.6748681240331,3.6749042823021,1.27217240451148e-10,7.02316857208168e-09,"Q1G7G9",1.61e-47,"TALPID3 protein","centrosome localization [GO:0051642]; cilium assembly [GO:0060271]; motile cilium assembly [GO:0044458]; smoothened signaling pathway [GO:0007224]","GO:0005737; GO:0005813; GO:0005814; GO:0007224; GO:0036064; GO:0044458; GO:0051642; GO:0060271"
"250","Pocillopora_acuta_HIv2___TS.g6682.t1",2368.98413027754,-9.97149425826053,3.34049894649836,1.36887255754588e-10,7.52827858264015e-09,"Q6GM82",2.43e-154,"Alanine aminotransferase 2 (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2)","2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]","GO:0004021; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853"
"251","Pocillopora_acuta_HIv2___TS.g5115.t2",13271.9800359766,5.76740772612988,1.17788992556152,1.40212906928712e-10,7.68196774930642e-09,"P07898",1.61e-11,"Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)","cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; glial cell differentiation [GO:0010001]; positive regulation of neuroblast proliferation [GO:0002052]; skeletal system development [GO:0001501]","GO:0001501; GO:0002052; GO:0005509; GO:0005540; GO:0005615; GO:0007155; GO:0007417; GO:0010001; GO:0030246; GO:0045202; GO:0072534"
"252","Pocillopora_acuta_HIv2___RNAseq.g19043.t1",733.86103339952,-11.2373924232637,3.10305489103247,1.42640438040647e-10,7.78547658799971e-09,"Q14AT5",0,"Anoctamin-7 (New gene expressed in prostate homolog) (Transmembrane protein 16G)","calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; establishment of localization in cell [GO:0051649]","GO:0005254; GO:0005783; GO:0005886; GO:0017128; GO:0046983; GO:0051649; GO:0061588; GO:0061589; GO:0061590; GO:0061591; GO:1902476"
"253","Pocillopora_acuta_HIv2___RNAseq.g22818.t1",223.144981708577,-12.5880529855445,3.65336428337646,1.44066574869418e-10,7.83375540944086e-09,NA,NA,NA,NA,NA
"254","Pocillopora_acuta_HIv2___RNAseq.g17427.t1",303.365582089317,-12.9905721138189,3.74892341243061,1.45475301884665e-10,7.88072946239622e-09,NA,NA,NA,NA,NA
"255","Pocillopora_acuta_HIv2___RNAseq.g19428.t1",952.546508063329,-11.8782020528428,3.07852402691245,1.5644398398827e-10,8.44330516569528e-09,"Q8IS64",0,"Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-)","proteolysis [GO:0006508]","GO:0004175; GO:0004222; GO:0005886; GO:0006508; GO:0008270"
"256","Pocillopora_acuta_HIv2___RNAseq.g29795.t1",402.139504546331,11.3568065538685,3.00752361262481,1.5825777128624e-10,8.5094438806103e-09,"O88799",2.25e-08,"Zonadhesin","binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; regulation of binding of sperm to zona pellucida [GO:2000359]","GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840; GO:2000359"
"257","Pocillopora_acuta_HIv2___RNAseq.g8849.t1",636.275971677191,-11.4565649301434,2.95405440341261,1.62682921456569e-10,8.71498435536225e-09,"Q59I44",6.43e-68,"2-haloacrylate reductase (EC 1.3.1.103)","halogenated hydrocarbon catabolic process [GO:0042206]","GO:0003960; GO:0005829; GO:0016628; GO:0042206; GO:0070402; GO:0102523"
"258","Pocillopora_acuta_HIv2___TS.g13882.t1c",196.682004132868,12.6423270373682,3.60904487629516,1.72701412732187e-10,9.18365159469982e-09,"Q20191",5.77e-07,"Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13)","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"259","Pocillopora_acuta_HIv2___RNAseq.g7509.t2",1718.62032504362,7.28294121465897,4.87315684685701,1.73415980019738e-10,9.18787082419596e-09,"Q9Y2G1",2e-151,"Myelin regulatory factor (EC 3.4.-.-) (Myelin gene regulatory factor) [Cleaved into: Myelin regulatory factor, N-terminal; Myelin regulatory factor, C-terminal]","central nervous system myelin maintenance [GO:0032286]; central nervous system myelination [GO:0022010]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein autoprocessing [GO:0016540]; response to cocaine [GO:0042220]; response to immobilization stress [GO:0035902]","GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005829; GO:0008233; GO:0014003; GO:0016540; GO:0022010; GO:0031643; GO:0032286; GO:0035902; GO:0042220; GO:0042802; GO:0043565; GO:0045893; GO:0048709; GO:0048714"
"260","Pocillopora_acuta_HIv2___RNAseq.g13583.t1",188.304964680578,-12.5028765956602,3.63906238371538,1.77815400845514e-10,9.38657648842888e-09,NA,NA,NA,NA,NA
"261","Pocillopora_acuta_HIv2___RNAseq.g7241.t1",474.333676086549,-10.2267559279458,2.55027836107056,1.79325650391766e-10,9.43187711733274e-09,"Q8WU66",1.99e-36,"Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)","hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505]","GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170"
"262","Pocillopora_acuta_HIv2___RNAseq.g26552.t1",8991.89050197275,-9.29147018709163,2.72468032469546,1.86341146782557e-10,9.76535632993807e-09,"Q9U6Y6",3.32e-59,"GFP-like fluorescent chromoprotein amFP486","bioluminescence [GO:0008218]; generation of precursor metabolites and energy [GO:0006091]","GO:0006091; GO:0008218"
"263","Pocillopora_acuta_HIv2___TS.g20196.t1",743.769775938976,-11.7948043173664,3.09537228817559,1.91722098543813e-10,1.00110773766704e-08,"Q3UZD5",8.48e-95,"Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.361) (PR domain zinc finger protein 6) (PR domain-containing protein 6) (PR domain-containing protein in smooth muscle)","methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of gene expression [GO:0010468]","GO:0000122; GO:0005634; GO:0010468; GO:0022008; GO:0032259; GO:0042802; GO:0045892; GO:0046872; GO:0051151; GO:0140944"
"264","Pocillopora_acuta_HIv2___RNAseq.g24078.t1",228.186832937449,-12.8022408731935,3.7545864625301,1.9296614868395e-10,1.00397927142613e-08,"Q96DX5",2.61e-33,"Ankyrin repeat and SOCS box protein 9 (ASB-9)","intracellular signal transduction [GO:0035556]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]","GO:0005739; GO:0005829; GO:0016567; GO:0031466; GO:0035556; GO:0043161; GO:0045732; GO:1990756"
"265","Pocillopora_acuta_HIv2___TS.g15797.t1",226.062481669673,-12.5033517144779,3.66291507073549,1.94004298390934e-10,1.00490229925184e-08,NA,NA,NA,NA,NA
"266","Pocillopora_acuta_HIv2___RNAseq.g3224.t1",1245.07091600311,-12.3541962716085,3.29237166170609,1.94533077841893e-10,1.00490229925184e-08,NA,NA,NA,NA,NA
"267","Pocillopora_acuta_HIv2___RNAseq.g20063.t1",1022.35153509226,-9.85715505949235,2.77788834861332,2.00093570287158e-10,1.02636335923947e-08,NA,NA,NA,NA,NA
"268","Pocillopora_acuta_HIv2___RNAseq.g25934.t1",281.793136760874,-12.8241589771883,3.77703731972251,2.00106794320748e-10,1.02636335923947e-08,"Q9TV36",4.47e-17,"Fibrillin-1 [Cleaved into: Asprosin]","anatomical structure morphogenesis [GO:0009653]","GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0008201; GO:0009653; GO:0031012"
"269","Pocillopora_acuta_HIv2___RNAseq.g28408.t1",303.661864320727,-7.21492569638079,1.54422768117999,2.02930660392081e-10,1.0371692833608e-08,"Q9DCR2",9.28e-107,"AP-3 complex subunit sigma-1 (AP-3 complex subunit sigma-3A) (Adaptor-related protein complex 3 subunit sigma-1) (Sigma-3A-adaptin) (Sigma3A-adaptin) (Sigma-adaptin 3a)","anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; synaptic vesicle coating [GO:0016183]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]","GO:0005769; GO:0005802; GO:0006886; GO:0006896; GO:0008089; GO:0016020; GO:0016183; GO:0016192; GO:0030123; GO:0030659; GO:0035654; GO:0036465; GO:0043231; GO:0046907; GO:0048490; GO:0060155; GO:0098793; GO:1903232; GO:1904115"
"270","Pocillopora_acuta_HIv2___RNAseq.g28741.t1",193.979634261383,-12.5223728127528,3.65116307161,2.10401184100824e-10,1.0678044655559e-08,"P57695",2.29e-71,"Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit)","cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; monoatomic ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; neuropeptide signaling pathway [GO:0007218]; response to alcohol [GO:0097305]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]","GO:0001964; GO:0004888; GO:0005886; GO:0006811; GO:0006821; GO:0006936; GO:0007218; GO:0008270; GO:0016594; GO:0016934; GO:0022824; GO:0030425; GO:0030594; GO:0030977; GO:0034707; GO:0043005; GO:0043025; GO:0043204; GO:0043231; GO:0045202; GO:0045211; GO:0051970; GO:0060012; GO:0060080; GO:0071230; GO:0071294; GO:0071361; GO:0097305; GO:1902476; GO:1902495"
"271","Pocillopora_acuta_HIv2___RNAseq.g14013.t1a",937.515505918064,-11.8823455505292,3.14530941093389,2.11231082236517e-10,1.06826796275139e-08,"O42574",1.37e-29,"Beta-1 adrenergic receptor (Beta-1 adrenoreceptor) (Beta-1 adrenoceptor) (x-BETA1AR)","adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; positive regulation of heart contraction [GO:0045823]","GO:0004940; GO:0005769; GO:0005886; GO:0045823; GO:0071880"
"272","Pocillopora_acuta_HIv2___RNAseq.g8080.t1",735.017606754467,-11.567861724306,3.1844573794175,2.15732477422363e-10,1.08483222414275e-08,"Q9P2E3",0,"NFX1-type zinc finger-containing protein 1","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607"
"273","Pocillopora_acuta_HIv2___RNAseq.g23418.t1",1185.96706002756,12.5683897097163,3.66622196823376,2.1600641631161e-10,1.08483222414275e-08,NA,NA,NA,NA,NA
"274","Pocillopora_acuta_HIv2___RNAseq.g26057.t1",470.870608811962,8.52400641893285,2.21279101855706,2.24809029792324e-10,1.12125441617799e-08,"Q96P65",6.23e-25,"Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155)","cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0016020; GO:0032870; GO:0042277"
"275","Pocillopora_acuta_HIv2___RNAseq.g6500.t1",142.045236368868,12.4448221850719,3.48728402248737,2.43422660080558e-10,1.20991936611862e-08,NA,NA,NA,NA,NA
"276","Pocillopora_acuta_HIv2___RNAseq.g29823.t1",598.356142947403,-9.12207134904177,2.477461099951,2.44962697064455e-10,1.21340426381516e-08,NA,NA,NA,NA,NA
"277","Pocillopora_acuta_HIv2___TS.g18521.t1b",182.216525273293,-12.3759894483806,3.60530267177168,2.46339238035676e-10,1.2160582726785e-08,NA,NA,NA,NA,NA
"278","Pocillopora_acuta_HIv2___RNAseq.g6446.t1",7264.0806341713,4.27396485334159,0.764677518476373,2.48816784621774e-10,1.22411087509161e-08,"B3EWZ3",0,"Coadhesin","","GO:0016020"
"279","Pocillopora_acuta_HIv2___TS.g23175.t1",218.460484313913,-12.4996751911466,3.66406572812199,2.52166846321423e-10,1.23638686955697e-08,"Q96RW7",3.37e-66,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711"
"280","Pocillopora_acuta_HIv2___RNAseq.g5386.t1",2718.69975807601,-1.2127954650651,2.50433472286646,2.69652638465822e-10,1.31765397390867e-08,NA,NA,NA,NA,NA
"281","Pocillopora_acuta_HIv2___RNAseq.g7573.t1",197.555023493453,-12.3887519130814,3.63644981595229,2.72437158125417e-10,1.32677813303907e-08,"Q96M20",4.21e-28,"Cyclic nucleotide-binding domain-containing protein 2","spermatogenesis [GO:0007283]","GO:0005829; GO:0007283; GO:0030552"
"282","Pocillopora_acuta_HIv2___TS.g19887.t1",525.99718908866,11.8141915649243,3.14995187800814,2.77126132917192e-10,1.34508469346116e-08,"Q92051",2.1e-38,"Carbonic anhydrase (EC 4.2.1.1) (Carbonate dehydratase)","carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539]; one-carbon metabolic process [GO:0006730]; regulation of pH [GO:0006885]","GO:0004089; GO:0005737; GO:0006730; GO:0006885; GO:0008270; GO:0015670; GO:0042539"
"283","Pocillopora_acuta_HIv2___TS.g25258.t1",2035.87614383464,-8.9547478641339,3.54944236857939,2.8382141518927e-10,1.37297423053431e-08,"B3EWY9",0,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020"
"284","Pocillopora_acuta_HIv2___RNAseq.1449_t",2692.51660313172,-6.51499319236055,4.90312479917957,2.87272335637009e-10,1.38503568755123e-08,"Q58A42",2.65e-67,"Protein DD3-3","","GO:0016020"
"285","Pocillopora_acuta_HIv2___RNAseq.g2734.t1",2074.16025618192,-1.08206899290518,2.10802594257369,2.94094090062511e-10,1.413038916234e-08,NA,NA,NA,NA,NA
"286","Pocillopora_acuta_HIv2___RNAseq.g39.t2",624.418501450814,11.613270114653,3.2058183788157,2.95034397609698e-10,1.413038916234e-08,"Q9IBG7",5.87e-17,"Kielin/chordin-like protein (Cysteine-rich motor neuron 2 protein) (CRIM-2) (Kielin)","","GO:0005576"
"287","Pocillopora_acuta_HIv2___RNAseq.g25891.t1",1602.0530952941,-9.57507699741442,2.67068561640276,2.96779791186983e-10,1.41670722763318e-08,"P48630",1.35e-119,"Omega-6 fatty acid desaturase, endoplasmic reticulum isozyme 1 (EC 1.14.19.-)","unsaturated fatty acid biosynthetic process [GO:0006636]","GO:0005789; GO:0006636; GO:0016491"
"288","Pocillopora_acuta_HIv2___RNAseq.g15526.t1",934.860262231967,-11.0783917903769,3.12358706591237,3.07572407938959e-10,1.453832453735e-08,"O93384",2.14e-162,"S-adenosylmethionine-dependent nucleotide dehydratase RSAD2 (SAND) (Radical S-adenosyl methionine domain-containing protein 2) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible) (Viperin)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of immune response [GO:0050778]","GO:0003824; GO:0005739; GO:0005789; GO:0005811; GO:0045087; GO:0046872; GO:0050778; GO:0051539; GO:0051607"
"289","Pocillopora_acuta_HIv2___RNAseq.g15097.t1",414.097998300102,-8.76672100489088,2.2558690576499,3.09143075136363e-10,1.4564968855936e-08,"Q16322",1.7e-08,"Potassium voltage-gated channel subfamily A member 10 (Voltage-gated potassium channel subunit Kv1.8)","action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]","GO:0001508; GO:0005221; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016020; GO:0051260; GO:0071805"
"290","Pocillopora_acuta_HIv2___RNAseq.g6506.t1",185.419361870884,-12.2854044560093,3.604952794626,3.21649250278694e-10,1.50761226546804e-08,NA,NA,NA,NA,NA
"291","Pocillopora_acuta_HIv2___RNAseq.g26602.t1",134.181647093054,12.4561128160253,3.53467902104552,3.22077011912073e-10,1.50761226546804e-08,NA,NA,NA,NA,NA
"292","Pocillopora_acuta_HIv2___RNAseq.g30398.t1",1296.99952263402,-1.56592705190042,6.16339595144424,3.31359830633046e-10,1.54606083557303e-08,"P83858",2.55e-24,"Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155)","cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0032870; GO:0042277; GO:0097730"
"293","Pocillopora_acuta_HIv2___RNAseq.g20587.t2",299.561781586977,-10.1313798668336,2.53858531738332,3.34031229584127e-10,1.55351373141634e-08,NA,NA,NA,NA,NA
"294","Pocillopora_acuta_HIv2___RNAseq.g710.t1",707.193089478224,-11.5349722935492,3.15334887896313,3.43878267074491e-10,1.59418437659149e-08,"Q7TN88",1e-49,"Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"295","Pocillopora_acuta_HIv2___RNAseq.g14886.t1",967.371642145282,-8.45773589656948,3.44235948409806,3.88326162515849e-10,1.79448869476973e-08,"Q9Y2U5",5.86e-73,"Mitogen-activated protein kinase kinase kinase 2 (EC 2.7.11.25) (MAPK/ERK kinase kinase 2) (MEK kinase 2) (MEKK 2)","cellular response to mechanical stimulus [GO:0071260]; intracellular signal transduction [GO:0035556]","GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0019901; GO:0035556; GO:0046872; GO:0071260; GO:0106310"
"296","Pocillopora_acuta_HIv2___RNAseq.g18767.t1",1916.46248474384,-1.12131405820383,2.19758179670231,4.37942653169206e-10,2.01092143982203e-08,"P50430",1.07e-114,"Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)","anterior head development [GO:0097065]; autophagy [GO:0006914]; colon epithelial cell migration [GO:0061580]; dermatan sulfate catabolic process [GO:0030209]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]","GO:0003943; GO:0004065; GO:0005764; GO:0006914; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030209; GO:0043627; GO:0043890; GO:0046872; GO:0051597; GO:0061580; GO:0097065"
"297","Pocillopora_acuta_HIv2___RNAseq.g16881.t1",324.156246578324,-10.0011062575393,2.60751303905904,4.56664006329432e-10,2.08365557966842e-08,NA,NA,NA,NA,NA
"298","Pocillopora_acuta_HIv2___TS.g18814.t1",407.539228353006,-10.3698143493609,2.78429406424173,4.82740011381067e-10,2.19570802660872e-08,NA,NA,NA,NA,NA
"299","Pocillopora_acuta_HIv2___RNAseq.21015_t",2419.08023419196,3.44625251059797,0.597369865072132,4.91125563191368e-10,2.22088235003693e-08,"Q95ND7",2.89e-40,"Coagulation factor IX (EC 3.4.21.22) (Christmas factor) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain]","blood coagulation [GO:0007596]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]","GO:0004175; GO:0004252; GO:0005509; GO:0005615; GO:0005788; GO:0005796; GO:0006508; GO:0007596; GO:0031638"
"300","Pocillopora_acuta_HIv2___RNAseq.g11521.t1",253.366267241985,-10.2177205745912,2.55289892567637,4.91345652663037e-10,2.22088235003693e-08,NA,NA,NA,NA,NA
"301","Pocillopora_acuta_HIv2___TS.g25259.t2",1914.03784261248,-12.3400369326509,4.0425085176402,4.96638195725482e-10,2.23781148379233e-08,"B3EWY9",0,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020"
"302","Pocillopora_acuta_HIv2___TS.g2952.t1",159.858019637123,-12.2135799475606,3.59782866711428,5.04071234610529e-10,2.26425041534369e-08,"A6QLU6",7.47e-15,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189"
"303","Pocillopora_acuta_HIv2___RNAseq.g21457.t1",161.154540073917,-12.1919261008084,3.58753270548788,5.07901047238777e-10,2.27439032422962e-08,"Q8NFZ0",1.53e-155,"F-box DNA helicase 1 (hFBH1) (EC 5.6.2.4) (DNA 3'-5' helicase 1) (F-box only protein 18)","DNA catabolic process [GO:0006308]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; replication fork processing [GO:0031297]; response to intra-S DNA damage checkpoint signaling [GO:0072429]","GO:0000724; GO:0000785; GO:0001934; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006308; GO:0006974; GO:0015616; GO:0016567; GO:0016853; GO:0016887; GO:0019005; GO:0031297; GO:0043138; GO:0072429; GO:1902231; GO:2000042"
"304","Pocillopora_acuta_HIv2___RNAseq.g14337.t1",183.555105935626,-12.4393709556681,3.72136020028187,5.12900156161426e-10,2.2896876107157e-08,"B8V7S0",2.54e-93,"CUB and peptidase domain-containing protein 1","acrosome reaction [GO:0007340]; proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508; GO:0007340"
"305","Pocillopora_acuta_HIv2___RNAseq.g29115.t1",762.405021667792,-8.4290561316454,2.74427055195064,5.16010021231728e-10,2.29648275295252e-08,"P15989",1.08e-10,"Collagen alpha-3(VI) chain","cell adhesion [GO:0007155]","GO:0004867; GO:0005581; GO:0005615; GO:0007155; GO:0062023"
"306","Pocillopora_acuta_HIv2___RNAseq.g19312.t1",4224.36052959852,-6.03267949575418,5.17698387334947,5.38298548558205e-10,2.37376530681277e-08,"P33435",6.65e-31,"Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13)","bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; collagen catabolic process [GO:0030574]; endochondral ossification [GO:0001958]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; growth plate cartilage development [GO:0003417]; heart development [GO:0007507]; positive regulation of pancreatic trypsinogen secretion [GO:1904244]; protein catabolic process [GO:0030163]; protein metabolic process [GO:0019538]; proteolysis [GO:0006508]; response to hormone [GO:0009725]","GO:0001958; GO:0001968; GO:0003417; GO:0004222; GO:0005509; GO:0005518; GO:0005576; GO:0005615; GO:0006508; GO:0007507; GO:0008233; GO:0008270; GO:0009725; GO:0019538; GO:0022617; GO:0030163; GO:0030198; GO:0030282; GO:0030574; GO:0031012; GO:0046581; GO:0048306; GO:0050750; GO:0060349; GO:1904244"
"307","Pocillopora_acuta_HIv2___TS.g6681.t1",1375.40247079999,-1.27187675055683,2.77233006310273,5.6631550296787e-10,2.48972262459796e-08,"Q6NYL5",2.28e-110,"Alanine aminotransferase 2-like (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2)","2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]","GO:0004021; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853"
"308","Pocillopora_acuta_HIv2___RNAseq.g4591.t1",324.238675625821,-12.9158194125593,3.88535563988581,5.70408270826264e-10,2.50011673613063e-08,NA,NA,NA,NA,NA
"309","Pocillopora_acuta_HIv2___RNAseq.g13576.t1",169.548760352034,-12.2608583735085,3.66695276462554,5.8235349465592e-10,2.5447616153182e-08,"P13608",5.61e-25,"Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)","cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; glial cell differentiation [GO:0010001]; positive regulation of neuroblast proliferation [GO:0002052]; skeletal system development [GO:0001501]","GO:0001501; GO:0002052; GO:0005509; GO:0005540; GO:0005576; GO:0005615; GO:0007155; GO:0007417; GO:0010001; GO:0030246; GO:0045202; GO:0072534"
"310","Pocillopora_acuta_HIv2___RNAseq.g24021.t1",787.072394614161,-11.7729551192226,3.2229789022595,5.87889711578109e-10,2.55726430025028e-08,"O88823",5.82e-13,"Protein JTB","apoptotic mitochondrial changes [GO:0008637]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; positive regulation of protein kinase activity [GO:0045860]; regulation of cell population proliferation [GO:0042127]","GO:0000278; GO:0000281; GO:0005737; GO:0005739; GO:0005813; GO:0005819; GO:0008637; GO:0016020; GO:0019901; GO:0030496; GO:0042127; GO:0045860"
"311","Pocillopora_acuta_HIv2___TS.g19999.t1",1687.93854435584,-8.63108345635179,3.3987839366621,5.88872393570041e-10,2.55726430025028e-08,"O42357",1.98e-31,"Retinal homeobox protein Rx2","camera-type eye photoreceptor cell differentiation [GO:0060219]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0045944; GO:0060219"
"312","Pocillopora_acuta_HIv2___RNAseq.g9825.t1",4116.90824066339,-6.7594265080723,2.7932822071118,5.90518719775715e-10,2.55726430025028e-08,"B8NHE3",6.07e-10,"Methyltransferase flvH (EC 2.1.1.-) (Flavunoidine biosynthesis cluster protein H)","methylation [GO:0032259]; terpenoid biosynthetic process [GO:0016114]","GO:0008168; GO:0016114; GO:0032259; GO:0046872"
"313","Pocillopora_acuta_HIv2___RNAseq.g913.t2",828.324464640465,-10.7788745978246,3.10315350761812,6.35817197176356e-10,2.74521192237577e-08,"Q0VE29",5.36e-06,"Sterile alpha motif domain-containing protein 12 (SAM domain-containing protein 12)","cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0007169; GO:0009898"
"314","Pocillopora_acuta_HIv2___TS.g11181.t1",232.349094023981,-12.537394754185,3.71372186059347,6.68079919262117e-10,2.87592498577597e-08,NA,NA,NA,NA,NA
"315","Pocillopora_acuta_HIv2___RNAseq.g3070.t1",186.231711242964,-12.3744921789054,3.69518374733026,7.04034949858378e-10,3.02170964829424e-08,NA,NA,NA,NA,NA
"316","Pocillopora_acuta_HIv2___TS.g16486.t1",427.524815118564,-10.0799047814824,2.66569622520285,7.32287066712196e-10,3.13366867838024e-08,NA,NA,NA,NA,NA
"317","Pocillopora_acuta_HIv2___RNAseq.g25241.t1",922.273299092604,-8.35827483970452,2.83731333140292,7.41903886481298e-10,3.16545658232021e-08,"Q5HZE0",5.8e-99,"Mitochondrial basic amino acids transporter (Carnitine/acylcarnitine translocase-like) (CACT-like) (Mitochondrial carnitine/acylcarnitine carrier protein CACL) (Mitochondrial ornithine transporter 3) (Solute carrier family 25 member 29)","acyl carnitine transmembrane transport [GO:1902616]; acyl carnitine transport [GO:0006844]; L-arginine transmembrane transport [GO:1903826]; L-histidine transmembrane transport [GO:0089709]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; organic cation transport [GO:0015695]; ornithine transport [GO:0015822]","GO:0005289; GO:0005292; GO:0005739; GO:0005743; GO:0006844; GO:0015174; GO:0015227; GO:0015695; GO:0015822; GO:0089709; GO:1902616; GO:1903401; GO:1903826; GO:1990575"
"318","Pocillopora_acuta_HIv2___RNAseq.g18859.t1",155.451692126755,-12.1629048658716,3.60898480757579,7.4778453569817e-10,3.18116338951127e-08,NA,NA,NA,NA,NA
"319","Pocillopora_acuta_HIv2___RNAseq.g17495.t1",695.276104890953,-11.6905800405212,3.24805223587447,7.68641968685419e-10,3.26030423315716e-08,"Q6AX80",2.12e-90,"Bis(5'-adenosyl)-triphosphatase enpp4 (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 4) (E-NPP 4) (NPP-4)","blood coagulation [GO:0007596]","GO:0005886; GO:0007596; GO:0046872; GO:0047710"
"320","Pocillopora_acuta_HIv2___RNAseq.g23744.t1",356.775799097496,-12.7431712116074,3.9342310585823,7.71676820014474e-10,3.26360629376882e-08,NA,NA,NA,NA,NA
"321","Pocillopora_acuta_HIv2___TS.g29407.t1",343.808020083342,-12.9455218693746,3.95073373984766,7.88483875950833e-10,3.32496524249354e-08,"O00339",1.29e-24,"Matrilin-2","axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; neuron migration [GO:0001764]; response to axon injury [GO:0048678]","GO:0001764; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0007411; GO:0008347; GO:0030198; GO:0031012; GO:0031104; GO:0048678; GO:0062023; GO:0120216"
"322","Pocillopora_acuta_HIv2___RNAseq.g1847.t1",595.300902733174,-11.0976535345546,3.08274828434864,8.07874644839014e-10,3.39683106481148e-08,NA,NA,NA,NA,NA
"323","Pocillopora_acuta_HIv2___TS.g17433.t1",262.801516314106,-9.8888597638339,2.4840653515278,8.1586619974116e-10,3.42048948204526e-08,NA,NA,NA,NA,NA
"324","Pocillopora_acuta_HIv2___RNAseq.g21572.t1a",170.494827583462,-12.1700535583221,3.66308965056217,8.32809707276832e-10,3.48143341215379e-08,"P63079",2.23e-50,"Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3)","brain development [GO:0007420]; cellular response to histamine [GO:0071420]; cellular response to zinc ion [GO:0071294]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; chemical synaptic transmission, postsynaptic [GO:0099565]; chloride transmembrane transport [GO:1902476]; circadian sleep/wake cycle, REM sleep [GO:0042747]; cochlea development [GO:0090102]; exploration behavior [GO:0035640]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hard palate development [GO:0060022]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; learning [GO:0007612]; memory [GO:0007613]; monoatomic ion transmembrane transport [GO:0034220]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuron development [GO:0048666]; regulation of postsynaptic membrane potential [GO:0060078]; reproductive behavior [GO:0019098]; response to anesthetic [GO:0072347]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; social behavior [GO:0035176]; synaptic transmission, GABAergic [GO:0051932]","GO:0004890; GO:0005216; GO:0005254; GO:0005886; GO:0007214; GO:0007268; GO:0007399; GO:0007420; GO:0007612; GO:0007613; GO:0009410; GO:0009986; GO:0019098; GO:0021549; GO:0022851; GO:0030594; GO:0030659; GO:0034220; GO:0034707; GO:0035176; GO:0035612; GO:0035640; GO:0042747; GO:0042802; GO:0043005; GO:0043195; GO:0045202; GO:0045211; GO:0048666; GO:0051932; GO:0060021; GO:0060022; GO:0060077; GO:0060078; GO:0060080; GO:0060119; GO:0060384; GO:0061744; GO:0071294; GO:0071420; GO:0072347; GO:0090102; GO:0098982; GO:0099565; GO:0099634; GO:1902476; GO:1902495; GO:1902711; GO:1904315; GO:1904862"
"325","Pocillopora_acuta_HIv2___RNAseq.g8217.t1",745.87324476123,-8.57099141013637,2.45045038648523,8.53724420844721e-10,3.55857925737696e-08,"Q16992",7.91e-09,"LWamide neuropeptides [Cleaved into: LWamide I; Metamorphosin A (MMA) (LWamide II); LWamide III; LWamide IV; LWamide V; LWamide VI; LWamide VII; LWamide VIII; LWamide IX]","extracellular matrix organization [GO:0030198]; neuropeptide signaling pathway [GO:0007218]","GO:0005615; GO:0007218; GO:0030020; GO:0030198; GO:0062023"
"326","Pocillopora_acuta_HIv2___RNAseq.g16129.t1",1785.1124394865,-6.34676448219874,4.89260481715423,8.61364897303065e-10,3.58010973407803e-08,"A1RYE4",9.57e-58,"Glyoxylate reductase (EC 1.1.1.26)","","GO:0005829; GO:0016618; GO:0030267; GO:0047964; GO:0051287"
"327","Pocillopora_acuta_HIv2___RNAseq.g30624.t2b",1458.34037951228,-8.25320622308124,4.24344882427549,8.67986521182632e-10,3.59729428148584e-08,"Q99NH0",5.34e-66,"Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein)","blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]","GO:0000785; GO:0001673; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246"
"328","Pocillopora_acuta_HIv2___RNAseq.g25446.t1",633.200937971067,-11.0010879351624,3.02319509749692,9.30598689967951e-10,3.83270315428156e-08,NA,NA,NA,NA,NA
"329","Pocillopora_acuta_HIv2___RNAseq.g619.t1",2642.45071876053,6.14733840499868,4.42039525246809,9.32737493298609e-10,3.83270315428156e-08,"Q6P1S6",3.47e-18,"Myotrophin","","GO:0005634; GO:0048471"
"330","Pocillopora_acuta_HIv2___RNAseq.g21562.t1",1563.29410087698,7.69428626084602,3.50710115064958,9.58060851187292e-10,3.92560684180538e-08,"Q923L3",5.79e-12,"CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1)","conditioned place preference [GO:1990708]; female gonad development [GO:0008585]; glucose homeostasis [GO:0042593]; male gonad development [GO:0008584]; mammary gland branching involved in pregnancy [GO:0060745]; memory [GO:0007613]; oviduct epithelium development [GO:0035846]; startle response [GO:0001964]","GO:0001964; GO:0007613; GO:0008584; GO:0008585; GO:0016020; GO:0035846; GO:0042593; GO:0060745; GO:1990708"
"331","Pocillopora_acuta_HIv2___RNAseq.g21375.t1",152.185947809757,-12.0347847536983,3.58294405042001,9.69008851276185e-10,3.95924972453637e-08,NA,NA,NA,NA,NA
"332","Pocillopora_acuta_HIv2___RNAseq.g7628.t1",523.535700384145,-10.336711096995,2.91372901442972,9.86778338661289e-10,4.02049630715405e-08,"Q704V6",2.62e-16,"Toll-like receptor 6 (CD antigen CD286)","cellular response to diacyl bacterial lipopeptide [GO:0071726]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; toll-like receptor signaling pathway [GO:0002224]","GO:0002224; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0030670; GO:0032731; GO:0035355; GO:0035663; GO:0038023; GO:0042802; GO:0045087; GO:0045121; GO:0061809; GO:0071723; GO:0071726; GO:1900227"
"333","Pocillopora_acuta_HIv2___RNAseq.g17781.t1",430.259679473374,-10.3932107303358,2.93450119566122,1.08601982236516e-09,4.39401453043883e-08,NA,NA,NA,NA,NA
"334","Pocillopora_acuta_HIv2___RNAseq.g27023.t1",1089.26043734581,7.9697534394658,4.84542539346834,1.08756720263904e-09,4.39401453043883e-08,NA,NA,NA,NA,NA
"335","Pocillopora_acuta_HIv2___RNAseq.g14642.t1",167.480075040321,-12.2003040674673,3.67361552787315,1.13572927257794e-09,4.57581843971233e-08,NA,NA,NA,NA,NA
"336","Pocillopora_acuta_HIv2___RNAseq.g3854.t1",848.165995444607,-1.31937235807174,3.03004882357897,1.15184231767996e-09,4.62784646747859e-08,"P30974",4.07e-26,"Tachykinin-like peptides receptor 86C (NKD)","G protein-coupled receptor signaling pathway [GO:0007186]; inter-male aggressive behavior [GO:0002121]; neuropeptide signaling pathway [GO:0007218]; tachykinin receptor signaling pathway [GO:0007217]","GO:0002121; GO:0004995; GO:0005886; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016020"
"337","Pocillopora_acuta_HIv2___RNAseq.g6379.t1",156.421421073687,-12.1917760345026,3.66704969153415,1.20637923813308e-09,4.83353720231493e-08,"A6QLU6",8.77e-21,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189"
"338","Pocillopora_acuta_HIv2___RNAseq.g6505.t1",1954.75622105436,8.09624261662431,2.48372435642332,1.27388545421658e-09,5.08991138391949e-08,NA,NA,NA,NA,NA
"339","Pocillopora_acuta_HIv2___RNAseq.18284_t",232.506557854377,-12.5003396817362,3.84281428960313,1.28839276985305e-09,5.13369504770095e-08,"Q21565",1.4e-128,"Putative ammonium transporter 3","ammonium homeostasis [GO:0097272]; ammonium transmembrane transport [GO:0072488]","GO:0005886; GO:0008519; GO:0072488; GO:0097272"
"340","Pocillopora_acuta_HIv2___RNAseq.g25699.t1",362.71124765533,-10.2373690972677,2.80575478229756,1.32112438015444e-09,5.2496546798225e-08,"Q90YK3",5.02e-162,"L-gulonolactone oxidase (LGO) (EC 1.1.3.8) (L-gulono-gamma-lactone oxidase) (GLO)","L-ascorbic acid biosynthetic process [GO:0019853]","GO:0003885; GO:0005789; GO:0019853; GO:0050105; GO:0050660; GO:0071949"
"341","Pocillopora_acuta_HIv2___RNAseq.g19434.t1",1914.29683892957,-8.27385272470931,4.08337888170271,1.32747853915394e-09,5.26045194255411e-08,NA,NA,NA,NA,NA
"342","Pocillopora_acuta_HIv2___RNAseq.g1877.t1",482.089962221999,-10.9051955140628,3.09934831649028,1.34165313989382e-09,5.28965224281163e-08,NA,NA,NA,NA,NA
"343","Pocillopora_acuta_HIv2___RNAseq.g28943.t1",161.347683153997,-11.9651912288657,3.60408218821559,1.34276964234992e-09,5.28965224281163e-08,NA,NA,NA,NA,NA
"344","Pocillopora_acuta_HIv2___RNAseq.7765_t",851.664689586922,-1.2543892152472,2.6939972328111,1.34813089055428e-09,5.28965224281163e-08,NA,NA,NA,NA,NA
"345","Pocillopora_acuta_HIv2___TS.g27848.t1",185402.900849584,-5.52599664396134,1.27035460768844,1.36523681140662e-09,5.33696898383389e-08,"Q86VQ3",2.61e-13,"Thioredoxin domain-containing protein 2 (Spermatid-specific thioredoxin-1) (Sptrx-1)","cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; spermatogenesis [GO:0007283]","GO:0004791; GO:0005737; GO:0007283; GO:0030154; GO:0045454"
"346","Pocillopora_acuta_HIv2___RNAseq.g7644.t1",573.932030486125,-11.0482363339345,3.23094399036347,1.40554192347152e-09,5.47971924018656e-08,"Q9BYK8",0,"3'-5' exoribonuclease HELZ2 (EC 3.1.13.1) (ATP-dependent RNA helicase PRIC285) (EC 3.6.4.13) (Helicase with zinc finger 2, transcriptional coactivator) (Helicase with zinc finger domain 2) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein)","positive regulation of transcription by RNA polymerase II [GO:0045944]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]","GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0008859; GO:0016020; GO:0016887; GO:0030374; GO:0035194; GO:0043186; GO:0045944; GO:0046872"
"347","Pocillopora_acuta_HIv2___RNAseq.g29592.t1",139.236206376654,-11.9813016374415,3.59348371366161,1.44630382052735e-09,5.60403232138336e-08,NA,NA,NA,NA,NA
"348","Pocillopora_acuta_HIv2___TS.g4312.t1",138.823575900051,-11.959250617321,3.58270297540256,1.44755579071243e-09,5.60403232138336e-08,"O70277",5.42e-20,"Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22)","negative regulation of translation [GO:0017148]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252]","GO:0000209; GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0017148; GO:0030371; GO:0030425; GO:0034141; GO:0042802; GO:0043161; GO:0061630; GO:0070534; GO:0098794; GO:0098978; GO:0140252"
"349","Pocillopora_acuta_HIv2___RNAseq.g23049.t1",892.322187563531,-8.79742095091659,2.69396607931125,1.45292596827901e-09,5.60403232138336e-08,"B3RFR8",7.89e-11,"Hydramacin-1 (Hm-1)","defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]","GO:0005576; GO:0016020; GO:0042742; GO:0044218; GO:0045087"
"350","Pocillopora_acuta_HIv2___TS.g9570.t1",7006.63804083127,6.83046251882724,2.21469461914126,1.46613435765858e-09,5.63993812478025e-08,NA,NA,NA,NA,NA
"351","Pocillopora_acuta_HIv2___RNAseq.g3441.t1",148.744932859109,-11.9986307379577,3.60815116295714,1.49071508954416e-09,5.71928463001769e-08,NA,NA,NA,NA,NA
"352","Pocillopora_acuta_HIv2___RNAseq.g22644.t1",1223.76428572696,-1.24460226561098,2.63578700895378,1.52007014831571e-09,5.81648005958689e-08,"P31597",1.72e-126,"Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1)","chloride transmembrane transport [GO:1902476]; cysteine transport [GO:0042883]; D-aspartate import across plasma membrane [GO:0070779]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]","GO:0005313; GO:0005314; GO:0005886; GO:0015108; GO:0015501; GO:0015813; GO:0016324; GO:0031901; GO:0031902; GO:0033229; GO:0042883; GO:0043005; GO:0045202; GO:0046872; GO:0055038; GO:0070779; GO:0098712; GO:0140009; GO:1902476"
"353","Pocillopora_acuta_HIv2___RNAseq.g5871.t1",975.156347879303,8.27414168653677,3.3296897052882,1.56680420997818e-09,5.96375160345381e-08,"Q96JQ5",3.47e-06,"Membrane-spanning 4-domains subfamily A member 4A (CD20 antigen-like 1) (Four-span transmembrane protein 1)","","GO:0005783; GO:0005794; GO:0005886; GO:0044853"
"354","Pocillopora_acuta_HIv2___RNAseq.10969_t",147.544540612849,-12.0195342756875,3.629371597413,1.5814831269318e-09,6.00382465825238e-08,"O43704",1.12e-55,"Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase)","3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; biogenic amine metabolic process [GO:0006576]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]","GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006576; GO:0006805; GO:0008146; GO:0009812; GO:0018958; GO:0030855; GO:0042403; GO:0050427; GO:0051923"
"355","Pocillopora_acuta_HIv2___TS.g25792.t1c",157.403227972141,-12.1936987143332,3.68692057704027,1.60608924962897e-09,6.08127615356898e-08,"Q8TD84",5.33e-23,"Cell adhesion molecule DSCAML1 (Down syndrome cell adhesion molecule 2) (Down syndrome cell adhesion molecule-like protein 1)","axon guidance [GO:0007411]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; dendrite self-avoidance [GO:0070593]; dorsal/ventral pattern formation [GO:0009953]; embryonic skeletal system morphogenesis [GO:0048704]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0001709; GO:0005615; GO:0005886; GO:0007156; GO:0007409; GO:0007411; GO:0007417; GO:0007420; GO:0009953; GO:0009986; GO:0030424; GO:0042803; GO:0045202; GO:0048704; GO:0070593; GO:0098632"
"356","Pocillopora_acuta_HIv2___RNAseq.g385.t1",1369.13096260708,-7.58762459207394,2.72758174789344,1.6444201713645e-09,6.21015492392068e-08,NA,NA,NA,NA,NA
"357","Pocillopora_acuta_HIv2___RNAseq.g17934.t1",667.74028875006,-8.83775295897212,2.69214652324298,1.66224176474928e-09,6.2611106472223e-08,NA,NA,NA,NA,NA
"358","Pocillopora_acuta_HIv2___RNAseq.g23857.t1",185.042253771809,-12.3184133060373,3.75077027443383,1.67428472251211e-09,6.29009200686107e-08,NA,NA,NA,NA,NA
"359","Pocillopora_acuta_HIv2___RNAseq.g28227.t1",162.777210999485,-12.1037795016523,3.69064767866425,1.68291714062444e-09,6.30614339947975e-08,"P10079",4.85e-90,"Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","","GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579"
"360","Pocillopora_acuta_HIv2___RNAseq.g11840.t1",608.420427976475,-11.1057381195143,3.23454596045744,1.75348467546127e-09,6.55359233743458e-08,"Q6PEI7",0,"CTP synthase 1 (EC 6.3.4.2) (CTP synthetase 1) (UTP--ammonia ligase 1)","'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; notochord development [GO:0030903]; pyrimidine nucleobase biosynthetic process [GO:0019856]","GO:0003883; GO:0005524; GO:0005737; GO:0006241; GO:0006541; GO:0019856; GO:0030903; GO:0042802; GO:0044210; GO:0097268"
"361","Pocillopora_acuta_HIv2___TS.g16956.t1a",186.395461631915,-12.1818957805269,3.69240560947754,1.77216667854887e-09,6.60634506147704e-08,"P51398",3.95e-28,"Small ribosomal subunit protein mS29 (28S ribosomal protein S29, mitochondrial) (MRP-S29) (S29mt) (Death-associated protein 3) (DAP-3) (Ionizing radiation resistance conferring protein)","apoptotic signaling pathway [GO:0097190]; mitochondrial translation [GO:0032543]","GO:0003723; GO:0003735; GO:0005525; GO:0005654; GO:0005739; GO:0005743; GO:0005763; GO:0032543; GO:0097190"
"362","Pocillopora_acuta_HIv2___RNAseq.g4628.t1",143.384199761355,-12.0097778545127,3.64769735128051,1.78422868811712e-09,6.63421175962108e-08,"Q9TU23",8.35e-07,"Centrosomal protein of 290 kDa (Cep290) (Nephrocystin-6)","camera-type eye development [GO:0043010]; ciliary basal body-plasma membrane docking [GO:0097711]; ciliary transition zone assembly [GO:1905349]; kidney development [GO:0001822]; non-motile cilium assembly [GO:1905515]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intracellular protein transport [GO:0090316]; protein transport [GO:0015031]","GO:0001822; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0015031; GO:0031410; GO:0032391; GO:0034451; GO:0035869; GO:0036038; GO:0043010; GO:0045893; GO:0090316; GO:0097711; GO:1905349; GO:1905515"
"363","Pocillopora_acuta_HIv2___RNAseq.g14914.t1",325.083977909077,-12.6620316813603,3.95371437413288,1.81151942609025e-09,6.71841460999215e-08,"Q8N371",2.56e-19,"Bifunctional peptidase and arginyl-hydroxylase JMJD5 (EC 1.14.11.73) (EC 3.4.-.-) (JmjC domain-containing protein 5) (Jumonji C domain-containing protein 5) (L-arginine (3R)-hydroxylase KDM8)","circadian regulation of gene expression [GO:0032922]; fibroblast proliferation [GO:0048144]; G2/M transition of mitotic cell cycle [GO:0000086]; in utero embryonic development [GO:0001701]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; protein destabilization [GO:0031648]; proteolysis [GO:0006508]; regulation of signal transduction by p53 class mediator [GO:1901796]","GO:0000086; GO:0001701; GO:0002039; GO:0003682; GO:0004175; GO:0004177; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006508; GO:0031648; GO:0032922; GO:0035064; GO:0045892; GO:0045893; GO:0046872; GO:0048144; GO:0051864; GO:0106157; GO:1901796"
"364","Pocillopora_acuta_HIv2___RNAseq.g31026.t1",710.677220915606,-9.82719671588296,2.79956039352849,1.8814686363987e-09,6.95999037260123e-08,NA,NA,NA,NA,NA
"365","Pocillopora_acuta_HIv2___RNAseq.g1200.t1",410.456973492759,-10.6454375684366,3.08964320746909,1.94264955827587e-09,7.14999227650699e-08,"P31649",0,"Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13)","amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; creatine transmembrane transport [GO:0015881]; gamma-aminobutyric acid import [GO:0051939]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; taurine transmembrane transport [GO:0015734]","GO:0005283; GO:0005308; GO:0005332; GO:0005368; GO:0005369; GO:0005886; GO:0006836; GO:0006865; GO:0015185; GO:0015734; GO:0015881; GO:0016323; GO:0016597; GO:0035725; GO:0042995; GO:0051939; GO:0089718"
"366","Pocillopora_acuta_HIv2___TS.g16229.t1",4088.82997827338,-1.04959815531206,2.01739901469895,1.94271775765158e-09,7.14999227650699e-08,NA,NA,NA,NA,NA
"367","Pocillopora_acuta_HIv2___RNAseq.g25589.t1",156.375849257961,-11.8732865942706,3.60778430123386,1.96170376212722e-09,7.20154396330157e-08,NA,NA,NA,NA,NA
"368","Pocillopora_acuta_HIv2___RNAseq.g18390.t1",242.237010228234,-9.44415159398701,2.46713143933113,1.99301993555044e-09,7.29798489817762e-08,NA,NA,NA,NA,NA
"369","Pocillopora_acuta_HIv2___RNAseq.g13977.t1",1008.24770555451,-6.8096960985414,4.81754665064603,2.01375874384446e-09,7.35530466438543e-08,"B3EWY9",0,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020"
"370","Pocillopora_acuta_HIv2___RNAseq.g15652.t1",146.946015513097,-11.9518805367047,3.61997121920122,2.04761526236386e-09,7.4601277468088e-08,"Q6P4F7",7e-37,"Rho GTPase-activating protein 11A (Rho-type GTPase-activating protein 11A)","positive regulation of GTPase activity [GO:0043547]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]","GO:0005096; GO:0005634; GO:0005829; GO:0007165; GO:0043547; GO:0051056"
"371","Pocillopora_acuta_HIv2___TS.g20127.t1b",1359.92324999169,-7.33150203079188,4.62074853151005,2.07382251333833e-09,7.53662533490593e-08,"Q5PQM2",1.52e-10,"Kinesin light chain 4 (KLC 4) (Kinesin-like protein 8)","microtubule-based movement [GO:0007018]","GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0019894"
"372","Pocillopora_acuta_HIv2___RNAseq.g344.t1",3346.9184450828,-1.00636716282555,1.86560733003787,2.12385207117541e-09,7.69909683144889e-08,"Q9LQU4",5.6e-16,"Protein PLANT CADMIUM RESISTANCE 2 (AtPCR2)","response to oxidative stress [GO:0006979]","GO:0005886; GO:0006979"
"373","Pocillopora_acuta_HIv2___RNAseq.g10736.t1",176.859999675485,-12.3761421681064,3.74219532794435,2.20589419754815e-09,7.95662186367493e-08,"A0A0C2SRU0",1.77e-79,"Decarboxylase iboD (EC 4.1.1.-) (Ibotenic acid biosynthesis cluster protein D)","phospholipid biosynthetic process [GO:0008654]","GO:0004609; GO:0008654"
"374","Pocillopora_acuta_HIv2___RNAseq.g23421.t1",760.151212985779,-11.0893129699137,3.2436091388206,2.22330626553159e-09,7.99947806583305e-08,NA,NA,NA,NA,NA
"375","Pocillopora_acuta_HIv2___RNAseq.g26118.t1",743.19810752368,-1.20752581076459,2.48962691333417,2.26654201616777e-09,8.13480489375947e-08,"C9D7C2",0,"Voltage-dependent calcium channel type A subunit alpha-1 (Cacophony protein)","calcium ion import across plasma membrane [GO:0098703]; chemical synaptic transmission [GO:0007268]","GO:0005509; GO:0005891; GO:0007268; GO:0008331; GO:0045202; GO:0098703"
"376","Pocillopora_acuta_HIv2___RNAseq.g1971.t1",260.726450049051,-10.2422316865483,2.87570259873254,2.35364206262666e-09,8.42650465193862e-08,"Q2QLF8",6.66e-13,"Cortactin-binding protein 2 (CortBP2)","","GO:0005938; GO:0043197; GO:0090443"
"377","Pocillopora_acuta_HIv2___RNAseq.g25689.t1",180.095814313841,-12.0167399495501,3.68276036266978,2.38286216190425e-09,8.51005390365013e-08,"Q61184",3e-24,"Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of insulin secretion [GO:0046676]","GO:0004930; GO:0005886; GO:0007186; GO:0007193; GO:0007623; GO:0008502; GO:0042562; GO:0043025; GO:0043235; GO:0046676; GO:0097159"
"378","Pocillopora_acuta_HIv2___RNAseq.g10927.t1",5557.52588219212,-4.22573042609599,0.832662915116538,2.40823430411986e-09,8.57948299871668e-08,"A0A0B5RUB0",9.02e-112,"Trimethylamine transporter (TMA transporter) (TMA-specific transporter)","","GO:0005886; GO:0022857"
"379","Pocillopora_acuta_HIv2___RNAseq.g5108.t1b",386.986622824301,-10.2663913509797,3.00881082304973,2.44700714970129e-09,8.6748802483528e-08,NA,NA,NA,NA,NA
"380","Pocillopora_acuta_HIv2___RNAseq.g7049.t1",175.142733381291,-12.1804834789123,3.75002320067466,2.48376862521865e-09,8.78367466874392e-08,"Q6JZS3",5e-83,"Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1)","","GO:0004497; GO:0005506; GO:0005789; GO:0020037; GO:0043231; GO:0070330"
"381","Pocillopora_acuta_HIv2___RNAseq.g24764.t1",547.641892946914,-10.2499523526227,3.18373898973164,2.57533415824446e-09,9.06317111066857e-08,"P60899",7.71e-71,"DNA-directed RNA polymerase II subunit RPB9 (RNA polymerase II subunit B9) (DNA-directed RNA polymerase II subunit I) (RNA polymerase II 14.5 kDa subunit) (RPB14.5)","maintenance of transcriptional fidelity during transcription elongation by RNA polymerase II [GO:0001193]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]","GO:0001193; GO:0003676; GO:0003899; GO:0005634; GO:0005665; GO:0005730; GO:0006283; GO:0006366; GO:0006367; GO:0008270"
"382","Pocillopora_acuta_HIv2___TS.g12848.t1",975.410062617966,7.10458785906655,4.59093440404276,2.60283642230769e-09,9.13772476025691e-08,"Q5RFW0",1.02e-17,"Scavenger receptor class A member 5","endocytosis [GO:0006897]; intracellular iron ion homeostasis [GO:0006879]; iron ion transmembrane transport [GO:0034755]; protein homotrimerization [GO:0070207]","GO:0005886; GO:0006879; GO:0006897; GO:0034755; GO:0070207; GO:0070287"
"383","Pocillopora_acuta_HIv2___RNAseq.g993.t1",2110.82545169326,-4.03712903750274,5.67440725139538,2.62771892504579e-09,9.20274250166158e-08,"P09917",2.26e-47,"Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34)","arachidonic acid metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; humoral immune response [GO:0006959]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426]","GO:0001937; GO:0002232; GO:0002523; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005576; GO:0005615; GO:0005635; GO:0005641; GO:0005654; GO:0005829; GO:0006691; GO:0006959; GO:0016363; GO:0016525; GO:0016787; GO:0019369; GO:0019370; GO:0019372; GO:0030501; GO:0031965; GO:0034440; GO:0034774; GO:0036336; GO:0036403; GO:0042593; GO:0042759; GO:0045598; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904813; GO:1904999; GO:2001301"
"384","Pocillopora_acuta_HIv2___TS.g17424.t1",236.411443527629,-12.3866995363286,3.80433863402433,2.68182305309982e-09,9.36953831884924e-08,NA,NA,NA,NA,NA
"385","Pocillopora_acuta_HIv2___TS.g21128.t1",169.891696028128,-12.1287636756343,3.71163637774532,2.76334259211538e-09,9.63108126562814e-08,"Q20JQ7",0,"Sodium channel protein type 4 subunit alpha B (Voltage-gated sodium channel subunit alpha Nav1.4b)","membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; sodium ion transmembrane transport [GO:0035725]","GO:0001518; GO:0005248; GO:0019228; GO:0030424; GO:0035725; GO:0086010"
"386","Pocillopora_acuta_HIv2___RNAseq.g17089.t1",175.086743847561,-12.0810073026721,3.68443861945423,2.94272316490184e-09,1.0182666951469e-07,"G5EG78",1.9e-101,"Peroxidasin homolog pxn-2 (EC 1.11.2.-)","axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; embryonic body morphogenesis [GO:0010172]; muscle attachment [GO:0016203]; negative regulation of axon regeneration [GO:0048681]; regulation of basement membrane organization [GO:0110011]; response to oxidative stress [GO:0006979]","GO:0004601; GO:0005604; GO:0005615; GO:0006979; GO:0007411; GO:0010172; GO:0016203; GO:0020037; GO:0046872; GO:0048681; GO:0071711; GO:0110011; GO:0140825"
"387","Pocillopora_acuta_HIv2___RNAseq.g16758.t1",155.698026509265,-12.1495462920676,3.73639300600648,3.06955235000376e-09,1.05709536167748e-07,NA,NA,NA,NA,NA
"388","Pocillopora_acuta_HIv2___RNAseq.g1127.t2",394.894998028904,10.3227088149175,3.20348769642754,3.08711835939264e-09,1.06013121572229e-07,"Q6V0K7",1.63e-26,"Oncoprotein-induced transcript 3 protein (Liver-specific zona pellucida domain-containing protein)","renal system process [GO:0003014]","GO:0003014; GO:0005509; GO:0005635"
"389","Pocillopora_acuta_HIv2___TS.g22704.t2",475.446607313009,-10.3509069374348,3.11695957616468,3.11036118201961e-09,1.06355234365796e-07,"Q5U206",1.45e-52,"Calmodulin-like protein 3","","GO:0005509; GO:0005737"
"390","Pocillopora_acuta_HIv2___RNAseq.g13690.t1",602.058500897069,10.583997151033,3.82888689379476,3.13180503330507e-09,1.06835915098407e-07,NA,NA,NA,NA,NA
"391","Pocillopora_acuta_HIv2___RNAseq.g15408.t1",273.674816434166,-9.41091753967175,2.54164611820029,3.17649043588583e-09,1.08105312152124e-07,NA,NA,NA,NA,NA
"392","Pocillopora_acuta_HIv2___RNAseq.g13403.t1",858.519794854355,-1.20504125633757,2.48474370674887,3.29334228355189e-09,1.11819020632147e-07,"Q86SS6",1.79e-35,"Synaptotagmin-9 (Synaptotagmin IX) (SytIX)","calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; calcium-ion regulated exocytosis [GO:0017156]; regulation of calcium ion-dependent exocytosis [GO:0017158]","GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0017156; GO:0017158; GO:0030276; GO:0030669; GO:0030672; GO:0031045; GO:0042802; GO:0070382; GO:0098686; GO:0099502"
"393","Pocillopora_acuta_HIv2___RNAseq.g175.t1",1221.92043470924,-6.88012450345106,5.22499098911887,3.30571019558463e-09,1.11976094306642e-07,NA,NA,NA,NA,NA
"394","Pocillopora_acuta_HIv2___RNAseq.g29275.t1",140.77521572938,-11.9004203150469,3.64221181372629,3.45068012375722e-09,1.16341811911479e-07,"Q09081",1.11e-116,"Potassium voltage-gated channel subfamily A member 2 (KC22) (Voltage-gated potassium channel subunit Kv1.2)","neuronal action potential [GO:0019228]; optic nerve structural organization [GO:0021633]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of circadian sleep/wake cycle, non-REM sleep [GO:0045188]; regulation of dopamine secretion [GO:0014059]; sensory perception of pain [GO:0019233]","GO:0005249; GO:0005251; GO:0005789; GO:0005886; GO:0008076; GO:0014059; GO:0019228; GO:0019233; GO:0021633; GO:0030027; GO:0030424; GO:0030425; GO:0031258; GO:0032809; GO:0033010; GO:0042734; GO:0043194; GO:0043204; GO:0043679; GO:0044224; GO:0045188; GO:0051260; GO:0071805"
"395","Pocillopora_acuta_HIv2___RNAseq.g21481.t1",792.065456771186,7.24523323269207,1.81144133277817,3.48717606438131e-09,1.17298871151654e-07,"P24821",5.67e-52,"Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)","bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to wounding [GO:0009611]","GO:0001558; GO:0001649; GO:0002009; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0005925; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009611; GO:0009612; GO:0010628; GO:0014012; GO:0016020; GO:0030155; GO:0030334; GO:0042475; GO:0045471; GO:0045545; GO:0050727; GO:0060447; GO:0060739; GO:0060740; GO:0062023; GO:0071300; GO:0071305; GO:0071774; GO:0071799; GO:0090733; GO:0098966"
"396","Pocillopora_acuta_HIv2___RNAseq.g26050.t1",4356.96245780312,7.80777038340867,2.37218114909185,3.5124549884974e-09,1.17757370905447e-07,"Q9IA95",9.55e-45,"Secreted frizzled-related protein 3 (sFRP-3) (Frizzled-related protein 1) (FrzB-1)","canonical Wnt signaling pathway [GO:0060070]; cochlea morphogenesis [GO:0090103]; convergent extension involved in organogenesis [GO:0060029]; epithelial cell development [GO:0002064]; hepatocyte differentiation [GO:0070365]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell development [GO:0010721]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hepatocyte differentiation [GO:0070367]; negative regulation of Wnt signaling pathway [GO:0030178]; neural crest cell differentiation [GO:0014033]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fat cell differentiation [GO:0045600]; somite development [GO:0061053]","GO:0002064; GO:0005615; GO:0005737; GO:0008285; GO:0010721; GO:0014033; GO:0017147; GO:0030178; GO:0030308; GO:0035567; GO:0043065; GO:0045600; GO:0060029; GO:0060070; GO:0061037; GO:0061053; GO:0070365; GO:0070367; GO:0090090; GO:0090103"
"397","Pocillopora_acuta_HIv2___RNAseq.g10024.t1",124.956797326471,-11.753542873203,3.57808269439513,3.51708961775118e-09,1.17757370905447e-07,NA,NA,NA,NA,NA
"398","Pocillopora_acuta_HIv2___RNAseq.g15159.t1",303.969221846213,-9.72739026390008,2.75572129056373,3.55145439937474e-09,1.18633340490892e-07,"Q7TN88",1.45e-54,"Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"399","Pocillopora_acuta_HIv2___RNAseq.g28715.t1",157.218490745542,-11.945210615011,3.69468445883721,3.63841949848686e-09,1.21258294069387e-07,NA,NA,NA,NA,NA
"400","Pocillopora_acuta_HIv2___RNAseq.g6366.t1",214.077295911434,-12.2570484263503,3.75647918125757,3.66500733818437e-09,1.21863600320687e-07,"Q7SY09",4.76e-36,"Adhesion G protein-coupled receptor L4","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; animal organ development [GO:0048513]; cell surface receptor signaling pathway [GO:0007166]","GO:0004930; GO:0005509; GO:0005886; GO:0007166; GO:0007189; GO:0048513"
"401","Pocillopora_acuta_HIv2___TS.g9752.t3",593.7277310131,-1.25734445512357,2.71079679172877,3.71341751017224e-09,1.23190070796173e-07,"Q14517",4.66e-21,"Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]","actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cellular response to angiotensin [GO:1904385]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis [GO:0003412]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens development in camera-type eye [GO:0002088]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]","GO:0002088; GO:0003382; GO:0003412; GO:0005509; GO:0005634; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0007015; GO:0007155; GO:0007156; GO:0007163; GO:0007267; GO:0009653; GO:0016324; GO:0016477; GO:0030027; GO:0030175; GO:0048471; GO:0070062; GO:0098609; GO:1904385; GO:1904754"
"402","Pocillopora_acuta_HIv2___RNAseq.g2526.t1",131.777735837222,-11.7820890468733,3.59723292687694,3.82387205672503e-09,1.26564039882084e-07,NA,NA,NA,NA,NA
"403","Pocillopora_acuta_HIv2___RNAseq.g14951.t1",847.297592672048,-8.2382119304722,2.56651454787949,3.84051803331647e-09,1.26824778159565e-07,"B3EWZ3",1.5e-76,"Coadhesin","","GO:0016020"
"404","Pocillopora_acuta_HIv2___RNAseq.g15257.t1",1581.91802845492,-7.30452679784332,2.48683449066426,3.87633745954939e-09,1.27716047869983e-07,NA,NA,NA,NA,NA
"405","Pocillopora_acuta_HIv2___TS.g5171.t1",295.198265472461,-9.49528426615781,2.6434138817504,4.02370921627066e-09,1.32270295691224e-07,"P52569",2.27e-146,"Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2)","amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-arginine transmembrane transport [GO:1903826]; L-ornithine transmembrane transport [GO:1903352]; transport across blood-brain barrier [GO:0150104]","GO:0000064; GO:0005886; GO:0006865; GO:0015171; GO:0015174; GO:0015179; GO:0015189; GO:0015807; GO:0030054; GO:0061459; GO:0089718; GO:0097638; GO:0150104; GO:1902475; GO:1903352; GO:1903826"
"406","Pocillopora_acuta_HIv2___TS.g19097.t2",208.317013045612,-12.3553477255754,3.85247270422173,4.28911597325152e-09,1.40675223213401e-07,"Q94887",1.07e-14,"Neurexin-4 (Neurexin IV)","axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; terminal button organization [GO:0072553]","GO:0003015; GO:0005886; GO:0005919; GO:0007391; GO:0008039; GO:0008104; GO:0008366; GO:0019991; GO:0021682; GO:0035151; GO:0045202; GO:0045216; GO:0048786; GO:0060857; GO:0061343; GO:0072553; GO:0097105"
"407","Pocillopora_acuta_HIv2___RNAseq.g10294.t1",175.429385145671,-12.2033257637192,3.78446851255597,4.36228542530866e-09,1.42429111493599e-07,"Q58A42",5.84e-70,"Protein DD3-3","","GO:0016020"
"408","Pocillopora_acuta_HIv2___RNAseq.g12752.t1",1551.67452238722,-6.72709701147309,5.18011600131841,4.42572272073625e-09,1.44174895118759e-07,"Q9UKP5",3.14e-146,"A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-)","aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508]","GO:0001822; GO:0003279; GO:0004222; GO:0005576; GO:0006508; GO:0008237; GO:0030198; GO:0031012; GO:0035904; GO:0046872; GO:0060976"
"409","Pocillopora_acuta_HIv2___RNAseq.g7553.t1",178.606610751168,-12.123627689548,3.76147299332261,4.53001804665599e-09,1.47240856240073e-07,"Q14517",2.69e-09,"Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]","actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cellular response to angiotensin [GO:1904385]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis [GO:0003412]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens development in camera-type eye [GO:0002088]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]","GO:0002088; GO:0003382; GO:0003412; GO:0005509; GO:0005634; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0007015; GO:0007155; GO:0007156; GO:0007163; GO:0007267; GO:0009653; GO:0016324; GO:0016477; GO:0030027; GO:0030175; GO:0048471; GO:0070062; GO:0098609; GO:1904385; GO:1904754"
"410","Pocillopora_acuta_HIv2___RNAseq.g15598.t1",2185.21135854465,-1.45949883765101,4.44920227036173,4.55586912183447e-09,1.47749082910793e-07,NA,NA,NA,NA,NA
"411","Pocillopora_acuta_HIv2___RNAseq.g10096.t1",187.351047511824,-12.1750236233746,3.76640080348542,4.58028404473584e-09,1.47791795891781e-07,NA,NA,NA,NA,NA
"412","Pocillopora_acuta_HIv2___RNAseq.g15137.t1",188.012888832924,-12.228248186123,3.85203860749756,4.58990802901236e-09,1.47791795891781e-07,"Q9Z2E3",0,"Serine/threonine-protein kinase/endoribonuclease IRE2 (Endoplasmic reticulum-to-nucleus signaling 2) (Inositol-requiring protein 2) (Ire1-beta) (IRE1b) (mIre1) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)]","apoptotic chromosome condensation [GO:0030263]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of JUN kinase activity [GO:0043507]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; response to endoplasmic reticulum stress [GO:0034976]; rRNA catabolic process [GO:0016075]","GO:0000287; GO:0004521; GO:0004674; GO:0005524; GO:0005829; GO:0006355; GO:0006397; GO:0006468; GO:0016075; GO:0030263; GO:0034976; GO:0036498; GO:0043507; GO:0044322; GO:0045892; GO:0051082; GO:0070059; GO:0106310; GO:1990604"
"413","Pocillopora_acuta_HIv2___RNAseq.g11039.t1",612.291924077895,-8.96476084972654,2.5993162458757,4.59444160525511e-09,1.47791795891781e-07,NA,NA,NA,NA,NA
"414","Pocillopora_acuta_HIv2___RNAseq.g18882.t1",213.343504217865,-9.20046891838187,2.46995585732651,4.69257759189417e-09,1.50495437448242e-07,NA,NA,NA,NA,NA
"415","Pocillopora_acuta_HIv2___RNAseq.g14869.t1",277.224405250264,-12.8956676697606,4.06159483467957,4.79522519013058e-09,1.53447206084179e-07,"Q9Y5X5",6.03e-26,"Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor)","cellular response to hormone stimulus [GO:0032870]; detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of MAPK cascade [GO:0043408]","GO:0004930; GO:0005886; GO:0007186; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0032870; GO:0042277; GO:0043408"
"416","Pocillopora_acuta_HIv2___RNAseq.g8276.t1",579.755694514519,-10.7215090876389,3.25779288517379,4.89584405150791e-09,1.55976846610155e-07,"Q6VAB6",7.67e-45,"Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1)","calcium-mediated signaling [GO:0019722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265]","GO:0004672; GO:0004674; GO:0005078; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007265; GO:0019722; GO:0031434; GO:0043410; GO:0046872; GO:0106310; GO:0120162"
"417","Pocillopora_acuta_HIv2___RNAseq.g3492.t1",120.360259548669,-11.6318228870756,3.55797158271238,5.10438959399908e-09,1.6226349689583e-07,NA,NA,NA,NA,NA
"418","Pocillopora_acuta_HIv2___RNAseq.g30992.t1",924.626802302463,-1.01171178021119,1.89222986732249,5.11907864605365e-09,1.6237358231693e-07,"Q9Z2J0",0,"Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (Yolk sac permease-like molecule 3)","brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814]","GO:0005737; GO:0005886; GO:0005903; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015143; GO:0015229; GO:0015882; GO:0016324; GO:0030324; GO:0033300; GO:0043229; GO:0070837"
"419","Pocillopora_acuta_HIv2___RNAseq.g16525.t1",160.960115596749,-9.44241070353,2.48613736315551,5.14364979089188e-09,1.62795953119169e-07,"Q6VTH5",1.59e-89,"Radial spoke head 1 homolog (Meichroacidin homolog) (Meichroacidin-like sperm-specific axonemal protein) (Testis-specific gene A2-like protein)","cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; spermatogenesis [GO:0007283]","GO:0001535; GO:0007283; GO:0030154; GO:0036126; GO:0051321; GO:0097729"
"420","Pocillopora_acuta_HIv2___RNAseq.673_t",1356.35628188467,8.2731520281929,3.51307287679491,5.23731205341391e-09,1.65398431311307e-07,"Q7TSY2",9.23e-33,"LHFPL tetraspan subfamily member 4 protein (Lipoma HMGIC fusion partner-like 4 protein)","gamma-aminobutyric acid receptor clustering [GO:0097112]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; regulation of inhibitory synapse assembly [GO:1905702]; sensory perception of sound [GO:0007605]","GO:0005886; GO:0007605; GO:0030425; GO:0045211; GO:0050811; GO:0060077; GO:0097112; GO:0098982; GO:0099572; GO:0099645; GO:1905702"
"421","Pocillopora_acuta_HIv2___RNAseq.g16193.t1",298.365124692412,-10.2284692719324,3.04288976875742,5.48936549547478e-09,1.72980789818186e-07,"Q496Y0",1.46e-90,"LON peptidase N-terminal domain and RING finger protein 3 (RING finger protein 127)","","GO:0005737; GO:0046872; GO:0061630"
"422","Pocillopora_acuta_HIv2___RNAseq.g13533.t1",410.709756185949,-10.442835487096,3.2291722918917,5.52656064861158e-09,1.73774289611995e-07,"Q6V4S5",4.55e-54,"Protein sidekick-2","camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]","GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0045202; GO:0060219"
"423","Pocillopora_acuta_HIv2___RNAseq.g16715.t1",164499.295892458,3.53373267711346,0.674689347559383,5.81754614287225e-09,1.81728932553821e-07,"Q9LF88",2.78e-07,"Late embryogenesis abundant protein At3g53040 (LEA domain-containing protein At3g53040)","floral organ abscission [GO:0010227]","GO:0005829; GO:0010227"
"424","Pocillopora_acuta_HIv2___RNAseq.g18966.t1",158.819416209824,-12.0422756252408,3.77096149115025,5.8297998275009e-09,1.81728932553821e-07,"P63142",1.56e-142,"Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2)","action potential [GO:0001508]; cerebral cortex development [GO:0021987]; corpus callosum development [GO:0022038]; neuronal action potential [GO:0019228]; optic nerve development [GO:0021554]; optic nerve structural organization [GO:0021633]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of circadian sleep/wake cycle, non-REM sleep [GO:0045188]; regulation of dopamine secretion [GO:0014059]; sensory perception of pain [GO:0019233]","GO:0001508; GO:0005249; GO:0005251; GO:0005768; GO:0005789; GO:0005886; GO:0008076; GO:0014059; GO:0015271; GO:0016020; GO:0019228; GO:0019233; GO:0019894; GO:0021554; GO:0021633; GO:0021987; GO:0022038; GO:0030027; GO:0030424; GO:0030425; GO:0031258; GO:0032809; GO:0033010; GO:0034705; GO:0042734; GO:0043194; GO:0043204; GO:0043679; GO:0044224; GO:0044305; GO:0045188; GO:0045211; GO:0051260; GO:0071805; GO:0097623; GO:0098978; GO:0099508; GO:1905030"
"425","Pocillopora_acuta_HIv2___RNAseq.g2199.t1",169.962640449185,-11.9075821645563,3.71892706953328,5.91851586303911e-09,1.84097663318274e-07,NA,NA,NA,NA,NA
"426","Pocillopora_acuta_HIv2___RNAseq.g15988.t1",402.615652985082,-10.0245394375214,3.06038802781604,6.0902907114517e-09,1.8894149424544e-07,NA,NA,NA,NA,NA
"427","Pocillopora_acuta_HIv2___RNAseq.g3500.t1",395.143572980361,-9.8227510270439,2.99386246411884,6.11342777287514e-09,1.8894149424544e-07,NA,NA,NA,NA,NA
"428","Pocillopora_acuta_HIv2___RNAseq.g9811.t1",280.135989197837,-9.94290072014985,2.92623941577017,6.19327195891293e-09,1.90790283020692e-07,"Q924H0",7.27e-29,"Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor)","cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of MAPK cascade [GO:0043408]","GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0042277; GO:0043408"
"429","Pocillopora_acuta_HIv2___RNAseq.g8523.t1",133.456897571417,-11.8512306930102,3.67983633399955,6.19962894218234e-09,1.90790283020692e-07,"B3EWZ3",2.54e-29,"Coadhesin","","GO:0016020"
"430","Pocillopora_acuta_HIv2___RNAseq.g27399.t1",695.194086628675,-9.98668772457119,3.42289142171178,6.54363079407636e-09,2.00523465689662e-07,"O57382",1.05e-16,"Tolloid-like protein 2 (EC 3.4.24.-) (Metalloprotease xolloid) (Xenopus tolloid)","cell differentiation [GO:0030154]; proteolysis [GO:0006508]","GO:0004222; GO:0005509; GO:0005576; GO:0006508; GO:0008270; GO:0030154"
"431","Pocillopora_acuta_HIv2___RNAseq.g19083.t1",2772.76454279608,7.62282882780769,2.29582026580382,6.59441383840708e-09,2.01652435007865e-07,"P0C6X2",6.74e-08,"Replicase polyprotein 1ab (pp1ab) (ORF1ab polyprotein) [Cleaved into: Host translation inhibitor nsp1 (nsp1) (p28); Non-structural protein 2 (nsp2) (p65); Papain-like proteinase nsp3 (PL-PRO) (EC 3.4.19.12) (EC 3.4.22.-) (Non-structural protein 3) (nsp3) (p210); Non-structural protein 4 (nsp4) (Peptide HD2) (p44); 3C-like proteinase nsp5 (3CL-PRO) (3CLp) (EC 3.4.22.-) (M-PRO) (nsp5) (p27); Non-structural protein 6 (nsp6); Non-structural protein 7 (nsp7) (p10); Non-structural protein 8 (nsp8) (p22); Viral protein genome-linked nsp9 (Non-structural protein 9) (nsp9) (RNA-capping enzyme subunit nsp9) (p12); Non-structural protein 10 (nsp10) (Growth factor-like peptide) (GFL) (p15); RNA-directed RNA polymerase nsp12 (Pol) (RdRp) (EC 2.7.7.48) (EC 2.7.7.50) (nsp12) (p100); Helicase nsp13 (Hel) (EC 3.6.4.12) (EC 3.6.4.13) (nsp13) (p67); Guanine-N7 methyltransferase nsp14 (ExoN) (EC 2.1.1.56) (EC 3.1.13.-) (nsp14); Uridylate-specific endoribonuclease nsp15 (EC 4.6.1.-) (NendoU) (nsp15) (p35); 2'-O-methyltransferase nsp16 (EC 2.1.1.57) (nsp16)]","DNA-templated transcription [GO:0006351]; induction by virus of host autophagy [GO:0039520]; proteolysis [GO:0006508]; symbiont-mediated degradation of host mRNA [GO:0039595]; symbiont-mediated perturbation of host ubiquitin-like protein modification [GO:0039648]; symbiont-mediated suppression of host ISG15-protein conjugation [GO:0039579]; symbiont-mediated suppression of host NF-kappaB cascade [GO:0085034]; symbiont-mediated suppression of host type I interferon-mediated signaling pathway [GO:0039502]; viral genome replication [GO:0019079]; viral protein processing [GO:0019082]; viral translational frameshifting [GO:0075523]; virus-mediated perturbation of host defense response [GO:0019049]","GO:0000175; GO:0003724; GO:0003727; GO:0003968; GO:0004197; GO:0004482; GO:0004483; GO:0004519; GO:0004843; GO:0005524; GO:0006351; GO:0006508; GO:0008242; GO:0008270; GO:0016020; GO:0016829; GO:0016887; GO:0019049; GO:0019079; GO:0019082; GO:0033644; GO:0039502; GO:0039520; GO:0039579; GO:0039595; GO:0039648; GO:0044172; GO:0044220; GO:0075523; GO:0085034"
"432","Pocillopora_acuta_HIv2___RNAseq.g7626.t1",648.380386902381,-7.39515506478833,3.49535578355161,6.70333753252706e-09,2.0455078917821e-07,"Q9V477",6.49e-15,"Toll-like receptor Tollo (Toll-like receptor 8)","axis elongation [GO:0003401]; convergent extension [GO:0060026]; innate immune response [GO:0045087]; peripheral nervous system neuron development [GO:0048935]; regulation of protein glycosylation [GO:0060049]; signal transduction [GO:0007165]","GO:0003401; GO:0005886; GO:0007165; GO:0016324; GO:0045087; GO:0048018; GO:0048935; GO:0060026; GO:0060049; GO:0061809"
"433","Pocillopora_acuta_HIv2___RNAseq.g13270.t1",193.255076777531,-8.78421196349655,2.22154883192178,7.01368181590447e-09,2.13570302705773e-07,NA,NA,NA,NA,NA
"434","Pocillopora_acuta_HIv2___TS.g19988.t1",141.406931162774,-11.5771967021503,3.63121254349769,7.11864158189104e-09,2.16310991261496e-07,NA,NA,NA,NA,NA
"435","Pocillopora_acuta_HIv2___RNAseq.g8086.t1",748.221244176246,-10.3278309560828,3.41325636329624,7.14108869365371e-09,2.16538169528317e-07,"Q8R151",1.86e-146,"NFX1-type zinc finger-containing protein 1","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607"
"436","Pocillopora_acuta_HIv2___RNAseq.g26672.t1",145.888738484697,-11.753580981515,3.65833002953646,7.21887218725453e-09,2.18438843758262e-07,"P54131",1.59e-110,"Neuronal acetylcholine receptor subunit alpha-7","calcium ion transport [GO:0006816]; cognition [GO:0050890]; intracellular calcium ion homeostasis [GO:0006874]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]","GO:0001540; GO:0001666; GO:0005886; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0032720; GO:0035094; GO:0042166; GO:0042803; GO:0043005; GO:0043410; GO:0045202; GO:0045211; GO:0045766; GO:0050890"
"437","Pocillopora_acuta_HIv2___TS.g3229.t1",1043.02960614867,7.88732943582164,2.69775289255009,7.27073105446222e-09,2.19548755682133e-07,NA,NA,NA,NA,NA
"438","Pocillopora_acuta_HIv2___TS.g1516.t1",150.250077371187,-9.02554265487585,2.38230690004612,7.36088545525123e-09,2.2180801505157e-07,"A0AUR5",8.27e-124,"Ubiquitin carboxyl-terminal hydrolase MINDY-3 (EC 3.4.19.12) (Deubiquitinating enzyme MINDY-3) (Protein CARP)","apoptotic process [GO:0006915]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]","GO:0004843; GO:0005634; GO:0006508; GO:0006915; GO:0071108; GO:1990380"
"439","Pocillopora_acuta_HIv2___RNAseq.g15141.t1",178.382300019555,-12.0688033269076,3.86599424278705,7.59166808252451e-09,2.28286667662442e-07,"Q8L8B8",1.54e-56,"Cytokinin riboside 5'-monophosphate phosphoribohydrolase LOG3 (EC 3.2.2.n1) (Protein LONELY GUY 3)","cytokinin biosynthetic process [GO:0009691]","GO:0005634; GO:0005829; GO:0009691; GO:0016799; GO:0102682"
"440","Pocillopora_acuta_HIv2___RNAseq.g24018.t1",147.620403608054,9.70329654141904,2.740240580558,7.63621244680989e-09,2.29149744461947e-07,NA,NA,NA,NA,NA
"441","Pocillopora_acuta_HIv2___RNAseq.g27413.t1",680.37379867378,-10.8068541218413,3.41398909371761,7.87278674093778e-09,2.35759808324895e-07,"P63079",4.11e-92,"Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3)","brain development [GO:0007420]; cellular response to histamine [GO:0071420]; cellular response to zinc ion [GO:0071294]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; chemical synaptic transmission, postsynaptic [GO:0099565]; chloride transmembrane transport [GO:1902476]; circadian sleep/wake cycle, REM sleep [GO:0042747]; cochlea development [GO:0090102]; exploration behavior [GO:0035640]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hard palate development [GO:0060022]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; learning [GO:0007612]; memory [GO:0007613]; monoatomic ion transmembrane transport [GO:0034220]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuron development [GO:0048666]; regulation of postsynaptic membrane potential [GO:0060078]; reproductive behavior [GO:0019098]; response to anesthetic [GO:0072347]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; social behavior [GO:0035176]; synaptic transmission, GABAergic [GO:0051932]","GO:0004890; GO:0005216; GO:0005254; GO:0005886; GO:0007214; GO:0007268; GO:0007399; GO:0007420; GO:0007612; GO:0007613; GO:0009410; GO:0009986; GO:0019098; GO:0021549; GO:0022851; GO:0030594; GO:0030659; GO:0034220; GO:0034707; GO:0035176; GO:0035612; GO:0035640; GO:0042747; GO:0042802; GO:0043005; GO:0043195; GO:0045202; GO:0045211; GO:0048666; GO:0051932; GO:0060021; GO:0060022; GO:0060077; GO:0060078; GO:0060080; GO:0060119; GO:0060384; GO:0061744; GO:0071294; GO:0071420; GO:0072347; GO:0090102; GO:0098982; GO:0099565; GO:0099634; GO:1902476; GO:1902495; GO:1902711; GO:1904315; GO:1904862"
"442","Pocillopora_acuta_HIv2___RNAseq.g9381.t1",374.196229111387,10.1703816261436,3.24703547828754,7.91127017512635e-09,2.36422751679809e-07,"Q60928",3.76e-122,"Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]","cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638]","GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006536; GO:0006749; GO:0006750; GO:0006751; GO:0007283; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0103068"
"443","Pocillopora_acuta_HIv2___RNAseq.g21627.t1",740.285196352006,-6.31854132516727,4.12038898810744,7.97322897407702e-09,2.37770057832293e-07,"Q96N23",0,"Cilia- and flagella-associated protein 54","cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; establishment of localization in cell [GO:0051649]; mucociliary clearance [GO:0120197]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283]","GO:0005576; GO:0005930; GO:0007283; GO:0051649; GO:0060271; GO:0060294; GO:0090660; GO:0120197; GO:0120316"
"444","Pocillopora_acuta_HIv2___RNAseq.g21884.t1",182.225498377468,-11.8940525593611,3.74932207758651,7.98923175515033e-09,2.37770057832293e-07,"Q9Y227",2.93e-168,"Ectonucleoside triphosphate diphosphohydrolase 4 (NTPDase 4) (EC 3.6.1.15) (EC 3.6.1.6) (Golgi UDPase) (Lysosomal apyrase-like protein of 70 kDa) (Uridine-diphosphatase) (UDPase) (EC 3.6.1.42)","CTP metabolic process [GO:0046036]; GDP catabolic process [GO:0046712]; nucleobase-containing small molecule catabolic process [GO:0034656]; UDP catabolic process [GO:0006256]","GO:0000139; GO:0000421; GO:0003924; GO:0004382; GO:0005765; GO:0005794; GO:0006256; GO:0016020; GO:0017110; GO:0017111; GO:0031410; GO:0034656; GO:0036384; GO:0043273; GO:0045134; GO:0046036; GO:0046712"
"445","Pocillopora_acuta_HIv2___RNAseq.g7443.t1",443.172271713954,-10.4097823356227,3.2407351637948,8.53918840767688e-09,2.52062900262527e-07,"Q32NG4",2.39e-94,"Glutamine amidotransferase-like class 1 domain-containing protein 1 (Ferry endosomal RAB5 effector complex subunit 5) (Fy-5) (Parkinson disease 7 domain-containing protein 1)","","GO:0005576; GO:0005769"
"446","Pocillopora_acuta_HIv2___RNAseq.g2173.t1",371.361882073016,-10.2966979242222,3.24066904783417,8.6435801225643e-09,2.54624730942505e-07,"Q8N0W5",4.39e-49,"IQ domain-containing protein K","",""
"447","Pocillopora_acuta_HIv2___RNAseq.g994.t1",1097.04685468941,-5.87548615787894,4.79616469881936,8.84907036962979e-09,2.60148280134807e-07,"P09917",1.46e-46,"Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34)","arachidonic acid metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; humoral immune response [GO:0006959]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426]","GO:0001937; GO:0002232; GO:0002523; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005576; GO:0005615; GO:0005635; GO:0005641; GO:0005654; GO:0005829; GO:0006691; GO:0006959; GO:0016363; GO:0016525; GO:0016787; GO:0019369; GO:0019370; GO:0019372; GO:0030501; GO:0031965; GO:0034440; GO:0034774; GO:0036336; GO:0036403; GO:0042593; GO:0042759; GO:0045598; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904813; GO:1904999; GO:2001301"
"448","Pocillopora_acuta_HIv2___TS.g12453.t2",884.199820296655,4.27468575754069,6.1019379052691,8.95404649457592e-09,2.62237105045419e-07,"O08746",2.22e-19,"Matrilin-2","axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; response to axon injury [GO:0048678]","GO:0001764; GO:0005509; GO:0005604; GO:0005615; GO:0007411; GO:0008347; GO:0030198; GO:0031012; GO:0031104; GO:0031175; GO:0048678; GO:0062023; GO:0120216"
"449","Pocillopora_acuta_HIv2___TS.g1768.t1",504.477650228987,-1.48505201906782,4.48450289136978,8.95638342729792e-09,2.62237105045419e-07,"P16621",2.14e-07,"Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR)","axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; hematopoietic stem cell homeostasis [GO:0061484]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; negative regulation of insulin receptor signaling pathway [GO:0046627]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic assembly at neuromuscular junction [GO:0051124]","GO:0004725; GO:0005001; GO:0005158; GO:0005925; GO:0007155; GO:0007283; GO:0007399; GO:0007411; GO:0007412; GO:0008045; GO:0008201; GO:0008594; GO:0009925; GO:0009986; GO:0030424; GO:0031252; GO:0031290; GO:0032093; GO:0045467; GO:0046627; GO:0048477; GO:0048675; GO:0048841; GO:0051124; GO:0051491; GO:0060269; GO:0061484; GO:0120034; GO:1903386"
"450","Pocillopora_acuta_HIv2___TS.g2144.t1",187.44216437744,-12.0488735512339,3.86777387529675,9.06532138605413e-09,2.6489052227856e-07,NA,NA,NA,NA,NA
"451","Pocillopora_acuta_HIv2___RNAseq.g13716.t1",1305.77810102607,-1.09325812237931,2.04131748248088,9.25293290339535e-09,2.69827462731271e-07,"D2IYS2",7.39e-70,"Tyrosine-protein kinase receptor torso (EC 2.7.10.1)","cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0043235; GO:0046872"
"452","Pocillopora_acuta_HIv2___TS.g28037.t1",120.114117307913,-11.5784713115042,3.66142107636819,1.00005061063219e-08,2.91040885959437e-07,NA,NA,NA,NA,NA
"453","Pocillopora_acuta_HIv2___TS.g16482.t1",595.102737753852,-9.74808962474393,3.51750000348824,1.02931023277695e-08,2.98954682869192e-07,"P31649",0,"Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13)","amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; creatine transmembrane transport [GO:0015881]; gamma-aminobutyric acid import [GO:0051939]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; taurine transmembrane transport [GO:0015734]","GO:0005283; GO:0005308; GO:0005332; GO:0005368; GO:0005369; GO:0005886; GO:0006836; GO:0006865; GO:0015185; GO:0015734; GO:0015881; GO:0016323; GO:0016597; GO:0035725; GO:0042995; GO:0051939; GO:0089718"
"454","Pocillopora_acuta_HIv2___TS.g12260.t1",509.973649229557,6.98097723185524,1.94070203134332,1.03441859503621e-08,2.99836283739553e-07,"P55024",3.06e-70,"Tyrosinase (EC 1.14.18.1) (Monophenol monooxygenase)","melanin biosynthetic process [GO:0042438]; pigmentation [GO:0043473]; response to blue light [GO:0009637]","GO:0004503; GO:0009637; GO:0033162; GO:0042438; GO:0042470; GO:0043473; GO:0046872"
"455","Pocillopora_acuta_HIv2___RNAseq.g1195.t1",121.864309158679,-11.4921960031982,3.59906677057978,1.04227732458814e-08,3.00908168120616e-07,"P24668",2.85e-06,"Cation-dependent mannose-6-phosphate receptor (CD Man-6-P receptor) (CD-MPR) (46 kDa mannose 6-phosphate receptor) (MPR 46)","intracellular protein transport [GO:0006886]; lysosomal transport [GO:0007041]; protein targeting to lysosome [GO:0006622]; secretion of lysosomal enzymes [GO:0033299]","GO:0005765; GO:0005768; GO:0005770; GO:0005802; GO:0006622; GO:0006886; GO:0007041; GO:0019904; GO:0033299; GO:0048471; GO:1905394"
"456","Pocillopora_acuta_HIv2___RNAseq.19049_t",22594.1017712648,-3.34090966894523,0.648150320054387,1.04543654880153e-08,3.00937983634138e-07,NA,NA,NA,NA,NA
"457","Pocillopora_acuta_HIv2___TS.g1731.t1",516.555249517255,-10.4115190790971,3.2530603570357,1.04654179872768e-08,3.00937983634138e-07,"P10079",5.83e-76,"Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","","GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579"
"458","Pocillopora_acuta_HIv2___RNAseq.g22676.t1",476.674802435943,-10.6818962346815,3.30347801455121,1.05435680833544e-08,3.02583668169918e-07,NA,NA,NA,NA,NA
"459","Pocillopora_acuta_HIv2___RNAseq.g1932.t1",163.973548814544,-11.935534689606,3.82359486758398,1.05919797024899e-08,3.03371078053098e-07,"P23999",4.72e-09,"Protein S-Myc","apoptotic process [GO:0006915]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0006915; GO:0046983"
"460","Pocillopora_acuta_HIv2___RNAseq.g14868.t1b",329.465398600593,-9.922223921731,3.01192208934665,1.11348572621954e-08,3.18289674783387e-07,"P46825",2.56e-08,"Kinesin light chain (KLC)","microtubule-based movement [GO:0007018]","GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0019894"
"461","Pocillopora_acuta_HIv2___RNAseq.g29822.t1",2126.25199022812,4.46065041310692,0.962085635948186,1.12352900505275e-08,3.20527091303411e-07,NA,NA,NA,NA,NA
"462","Pocillopora_acuta_HIv2___RNAseq.g14726.t1",143.755575253737,-11.9800108865336,3.72487171641044,1.13854313257781e-08,3.24171021055225e-07,NA,NA,NA,NA,NA
"463","Pocillopora_acuta_HIv2___RNAseq.g24123.t1",284.034595306127,-9.80593689864723,2.95203908557316,1.21660997706397e-08,3.45718009985328e-07,NA,NA,NA,NA,NA
"464","Pocillopora_acuta_HIv2___RNAseq.6942_t",1070.86015112357,-11.0278905109294,3.43048903693868,1.2364600590439e-08,3.50669770470803e-07,"Q8CBH5",5.47e-52,"Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2)","adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]","GO:0002250; GO:0005886; GO:0032393; GO:0042288; GO:0042590"
"465","Pocillopora_acuta_HIv2___RNAseq.g4978.t1",626.035372161439,-10.4660507192481,3.31697445080513,1.24182504384023e-08,3.51502102428672e-07,"Q6P1X6",1.81e-68,"UPF0598 protein C8orf82","",""
"466","Pocillopora_acuta_HIv2___RNAseq.g7550.t1",700.369251626463,-7.10663557795761,4.34292440321501,1.24669510892747e-08,3.52191368272009e-07,"Q8VI63",1.13e-69,"MOB kinase activator 2 (Mob2 homolog) (Mps one binder kinase activator-like 2) (Ovary-specific MOB-like protein)","actin cytoskeleton organization [GO:0030036]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein phosphorylation [GO:0001934]; signal transduction [GO:0007165]","GO:0001934; GO:0005634; GO:0005737; GO:0007165; GO:0010976; GO:0030036; GO:0030295; GO:0044306; GO:0046872; GO:0048471"
"467","Pocillopora_acuta_HIv2___TS.g11075.t2",373.064562057703,-9.93984190552158,3.13178289586097,1.27867835135588e-08,3.59821083151973e-07,"P30051",0,"Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13)","cellular response to retinoic acid [GO:0071300]; embryonic heart tube morphogenesis [GO:0003143]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; hippo signaling [GO:0035329]; lateral mesoderm development [GO:0048368]; notochord development [GO:0030903]; paraxial mesoderm development [GO:0048339]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; transition between fast and slow fiber [GO:0014883]","GO:0000978; GO:0000981; GO:0003143; GO:0003700; GO:0005634; GO:0005667; GO:0006355; GO:0006357; GO:0007507; GO:0010468; GO:0014883; GO:0030307; GO:0030903; GO:0035329; GO:0042127; GO:0045893; GO:0045944; GO:0048339; GO:0048368; GO:0048568; GO:0071300; GO:0140552; GO:1902459"
"468","Pocillopora_acuta_HIv2___TS.g5006.t1c",506.296844231968,-1.34470801535168,3.17902900572403,1.30429885024164e-08,3.66318030483398e-07,NA,NA,NA,NA,NA
"469","Pocillopora_acuta_HIv2___RNAseq.g10393.t1",270.13557583126,-9.57708485283915,2.93946869315628,1.33472218981663e-08,3.73849267893196e-07,"A9UMP7",1.21e-72,"Enolase 4 (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase)","glycolytic process [GO:0006096]","GO:0000015; GO:0000287; GO:0004634; GO:0006096"
"470","Pocillopora_acuta_HIv2___RNAseq.g672.t1",528.012808858935,-10.3692294338882,3.25299962860475,1.33628368017687e-08,3.73849267893196e-07,"B3EWZ3",2.84e-96,"Coadhesin","","GO:0016020"
"471","Pocillopora_acuta_HIv2___RNAseq.12690_t",645.084818474978,-10.157962742096,3.33220793506536,1.37037664273003e-08,3.82647254062687e-07,"Q9VQX4",0,"Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21)","NAD salvage [GO:0034355]; response to oxidative stress [GO:0006979]","GO:0004516; GO:0005829; GO:0006979; GO:0016740; GO:0034355; GO:0046872"
"472","Pocillopora_acuta_HIv2___RNAseq.g29670.t2",209.219227652221,-12.2128084332167,3.94915574031289,1.39167103572882e-08,3.86214850837327e-07,"Q16281",1.33e-122,"Cyclic nucleotide-gated channel alpha-3 (CNG channel alpha-3) (CNG-3) (CNG3) (Cone photoreceptor cGMP-gated channel subunit alpha-3)","inorganic cation import across plasma membrane [GO:0098659]; monoatomic cation transmembrane transport [GO:0098655]; monoatomic cation transport [GO:0006812]; response to cAMP [GO:0051591]; response to magnesium ion [GO:0032026]; signal transduction [GO:0007165]; visual perception [GO:0007601]","GO:0005222; GO:0005223; GO:0005262; GO:0005272; GO:0005886; GO:0006812; GO:0007165; GO:0007601; GO:0015276; GO:0017022; GO:0017071; GO:0030425; GO:0030553; GO:0032026; GO:0043194; GO:0043204; GO:0044877; GO:0045296; GO:0051591; GO:0097386; GO:0098655; GO:0098659; GO:1902495"
"473","Pocillopora_acuta_HIv2___RNAseq.g20653.t1",563.476190521502,6.27916278863448,4.45273034405469,1.39214783458956e-08,3.86214850837327e-07,NA,NA,NA,NA,NA
"474","Pocillopora_acuta_HIv2___RNAseq.g7243.t1",147.910878249033,-11.7051697955084,3.74967670765526,1.39383401643449e-08,3.86214850837327e-07,"Q8WU66",1.73e-32,"Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)","hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505]","GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170"
"475","Pocillopora_acuta_HIv2___RNAseq.g14744.t1",298.315985477422,-9.80719067950018,3.12154786992975,1.40121936812503e-08,3.87518870756413e-07,"Q7SC45",1.39e-33,"Protein btn-1","L-arginine transmembrane transport [GO:1903826]; lysine transport [GO:0015819]; regulation of intracellular pH [GO:0051453]","GO:0000324; GO:0005773; GO:0005774; GO:0015819; GO:0051453; GO:1903826"
"476","Pocillopora_acuta_HIv2___RNAseq.g8965.t1",348.376074581586,-10.035032867012,3.25613427008197,1.49744703142134e-08,4.13341104245768e-07,"Q640L5",8.02e-105,"Coiled-coil domain-containing protein 18","","GO:0005737; GO:0034451"
"477","Pocillopora_acuta_HIv2___RNAseq.g673.t1",447.099874280538,8.76271867274111,2.8308331734464,1.56614649550886e-08,4.31480817353147e-07,"O15460",4.76e-137,"Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2)","","GO:0004656; GO:0005506; GO:0005654; GO:0005783; GO:0005788; GO:0005829; GO:0009055; GO:0031418; GO:0043231"
"478","Pocillopora_acuta_HIv2___RNAseq.g7635.t1",6055.09317309642,3.82589955121025,0.787517108163696,1.59073299913589e-08,4.36591311185986e-07,"C0H690",1.84e-11,"Small cysteine-rich protein 1 (Amil-SCRiP1) (SCRiP1)","","GO:0005576; GO:0042151; GO:0090729"
"479","Pocillopora_acuta_HIv2___RNAseq.g21538.t1",130.209241528971,-11.7363044492385,3.69491252831839,1.63038141426813e-08,4.46625696514663e-07,"O43704",2.35e-56,"Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase)","3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; biogenic amine metabolic process [GO:0006576]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]","GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006576; GO:0006805; GO:0008146; GO:0009812; GO:0018958; GO:0030855; GO:0042403; GO:0050427; GO:0051923"
"480","Pocillopora_acuta_HIv2___RNAseq.g3580.t1",975.169963019767,-1.37169932877058,3.132700000126,1.63417046420459e-08,4.46817421441497e-07,"Q7ZSX3",2.09e-57,"Pancreas transcription factor 1 subunit alpha (Pancreas-specific transcription factor 1a) (bHLH transcription factor p48)","amacrine cell differentiation [GO:0035881]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; developmental process [GO:0032502]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; hindbrain development [GO:0030902]; neuron development [GO:0048666]; pancreas development [GO:0031016]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; retinoic acid receptor signaling pathway [GO:0048384]; tissue development [GO:0009888]","GO:0000977; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006355; GO:0006357; GO:0009887; GO:0009888; GO:0030154; GO:0030902; GO:0031016; GO:0031017; GO:0032502; GO:0035881; GO:0043565; GO:0045893; GO:0046983; GO:0048384; GO:0048666; GO:0048699"
"481","Pocillopora_acuta_HIv2___RNAseq.g30417.t1",444.065290897144,-7.2664331667044,3.31709549049606,1.64798240804901e-08,4.49743727358886e-07,NA,NA,NA,NA,NA
"482","Pocillopora_acuta_HIv2___TS.g18947.t1",17030.606210404,-3.35736836972465,0.664919936067497,1.67047180701767e-08,4.53798385910799e-07,"Q9QWN8",4.06e-57,"Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41)","actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; adult behavior [GO:0030534]; cellular response to ethanol [GO:0071361]; cerebellar Purkinje cell layer morphogenesis [GO:0021692]; multicellular organism growth [GO:0035264]; postsynapse organization [GO:0099173]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of postsynaptic specialization assembly [GO:0099150]; synapse assembly [GO:0007416]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005200; GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0007416; GO:0008021; GO:0008091; GO:0016079; GO:0016081; GO:0016192; GO:0016324; GO:0016363; GO:0017158; GO:0021692; GO:0030036; GO:0030054; GO:0030534; GO:0030864; GO:0033010; GO:0035264; GO:0042995; GO:0043025; GO:0048471; GO:0051015; GO:0051693; GO:0071361; GO:0098688; GO:0098793; GO:0098918; GO:0098978; GO:0099150; GO:0099173; GO:0099186; GO:0099189"
"483","Pocillopora_acuta_HIv2___RNAseq.g22977.t1",124.38488833886,-11.7148282295451,3.6832438467742,1.67225207197494e-08,4.53798385910799e-07,NA,NA,NA,NA,NA
"484","Pocillopora_acuta_HIv2___RNAseq.g18756.t2",130.629689073319,-11.5644527315142,3.71131525503225,1.67546854554832e-08,4.53819794809192e-07,"O75382",1.34e-10,"Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22) (RING finger protein 97)","negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]","GO:0000209; GO:0005737; GO:0005769; GO:0005794; GO:0007399; GO:0008270; GO:0015031; GO:0017148; GO:0030371; GO:0030425; GO:0034141; GO:0042802; GO:0043161; GO:0061630; GO:0070534"
"485","Pocillopora_acuta_HIv2___RNAseq.g9165.t1",258.445565897004,-10.0020006940688,3.05394839017297,1.73625888071381e-08,4.69406513096159e-07,NA,NA,NA,NA,NA
"486","Pocillopora_acuta_HIv2___RNAseq.g27209.t1",284.55292772011,-9.64349135166027,2.96871863696347,1.78000881078117e-08,4.80336705954083e-07,NA,NA,NA,NA,NA
"487","Pocillopora_acuta_HIv2___RNAseq.g18640.t1",150.631664968056,-11.8439541443873,3.86031869318448,1.78463997476091e-08,4.80550744415891e-07,"D2GXS7",1.03e-40,"Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2)","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]","GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0030371; GO:0043161; GO:0043523; GO:0061630"
"488","Pocillopora_acuta_HIv2___RNAseq.g8521.t2",282.523299634093,-8.4432714155383,2.53903735269769,1.787446767808e-08,4.80550744415891e-07,"P55023",1.56e-19,"Tyrosinase (EC 1.14.18.1) (Monophenol monooxygenase)","melanin biosynthetic process [GO:0042438]","GO:0004503; GO:0042438; GO:0046872"
"489","Pocillopora_acuta_HIv2___TS.g29621.t1",108.096164372217,-11.5560601429418,3.67767740774881,1.79286089199633e-08,4.81112058290072e-07,"O75581",0,"Low-density lipoprotein receptor-related protein 6 (LRP-6)","canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055]","GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0051091; GO:0060070; GO:0071397; GO:0071542; GO:0071901; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909"
"490","Pocillopora_acuta_HIv2___RNAseq.g17953.t1",487.413425434407,9.60454592768151,3.50030877412611,1.80988283588061e-08,4.84780469225502e-07,NA,NA,NA,NA,NA
"491","Pocillopora_acuta_HIv2___RNAseq.g14952.t1",100.504765074165,-11.3803364332101,3.58990583698165,1.83894912251632e-08,4.91655454862773e-07,"B3EWZ3",5.23e-51,"Coadhesin","","GO:0016020"
"492","Pocillopora_acuta_HIv2___RNAseq.g3741.t1",229.974031769155,-9.76564994434031,2.96210430380808,1.87010650379067e-08,4.99063108317865e-07,"Q8R323",0,"Replication factor C subunit 3 (Activator 1 38 kDa subunit) (A1 38 kDa subunit) (Activator 1 subunit 3) (Replication factor C 38 kDa subunit) (RF-C 38 kDa subunit) (RFC38)","DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; response to organophosphorus [GO:0046683]","GO:0003677; GO:0003689; GO:0005634; GO:0005663; GO:0006261; GO:0006281; GO:0016887; GO:0017116; GO:0031390; GO:0046683; GO:1900264"
"493","Pocillopora_acuta_HIv2___RNAseq.g21476.t1",97.5912124262545,-8.83974852331602,2.25730436737934,1.89833915282896e-08,5.04734880634523e-07,"P24821",1.15e-46,"Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)","bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to wounding [GO:0009611]","GO:0001558; GO:0001649; GO:0002009; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0005925; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009611; GO:0009612; GO:0010628; GO:0014012; GO:0016020; GO:0030155; GO:0030334; GO:0042475; GO:0045471; GO:0045545; GO:0050727; GO:0060447; GO:0060739; GO:0060740; GO:0062023; GO:0071300; GO:0071305; GO:0071774; GO:0071799; GO:0090733; GO:0098966"
"494","Pocillopora_acuta_HIv2___RNAseq.g720.t1",1195.83569752563,-6.83155216630994,2.76306887711047,1.95374449044119e-08,5.18513033206264e-07,NA,NA,NA,NA,NA
"495","Pocillopora_acuta_HIv2___RNAseq.g16404.t1",128.520335179793,-7.24527246359344,1.8267322954556,2.03438099894067e-08,5.38924666093001e-07,NA,NA,NA,NA,NA
"496","Pocillopora_acuta_HIv2___RNAseq.g28213.t1",2856.05827329361,-1.20055829403667,2.43360457684945,2.05467018088561e-08,5.43304378360684e-07,"C3ZQF9",4.07e-23,"QRFP-like peptide receptor","cellular response to hormone stimulus [GO:0032870]; cellular response to peptide [GO:1901653]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0032870; GO:0042277; GO:1901653"
"497","Pocillopora_acuta_HIv2___RNAseq.g8582.t1",396.200784749825,-10.3734444513066,3.30442773340486,2.07761500921557e-08,5.48369041848431e-07,NA,NA,NA,NA,NA
"498","Pocillopora_acuta_HIv2___RNAseq.g2780.t1",379.656734273056,-1.46312222290662,4.20397267227094,2.10733055867293e-08,5.55199074692993e-07,"Q7YS61",3.27e-112,"tRNA (cytosine(38)-C(5))-methyltransferase (EC 2.1.1.204) (DNA (cytosine-5)-methyltransferase-like protein 2) (Dnmt2)","tRNA methylation [GO:0030488]; tRNA stabilization [GO:0036416]","GO:0003723; GO:0005634; GO:0005737; GO:0016428; GO:0030488; GO:0036416"
"499","Pocillopora_acuta_HIv2___RNAseq.g11785.t1",185.500463514639,-12.1556665010683,3.87596408226079,2.12751003187747e-08,5.59496456383194e-07,"P79888",7.01e-51,"S-adenosylmethionine decarboxylase proenzyme (AdoMetDC) (SAMDC) (EC 4.1.1.50) [Cleaved into: S-adenosylmethionine decarboxylase alpha chain; S-adenosylmethionine decarboxylase beta chain]","spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]","GO:0004014; GO:0006597; GO:0008295"
"500","Pocillopora_acuta_HIv2___RNAseq.g16070.t1",127.99356372656,-11.5682470357404,3.76081620419925,2.15157042424418e-08,5.64796998480359e-07,NA,NA,NA,NA,NA
"501","Pocillopora_acuta_HIv2___TS.g18900.t1",320.154464622215,-9.62758869703819,3.17365856982658,2.2920531085982e-08,5.99498303124129e-07,NA,NA,NA,NA,NA
"502","Pocillopora_acuta_HIv2___RNAseq.g12573.t1",9305.29095810737,-5.5241308721434,1.50926831730804,2.34015716164749e-08,6.10975328268398e-07,NA,NA,NA,NA,NA
"503","Pocillopora_acuta_HIv2___RNAseq.g22296.t1",560.58780770675,-1.29494118439831,2.70532468874044,2.43354995275287e-08,6.34213811110226e-07,"Q5DTY9",4.9e-43,"BTB/POZ domain-containing protein KCTD16","protein homooligomerization [GO:0051260]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]","GO:0008277; GO:0042734; GO:0042995; GO:0043235; GO:0045211; GO:0051260"
"504","Pocillopora_acuta_HIv2___RNAseq.g12548.t1b",125.972937957615,-11.4287825420901,3.6963732750838,2.43886426970612e-08,6.34455625845851e-07,"Q9DBQ9",9.59e-50,"Transcriptional protein SWT1","","GO:0005634"
"505","Pocillopora_acuta_HIv2___RNAseq.g22394.t1",622.246947671507,-10.2053040046771,3.40075392314277,2.47416892665147e-08,6.4248436903208e-07,NA,NA,NA,NA,NA
"506","Pocillopora_acuta_HIv2___RNAseq.g15709.t1",395.864670932925,-10.2867793397303,3.27939192426536,2.58645091103643e-08,6.70437741527435e-07,NA,NA,NA,NA,NA
"507","Pocillopora_acuta_HIv2___TS.g21030.t2",881.776434015257,-1.02859597885404,1.89870552123847,2.65807345086229e-08,6.86542399879859e-07,"Q2I327",1.48e-41,"Doublesex- and mab-3-related transcription factor A2 (Doublesex- and mab-3-related transcription factor 5)","sex differentiation [GO:0007548]","GO:0000978; GO:0000981; GO:0005634; GO:0007548; GO:0046872"
"508","Pocillopora_acuta_HIv2___RNAseq.g1274.t1",255.64261169626,-11.9464515662305,3.98597500203418,2.67068555847474e-08,6.88570337215305e-07,"Q6P8B3",1.15e-173,"Speckle-type POZ protein","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]","GO:0005634; GO:0016567; GO:0016607; GO:0031463; GO:0043161"
"509","Pocillopora_acuta_HIv2___RNAseq.25384_t",433.724339600263,-1.32929999600412,3.07325037783474,2.73879879220578e-08,7.04875190933531e-07,"B3TP03",7.71e-126,"Cationic amino acid transporter 2 (CAT-2) (CAT2) (cCAT-2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2)","L-arginine import across plasma membrane [GO:0097638]; L-lysine import across plasma membrane [GO:0097639]; L-ornithine transmembrane transport [GO:1903352]","GO:0000064; GO:0005737; GO:0005794; GO:0005886; GO:0015189; GO:0031410; GO:0061459; GO:0097638; GO:0097639; GO:1903352"
"510","Pocillopora_acuta_HIv2___TS.g8089.t1",326.160840258056,-9.25641987628543,2.85813492854415,2.78849516182933e-08,7.1639065756127e-07,"Q02290",8.03e-07,"Endo-1,4-beta-xylanase B (Xylanase B) (EC 3.2.1.8) (1,4-beta-D-xylan xylanohydrolase B)","xylan catabolic process [GO:0045493]","GO:0005576; GO:0030248; GO:0031176; GO:0045493"
"511","Pocillopora_acuta_HIv2___RNAseq.g25691.t1",566.031155267787,-10.3764163152531,3.31888077540462,2.81998833313631e-08,7.21538342649568e-07,"Q5RC04",5.13e-159,"Ras-GEF domain-containing family member 1B","Ras protein signal transduction [GO:0007265]","GO:0005085; GO:0005769; GO:0005770; GO:0005886; GO:0007265; GO:0030496"
"512","Pocillopora_acuta_HIv2___RNAseq.g8220.t1",328.178762902617,-10.0645054556363,3.20618959487386,2.82349766274651e-08,7.21538342649568e-07,NA,NA,NA,NA,NA
"513","Pocillopora_acuta_HIv2___RNAseq.g17559.t1",552.611619037662,-6.62293977173011,3.77327995164036,2.921155794896e-08,7.45178084962536e-07,"P34410",2.48e-29,"TWiK family of potassium channels protein 7","potassium ion transmembrane transport [GO:0071805]; stabilization of membrane potential [GO:0030322]","GO:0005886; GO:0015271; GO:0022841; GO:0030322; GO:0071805"
"514","Pocillopora_acuta_HIv2___RNAseq.g24455.t1",302.293861394897,-9.57412265115299,3.22251242904392,3.04849453865436e-08,7.74928383253016e-07,NA,NA,NA,NA,NA
"515","Pocillopora_acuta_HIv2___RNAseq.g19116.t1",614.653193044081,-7.49993181550528,3.33526133657382,3.1410794591703e-08,7.97062689428759e-07,"Q7TN84",2.18e-32,"Synaptotagmin-14 (Synaptotagmin XIV) (SytXIV)","","GO:0005543; GO:0016020; GO:0042802"
"516","Pocillopora_acuta_HIv2___RNAseq.g13312.t1",811.72965471155,-4.89677234609241,4.52520575759297,3.15519391440539e-08,7.99242115200694e-07,NA,NA,NA,NA,NA
"517","Pocillopora_acuta_HIv2___RNAseq.g1812.t1",9662.94937539683,3.7931899700518,0.799071256517558,3.36750745196465e-08,8.48564943993322e-07,"P12716",0,"Actin, cytoplasmic (EC 3.6.4.-) [Cleaved into: Actin, cytoplasmic, intermediate form]","","GO:0005524; GO:0005737; GO:0005856; GO:0016787"
"518","Pocillopora_acuta_HIv2___RNAseq.g33.t1",30447.9102108154,-2.83711057796644,0.558014908867283,3.46930199180889e-08,8.72695374078675e-07,"G8HTB6",6.7e-42,"ZP domain-containing protein","","GO:0016020"
"519","Pocillopora_acuta_HIv2___RNAseq.6093_tb",123.150744365596,-7.91673059250083,2.19738960126611,3.514604338985e-08,8.81026640538631e-07,"Q8K5B3",2.12e-22,"Multiple coagulation factor deficiency protein 2 homolog (Neural stem cell-derived neuronal survival protein)","carboxylic acid metabolic process [GO:0019752]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]","GO:0005509; GO:0005576; GO:0005783; GO:0005793; GO:0005794; GO:0015031; GO:0016192; GO:0019752"
"520","Pocillopora_acuta_HIv2___RNAseq.g25909.t1",129.504017661606,-11.5330717504256,3.81123515405445,3.56699994685707e-08,8.91501349535819e-07,NA,NA,NA,NA,NA
"521","Pocillopora_acuta_HIv2___RNAseq.g13552.t1",463.707549207443,-10.1308969763139,3.4118438624825,3.56871737680613e-08,8.91501349535819e-07,"P48547",3.35e-106,"Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4)","action potential [GO:0001508]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellum development [GO:0021549]; corpus callosum development [GO:0022038]; globus pallidus development [GO:0021759]; optic nerve development [GO:0021554]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein tetramerization [GO:0051262]; response to amine [GO:0014075]; response to auditory stimulus [GO:0010996]; response to fibroblast growth factor [GO:0071774]; response to light intensity [GO:0009642]; response to nerve growth factor [GO:1990089]; response to potassium ion [GO:0035864]; response to toxic substance [GO:0009636]","GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0009636; GO:0009642; GO:0009986; GO:0010996; GO:0014075; GO:0019894; GO:0021549; GO:0021554; GO:0021759; GO:0022038; GO:0030673; GO:0032590; GO:0032809; GO:0035864; GO:0042734; GO:0043679; GO:0044305; GO:0044325; GO:0045211; GO:0051260; GO:0051262; GO:0071466; GO:0071774; GO:0071805; GO:0099508; GO:1901381; GO:1990089"
"522","Pocillopora_acuta_HIv2___RNAseq.g15567.t1",456.827221571118,-8.47313054109375,2.96507723039232,3.61581885930566e-08,9.01710413465467e-07,"P54357",2.51e-43,"Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain)","actin filament-based movement [GO:0030048]","GO:0005509; GO:0005829; GO:0016460; GO:0017022; GO:0030048; GO:0031475; GO:0031476; GO:0031477; GO:0032036"
"523","Pocillopora_acuta_HIv2___RNAseq.g4482.t1",698.606251710426,-6.62626548707491,4.18738250218559,3.66917955861886e-08,9.1222880748184e-07,NA,NA,NA,NA,NA
"524","Pocillopora_acuta_HIv2___RNAseq.g4938.t1",145.737455678457,-11.7812447777536,3.91826391475229,3.67061093718495e-08,9.1222880748184e-07,"E7FAM5",1.12e-121,"E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177"
"525","Pocillopora_acuta_HIv2___TS.g17158.t1",132.027835699952,-5.6960623265728,1.3899164376722,3.79685815445145e-08,9.41985529090665e-07,NA,NA,NA,NA,NA
"526","Pocillopora_acuta_HIv2___RNAseq.g1119.t1",934.210540933629,1.8485101145677,6.732507507849,3.83430698090581e-08,9.49647537188726e-07,"Q8C6K9",5.82e-52,"Collagen alpha-6(VI) chain","cell adhesion [GO:0007155]","GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023"
"527","Pocillopora_acuta_HIv2___RNAseq.g28097.t1b",100.538406776974,-11.3173809194611,3.65397707790143,3.85660689815218e-08,9.53537814955097e-07,NA,NA,NA,NA,NA
"528","Pocillopora_acuta_HIv2___RNAseq.g19152.t1",364.257946022413,-9.93359877383002,3.45732767664097,3.87931997626753e-08,9.57516794142212e-07,"P30825",7.14e-165,"High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter)","amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-arginine transmembrane transport [GO:1903826]; L-histidine import across plasma membrane [GO:1903810]; L-ornithine transmembrane transport [GO:1903352]; lysine transport [GO:0015819]; ornithine transport [GO:0015822]; positive regulation of T cell proliferation [GO:0042102]; transport across blood-brain barrier [GO:0150104]","GO:0000064; GO:0001618; GO:0005290; GO:0005886; GO:0006865; GO:0009925; GO:0015171; GO:0015174; GO:0015189; GO:0015807; GO:0015819; GO:0015822; GO:0016020; GO:0016323; GO:0016324; GO:0032991; GO:0042102; GO:0061459; GO:0089718; GO:0097638; GO:0150104; GO:1903352; GO:1903810; GO:1903826"
"529","Pocillopora_acuta_HIv2___RNAseq.g8219.t1",577.021992761047,-10.109546935933,3.3321816100745,3.91580131340623e-08,9.64874790410694e-07,NA,NA,NA,NA,NA
"530","Pocillopora_acuta_HIv2___TS.g21290.t1",463.981529188155,7.120654341681,4.68081910931276,3.9323054510023e-08,9.67293640192131e-07,NA,NA,NA,NA,NA
"531","Pocillopora_acuta_HIv2___RNAseq.g30954.t1",542.335819053487,6.470950478046,2.44217177017121,3.99453282313985e-08,9.80932474599231e-07,"A1KZ92",2.07e-33,"Probable oxidoreductase PXDNL (EC 1.-.-.-) (Cardiac peroxidase) (Inactive peroxidasin-like protein) (Polysomal ribonuclease 1) (PRM1) (Vascular peroxidase 2)","hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]","GO:0004519; GO:0004601; GO:0005615; GO:0005783; GO:0005886; GO:0006979; GO:0020037; GO:0042744; GO:0046872; GO:0140825"
"532","Pocillopora_acuta_HIv2___RNAseq.g12215.t1",490.349528173503,-7.37821685090191,3.5426691083684,4.06274515734169e-08,9.94307038169038e-07,"P08629",3.14e-30,"Thioredoxin (Trx)","positive regulation of DNA binding [GO:0043388]; response to radiation [GO:0009314]","GO:0005576; GO:0005634; GO:0005737; GO:0009314; GO:0015035; GO:0043388"
"533","Pocillopora_acuta_HIv2___RNAseq.g12796.t1",189.865687458002,-12.1357658760106,3.96933661660021,4.09462757156473e-08,9.98730070743883e-07,"Q4HX89",1.23e-41,"Protein BTN1","amino acid transport [GO:0006865]","GO:0005774; GO:0006865"
"534","Pocillopora_acuta_HIv2___TS.g20646.t1",113.521512290606,-11.3617419903676,3.70943819746305,4.18080543297587e-08,1.0170307826362e-06,NA,NA,NA,NA,NA
"535","Pocillopora_acuta_HIv2___TS.g2710.t1",25241.7068372189,-2.77483874029913,0.545409700186054,4.18372037934555e-08,1.0170307826362e-06,"G8HTB6",2.94e-156,"ZP domain-containing protein","","GO:0016020"
"536","Pocillopora_acuta_HIv2___TS.g16852.t1",9806.12586180218,-6.05218323847098,1.46791216272721,4.2071234152788e-08,1.02100391071464e-06,NA,NA,NA,NA,NA
"537","Pocillopora_acuta_HIv2___TS.g10567.t1",1767.88110476561,-3.82879533552066,4.89473498828565,4.45413648734402e-08,1.07733495239037e-06,NA,NA,NA,NA,NA
"538","Pocillopora_acuta_HIv2___RNAseq.g10683.t1",709.010726469878,-1.13097315913796,2.20967147447384,4.46257033385815e-08,1.07757290999874e-06,"Q9VCA2",5.37e-73,"Organic cation transporter protein","apoptotic process [GO:0006915]; monoatomic ion transport [GO:0006811]","GO:0006811; GO:0006915; GO:0016020; GO:0022857"
"539","Pocillopora_acuta_HIv2___RNAseq.g22675.t2",2729.83046484347,-3.7602530151549,0.8114117270991,4.51931736578655e-08,1.08945677297894e-06,NA,NA,NA,NA,NA
"540","Pocillopora_acuta_HIv2___RNAseq.g28451.t1",35500.3421110759,3.78470047187825,0.824738734621143,4.54496973621685e-08,1.09381767495242e-06,NA,NA,NA,NA,NA
"541","Pocillopora_acuta_HIv2___RNAseq.g367.t1",388.933550516527,-9.9678408439713,3.39218445044289,4.58393149063089e-08,1.10136187841338e-06,"G8HTB6",6.37e-37,"ZP domain-containing protein","","GO:0016020"
"542","Pocillopora_acuta_HIv2___RNAseq.g18214.t1",325.638543771285,-9.71153495428555,3.3333380817777,4.6016078885015e-08,1.10196963865377e-06,"A0A1D5NSM8",1.02e-53,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)","cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of complement activation, classical pathway [GO:0045959]","GO:0001945; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0045959; GO:0090136"
"543","Pocillopora_acuta_HIv2___RNAseq.g14020.t1",192.015211131491,-11.9896405696236,3.95585920903051,4.73958310998545e-08,1.13311289426164e-06,"G8HTB6",3.1e-10,"ZP domain-containing protein","","GO:0016020"
"544","Pocillopora_acuta_HIv2___RNAseq.g14732.t1",1589.69937243968,5.53541619786482,1.49057558774643,4.76107202323406e-08,1.13637204198115e-06,NA,NA,NA,NA,NA
"545","Pocillopora_acuta_HIv2___TS.g8259.t1b",611.373388321682,5.97373148141043,4.26389540590176,4.88877282869855e-08,1.16492932774787e-06,"P13590",6.63e-23,"Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1)","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synaptic membrane adhesion [GO:0099560]","GO:0005886; GO:0007156; GO:0099560"
"546","Pocillopora_acuta_HIv2___RNAseq.g14728.t1",490.644217686924,-9.91311613157699,3.64820688177323,4.94065503587648e-08,1.17535582958746e-06,NA,NA,NA,NA,NA
"547","Pocillopora_acuta_HIv2___RNAseq.g19648.t1",108.374212776461,-11.2173404770802,3.64754759110875,5.02252488842498e-08,1.19091475387179e-06,"Q6GPB9",0,"Dynein axonemal intermediate chain 4 (WD repeat-containing protein 78)","","GO:0005856; GO:0031514; GO:0120293"
"548","Pocillopora_acuta_HIv2___TS.g8093.t1",595.165127859721,-6.04337276233989,4.96989664572947,5.05870778565905e-08,1.19557433679367e-06,NA,NA,NA,NA,NA
"549","Pocillopora_acuta_HIv2___RNAseq.g12618.t1",235.542586495445,-9.27344951478706,3.08273150428842,5.19917912494572e-08,1.22277929858886e-06,NA,NA,NA,NA,NA
"550","Pocillopora_acuta_HIv2___RNAseq.g21369.t1",799.681820204085,10.9857012898103,5.13697812424224,5.21836608770349e-08,1.22529946578804e-06,NA,NA,NA,NA,NA
"551","Pocillopora_acuta_HIv2___RNAseq.g27370.t1",522.275412147148,-6.89790346070989,2.93230438816532,5.30610737857742e-08,1.24186953274666e-06,NA,NA,NA,NA,NA
"552","Pocillopora_acuta_HIv2___RNAseq.g21261.t1",254.975517794546,-9.34668403710971,3.12605678255886,5.34479006692566e-08,1.24837272831807e-06,"Q00808",4.43e-11,"Vegetative incompatibility protein HET-E-1","","GO:0005525"
"553","Pocillopora_acuta_HIv2___RNAseq.20930_t",12932.7641873083,4.17802367959297,0.958496627768251,5.35115522370855e-08,1.24837272831807e-06,"B8EIZ7",3.42e-180,"Trimethylamine monooxygenase (TMA monooxygenase) (Tmm) (EC 1.14.13.148)","","GO:0004499; GO:0034899; GO:0047822; GO:0050660; GO:0050661"
"554","Pocillopora_acuta_HIv2___TS.g3863.t1",332.130659162261,-9.85087249982626,3.63322916536271,5.36167207664372e-08,1.24881199543599e-06,"O88813",0,"Long-chain-fatty-acid--CoA ligase 5 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 5) (LACS 5)","cellular response to insulin stimulus [GO:0032869]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; positive regulation of triglyceride biosynthetic process [GO:0010867]; response to cholesterol [GO:0070723]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to sucrose [GO:0009744]","GO:0001676; GO:0004467; GO:0005524; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0005886; GO:0006631; GO:0007584; GO:0009744; GO:0009749; GO:0010747; GO:0010867; GO:0016020; GO:0032869; GO:0035338; GO:0047676; GO:0070723; GO:0090434"
"555","Pocillopora_acuta_HIv2___RNAseq.g1187.t1",403.69447428007,-10.0847271118013,3.24266838327992,5.38614935756441e-08,1.25249621073652e-06,NA,NA,NA,NA,NA
"556","Pocillopora_acuta_HIv2___RNAseq.g16285.t1",1143.46418208127,6.33257762396093,2.0783344510274,5.4196935079391e-08,1.25827362598445e-06,"Q01484",3.37e-06,"Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)","atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]","GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008093; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259"
"557","Pocillopora_acuta_HIv2___RNAseq.g3735.t1",483.811508840921,-7.30414797215918,4.11028428142742,5.46854137439002e-08,1.26757984678169e-06,NA,NA,NA,NA,NA
"558","Pocillopora_acuta_HIv2___RNAseq.g22749.t1",578.594742820273,-6.06828535057392,3.72443944879495,5.5624660686927e-08,1.28318196519252e-06,"Q6EJB7",7.95e-60,"Transcription factor Sox-3","brain development [GO:0007420]; central nervous system development [GO:0007417]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; otic placode development [GO:1905040]; otic placode formation [GO:0043049]; ovarian follicle development [GO:0001541]; peripheral nervous system development [GO:0007422]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000978; GO:0001228; GO:0001541; GO:0005634; GO:0006357; GO:0007417; GO:0007420; GO:0007422; GO:0030182; GO:0043049; GO:0045944; GO:1905040"
"559","Pocillopora_acuta_HIv2___TS.g13342.t1",123.653371550396,-8.42899719128227,2.41215211332094,5.58246017929987e-08,1.28574369479926e-06,"Q7Z494",1.2e-38,"Nephrocystin-3","atrial septum development [GO:0003283]; cilium assembly [GO:0060271]; convergent extension [GO:0060026]; convergent extension involved in gastrulation [GO:0060027]; determination of intestine left/right asymmetry [GO:0071908]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; determination of stomach left/right asymmetry [GO:0071909]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment or maintenance of cell polarity [GO:0007163]; extracellular matrix organization [GO:0030198]; heart looping [GO:0001947]; kidney development [GO:0001822]; kidney morphogenesis [GO:0060993]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; maintenance of animal organ identity [GO:0048496]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; ureter development [GO:0072189]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001947; GO:0003283; GO:0005576; GO:0005829; GO:0005929; GO:0006629; GO:0007163; GO:0007368; GO:0016055; GO:0030198; GO:0030324; GO:0035469; GO:0045494; GO:0048496; GO:0060026; GO:0060027; GO:0060271; GO:0060287; GO:0060993; GO:0071908; GO:0071909; GO:0071910; GO:0072189; GO:0090090; GO:0097543; GO:0097546; GO:1905515; GO:2000095"
"560","Pocillopora_acuta_HIv2___RNAseq.g19392.t1",343.308985662354,-1.03447124547342,1.95220516663312,6.10990201326076e-08,1.39831681518677e-06,"A2AP18",8.2e-180,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2)","lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; release of sequestered calcium ion into cytosol [GO:0051209]","GO:0004435; GO:0004629; GO:0005509; GO:0005737; GO:0005886; GO:0007200; GO:0016042; GO:0046488; GO:0048015; GO:0051209"
"561","Pocillopora_acuta_HIv2___RNAseq.g20232.t1",90.204866967561,-11.1596771855406,3.62085450594379,6.3524890828754e-08,1.45153873767314e-06,"Q8TER0",6.47e-56,"Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1) (IRE-BP1)","cell-matrix adhesion [GO:0007160]","GO:0005112; GO:0005509; GO:0005576; GO:0007160; GO:0031012"
"562","Pocillopora_acuta_HIv2___RNAseq.g18162.t1",227.651838111013,-11.5563901930521,4.04802551755127,6.39730865302362e-08,1.45947432740274e-06,"B3DFV0",2.99e-25,"LYR motif-containing protein 9","",""
"563","Pocillopora_acuta_HIv2___RNAseq.g3013.t1",198.097621881605,-8.86519609005111,3.06696347270666,6.44131731886293e-08,1.46489329717034e-06,NA,NA,NA,NA,NA
"564","Pocillopora_acuta_HIv2___TS.g3401.t1",92.6948107633524,-11.2018977301378,3.63535496649796,6.4636087124388e-08,1.46765520277417e-06,"Q0V8E4",8.22e-94,"Asparagine synthetase domain-containing protein 1","asparagine biosynthetic process [GO:0006529]; glutamine metabolic process [GO:0006541]","GO:0004066; GO:0006529; GO:0006541"
"565","Pocillopora_acuta_HIv2___TS.g18522.t1a",495.555808296377,-6.65762847524016,3.06866730763789,6.708057972866e-08,1.52077351911495e-06,NA,NA,NA,NA,NA
"566","Pocillopora_acuta_HIv2___RNAseq.g9900.t1",294.089431598299,-9.8826726867088,3.24396865399617,6.85407122483861e-08,1.55144422842043e-06,NA,NA,NA,NA,NA
"567","Pocillopora_acuta_HIv2___RNAseq.g25181.t1",191.698986966452,-9.43936469670881,3.10278128466714,6.88149891479563e-08,1.55510538433393e-06,"Q9CQ40",1.74e-19,"Large ribosomal subunit protein mL49 (39S ribosomal protein L49, mitochondrial) (L49mt) (MRP-L49)","mitochondrial translation [GO:0032543]","GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0032543"
"568","Pocillopora_acuta_HIv2___RNAseq.g15830.t1",578.69738830599,-3.51761257775744,0.751763304446175,6.89174883405732e-08,1.55510538433393e-06,NA,NA,NA,NA,NA
"569","Pocillopora_acuta_HIv2___RNAseq.g11747.t1",567.232966867167,-1.04803638836015,1.98366269088759,6.91956274076517e-08,1.55894946234311e-06,"Q3SYV5",5.43e-80,"Tetraspanin-33 (Tspan-33)","protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]","GO:0005737; GO:0005886; GO:0005912; GO:0051604; GO:0072659"
"570","Pocillopora_acuta_HIv2___RNAseq.g11882.t1",417.31323745721,-1.54925093681809,5.65812569079108,7.07245517120734e-08,1.59091744317796e-06,"O00628",7.6e-126,"Peroxisomal targeting signal 2 receptor (PTS2 receptor) (Peroxin-7)","endochondral ossification [GO:0001958]; ether lipid biosynthetic process [GO:0008611]; fatty acid beta-oxidation [GO:0006635]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625]","GO:0001764; GO:0001958; GO:0005053; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0007031; GO:0008611; GO:0016558; GO:0019899; GO:0042803"
"571","Pocillopora_acuta_HIv2___RNAseq.g1504.t1",415.223847450787,-6.23385706569046,3.95746022239448,7.27407671392939e-08,1.63373052158812e-06,"Q9WYJ1",2.66e-76,"L-threonine ammonia-lyase (EC 4.3.1.19) (L-serine ammonia-lyase) (EC 4.3.1.17) (Threonine dehydratase)","isoleucine biosynthetic process [GO:0009097]; L-serine catabolic process [GO:0006565]; threonine catabolic process [GO:0006567]","GO:0003941; GO:0004794; GO:0006565; GO:0006567; GO:0009097; GO:0030170"
"572","Pocillopora_acuta_HIv2___RNAseq.g10518.t1",136.689837543789,-11.5160897478449,3.83144508694675,7.30294031492556e-08,1.63625880050565e-06,"A5D8N2",1.26e-75,"Protein DPCD","",""
"573","Pocillopora_acuta_HIv2___RNAseq.g4757.t1",627.126961368613,-1.08371418108182,2.0756791810416,7.30795896796633e-08,1.63625880050565e-06,"Q92556",0,"Engulfment and cell motility protein 1 (Protein ced-12 homolog)","actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell motility [GO:0048870]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]","GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0007015; GO:0016020; GO:0016601; GO:0017124; GO:0030036; GO:0032045; GO:0048870"
"574","Pocillopora_acuta_HIv2___RNAseq.g30591.t1",105.230581610497,-11.258378211068,3.72717849916066,7.50349702006562e-08,1.67485464349119e-06,NA,NA,NA,NA,NA
"575","Pocillopora_acuta_HIv2___TS.g9749.t1",91.5713759454203,-11.0317763549549,3.5881984021498,7.59685428176015e-08,1.69308012837255e-06,"P10079",2.84e-72,"Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","","GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579"
"576","Pocillopora_acuta_HIv2___RNAseq.g3974.t1",383.311981062322,-1.00808204143999,1.88944843183574,8.47570980580082e-08,1.88025562317643e-06,"Q5XK92",0,"Protein CIP2A homolog L","chromosome organization [GO:0051276]; DNA damage response [GO:0006974]","GO:0004864; GO:0005694; GO:0005737; GO:0006974; GO:0051276"
"577","Pocillopora_acuta_HIv2___RNAseq.g1103.t1",548.103799979681,-9.72681730442855,3.69568764653577,8.51562012039655e-08,1.88557186752185e-06,"Q96EH3",2.75e-24,"Mitochondrial assembly of ribosomal large subunit protein 1","negative regulation of mitochondrial translation [GO:0070130]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of translation [GO:0017148]; ribosomal large subunit biogenesis [GO:0042273]","GO:0005739; GO:0005759; GO:0005829; GO:0017148; GO:0042273; GO:0043023; GO:0070130; GO:0090071; GO:0140978"
"578","Pocillopora_acuta_HIv2___RNAseq.g20584.t1",1077.43875565576,5.50116202354791,1.491025758425,8.60302508272045e-08,1.89686211579983e-06,NA,NA,NA,NA,NA
"579","Pocillopora_acuta_HIv2___RNAseq.g12560.t1",282.368854717941,-9.45492172329985,3.32090777211535,8.67156026023798e-08,1.90906312943808e-06,NA,NA,NA,NA,NA
"580","Pocillopora_acuta_HIv2___RNAseq.g14724.t1",1653.60689603483,-5.15080113578471,4.23876854574933,8.70451601166438e-08,1.91340607283759e-06,NA,NA,NA,NA,NA
"581","Pocillopora_acuta_HIv2___RNAseq.g10475.t1",124.644748807805,-11.4286991319928,3.80269829475197,8.74590770391492e-08,1.91958739043134e-06,"Q9NZM1",0,"Myoferlin (Fer-1-like protein 3)","blood circulation [GO:0008015]; muscle contraction [GO:0006936]; plasma membrane repair [GO:0001778]; regulation of neurotransmitter secretion [GO:0046928]","GO:0001778; GO:0005509; GO:0005543; GO:0005635; GO:0005886; GO:0005901; GO:0006936; GO:0008015; GO:0030672; GO:0031410; GO:0031965; GO:0034451; GO:0043231; GO:0046928; GO:0070062"
"582","Pocillopora_acuta_HIv2___RNAseq.g16722.t1",461.129665980811,-6.26607359476899,2.03304715847715,8.94096153394978e-08,1.95942526707651e-06,"A6NFN9",3.59e-59,"Protein ANKUB1 (Ankyrin repeat and ubiquitin domain-containing 1)","",""
"583","Pocillopora_acuta_HIv2___RNAseq.g26808.t1",339.308661844513,-8.46092046384158,2.76568163015827,9.20410529895754e-08,2.00192750442289e-06,NA,NA,NA,NA,NA
"584","Pocillopora_acuta_HIv2___RNAseq.g7107.t1",303.667043588515,-9.69728537551833,3.29352143785049,9.25917095596627e-08,2.01088061121766e-06,"O02833",9.97e-24,"Insulin-like growth factor-binding protein complex acid labile subunit (ALS)","cell adhesion [GO:0007155]","GO:0005576; GO:0005886; GO:0007155"
"585","Pocillopora_acuta_HIv2___TS.g16770.t1",578.612156492158,-5.91435577033453,4.27036831066269,9.31349366939508e-08,2.01964576363014e-06,NA,NA,NA,NA,NA
"586","Pocillopora_acuta_HIv2___RNAseq.g12258.t1",434.161742988113,4.7360421570449,5.16360473324809,9.72989504403877e-08,2.1036353051865e-06,"F1NWE3",1.64e-24,"Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha)","negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]; peptidyl-tyrosine dephosphorylation [GO:0035335]; synaptic membrane adhesion [GO:0099560]","GO:0004725; GO:0005886; GO:0008201; GO:0030424; GO:0030426; GO:0030517; GO:0030672; GO:0035335; GO:0042803; GO:0043204; GO:0043395; GO:0048671; GO:0048681; GO:0061000; GO:0098839; GO:0099560"
"587","Pocillopora_acuta_HIv2___TS.g27307.t1",535.785514532457,-4.81764044662892,5.25366123819165,1.00503628464869e-07,2.16715610381593e-06,"Q6B9X6",1.04e-16,"Alpha-protein kinase vwkA (EC 2.7.11.1) (von Willebrand factor A alpha-kinase) (vWF kinase)","contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288]","GO:0000281; GO:0000331; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006971; GO:0018209; GO:0031038; GO:0031156; GO:0031164; GO:0031288; GO:0033298; GO:0048471; GO:0070177; GO:0106310"
"588","Pocillopora_acuta_HIv2___RNAseq.10010_t",685.382212840851,-1.47663813069808,3.59446244005872,1.00536625114801e-07,2.16715610381593e-06,"O75762",6.47e-137,"Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor)","calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular response to hydrogen peroxide [GO:0070301]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transport [GO:0006811]; protein homotetramerization [GO:0051289]; response to cold [GO:0009409]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]","GO:0005262; GO:0005886; GO:0006811; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014070; GO:0015267; GO:0015278; GO:0019233; GO:0032421; GO:0042802; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0051289; GO:0070301; GO:0070588; GO:0097604"
"589","Pocillopora_acuta_HIv2___RNAseq.g18385.t1",410.637004646469,8.07081253350698,2.68333442526601,1.0167832265953e-07,2.18850484962417e-06,"O95429",3.1e-07,"BAG family molecular chaperone regulator 4 (BAG-4) (Bcl-2-associated athanogene 4) (Silencer of death domains)","cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mRNA modification [GO:0090367]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion [GO:0045785]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; ruffle assembly [GO:0097178]","GO:0000774; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0010763; GO:0016020; GO:0030838; GO:0031625; GO:0033138; GO:0043066; GO:0044877; GO:0045785; GO:0050821; GO:0051087; GO:0051496; GO:0051897; GO:0071356; GO:0071364; GO:0072659; GO:0090367; GO:0097178; GO:1903215"
"590","Pocillopora_acuta_HIv2___RNAseq.g5826.t1",542.666453766602,-7.19811214144828,3.20926439690508,1.11310723229934e-07,2.38165429112095e-06,"Q9BVS4",5.13e-150,"Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2)","maturation of SSU-rRNA [GO:0030490]; positive regulation of ribosomal small subunit export from nucleus [GO:2000208]; positive regulation of rRNA processing [GO:2000234]; protein autophosphorylation [GO:0046777]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ribosomal small subunit biogenesis [GO:0042274]","GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0030071; GO:0030490; GO:0030688; GO:0042274; GO:0046777; GO:0046872; GO:0106310; GO:2000208; GO:2000234"
"591","Pocillopora_acuta_HIv2___RNAseq.g5752.t1",90.4847002374835,-11.0002045507538,3.66734167286397,1.13525602240181e-07,2.4218795144572e-06,"Q9NX04",5.38e-18,"AFG2-interacting ribosome maturation factor (Ribosome biogenesis protein C1orf109)","ribosomal large subunit biogenesis [GO:0042273]","GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0042273"
"592","Pocillopora_acuta_HIv2___RNAseq.g28466.t1",431.131496060928,-1.0856487203892,1.94272677367197,1.14790425564083e-07,2.44525583999838e-06,"O73874",8.06e-14,"Ephrin-B2a","angioblast cell migration involved in selective angioblast sprouting [GO:0035475]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; optic vesicle morphogenesis [GO:0003404]; regulation of chemotaxis [GO:0050920]; rhombomere boundary formation [GO:0021654]; somitogenesis [GO:0001756]; synaptic target recognition [GO:0008039]","GO:0001568; GO:0001756; GO:0002042; GO:0003404; GO:0005886; GO:0007155; GO:0007411; GO:0007412; GO:0008039; GO:0009952; GO:0021654; GO:0035475; GO:0042734; GO:0046875; GO:0048013; GO:0048514; GO:0050920; GO:0098978"
"593","Pocillopora_acuta_HIv2___RNAseq.g24860.t1",907.634386168352,-6.83215397185304,3.61292025871239,1.17865895956491e-07,2.49606488889412e-06,"P55862",0,"DNA replication licensing factor mcm5-A (xMCM5-A) (EC 3.6.4.12) (CDC46 homolog A) (xCDC46-A) (CDC46p) (p92)","DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; premeiotic DNA replication [GO:0006279]; regulation of DNA-templated DNA replication initiation [GO:0030174]","GO:0000785; GO:0003688; GO:0004386; GO:0005524; GO:0006268; GO:0006270; GO:0006279; GO:0016887; GO:0030174; GO:0042555; GO:0071162"
"594","Pocillopora_acuta_HIv2___RNAseq.g20876.t1",5283.94813479518,3.14768922265228,0.669361922762632,1.18490854251323e-07,2.50563116358352e-06,"Q9R0R1",1.28e-16,"Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228)","iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756]","GO:0005506; GO:0005615; GO:0005769; GO:0005886; GO:0006826; GO:0009986; GO:0010756; GO:0055037; GO:0090091; GO:0098552; GO:1900025"
"595","Pocillopora_acuta_HIv2___RNAseq.g19040.t1",487.652648254541,-9.83506064410067,3.99671607849238,1.19182524507306e-07,2.5165781525163e-06,"O35125",1.38e-111,"Leucine-rich repeat-containing protein 23 (Leucine-rich protein B7)","flagellated sperm motility [GO:0030317]; radial spoke assembly [GO:0062177]","GO:0005737; GO:0005829; GO:0005856; GO:0030317; GO:0036126; GO:0062177"
"596","Pocillopora_acuta_HIv2___RNAseq.g14615.t1",376.115634416498,-6.45942621199546,3.7055634037436,1.20114272805727e-07,2.5325551630642e-06,"Q7Z591",1.4e-16,"Microtubule organization protein AKNA (AT-hook-containing transcription factor)","delamination [GO:0060232]; epithelial to mesenchymal transition [GO:0001837]; neuroblast delamination [GO:0060234]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727]","GO:0001650; GO:0001837; GO:0003677; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0016020; GO:0021849; GO:0043231; GO:0045944; GO:0050727; GO:0060232; GO:0060234"
"597","Pocillopora_acuta_HIv2___RNAseq.g21849.t1a",277.488248781524,-7.98661647823296,2.72883047293589,1.22110934643822e-07,2.57090619896396e-06,NA,NA,NA,NA,NA
"598","Pocillopora_acuta_HIv2___RNAseq.g5340.t1",196.919419142573,-8.45577102464184,2.75896294059954,1.28618575408699e-07,2.70398121324334e-06,NA,NA,NA,NA,NA
"599","Pocillopora_acuta_HIv2___RNAseq.g6079.t1",264.628793326,-9.34074610677944,3.21386135589436,1.29125203336895e-07,2.71069222215508e-06,"Q54468",2.71e-141,"Chitobiase (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (N-acetyl-beta-glucosaminidase)","chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]","GO:0000272; GO:0004563; GO:0006032; GO:0030247; GO:0042597; GO:0102148"
"600","Pocillopora_acuta_HIv2___RNAseq.g2743.t1",91.7251371381789,-10.9656987127129,3.63922980703933,1.29667460410594e-07,2.71813064837512e-06,NA,NA,NA,NA,NA
"601","Pocillopora_acuta_HIv2___RNAseq.g18125.t1",6023.76035719744,3.13860793201094,0.671064983558462,1.30101825778136e-07,2.72328915782193e-06,"Q9R0R1",1.28e-16,"Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228)","iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756]","GO:0005506; GO:0005615; GO:0005769; GO:0005886; GO:0006826; GO:0009986; GO:0010756; GO:0055037; GO:0090091; GO:0098552; GO:1900025"
"602","Pocillopora_acuta_HIv2___RNAseq.2533_t",3992.1710047385,6.24251617847119,3.8840114592238,1.31372312162268e-07,2.74316765743975e-06,"Q96RW7",4.56e-34,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711"
"603","Pocillopora_acuta_HIv2___TS.g4671.t2",270.193672336745,-1.23806807184863,2.61846565400358,1.31430806596083e-07,2.74316765743975e-06,"P52485",3.94e-98,"Ubiquitin-conjugating enzyme E2-24 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 2) (Ubiquitin carrier protein) (Ubiquitin-protein ligase)","lipid storage [GO:0019915]; protein polyubiquitination [GO:0000209]","GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0019915; GO:0061631"
"604","Pocillopora_acuta_HIv2___RNAseq.g24441.t1",244.393654049457,5.46310491698353,1.49217489168308,1.39598605419133e-07,2.90108366204358e-06,NA,NA,NA,NA,NA
"605","Pocillopora_acuta_HIv2___RNAseq.g12987.t1",5067.40203808066,5.06690880773924,1.40766562094195,1.40821581392028e-07,2.92230036334906e-06,"Q6V0I7",1.97e-109,"Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)","cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008]","GO:0005509; GO:0005886; GO:0007156; GO:0007157; GO:0021987; GO:0022008; GO:0035329; GO:0070062; GO:0098609"
"606","Pocillopora_acuta_HIv2___RNAseq.g4969.t1",364.825354305009,-1.11583788365282,2.15467480367862,1.41185959770104e-07,2.92566435833063e-06,"F1NPG5",2.04e-30,"Centromere protein T (CENP-T)","cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic cell cycle [GO:0000278]","GO:0000278; GO:0000776; GO:0003677; GO:0005634; GO:0007059; GO:0046982; GO:0051301; GO:0051382"
"607","Pocillopora_acuta_HIv2___RNAseq.g10902.t1",169.234427106844,-8.93197524851328,3.10514162054515,1.42450683787834e-07,2.94764905623352e-06,NA,NA,NA,NA,NA
"608","Pocillopora_acuta_HIv2___RNAseq.g20846.t1",519.710041943882,-8.72908038727743,3.18386563325016,1.43511163203073e-07,2.96535066367035e-06,"Q80ZA4",0,"Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86)","sensory perception of sound [GO:0007605]","GO:0007605; GO:0016020; GO:0032426; GO:0120234"
"609","Pocillopora_acuta_HIv2___RNAseq.g7881.t1",255.101254925566,-9.39928702188564,3.32303665909284,1.44740535179394e-07,2.98223233737145e-06,"Q8IY21",1.62e-32,"Probable ATP-dependent RNA helicase DDX60 (EC 3.6.4.13) (DEAD box protein 60)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615]","GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005737; GO:0005829; GO:0009615; GO:0016887; GO:0045087; GO:0045111; GO:0051607; GO:1900245; GO:1900246"
"610","Pocillopora_acuta_HIv2___RNAseq.g17622.t1",186.939159792039,-9.18586350775844,3.24426063504661,1.47865058819407e-07,3.03795484483509e-06,"P35521",1.81e-42,"Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln))","cell volume homeostasis [GO:0006884]; chloride transmembrane transport [GO:1902476]; mRNA cis splicing, via spliceosome [GO:0045292]; potassium ion transmembrane transport [GO:0071805]; spliceosomal snRNP assembly [GO:0000387]","GO:0000387; GO:0005229; GO:0005267; GO:0005634; GO:0005681; GO:0005829; GO:0005856; GO:0005886; GO:0006884; GO:0008289; GO:0016020; GO:0032991; GO:0034709; GO:0034715; GO:0036094; GO:0045292; GO:0071805; GO:1902476; GO:1990935"
"611","Pocillopora_acuta_HIv2___RNAseq.g10343.t1",180.956691067974,9.46293255639878,3.31399728006812,1.50181989303073e-07,3.08118055784346e-06,"Q8R508",1.12e-09,"Protocadherin Fat 3 (FAT tumor suppressor homolog 3)","cell morphogenesis involved in neuron differentiation [GO:0048667]; cell-cell adhesion [GO:0098609]; dendrite development [GO:0016358]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; interneuron migration [GO:1904936]; negative regulation of dendrite development [GO:2000171]; retina layer formation [GO:0010842]","GO:0005509; GO:0005886; GO:0007156; GO:0010842; GO:0016358; GO:0030425; GO:0048667; GO:0098609; GO:1904936; GO:2000171"
"612","Pocillopora_acuta_HIv2___RNAseq.g16169.t1",850.974397506806,-1.10559920764414,2.06326268816081,1.51900655429647e-07,3.11202702568613e-06,"P29674",7.07e-103,"LIM/homeobox protein Lhx1 (LIM homeobox protein 1) (Homeobox protein Lim-1) (Xlim1) (x-Lhx1) (xLIM-1)","anterior/posterior pattern specification [GO:0009952]; axis specification [GO:0009798]; cell migration involved in gastrulation [GO:0042074]; chordate embryonic development [GO:0043009]; muscle organ development [GO:0007517]; nephron tubule development [GO:0072080]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; notochord development [GO:0030903]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric field specification [GO:0039003]; pronephric nephron tubule development [GO:0039020]; pronephros development [GO:0048793]; regionalization [GO:0003002]; regulation of pronephros size [GO:0035565]; response to retinoic acid [GO:0032526]","GO:0000977; GO:0000981; GO:0001221; GO:0003002; GO:0005634; GO:0005667; GO:0007517; GO:0008270; GO:0009798; GO:0009952; GO:0022008; GO:0030182; GO:0030903; GO:0032526; GO:0035565; GO:0039003; GO:0039020; GO:0042074; GO:0043009; GO:0043565; GO:0045893; GO:0045944; GO:0048793; GO:0072080"
"613","Pocillopora_acuta_HIv2___TS.g10386.t1",510.331627417504,-6.12208969394132,3.18169130259351,1.53937653278038e-07,3.14929875107998e-06,NA,NA,NA,NA,NA
"614","Pocillopora_acuta_HIv2___RNAseq.g25935.t1",41416.6959166268,3.66254966164606,0.839729123943442,1.56159025853877e-07,3.1812452816204e-06,"B3EWZ6",0,"MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2)","","GO:0005576; GO:0016020"
"615","Pocillopora_acuta_HIv2___RNAseq.g15370.t1",233.924568565192,-1.30608032061532,2.93813892654512,1.57167048777198e-07,3.19727734671362e-06,"P97259",5.31e-175,"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]","positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0000139; GO:0004864; GO:0005576; GO:0018279; GO:0030144; GO:0030145; GO:0030335; GO:1904894"
"616","Pocillopora_acuta_HIv2___RNAseq.g28765.t1",262.858077742028,-9.4717116045251,3.44634561909942,1.57802679090061e-07,3.20569936848125e-06,NA,NA,NA,NA,NA
"617","Pocillopora_acuta_HIv2___RNAseq.g3924.t1",149.157933080526,8.91231671251361,3.22644584993891,1.58558517539448e-07,3.21653632214666e-06,NA,NA,NA,NA,NA
"618","Pocillopora_acuta_HIv2___RNAseq.g6948.t1",113.892902721942,-11.2345133755193,3.7627867491389,1.60971133950014e-07,3.25634472930489e-06,NA,NA,NA,NA,NA
"619","Pocillopora_acuta_HIv2___RNAseq.g6074.t1",332.265630230546,-9.39436244443354,3.48487925260849,1.68762127144273e-07,3.39955182994704e-06,NA,NA,NA,NA,NA
"620","Pocillopora_acuta_HIv2___RNAseq.g21964.t1",554.628006865098,-1.07384545826734,2.04410408809492,1.68866443640407e-07,3.39955182994704e-06,NA,NA,NA,NA,NA
"621","Pocillopora_acuta_HIv2___RNAseq.g6157.t1",430.777539107758,-1.03162857837977,1.93529269480617,1.69694579854673e-07,3.40897555974721e-06,"Q96DC8",5.6e-121,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial","fatty acid metabolic process [GO:0006631]; positive regulation of cellular response to insulin stimulus [GO:1900078]","GO:0004300; GO:0005739; GO:0006631; GO:0016836; GO:1900078"
"622","Pocillopora_acuta_HIv2___RNAseq.g11700.t1",324.376977836821,-9.68910118402961,3.98560710530862,1.71357790281276e-07,3.4376131465026e-06,"P43247",0,"DNA mismatch repair protein Msh2 (MutS protein homolog 2)","B cell differentiation [GO:0030183]; B cell mediated immunity [GO:0019724]; determination of adult lifespan [GO:0008340]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; protein localization to chromatin [GO:0071168]; regulation of cell cycle [GO:0051726]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204]","GO:0000287; GO:0000400; GO:0001701; GO:0002204; GO:0003677; GO:0003682; GO:0003684; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0006119; GO:0006281; GO:0006298; GO:0006301; GO:0006302; GO:0006312; GO:0006974; GO:0007281; GO:0008340; GO:0008584; GO:0008630; GO:0010165; GO:0010224; GO:0016446; GO:0016447; GO:0016887; GO:0019237; GO:0019724; GO:0030183; GO:0030983; GO:0031573; GO:0032137; GO:0032142; GO:0032143; GO:0032181; GO:0032301; GO:0032302; GO:0032357; GO:0032405; GO:0042771; GO:0042803; GO:0043524; GO:0043531; GO:0043570; GO:0045190; GO:0045910; GO:0048298; GO:0048304; GO:0051726; GO:0071168; GO:0140664"
"623","Pocillopora_acuta_HIv2___RNAseq.g14867.t1",236.324861356435,-9.42908796526981,3.22435878895887,1.74279908654176e-07,3.48656237728077e-06,"Q5PQM2",1.36e-07,"Kinesin light chain 4 (KLC 4) (Kinesin-like protein 8)","microtubule-based movement [GO:0007018]","GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0019894"
"624","Pocillopora_acuta_HIv2___RNAseq.g8316.t1",245.116187540382,-1.20454420236632,2.4697999306103,1.86796635393928e-07,3.71052965768015e-06,"Q9Z160",0,"Conserved oligomeric Golgi complex subunit 1 (COG complex subunit 1) (Component of oligomeric Golgi complex 1) (Low density lipoprotein receptor defect B-complementing protein)","glycosylation [GO:0070085]; Golgi organization [GO:0007030]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]","GO:0000139; GO:0000301; GO:0005794; GO:0007030; GO:0015031; GO:0017119; GO:0070085"
"625","Pocillopora_acuta_HIv2___RNAseq.g28909.t1",374.167179606024,-7.01061233025132,3.14503778034771,1.88366908814314e-07,3.73224516313732e-06,"Q3UHX0",2.26e-46,"Nucleolar protein 8","cellular response to leukemia inhibitory factor [GO:1990830]; protein localization to nucleolus [GO:1902570]; rRNA processing [GO:0006364]","GO:0003723; GO:0005730; GO:0006364; GO:1902570; GO:1990830"
"626","Pocillopora_acuta_HIv2___RNAseq.g7452.t1",80.6849919977347,-10.7466540061699,3.58111775800493,1.96914400857695e-07,3.89238147203067e-06,"P0CI65",3.08e-32,"Nephrocystin-3","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"627","Pocillopora_acuta_HIv2___RNAseq.g8864.t1",28998.8049452589,-4.39943874997544,1.13879091561272,1.969872260458e-07,3.89238147203067e-06,NA,NA,NA,NA,NA
"628","Pocillopora_acuta_HIv2___TS.g29166.t1",302.343248489353,-5.61715854265814,3.54921653658405,1.98115781356057e-07,3.90934060236564e-06,"Q13163",0,"Dual specificity mitogen-activated protein kinase kinase 5 (MAP kinase kinase 5) (MAPKK 5) (EC 2.7.12.2) (MAPK/ERK kinase 5) (MEK 5)","cellular response to growth factor stimulus [GO:0071363]; cellular response to laminar fluid shear stress [GO:0071499]; ERK5 cascade [GO:0070375]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; MAPK cascade [GO:0000165]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165]","GO:0000122; GO:0000165; GO:0004672; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005819; GO:0007165; GO:0007507; GO:0030307; GO:0032088; GO:0032717; GO:0034115; GO:0034392; GO:0043154; GO:0043406; GO:0045944; GO:0046872; GO:0048009; GO:0050679; GO:0051247; GO:0060761; GO:0070375; GO:0071363; GO:0071499; GO:0090051; GO:0106310; GO:2000342; GO:2001240"
"629","Pocillopora_acuta_HIv2___RNAseq.g12898.t1",423.478465215243,-1.00216717904103,1.86457032868562,2.02667708037875e-07,3.99371352732946e-06,"Q8NFF2",1.74e-134,"Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4)","amelogenesis [GO:0097186]; calcium ion export across plasma membrane [GO:1990034]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; drinking behavior [GO:0042756]; enamel mineralization [GO:0070166]; intracellular calcium ion homeostasis [GO:0006874]; membrane repolarization [GO:0086009]; monoatomic ion transport [GO:0006811]; negative regulation of calcium-mediated signaling [GO:0050849]; olfactory nerve maturation [GO:0021630]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; potassium ion transmembrane transport [GO:0071805]; regulation of eating behavior [GO:1903998]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to high light intensity [GO:0009644]; response to melanocyte-stimulating hormone [GO:1990680]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725]","GO:0005262; GO:0005516; GO:0005737; GO:0005886; GO:0006811; GO:0006874; GO:0007602; GO:0007608; GO:0008273; GO:0008277; GO:0009644; GO:0010628; GO:0015293; GO:0016020; GO:0016324; GO:0021630; GO:0031982; GO:0035725; GO:0036368; GO:0042756; GO:0048306; GO:0050849; GO:0050911; GO:0055074; GO:0070166; GO:0070588; GO:0071486; GO:0071805; GO:0086009; GO:0097186; GO:0098703; GO:0120199; GO:1903998; GO:1990034; GO:1990680; GO:1990834"
"630","Pocillopora_acuta_HIv2___RNAseq.g18059.t1",326.768182193263,-1.34190644321331,3.13252972085224,2.03731760078583e-07,4.009219289492e-06,"Q9NHW7",1.68e-63,"Aquaporin AQPAe.a","","GO:0015267; GO:0016020"
"631","Pocillopora_acuta_HIv2___RNAseq.g4732.t1",8464.82536451138,-4.18103397645119,1.09059113976494,2.06191586241625e-07,4.04113157642122e-06,"O97341",2.12e-38,"Calmodulin (CaM)","","GO:0005509; GO:0030234"
"632","Pocillopora_acuta_HIv2___TS.g11111.t2",5024.11627672245,2.93677968295172,0.631607752303773,2.0649007847475e-07,4.04150540603355e-06,"Q13228",0,"Methanethiol oxidase (MTO) (EC 1.8.3.4) (56 kDa selenium-binding protein) (SBP56) (SP56) (Selenium-binding protein 1)","protein transport [GO:0015031]","GO:0001650; GO:0005615; GO:0005730; GO:0005829; GO:0008430; GO:0015031; GO:0016020; GO:0018549; GO:0070062"
"633","Pocillopora_acuta_HIv2___RNAseq.g17047.t1",87.493730148627,-8.60610870903766,2.71478311373168,2.08404813642824e-07,4.07346922233758e-06,"P32456",2.12e-09,"Guanylate-binding protein 2 (EC 3.6.5.-) (GTP-binding protein 2) (GBP-2) (HuGBP-2) (Guanine nucleotide-binding protein 2) (Interferon-induced guanylate-binding protein 2)","activation of innate immune response [GO:0002218]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to type II interferon [GO:0071346]; cytolysis in another organism [GO:0051715]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; immune response [GO:0006955]; positive regulation of AIM2 inflammasome complex assembly [GO:0140973]; positive regulation of pyroptotic inflammatory response [GO:0140639]; protein localization to nucleus [GO:0034504]","GO:0000139; GO:0002218; GO:0003924; GO:0004866; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006955; GO:0030659; GO:0031410; GO:0034504; GO:0042742; GO:0042802; GO:0042803; GO:0042832; GO:0048471; GO:0050830; GO:0051607; GO:0051715; GO:0071222; GO:0071346; GO:0071347; GO:0071356; GO:0140639; GO:0140678; GO:0140973"
"634","Pocillopora_acuta_HIv2___RNAseq.g584.t3a",436.600226122974,-9.51398231549061,4.14521684604709,2.09995998037192e-07,4.09903119515513e-06,"Q28295",4.27e-97,"von Willebrand factor (vWF)","blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; hemostasis [GO:0007599]; platelet activation [GO:0030168]","GO:0002020; GO:0005178; GO:0005518; GO:0005576; GO:0005615; GO:0005783; GO:0007155; GO:0007596; GO:0007599; GO:0019865; GO:0030168; GO:0031012; GO:0031589; GO:0033093; GO:0042802; GO:0051087; GO:0062023"
"635","Pocillopora_acuta_HIv2___RNAseq.g9085.t1",7563.81025980618,3.02206875535546,0.653308721640851,2.10531730899171e-07,4.1027561729048e-06,"Q96PZ7",8.15e-53,"CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1)","conditioned place preference [GO:1990708]; female gonad development [GO:0008585]; glucose homeostasis [GO:0042593]; male gonad development [GO:0008584]; mammary gland branching involved in pregnancy [GO:0060745]; memory [GO:0007613]; oviduct epithelium development [GO:0035846]; startle response [GO:0001964]","GO:0001964; GO:0007613; GO:0008584; GO:0008585; GO:0016020; GO:0035846; GO:0042593; GO:0060745; GO:1990708"
"636","Pocillopora_acuta_HIv2___RNAseq.g28502.t1",2555.16546812714,6.58988917711385,2.46691105228441,2.10754136923968e-07,4.1027561729048e-06,"B3EWY9",4.64e-28,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020"
"637","Pocillopora_acuta_HIv2___RNAseq.g28742.t1",119.786451567165,-11.4470546466931,3.9391668114959,2.19738114388518e-07,4.27189796574668e-06,"Q25060",2.23e-22,"LWamide neuropeptides [Cleaved into: LWamide I; LWamide II; LWS]","neuropeptide signaling pathway [GO:0007218]","GO:0005576; GO:0007218"
"638","Pocillopora_acuta_HIv2___RNAseq.g7998.t1",122.376097363134,-10.9058303938998,3.78553851481935,2.21013042104959e-07,4.29091629665252e-06,"Q6H601",1.44e-23,"DEAD-box ATP-dependent RNA helicase 22 (EC 3.6.4.13)","","GO:0003724; GO:0003729; GO:0005524; GO:0009507; GO:0016887"
"639","Pocillopora_acuta_HIv2___RNAseq.g28991.t1",292.533200340185,-9.15711240206932,3.4428922308524,2.23288582627531e-07,4.32928426156114e-06,"Q8C4M7",1.03e-13,"Centromere protein U (CENP-U) (MLF1-interacting protein)","chordate embryonic development [GO:0043009]; chromosome segregation [GO:0007059]","GO:0000939; GO:0005634; GO:0005654; GO:0005737; GO:0007059; GO:0034451; GO:0043009"
"640","Pocillopora_acuta_HIv2___RNAseq.g26058.t1",292.935288567139,-7.74784910786824,2.64718154158377,2.25389571124616e-07,4.35251636414745e-06,"O15973",1.7e-18,"Rhodopsin, GQ-coupled (GQ-rhodopsin)","cellular response to light stimulus [GO:0071482]; phototransduction [GO:0007602]; visual perception [GO:0007601]","GO:0005886; GO:0007601; GO:0007602; GO:0008020; GO:0071482"
"641","Pocillopora_acuta_HIv2___RNAseq.g30929.t1",215.760983612499,-1.20271691064371,2.47196948107308,2.28798388793085e-07,4.41245319400425e-06,"Q53FA7",2.68e-124,"Quinone oxidoreductase PIG3 (EC 1.6.5.5) (NADPH:quinone reductase PIG3) (Tumor protein p53-inducible protein 3) (Protein PIG3) (p53-induced gene 3 protein)","NADP metabolic process [GO:0006739]","GO:0003960; GO:0005829; GO:0006739; GO:0042803; GO:0048038; GO:0070402"
"642","Pocillopora_acuta_HIv2___RNAseq.g11868.t1",321.45389292764,-9.21450130744796,3.77447422455384,2.33127420265777e-07,4.48995340442637e-06,"Q8IYF3",1.8e-155,"Testis-expressed protein 11 (Protein ZIP4 homolog) (ZIP4H)","apoptotic process [GO:0006915]; chiasma assembly [GO:0051026]; ectopic germ cell programmed cell death [GO:0035234]; fertilization [GO:0009566]; male gonad development [GO:0008584]; male meiosis chromosome segregation [GO:0007060]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of reproductive process [GO:2000242]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; synaptonemal complex assembly [GO:0007130]","GO:0000712; GO:0000801; GO:0005694; GO:0006311; GO:0006915; GO:0007060; GO:0007130; GO:0007131; GO:0008584; GO:0009566; GO:0035234; GO:0043066; GO:0051026; GO:0051093; GO:2000242"
"643","Pocillopora_acuta_HIv2___RNAseq.g13936.t1",415.01767237816,-1.02722756835166,1.88498810901621,2.4233068702789e-07,4.64863535433873e-06,NA,NA,NA,NA,NA
"644","Pocillopora_acuta_HIv2___TS.g25579.t1",144.152661188822,-8.38608764014187,2.80230558710725,2.46308659681311e-07,4.71244504448476e-06,NA,NA,NA,NA,NA
"645","Pocillopora_acuta_HIv2___RNAseq.g21527.t1",228.335292813313,-1.09232452657948,2.10232628791312,2.49267327362975e-07,4.76243272247478e-06,"Q6BZW3",8.15e-41,"Protein BTN1","L-arginine transmembrane transport [GO:1903826]; lysine transport [GO:0015819]; regulation of intracellular pH [GO:0051453]","GO:0000324; GO:0005773; GO:0005774; GO:0015819; GO:0022857; GO:0051453; GO:1903826"
"646","Pocillopora_acuta_HIv2___RNAseq.g29870.t1",86.7106421628634,-10.7888720628928,3.64710519476097,2.49579922817747e-07,4.76243272247478e-06,NA,NA,NA,NA,NA
"647","Pocillopora_acuta_HIv2___RNAseq.g12115.t1",238.615884202611,-8.2880067366248,3.5863162260099,2.5819519958809e-07,4.92033645170242e-06,"O14495",2.17e-48,"Phospholipid phosphatase 3 (EC 3.1.3.-) (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 3) (PAP2-beta) (Phosphatidate phosphohydrolase type 2b) (Phosphatidic acid phosphatase 2b) (PAP-2b) (PAP2b) (Vascular endothelial growth factor and type I collagen-inducible protein) (VCIP)","Bergmann glial cell differentiation [GO:0060020]; blood vessel development [GO:0001568]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by integrin [GO:0033631]; ceramide metabolic process [GO:0006672]; gastrulation with mouth forming second [GO:0001702]; homotypic cell-cell adhesion [GO:0034109]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of protein phosphorylation [GO:0001933]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein stabilization [GO:0050821]; regulation of sphingolipid mediated signaling pathway [GO:1902068]; regulation of Wnt signaling pathway [GO:0030111]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; signal transduction [GO:0007165]; sphingolipid catabolic process [GO:0030149]; sphingosine metabolic process [GO:0006670]; wound healing [GO:0042060]","GO:0000139; GO:0001568; GO:0001702; GO:0001933; GO:0005178; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0005912; GO:0006644; GO:0006670; GO:0006672; GO:0006890; GO:0007165; GO:0007229; GO:0008195; GO:0010595; GO:0016020; GO:0016323; GO:0022409; GO:0030111; GO:0030149; GO:0033116; GO:0033631; GO:0034109; GO:0042060; GO:0042392; GO:0045121; GO:0046839; GO:0050731; GO:0050821; GO:0051091; GO:0060020; GO:0070971; GO:0098609; GO:0106235; GO:1902068"
"648","Pocillopora_acuta_HIv2___RNAseq.g15950.t1",144.145123775651,8.17608818030247,2.85217049883529,2.63619016028529e-07,5.01708611557454e-06,NA,NA,NA,NA,NA
"649","Pocillopora_acuta_HIv2___RNAseq.g8821.t1",15967.8005170179,3.00420767847167,0.657280947073452,2.66272779062243e-07,5.05574845802589e-06,"P01026",2.73e-170,"Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2]","amyloid-beta clearance [GO:0097242]; chemotaxis [GO:0006935]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; complement receptor mediated signaling pathway [GO:0002430]; complement-dependent cytotoxicity [GO:0097278]; complement-mediated synapse pruning [GO:0150062]; fatty acid metabolic process [GO:0006631]; inflammatory response [GO:0006954]; neuron remodeling [GO:0016322]; oviduct epithelium development [GO:0035846]; positive regulation of activation of membrane attack complex [GO:0001970]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of developmental growth [GO:0048639]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of lipid storage [GO:0010884]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of type IIa hypersensitivity [GO:0001798]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of triglyceride biosynthetic process [GO:0010866]; response to bacterium [GO:0009617]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to magnesium ion [GO:0032026]; response to progesterone [GO:0032570]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; tolerance induction [GO:0002507]; vascular associated smooth muscle cell differentiation [GO:0035886]; vertebrate eye-specific patterning [GO:0150064]","GO:0001798; GO:0001934; GO:0001970; GO:0002430; GO:0002507; GO:0004866; GO:0005576; GO:0005615; GO:0006631; GO:0006935; GO:0006954; GO:0006956; GO:0006957; GO:0006958; GO:0008289; GO:0009410; GO:0009617; GO:0009986; GO:0010575; GO:0010828; GO:0010866; GO:0010884; GO:0016322; GO:0031715; GO:0032026; GO:0032355; GO:0032570; GO:0032991; GO:0035846; GO:0035886; GO:0043627; GO:0045745; GO:0045766; GO:0048260; GO:0048639; GO:0050766; GO:0051384; GO:0060041; GO:0060100; GO:0070374; GO:0097242; GO:0097278; GO:0150062; GO:0150064; GO:2000427"
"650","Pocillopora_acuta_HIv2___RNAseq.g14373.t1",969.063918075449,10.7490935199859,8.4861603470818,2.66699120124015e-07,5.05574845802589e-06,"Q801S8",2.99e-16,"Collagen alpha-1(VI) chain","cell adhesion [GO:0007155]","GO:0005576; GO:0005581; GO:0007155; GO:0062023"
"651","Pocillopora_acuta_HIv2___RNAseq.g24923.t1",212.854913156409,-9.12736843034122,3.49787818333433,2.69628136782277e-07,5.09791028812921e-06,"Q96IY1",7.53e-11,"Kinetochore-associated protein NSL1 homolog","attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]","GO:0000070; GO:0000444; GO:0000776; GO:0000922; GO:0000940; GO:0005634; GO:0005829; GO:0008608; GO:0016607; GO:0051301"
"652","Pocillopora_acuta_HIv2___RNAseq.g3911.t1",242.524364160997,-1.12401507258306,2.19558072090546,2.73882218289711e-07,5.1581151111229e-06,"Q6DGQ8",1.38e-96,"Nucleoside diphosphate kinase homolog 5 (3'-5' exonuclease NME5) (EC 3.1.-.-)","cilium movement [GO:0003341]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; UTP biosynthetic process [GO:0006228]","GO:0003341; GO:0004550; GO:0005929; GO:0006183; GO:0006228; GO:0006241; GO:0008408; GO:1902176"
"653","Pocillopora_acuta_HIv2___RNAseq.g7100.t1",313.96233441298,-5.11112889948071,4.42094096442309,2.74715481849791e-07,5.16708027239971e-06,"Q9DBN1",1.28e-72,"Stimulated by retinoic acid gene 6 protein-like (STRA6-like protein) (Retinol-binding protein 4 receptor 2) (RBP4 receptor 2)","establishment of localization in cell [GO:0051649]; retinol transport [GO:0034633]; vitamin A import into cell [GO:0071939]","GO:0005886; GO:0034632; GO:0034633; GO:0038023; GO:0051649; GO:0071939"
"654","Pocillopora_acuta_HIv2___RNAseq.g7217.t1",250.824848780073,-9.10985652282866,3.47549504535322,2.8532063352355e-07,5.3595813549151e-06,"Q3U481",1.02e-29,"Major facilitator superfamily domain-containing protein 12 (Protein grizzled)","carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021]","GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0043474; GO:0048021; GO:0048022; GO:1903712"
"655","Pocillopora_acuta_HIv2___RNAseq.g15551.t1",74.3271776341929,-8.25015813115003,2.47198236420821,2.86150099579933e-07,5.3681907137797e-06,NA,NA,NA,NA,NA
"656","Pocillopora_acuta_HIv2___RNAseq.g25869.t1",286.420135232824,-9.4367750634951,3.51096407735598,2.93332172744279e-07,5.49579863545759e-06,"Q5RJA1",1.33e-153,"DNA-binding protein RFX6 (Regulatory factor X 6)","endocrine pancreas development [GO:0031018]; glucose homeostasis [GO:0042593]; pancreatic A cell differentiation [GO:0003310]; pancreatic D cell differentiation [GO:0003311]; pancreatic epsilon cell differentiation [GO:0090104]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell differentiation [GO:0003309]","GO:0000976; GO:0000978; GO:0000981; GO:0003309; GO:0003310; GO:0003311; GO:0005634; GO:0006357; GO:0031018; GO:0035774; GO:0042593; GO:0045893; GO:0045944; GO:0050796; GO:0090104"
"657","Pocillopora_acuta_HIv2___RNAseq.g5360.t1",214.921094055806,-9.16260988942022,3.81545222819749,2.97015607126825e-07,5.54948697349667e-06,"E2RYF8",6.49e-74,"Targeting protein for Xklp2 homolog (TPX2 homolog) (Microtubule-associated protein TPX2 homolog)","regulation of mitotic spindle organization [GO:0060236]","GO:0005634; GO:0005737; GO:0005819; GO:0005874; GO:0060236"
"658","Pocillopora_acuta_HIv2___RNAseq.g15816.t1",245.604656988575,-8.986930028072,3.47305158406174,2.97626168360566e-07,5.54948697349667e-06,"Q9XWN7",2.18e-51,"Nucleoside hydrolase (EC 3.2.2.-) (EC 3.2.2.1) (EC 3.2.2.2) (EC 3.2.2.3) (EC 3.2.2.7) (EC 3.2.2.8)","nucleobase-containing compound metabolic process [GO:0006139]","GO:0006139; GO:0016799; GO:0046872"
"659","Pocillopora_acuta_HIv2___TS.g22016.t1",313.331384951986,-6.5168750023993,2.42083897059806,2.97951413179497e-07,5.54948697349667e-06,"A2TLM1",3.3e-97,"Ribose-5-phosphate isomerase (EC 5.3.1.6) (Phosphoriboisomerase)","D-ribose metabolic process [GO:0006014]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]","GO:0004751; GO:0005737; GO:0006014; GO:0009052"
"660","Pocillopora_acuta_HIv2___RNAseq.g439.t1",278.048121039085,-1.06657204884454,2.02708485785673,2.99871555660118e-07,5.56783335182022e-06,"O08760",5.68e-103,"N-glycosylase/DNA lyase [Includes: 8-oxoguanine DNA glycosylase (EC 3.2.2.-); DNA-(apurinic or apyrimidinic site) lyase (AP lyase) (EC 4.2.99.18)]","base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; nucleotide-excision repair [GO:0006289]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to light stimulus [GO:0009416]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314]; response to xenobiotic stimulus [GO:0009410]","GO:0000702; GO:0000978; GO:0003677; GO:0003684; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0006285; GO:0006289; GO:0006355; GO:0006974; GO:0006979; GO:0008017; GO:0008534; GO:0009314; GO:0009410; GO:0009416; GO:0016363; GO:0016607; GO:0019104; GO:0019899; GO:0032355; GO:0032357; GO:0032991; GO:0034039; GO:0034614; GO:0043066; GO:0044029; GO:0045471; GO:0045944; GO:0051593; GO:0071276; GO:0140078; GO:1901291"
"661","Pocillopora_acuta_HIv2___TS.g14315.t1b",424.844763112884,-1.22721891112561,2.55296103124346,3.08747290277611e-07,5.72528308535304e-06,"Q6A4L1",0,"Solute carrier family 12 member 8","potassium ion transport [GO:0006813]","GO:0006813; GO:0015377; GO:0016020"
"662","Pocillopora_acuta_HIv2___TS.g13410.t1",150.95880037018,8.99949621426874,3.50747915194506,3.11674620455587e-07,5.76478479574119e-06,NA,NA,NA,NA,NA
"663","Pocillopora_acuta_HIv2___RNAseq.g3485.t1",73.3054284006749,-10.7346015883171,3.6180092908252,3.16062209010125e-07,5.83102524377863e-06,"V6CLA2",7.35e-23,"E3 ubiquitin-protein ligase hecd-1 (EC 2.3.2.26)","determination of adult lifespan [GO:0008340]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; regulation of cell fate specification [GO:0042659]; regulation of germ cell proliferation [GO:1905936]; regulation of response to oxidative stress [GO:1902882]; regulation of vulval development [GO:0040028]","GO:0008340; GO:0016607; GO:0032436; GO:0040028; GO:0042659; GO:0043161; GO:0045746; GO:0045747; GO:0046872; GO:0061630; GO:0070534; GO:1902882; GO:1905936"
"664","Pocillopora_acuta_HIv2___RNAseq.g18062.t1",303.700828246994,8.91094248864813,3.53289098294921,3.27085775671649e-07,6.0079778680529e-06,NA,NA,NA,NA,NA
"665","Pocillopora_acuta_HIv2___RNAseq.g5488.t1",115.404113864968,-11.3812288045092,3.91587754613935,3.27315165930979e-07,6.0079778680529e-06,"Q5KQT7",1.69e-101,"Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)","estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]","GO:0004497; GO:0005506; GO:0005743; GO:0005789; GO:0006631; GO:0006694; GO:0008210; GO:0020037; GO:0030544; GO:0042572; GO:0043231; GO:0051879; GO:0070330; GO:0101020; GO:0101021; GO:0106256"
"666","Pocillopora_acuta_HIv2___RNAseq.g25912.t1",515.76815183459,-9.72425294654399,5.02052669485772,3.31044809875749e-07,6.06191726706403e-06,NA,NA,NA,NA,NA
"667","Pocillopora_acuta_HIv2___RNAseq.g6743.t1",631.464652238243,-5.01522018609081,3.66803732863298,3.31091996749211e-07,6.06191726706403e-06,"B2GUB3",2.27e-180,"Tubulin tyrosine ligase 3 (EC 6.3.2.-) (Tubulin--tyrosine ligase protein 3)","protein polyglycylation [GO:0018094]","GO:0005524; GO:0005737; GO:0005874; GO:0018094; GO:0031514; GO:0046872; GO:0070736"
"668","Pocillopora_acuta_HIv2___RNAseq.g6350.t1",1498.34017104801,-5.95294858935764,2.16895566648695,3.36689499083038e-07,6.14883448830437e-06,"B3EWY8",8.13e-08,"Skeletal aspartic acid-rich protein 2","","GO:0016020"
"669","Pocillopora_acuta_HIv2___RNAseq.g26790.t1",144.921778528511,-9.00969561987811,3.31009187920968,3.45080077580493e-07,6.29412136459553e-06,NA,NA,NA,NA,NA
"670","Pocillopora_acuta_HIv2___RNAseq.g15172.t1",11660.5074946994,3.64908954605074,0.887734804157763,3.51941713238147e-07,6.41119010110397e-06,"P86982",1.98e-27,"Insoluble matrix shell protein 1 (IMSP1)","","GO:0005576"
"671","Pocillopora_acuta_HIv2___RNAseq.g30609.t1",72.7282646220258,-10.6460775814961,3.62492721776229,3.57251642624048e-07,6.49973303008079e-06,NA,NA,NA,NA,NA
"672","Pocillopora_acuta_HIv2___RNAseq.g24800.t1",329.339442485158,-5.78867578760079,1.93293874461234,3.64884872812801e-07,6.63026984970397e-06,"E7FAM5",1.82e-11,"E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177"
"673","Pocillopora_acuta_HIv2___TS.g28493.t1",653.628186451029,-1.30332456971318,2.31998041325243,3.66717937780753e-07,6.65521738025196e-06,NA,NA,NA,NA,NA
"674","Pocillopora_acuta_HIv2___RNAseq.g21637.t1",81.1276123362451,-7.97143556426167,2.37817130433408,3.83022729803081e-07,6.93371810246778e-06,"A0A1D5PUP4",1.11e-24,"Reversion-inducing cysteine-rich protein with Kazal motifs","blood vessel maturation [GO:0001955]; canonical Wnt signaling pathway [GO:0060070]; extracellular matrix organization [GO:0030198]; negative regulation of metalloendopeptidase activity [GO:1904684]; regulation of angiogenesis [GO:0045765]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]","GO:0001955; GO:0002040; GO:0004866; GO:0004867; GO:0005615; GO:0005886; GO:0008191; GO:0015026; GO:0030198; GO:0045765; GO:0060070; GO:0090210; GO:0098552; GO:1904684; GO:1990909"
"675","Pocillopora_acuta_HIv2___RNAseq.g20556.t1",154.652189714123,-8.69243147569365,3.27570819153819,4.01113179770388e-07,7.2340411872804e-06,"Q9HB75",6.98e-08,"p53-induced death domain-containing protein 1 (EC 3.4.21.-) (Leucine-rich repeat and death domain-containing protein) [Cleaved into: PIDD-N; PIDD-C; PIDD-CC]","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoprocessing [GO:0016540]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; signal transduction [GO:0007165]","GO:0004175; GO:0005123; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006915; GO:0006919; GO:0006974; GO:0006977; GO:0007165; GO:0008625; GO:0016540; GO:0043065; GO:0043066; GO:0043122; GO:0051092; GO:1905369"
"676","Pocillopora_acuta_HIv2___RNAseq.g13103.t1",2431.04611628532,6.2991897381713,2.59494620212274,4.05322454863049e-07,7.3008517897125e-06,NA,NA,NA,NA,NA
"677","Pocillopora_acuta_HIv2___TS.g1897.t1",90.6378895175458,-11.0723052275272,3.7977452352495,4.07877841706017e-07,7.33774266472118e-06,NA,NA,NA,NA,NA
"678","Pocillopora_acuta_HIv2___RNAseq.g22559.t1",3596.94262808464,3.24794174170916,0.750637867550368,4.08567721189259e-07,7.34102300531856e-06,"Q9GLP1",6.04e-27,"Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain]","blood circulation [GO:0008015]; blood coagulation [GO:0007596]","GO:0005507; GO:0005576; GO:0007596; GO:0008015; GO:0031091"
"679","Pocillopora_acuta_HIv2___TS.g20880.t1",77.2218040403559,-10.7330721197711,3.64042070084216,4.13977587846933e-07,7.41979161167043e-06,"Q8R1U2",2.51e-08,"Cell growth regulator with EF hand domain protein 1 (Cell growth regulatory gene 11 protein) (Hydrophobestin)","cell adhesion [GO:0007155]; negative regulation of cell growth [GO:0030308]; regulation of cell cycle [GO:0051726]","GO:0005509; GO:0005576; GO:0007155; GO:0030308; GO:0051726"
"680","Pocillopora_acuta_HIv2___RNAseq.g19299.t1",266.147435815686,1.66746669563763,4.17064031692062,4.26678644597667e-07,7.61911100674155e-06,NA,NA,NA,NA,NA
"681","Pocillopora_acuta_HIv2___RNAseq.g26161.t1",508.625014092727,-9.11912442983252,4.16787377721188,4.27221981229204e-07,7.61940658014699e-06,"Q9Y711",2.01e-82,"Alternative oxidase, mitochondrial (EC 1.-.-.-)","alternative respiration [GO:0010230]","GO:0005743; GO:0009916; GO:0010230; GO:0046872; GO:0070469"
"682","Pocillopora_acuta_HIv2___RNAseq.g11580.t1",148.096171726209,-11.2940632066035,4.14590891394215,4.34962611244978e-07,7.72886880718349e-06,"Q96RW7",9.94e-21,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711"
"683","Pocillopora_acuta_HIv2___TS.g19499.t2",256.054527035565,-1.14489126044851,2.25476223797158,4.35576297531319e-07,7.73027676993005e-06,"P49013",5.45e-61,"Fibropellin-3 (Epidermal growth factor-related protein 3) (Fibropellin III) (Fibropellin-c) (SpEGF III)","","GO:0005509; GO:0005576; GO:0009374"
"684","Pocillopora_acuta_HIv2___RNAseq.4782_t",303.099993745203,-4.56168650065538,4.73901412760429,4.39912084250564e-07,7.7785921596579e-06,NA,NA,NA,NA,NA
"685","Pocillopora_acuta_HIv2___RNAseq.g24760.t1",205.983533024016,-8.955262383749,3.50822779793429,4.53470816445486e-07,7.98334888423673e-06,"Q9TT38",0,"Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase (EC 3.1.1.5)]","arachidonic acid metabolic process [GO:0019369]; glycerol metabolic process [GO:0006071]; leukotriene biosynthetic process [GO:0019370]; monoacylglycerol biosynthetic process [GO:0006640]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylglycerol catabolic process [GO:0034478]; prostaglandin biosynthetic process [GO:0001516]","GO:0000139; GO:0001516; GO:0004622; GO:0005509; GO:0005544; GO:0005635; GO:0005737; GO:0005783; GO:0005829; GO:0006071; GO:0006640; GO:0008374; GO:0010314; GO:0019369; GO:0019370; GO:0032266; GO:0034478; GO:0034638; GO:0047498; GO:0047499; GO:0070273; GO:1902387"
"686","Pocillopora_acuta_HIv2___RNAseq.g26341.t1",452.741673719425,-7.11865229004989,3.16468802153149,4.53699722265113e-07,7.98334888423673e-06,"Q8LAD0",4.32e-57,"Probable pyridoxal 5'-phosphate synthase subunit PDX2 (AtPDX2) (EC 4.3.3.6) (Protein EMBRYO DEFECTIVE 2407) (Pyridoxal 5'-phosphate synthase glutaminase subunit) (EC 3.5.1.2)","glutamine metabolic process [GO:0006541]; pyridoxal phosphate biosynthetic process [GO:0042823]; vitamin B6 biosynthetic process [GO:0042819]","GO:0004359; GO:0005829; GO:0006541; GO:0036381; GO:0042819; GO:0042823; GO:0046982"
"687","Pocillopora_acuta_HIv2___RNAseq.g4498.t1",118.221039505953,-10.8023840591458,3.82474736999869,4.55021652446779e-07,7.99688114336598e-06,NA,NA,NA,NA,NA
"688","Pocillopora_acuta_HIv2___TS.g17854.t1",2083.02089718451,-1.45836171212632,3.4326981538466,4.73993275261231e-07,8.29001056031251e-06,NA,NA,NA,NA,NA
"689","Pocillopora_acuta_HIv2___TS.g14960.t2",557.925299343715,-1.13137308500592,2.10352351991025,4.86264965266803e-07,8.48412117927507e-06,"Q91755",4.95e-80,"Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6)","detection of cold stimulus involved in thermoception [GO:0120169]","GO:0004970; GO:0005234; GO:0005886; GO:0015277; GO:0022849; GO:0045211; GO:0120169"
"690","Pocillopora_acuta_HIv2___RNAseq.g4214.t1",70.4172962348968,-10.5379775713526,3.62900601150399,4.94660766041013e-07,8.62020881929785e-06,"A1DWM3",1.17e-29,"Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2 homolog)","antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]","GO:0005886; GO:0042590"
"691","Pocillopora_acuta_HIv2___RNAseq.g24299.t1",517.007717691082,4.32964891587457,1.18699401805072,4.95355299183772e-07,8.62192424475822e-06,NA,NA,NA,NA,NA
"692","Pocillopora_acuta_HIv2___TS.g6578.t1",358.663427869422,-1.44667295868444,3.04656725232668,4.97695243711956e-07,8.65224039068477e-06,"B8V7Q1",0,"Protocadherin-like protein","adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0000902; GO:0005509; GO:0005912; GO:0007043; GO:0007156; GO:0016339; GO:0016342; GO:0034332; GO:0044331; GO:0045296"
"693","Pocillopora_acuta_HIv2___RNAseq.g4886.t1",175.210210735635,-8.67976146833332,3.28770979170043,5.04698240351994e-07,8.76345179886103e-06,"Q19673",3.3e-10,"Putative tyrosinase-like protein tyr-3","","GO:0004497; GO:0046872"
"694","Pocillopora_acuta_HIv2___RNAseq.g15196.t1",310.382272120971,5.78928032459099,3.66344566297991,5.09966420416364e-07,8.83371773042191e-06,"Q55DA0",1.11e-53,"ABC transporter G family member 22 (ABC transporter ABCG.22)","aggregation involved in sorocarp development [GO:0031152]; cell motility [GO:0048870]; sorocarp morphogenesis [GO:0031288]; transmembrane transport [GO:0055085]","GO:0005524; GO:0016020; GO:0016887; GO:0031152; GO:0031288; GO:0042626; GO:0048870; GO:0055085; GO:0140359"
"695","Pocillopora_acuta_HIv2___RNAseq.g28226.t2",750.903428387654,5.6050631709912,4.58117050796131,5.16802852024486e-07,8.93074844884369e-06,"P07207",5.94e-69,"Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]","actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]","GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048"
"696","Pocillopora_acuta_HIv2___RNAseq.g1013.t1",224.539873585205,-8.93535293733735,3.93943294292328,5.20303590137308e-07,8.98051447225062e-06,NA,NA,NA,NA,NA
"697","Pocillopora_acuta_HIv2___RNAseq.g1000.t1",555.25501334569,-4.95069378591015,4.492611870922,5.22746369691687e-07,9.01192311230103e-06,NA,NA,NA,NA,NA
"698","Pocillopora_acuta_HIv2___TS.g11473.t1",316.836395328846,-1.69263222980521,22.3670363460845,5.37200770077856e-07,9.2281139410999e-06,NA,NA,NA,NA,NA
"699","Pocillopora_acuta_HIv2___RNAseq.g219.t1",168.31613187294,-5.08830135230513,1.31860205770762,5.44771834387592e-07,9.33599503860441e-06,"A4IF63",8.41e-25,"Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2)","negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]","GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0017148; GO:0030371; GO:0043161; GO:0043523; GO:0061630"
"700","Pocillopora_acuta_HIv2___RNAseq.g17090.t1",5915.60172920038,-5.74104464183774,2.90221847105208,5.6305216060468e-07,9.6150961640922e-06,"G5EG78",7e-92,"Peroxidasin homolog pxn-2 (EC 1.11.2.-)","axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; embryonic body morphogenesis [GO:0010172]; muscle attachment [GO:0016203]; negative regulation of axon regeneration [GO:0048681]; regulation of basement membrane organization [GO:0110011]; response to oxidative stress [GO:0006979]","GO:0004601; GO:0005604; GO:0005615; GO:0006979; GO:0007411; GO:0010172; GO:0016203; GO:0020037; GO:0046872; GO:0048681; GO:0071711; GO:0110011; GO:0140825"
"701","Pocillopora_acuta_HIv2___RNAseq.g709.t1",15945.586082239,3.31465641464002,0.790318860940209,5.64701751738139e-07,9.63189402964674e-06,NA,NA,NA,NA,NA
"702","Pocillopora_acuta_HIv2___RNAseq.g11876.t1",195.788641002293,9.03196363376051,3.69840846173643,5.66212797188111e-07,9.64629198884434e-06,"B3EWY9",4.02e-13,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020"
"703","Pocillopora_acuta_HIv2___RNAseq.g4469.t1",556.814435217407,-5.21662866835663,3.64035569801161,5.68247810677343e-07,9.66957215722011e-06,"Q5ZKY0",3.8e-54,"Endosomal/lysosomal proton channel TMEM175 (Potassium channel TMEM175) (Transmembrane protein 175)","lysosomal lumen pH elevation [GO:0035752]; neuron cellular homeostasis [GO:0070050]; phagosome-lysosome fusion [GO:0090385]; potassium ion transmembrane transport [GO:0071805]; proton transmembrane transport [GO:1902600]; regulation of lysosomal lumen pH [GO:0035751]","GO:0005267; GO:0005764; GO:0005765; GO:0005768; GO:0010008; GO:0015252; GO:0022841; GO:0035751; GO:0035752; GO:0050544; GO:0070050; GO:0071805; GO:0090385; GO:1902600"
"704","Pocillopora_acuta_HIv2___RNAseq.g29560.t1",4031.65016075501,-5.11792369589211,1.90042231644463,5.72919450920375e-07,9.72618185224449e-06,"Q8T882",9.23e-164,"Tauropine dehydrogenase (TaDH) (EC 1.5.1.23) (NAD: tauropine oxidoreductase)","","GO:0050325"
"705","Pocillopora_acuta_HIv2___RNAseq.g19258.t1",102.97848240713,-8.10117552705426,2.81494843686699,5.77097364783863e-07,9.78562284200913e-06,"Q7VWH8",3.5e-21,"Phosphonoacetaldehyde hydrolase (Phosphonatase) (EC 3.11.1.1) (Phosphonoacetaldehyde phosphonohydrolase)","organic phosphonate catabolic process [GO:0019700]","GO:0000287; GO:0019700; GO:0050194"
"706","Pocillopora_acuta_HIv2___RNAseq.g22691.t1",536.924145347434,5.8611214968978,2.00340924236052,5.7923418791187e-07,9.81035514514905e-06,"E9PUQ8",0,"Diacylglycerol kinase delta (DAG kinase delta) (EC 2.7.1.107)","diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of protein kinase C signaling [GO:0090038]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein transport [GO:0015031]","GO:0004143; GO:0005524; GO:0005829; GO:0005886; GO:0005905; GO:0006654; GO:0006897; GO:0007205; GO:0015031; GO:0019900; GO:0031410; GO:0035556; GO:0042802; GO:0042803; GO:0045742; GO:0046339; GO:0046834; GO:0046872; GO:0046982; GO:0090038; GO:2000370"
"707","Pocillopora_acuta_HIv2___RNAseq.g4785.t1",1227.37861831238,3.09715388259877,0.71357230572395,5.91632644268238e-07,1.00086252242056e-05,"P12263",1.54e-09,"Coagulation factor VIII (Procoagulant component)","acute-phase response [GO:0006953]; blood coagulation, intrinsic pathway [GO:0007597]","GO:0005507; GO:0005615; GO:0006953; GO:0007597; GO:0016491"
"708","Pocillopora_acuta_HIv2___TS.g28596.t2",335.501844755243,-1.62815893966091,3.7430559046284,6.06812411142757e-07,1.02295276395907e-05,NA,NA,NA,NA,NA
"709","Pocillopora_acuta_HIv2___RNAseq.g15552.t1",171.76777785772,-8.60467471848771,3.33449224376137,6.30123318115376e-07,1.05732061174255e-05,NA,NA,NA,NA,NA
"710","Pocillopora_acuta_HIv2___RNAseq.g2983.t1",110.937925636901,-8.32178226729748,3.03464313937734,6.33704239336554e-07,1.0620971167745e-05,NA,NA,NA,NA,NA
"711","Pocillopora_acuta_HIv2___RNAseq.g25003.t1",714.910070440306,-5.7643670931222,2.72395394341475,6.38856165383553e-07,1.06949254353099e-05,"B3EWY9",0,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020"
"712","Pocillopora_acuta_HIv2___RNAseq.g29861.t1",105.932476822471,-7.92028745544076,2.71989011951136,6.41046964583183e-07,1.07191945615389e-05,"Q6ZV65",5.43e-38,"Protein FAM47E","protein localization to chromatin [GO:0071168]; transcription initiation-coupled chromatin remodeling [GO:0045815]","GO:0000785; GO:0005634; GO:0005737; GO:0008047; GO:0045815; GO:0071168"
"713","Pocillopora_acuta_HIv2___RNAseq.g11547.t1",85.2066714849237,-10.7862438708142,3.8154083603668,6.42068580987063e-07,1.07238798561165e-05,"Q96P65",8.58e-28,"Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155)","cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0016020; GO:0032870; GO:0042277"
"714","Pocillopora_acuta_HIv2___RNAseq.g20058.t1",93.9282699414583,-10.678300928593,3.78423768712177,6.46427220413927e-07,1.07842252780473e-05,NA,NA,NA,NA,NA
"715","Pocillopora_acuta_HIv2___RNAseq.g4080.t1",2298.64897734108,4.29749234339526,1.23188118616822,6.5370679501242e-07,1.08805697158339e-05,NA,NA,NA,NA,NA
"716","Pocillopora_acuta_HIv2___RNAseq.g30772.t1",345.136392942817,-1.0123432307651,1.95484140858668,6.61261029590964e-07,1.0981032757754e-05,NA,NA,NA,NA,NA
"717","Pocillopora_acuta_HIv2___RNAseq.g29595.t1",364.638587823375,-5.95987609510236,3.62627489544896,6.68533109676276e-07,1.10890629568322e-05,"Q8R197",7.75e-59,"S-acyl fatty acid synthase thioesterase, medium chain (EC 3.1.2.14) (Oleoyl-ACP hydrolase) (Thioesterase II) (Thioesterase domain-containing protein 1)","lipid biosynthetic process [GO:0008610]; medium-chain fatty acid biosynthetic process [GO:0051792]","GO:0005829; GO:0008610; GO:0016297; GO:0051792"
"718","Pocillopora_acuta_HIv2___RNAseq.g7498.t1",335.771119262811,-1.00694963343454,1.88189455060028,6.74161509361677e-07,1.11454640226817e-05,"A7SLW1",0,"Branched-chain-amino-acid aminotransferase (EC 2.6.1.42)","L-leucine biosynthetic process [GO:0009098]; valine biosynthetic process [GO:0009099]","GO:0004084; GO:0005739; GO:0009098; GO:0009099; GO:0050048; GO:0052654; GO:0052655; GO:0052656"
"719","Pocillopora_acuta_HIv2___RNAseq.g20766.t1",128.288280525557,-8.55398218928998,3.19963608327554,6.74245092633189e-07,1.11454640226817e-05,"P16157",9.43e-08,"Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)","cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]","GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014"
"720","Pocillopora_acuta_HIv2___RNAseq.g25161.t1",299.217201356151,-8.64390728331284,3.72674887406187,6.86547686205856e-07,1.13358741247506e-05,"Q9Y3B7",8.69e-55,"Large ribosomal subunit protein uL11m (39S ribosomal protein L11, mitochondrial) (L11mt) (MRP-L11)","mitochondrial translation [GO:0032543]; translation [GO:0006412]","GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0006412; GO:0032543; GO:0070180"
"721","Pocillopora_acuta_HIv2___RNAseq.g14060.t1",664.041919546602,-1.07490696576404,1.89638776489099,6.97752596874686e-07,1.14946395913388e-05,"A7UKY7",9.87e-67,"Insulinoma-associated protein 1 (Zinc finger protein IA-1)","endocrine pancreas development [GO:0031018]; endodermal cell differentiation [GO:0035987]; gland development [GO:0048732]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; pancreatic A cell differentiation [GO:0003310]; transdifferentiation [GO:0060290]; type B pancreatic cell differentiation [GO:0003309]","GO:0000122; GO:0000978; GO:0003309; GO:0003310; GO:0003700; GO:0005634; GO:0007399; GO:0017053; GO:0031018; GO:0031490; GO:0035987; GO:0046872; GO:0048732; GO:0060290"
"722","Pocillopora_acuta_HIv2___RNAseq.g23879.t1",310.566223860072,-4.44062049346011,4.33692170551255,6.99074384856052e-07,1.1503312744662e-05,"Q60HG9",0,"Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II)","carnitine metabolic process [GO:0009437]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid metabolic process [GO:0001676]","GO:0001676; GO:0004095; GO:0005743; GO:0006635; GO:0008458; GO:0009437; GO:0016746"
"723","Pocillopora_acuta_HIv2___RNAseq.g9824.t1",3467.23763013346,-5.54804066681195,2.63131536438428,7.16935925576823e-07,1.17704440721262e-05,"B8NHE3",6.7e-11,"Methyltransferase flvH (EC 2.1.1.-) (Flavunoidine biosynthesis cluster protein H)","methylation [GO:0032259]; terpenoid biosynthetic process [GO:0016114]","GO:0008168; GO:0016114; GO:0032259; GO:0046872"
"724","Pocillopora_acuta_HIv2___TS.g805.t1a",1602.31304332393,-1.33744998821291,2.56334886280721,7.21378936676085e-07,1.18299602495271e-05,"P19623",1.01e-149,"Spermidine synthase (SPDSY) (EC 2.5.1.16) (Putrescine aminopropyltransferase)","cellular response to leukemia inhibitory factor [GO:1990830]; polyamine metabolic process [GO:0006595]; spermidine biosynthetic process [GO:0008295]","GO:0004766; GO:0005829; GO:0006595; GO:0008295; GO:0042802; GO:0042803; GO:1990830"
"725","Pocillopora_acuta_HIv2___RNAseq.g13784.t1",113.997873020613,8.5569057213227,3.44776411351556,7.22809123049635e-07,1.1839989983907e-05,"Q04604",7.19e-103,"Tyrosinase (EC 1.14.18.1) (Monophenol monooxygenase)","melanin biosynthetic process from tyrosine [GO:0006583]","GO:0004503; GO:0005507; GO:0006583; GO:0033162; GO:0042470"
"726","Pocillopora_acuta_HIv2___RNAseq.g9723.t1",149.270272404236,-1.29056869737048,2.84732632411644,7.38869245721812e-07,1.2034915281667e-05,"P29241",1.2e-48,"ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase (EC 3.2.2.-) (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase) (EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase) (ADPRC) (ADRC) (NAD glycohydrolase) (NAD(+) nucleosidase) (NADase)","positive regulation of B cell proliferation [GO:0030890]; single fertilization [GO:0007338]","GO:0003953; GO:0005886; GO:0007338; GO:0016740; GO:0016849; GO:0030890; GO:0031410; GO:0061809"
"727","Pocillopora_acuta_HIv2___TS.g17699.t2",262.889461154415,-1.15438104240542,2.27398438952679,7.44550548060604e-07,1.21138122915057e-05,"Q3UVD5",3.11e-27,"Leucine-rich repeat-containing G-protein coupled receptor 6","bone regeneration [GO:1990523]; cell population proliferation [GO:0008283]; positive regulation of cell migration [GO:0030335]; positive regulation of Wnt signaling pathway [GO:0030177]; tissue regeneration [GO:0042246]; Wnt signaling pathway [GO:0016055]","GO:0004930; GO:0005615; GO:0005886; GO:0008283; GO:0016055; GO:0016500; GO:0030177; GO:0030335; GO:0031012; GO:0031982; GO:0042246; GO:1990523"
"728","Pocillopora_acuta_HIv2___RNAseq.g8913.t1",760.921789243271,-3.00504334827626,0.695729432640036,7.57970721459392e-07,1.23044764480232e-05,"P10079",3.51e-11,"Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","","GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579"
"729","Pocillopora_acuta_HIv2___RNAseq.g6559.t1",684.897710987234,5.8561447819758,2.29245461938543,8.04289207121984e-07,1.30417478607762e-05,"A7RX26",0,"Probable imidazolonepropionase (EC 3.5.2.7) (Amidohydrolase domain-containing protein 1 homolog)","L-histidine catabolic process [GO:0006548]; L-histidine catabolic process to glutamate and formamide [GO:0019556]; L-histidine catabolic process to glutamate and formate [GO:0019557]","GO:0005737; GO:0006548; GO:0019556; GO:0019557; GO:0046872; GO:0050480"
"730","Pocillopora_acuta_HIv2___RNAseq.g23181.t1",528.624851597731,-8.88021346206667,4.68820166290529,8.06868538108687e-07,1.30543026120851e-05,"Q17LW0",7.15e-107,"Myosin-VIIa (Protein crinkled)","actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]","GO:0000146; GO:0003779; GO:0005524; GO:0005737; GO:0007605; GO:0008407; GO:0016459; GO:0030048; GO:0032027; GO:0035317; GO:0048800; GO:0071944; GO:0120025"
"731","Pocillopora_acuta_HIv2___RNAseq.g9090.t1",169.7101423904,-7.19083392486996,2.68556374688789,8.20640870953439e-07,1.32202400764621e-05,"Q9WUW9",7.37e-52,"Sulfotransferase 1C2A (ST1C2A) (rSULT1C2A) (EC 2.8.2.1) (Sulfotransferase K2)","sulfation [GO:0051923]","GO:0004062; GO:0005737; GO:0005764; GO:0008146; GO:0051923"
"732","Pocillopora_acuta_HIv2___RNAseq.g3509.t1",137.23526639955,5.67747055170967,3.23841996566577,8.25230110771048e-07,1.3262364802436e-05,"V6CLA2",7.25e-18,"E3 ubiquitin-protein ligase hecd-1 (EC 2.3.2.26)","determination of adult lifespan [GO:0008340]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; regulation of cell fate specification [GO:0042659]; regulation of germ cell proliferation [GO:1905936]; regulation of response to oxidative stress [GO:1902882]; regulation of vulval development [GO:0040028]","GO:0008340; GO:0016607; GO:0032436; GO:0040028; GO:0042659; GO:0043161; GO:0045746; GO:0045747; GO:0046872; GO:0061630; GO:0070534; GO:1902882; GO:1905936"
"733","Pocillopora_acuta_HIv2___RNAseq.g30904.t1",207.366849951932,-8.81017660374662,3.37473834209142,8.28988511317957e-07,1.32932259730631e-05,"P27163",4.14e-15,"Calmodulin-2 (CaM-2)","","GO:0005509; GO:0030234"
"734","Pocillopora_acuta_HIv2___RNAseq.26328_t",293.952567178692,-6.39606932963535,2.77238510400829,8.43935200363802e-07,1.35029632058208e-05,NA,NA,NA,NA,NA
"735","Pocillopora_acuta_HIv2___TS.g28908.t1",330.892129866623,-5.63731870570994,1.94797791060609,8.50420353010179e-07,1.3591690592198e-05,"Q0IIL7",7.88e-06,"Complexin-1","regulation of neurotransmitter secretion [GO:0046928]; synaptic vesicle exocytosis [GO:0016079]","GO:0000149; GO:0005829; GO:0016079; GO:0019905; GO:0031201; GO:0043195; GO:0043204; GO:0046928"
"736","Pocillopora_acuta_HIv2___RNAseq.17790_t",8086.66498713056,3.39384838095833,0.841610663591829,8.53288554926973e-07,1.3622478651726e-05,NA,NA,NA,NA,NA
"737","Pocillopora_acuta_HIv2___RNAseq.26321_t",275.957116094281,-1.44269504088896,6.50243433521085,8.68507202358338e-07,1.38408890690397e-05,"Q5U374",3.26e-111,"Kelch-like protein 12","anterior/posterior pattern specification [GO:0009952]; convergent extension involved in axis elongation [GO:0060028]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055]","GO:0006513; GO:0006888; GO:0009952; GO:0014029; GO:0014032; GO:0016055; GO:0030127; GO:0030134; GO:0031463; GO:0048208; GO:0060028"
"738","Pocillopora_acuta_HIv2___TS.g17564.t1",121.614244317315,-8.59467440158399,3.39306096061142,8.69755071906476e-07,1.38408890690397e-05,"O15254",0,"Peroxisomal acyl-coenzyme A oxidase 3 (EC 1.3.3.6) (Branched-chain acyl-CoA oxidase) (BRCACox) (Pristanoyl-CoA oxidase)","fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]","GO:0005504; GO:0005777; GO:0005782; GO:0005829; GO:0016020; GO:0016402; GO:0033540; GO:0050660; GO:0055088; GO:0071949"
"739","Pocillopora_acuta_HIv2___TS.g29618.t1",80.5444454545595,-8.12181892363651,2.85662233844399,9.02713822319923e-07,1.43416094729869e-05,"O75581",0,"Low-density lipoprotein receptor-related protein 6 (LRP-6)","canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055]","GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0051091; GO:0060070; GO:0071397; GO:0071542; GO:0071901; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909"
"740","Pocillopora_acuta_HIv2___RNAseq.g28986.t1",400.526022720074,-5.92374732154284,3.7491514477007,9.04753261192689e-07,1.43490692652314e-05,NA,NA,NA,NA,NA
"741","Pocillopora_acuta_HIv2___RNAseq.g15149.t1",1373.29593512977,-1.46151564734795,2.95017836440039,9.39385255583844e-07,1.48678364070093e-05,NA,NA,NA,NA,NA
"742","Pocillopora_acuta_HIv2___RNAseq.g17695.t1",183.227814604133,-5.62556583635548,1.97932667152752,9.39518976493813e-07,1.48678364070093e-05,"Q7RTR2",4.3e-74,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223"
"743","Pocillopora_acuta_HIv2___TS.g23073.t1",71.5722372876972,-10.3078690790067,3.6315971122151,9.43449205453928e-07,1.49137150903668e-05,NA,NA,NA,NA,NA
"744","Pocillopora_acuta_HIv2___RNAseq.g17236.t1",86.7427442155141,-6.36766554505924,2.051250551308,9.58362523087639e-07,1.51329208885804e-05,NA,NA,NA,NA,NA
"745","Pocillopora_acuta_HIv2___RNAseq.g13970.t2",372.905921792342,-8.56160505833336,3.82580384715396,9.81421003841717e-07,1.54464346023576e-05,"Q8TAM2",0,"Tetratricopeptide repeat protein 8 (TPR repeat protein 8) (Bardet-Biedl syndrome 8 protein)","axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cilium assembly [GO:0060271]; establishment of anatomical structure orientation [GO:0048560]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; fat cell differentiation [GO:0045444]; inner ear receptor cell stereocilium organization [GO:0060122]; multi-ciliated epithelial cell differentiation [GO:1903251]; multicellular organism growth [GO:0035264]; non-motile cilium assembly [GO:1905515]; olfactory bulb development [GO:0021772]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; regulation of protein localization [GO:0032880]; regulation of stress fiber assembly [GO:0051492]; renal tubule development [GO:0061326]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893]","GO:0001736; GO:0005813; GO:0005829; GO:0005929; GO:0007411; GO:0007608; GO:0015031; GO:0021772; GO:0032391; GO:0032880; GO:0034451; GO:0034464; GO:0035264; GO:0036064; GO:0045198; GO:0045444; GO:0048560; GO:0050893; GO:0051492; GO:0060122; GO:0060170; GO:0060219; GO:0060271; GO:0061326; GO:0061629; GO:0072659; GO:0097730; GO:1903251; GO:1905515"
"746","Pocillopora_acuta_HIv2___RNAseq.g2384.t1",386.949675165107,-1.40928926124706,2.74135234291718,9.90624185355386e-07,1.55743350184568e-05,"P02597",2.19e-39,"Calmodulin, striated muscle","","GO:0005509; GO:0005737"
"747","Pocillopora_acuta_HIv2___RNAseq.g17162.t1",189.760137595328,-8.53004016861028,3.48925102984074,1.00655011676636e-06,1.57903914196406e-05,"Q76KP1",1.37e-82,"N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 (NGalNAc-T1) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase IV) (Beta4GalNAc-T4) (Beta4GalNAcT4)","","GO:0008376; GO:0032580; GO:0033842"
"748","Pocillopora_acuta_HIv2___RNAseq.g12801.t1b",184.466244039598,-8.48043762386662,3.3619729174328,1.04559717556799e-06,1.63497486999086e-05,"Q56A36",1.5e-22,"Hematopoietic SH2 domain-containing protein homolog","signal transduction [GO:0007165]","GO:0005737; GO:0007165"
"749","Pocillopora_acuta_HIv2___TS.g21317.t2",279.534150315599,-7.90183293404136,3.16672552394318,1.05384456555784e-06,1.64431583562337e-05,"Q9D3U0",2.3e-125,"tRNA pseudouridine synthase Pus10 (EC 5.4.99.25) (Coiled-coil domain-containing protein 139) (tRNA pseudouridine 55 synthase) (Psi55 synthase) (tRNA pseudouridylate synthase) (tRNA-uridine isomerase)","primary miRNA processing [GO:0031053]; tRNA pseudouridine synthesis [GO:0031119]","GO:0005634; GO:0005737; GO:0005739; GO:0009982; GO:0031053; GO:0031119; GO:0046872; GO:0070878; GO:0106029; GO:0160148"
"750","Pocillopora_acuta_HIv2___RNAseq.g5341.t1",2339.32055669593,4.95347116431506,3.00241883300712,1.07618191404776e-06,1.67555384335703e-05,NA,NA,NA,NA,NA
"751","Pocillopora_acuta_HIv2___RNAseq.18718_t",265.132738380105,-8.63497052289623,3.44924343453856,1.10674443380657e-06,1.71759136165003e-05,NA,NA,NA,NA,NA
"752","Pocillopora_acuta_HIv2___TS.g28111.t1",363.677410884631,-3.86336023344185,5.28405561606445,1.11484755812862e-06,1.7264620000827e-05,"Q7TPD1",0,"F-box only protein 11","negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004842; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0006511; GO:0007605; GO:0008270; GO:0010719; GO:0016274; GO:0016567; GO:0042981; GO:0043161; GO:0045732; GO:1904878; GO:1990756"
"753","Pocillopora_acuta_HIv2___RNAseq.g26862.t1",335.489418510941,-1.3747499963128,2.67798118432658,1.12704535696264e-06,1.74162222682774e-05,NA,NA,NA,NA,NA
"754","Pocillopora_acuta_HIv2___TS.g21601.t1",154.91928275956,-6.15751460951917,1.94333077576376,1.15913198843638e-06,1.78358351922806e-05,NA,NA,NA,NA,NA
"755","Pocillopora_acuta_HIv2___RNAseq.g5807.t1",9139.3164167662,4.45541177573663,1.40923493267101,1.18122359522996e-06,1.81179407013851e-05,"Q8I335",2.76e-08,"Translation factor GUF1 homolog, mitochondrial (EC 3.6.5.-) (Elongation factor 4 homolog) (EF-4) (GTPase GUF1 homolog) (Ribosomal back-translocase)","positive regulation of translation [GO:0045727]; translation [GO:0006412]","GO:0003924; GO:0005525; GO:0005743; GO:0006412; GO:0043022; GO:0045727"
"756","Pocillopora_acuta_HIv2___RNAseq.g4097.t1",64440.9190646108,-4.71876609414254,1.41949085292693,1.18772689219487e-06,1.81983917041383e-05,NA,NA,NA,NA,NA
"757","Pocillopora_acuta_HIv2___RNAseq.g7215.t1",116.668353188051,-7.99716406896862,3.01893290266262,1.18920775186044e-06,1.81991114092626e-05,"Q3U481",4.13e-30,"Major facilitator superfamily domain-containing protein 12 (Protein grizzled)","carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021]","GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0043474; GO:0048021; GO:0048022; GO:1903712"
"758","Pocillopora_acuta_HIv2___RNAseq.g25207.t1",281.735649112322,-1.48664860479727,3.05685969945063,1.19029033415117e-06,1.81991114092626e-05,NA,NA,NA,NA,NA
"759","Pocillopora_acuta_HIv2___RNAseq.g31067.t1",208.117822889682,-7.47050926616739,3.35331412459462,1.19750234814313e-06,1.8290046424015e-05,NA,NA,NA,NA,NA
"760","Pocillopora_acuta_HIv2___RNAseq.g9293.t1",214.074366971945,-1.24214349702327,2.68875412188925,1.25256852912275e-06,1.90306210138986e-05,"Q9CR50",1.88e-50,"RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0005102; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0051865; GO:0061630; GO:0072344"
"761","Pocillopora_acuta_HIv2___RNAseq.g2436.t1",3002.38733152766,-3.0226438375374,0.734034151576399,1.27312194615018e-06,1.93225979319162e-05,NA,NA,NA,NA,NA
"762","Pocillopora_acuta_HIv2___RNAseq.g1508.t1",634.708891492389,-4.70405719692495,4.74238626722173,1.38578699678792e-06,2.08791907516046e-05,"Q27084",1.79e-76,"Tachylectin-2 (Lectin L10c)","innate immune response [GO:0045087]","GO:0005576; GO:0030246; GO:0045087"
"763","Pocillopora_acuta_HIv2___RNAseq.g31.t1",1891.4383734855,-1.04735870853319,1.79310615646222,1.40000200917997e-06,2.10714142151708e-05,"G8HTB6",3.14e-49,"ZP domain-containing protein","","GO:0016020"
"764","Pocillopora_acuta_HIv2___RNAseq.g832.t1",245.177669393564,-6.56878944622916,2.45036709637861,1.43060924616381e-06,2.15097007656064e-05,"A0A2B4RNI3",6.97e-23,"Cyclic GMP-AMP synthase-like receptor 2 (Sp-cGLR2) (EC 2.7.7.86)","innate immune response [GO:0045087]","GO:0005524; GO:0005525; GO:0045087; GO:0046872; GO:0061501"
"765","Pocillopora_acuta_HIv2___RNAseq.g15454.t1",1988.13473761149,-5.63453154119441,2.6475197453907,1.46165043353335e-06,2.18627837338432e-05,NA,NA,NA,NA,NA
"766","Pocillopora_acuta_HIv2___RNAseq.2466_t",596.648890404588,5.69770848902838,2.54228540870415,1.48978332891021e-06,2.22375914028455e-05,NA,NA,NA,NA,NA
"767","Pocillopora_acuta_HIv2___RNAseq.g19327.t1",462.840455730804,-1.13454367060365,1.9952079997284,1.51050468062471e-06,2.25236491758308e-05,NA,NA,NA,NA,NA
"768","Pocillopora_acuta_HIv2___TS.g21980.t1",267.082552881012,-7.80311152193673,3.33504515371819,1.53876534563724e-06,2.28508233668348e-05,"Q9GSB0",3.83e-10,"Crt homolog 1 (Chloroquine resistance transporter paralog 1) (DdCRTp1)","amino acid transport [GO:0006865]","GO:0005774; GO:0006865; GO:0012506; GO:0042910"
"769","Pocillopora_acuta_HIv2___RNAseq.g28425.t1",213.883144529234,-1.32562260280166,2.86070642528147,1.55162098479772e-06,2.30180983837069e-05,"O60678",2.98e-171,"Protein arginine N-methyltransferase 3 (EC 2.1.1.319) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3)","chromatin remodeling [GO:0006338]; methylation [GO:0032259]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of retinoic acid biosynthetic process [GO:1900053]","GO:0005634; GO:0005737; GO:0005829; GO:0006338; GO:0008168; GO:0016274; GO:0031397; GO:0032259; GO:0035241; GO:0035242; GO:0042054; GO:0043022; GO:0046872; GO:1900053"
"770","Pocillopora_acuta_HIv2___RNAseq.g3025.t1",345.304050505396,-1.00590536462255,1.86264093053207,1.57253601416758e-06,2.32568107453169e-05,"Q9QXV3",1.25e-69,"Inhibitor of growth protein 1","negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of stem cell population maintenance [GO:1902459]; protein import into nucleus [GO:0006606]; regulation of programmed cell death [GO:0043067]","GO:0000122; GO:0005634; GO:0006606; GO:0030336; GO:0030512; GO:0035064; GO:0043067; GO:0045893; GO:0046872; GO:0070822; GO:1902455; GO:1902459"
"771","Pocillopora_acuta_HIv2___RNAseq.g17476.t1",168.463613696132,-8.22178812409498,3.5663624500797,1.59751971819683e-06,2.35061294038646e-05,"A5PJF4",7.28e-10,"Transmembrane protein 218","","GO:0005929; GO:0016020"
"772","Pocillopora_acuta_HIv2___RNAseq.g15279.t1",1874.32537199299,5.71543099625217,2.58606287650892,1.66946264018255e-06,2.44899671679518e-05,"O95236",1.64e-12,"Apolipoprotein L3 (Apolipoprotein L-III) (ApoL-III) (TNF-inducible protein CG12-1) (CG12_1)","inflammatory response [GO:0006954]; lipoprotein metabolic process [GO:0042157]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]","GO:0005319; GO:0005576; GO:0005737; GO:0006954; GO:0008289; GO:0016020; GO:0042157; GO:0043123"
"773","Pocillopora_acuta_HIv2___RNAseq.g7625.t1",56.7660190644875,-10.1893352285053,3.64065304816656,1.67341327774202e-06,2.4523049290031e-05,"Q15399",3.37e-10,"Toll-like receptor 1 (Toll/interleukin-1 receptor-like protein) (TIL) (CD antigen CD281)","cellular response to triacyl bacterial lipopeptide [GO:0071727]; detection of triacyl bacterial lipopeptide [GO:0042495]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage activation [GO:0042116]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of tumor necrosis factor production [GO:0032760]; signal transduction [GO:0007165]; toll-like receptor signaling pathway [GO:0002224]","GO:0002224; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0006955; GO:0007165; GO:0016020; GO:0030670; GO:0032755; GO:0032757; GO:0032760; GO:0034137; GO:0035354; GO:0035663; GO:0038023; GO:0042116; GO:0042495; GO:0042802; GO:0043235; GO:0045087; GO:0045121; GO:0061809; GO:0071723; GO:0071727"
"774","Pocillopora_acuta_HIv2___RNAseq.g29984.t1",336.568885572805,-8.19583455513641,3.72438092691254,1.67824526067143e-06,2.45689670550118e-05,"P87387",1.57e-100,"Protein Wnt-2b-A (Wnt-2b) (XWnt-2b) (XWnt-2)","system development [GO:0048731]; Wnt signaling pathway [GO:0016055]","GO:0005102; GO:0005576; GO:0016055; GO:0048731"
"775","Pocillopora_acuta_HIv2___RNAseq.g10069.t1",218.452432099583,3.09329345983325,0.755303530864408,1.70948043444261e-06,2.50009352919898e-05,NA,NA,NA,NA,NA
"776","Pocillopora_acuta_HIv2___RNAseq.g29124.t1",396.744424828575,-3.87453429745158,4.05508101118983,1.72627068952285e-06,2.52209891447056e-05,"Q6NX31",0,"DNA replication licensing factor mcm7 (EC 3.6.4.12) (CDC47 homolog) (Minichromosome maintenance protein 7)","DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-templated DNA replication initiation [GO:0030174]","GO:0000785; GO:0003677; GO:0003678; GO:0005524; GO:0006268; GO:0006270; GO:0016887; GO:0030174; GO:0042555; GO:0046872; GO:0071162"
"777","Pocillopora_acuta_HIv2___RNAseq.g12287.t1",160.939659886312,-6.29951637698291,3.09906228075976,1.73717789907528e-06,2.53547337358475e-05,"P16621",3.33e-16,"Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR)","axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; hematopoietic stem cell homeostasis [GO:0061484]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; negative regulation of insulin receptor signaling pathway [GO:0046627]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic assembly at neuromuscular junction [GO:0051124]","GO:0004725; GO:0005001; GO:0005158; GO:0005925; GO:0007155; GO:0007283; GO:0007399; GO:0007411; GO:0007412; GO:0008045; GO:0008201; GO:0008594; GO:0009925; GO:0009986; GO:0030424; GO:0031252; GO:0031290; GO:0032093; GO:0045467; GO:0046627; GO:0048477; GO:0048675; GO:0048841; GO:0051124; GO:0051491; GO:0060269; GO:0061484; GO:0120034; GO:1903386"
"778","Pocillopora_acuta_HIv2___RNAseq.g26393.t1",555.40944293767,-3.61832480360814,0.981397586401094,1.75402170384818e-06,2.55747680690122e-05,"Q2HJ86",0,"Tubulin alpha-1D chain (EC 3.6.5.-) [Cleaved into: Detyrosinated tubulin alpha-1D chain]","microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]","GO:0000226; GO:0000278; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0016787; GO:0046872"
"779","Pocillopora_acuta_HIv2___TS.g19040.t1",79.63900163295,-10.6841537430057,3.89809326061503,1.76201164230983e-06,2.56395738373937e-05,"Q9UIJ7",1.38e-58,"GTP:AMP phosphotransferase AK3, mitochondrial (EC 2.7.4.10) (Adenylate kinase 3) (Adenylate kinase 3 alpha-like 1) (Adenylate kinase isozyme 3)","ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; blood coagulation [GO:0007596]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; UTP metabolic process [GO:0046051]","GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0006172; GO:0007596; GO:0009142; GO:0046033; GO:0046039; GO:0046041; GO:0046051; GO:0046899"
"780","Pocillopora_acuta_HIv2___RNAseq.g22509.t1",1219.75158996978,5.77032955563383,2.57047315052368,1.78211143760857e-06,2.59059897824828e-05,"Q95JR6",1.75e-25,"Cyclic nucleotide-binding domain-containing protein 2","spermatogenesis [GO:0007283]","GO:0005829; GO:0007283; GO:0030552"
"781","Pocillopora_acuta_HIv2___RNAseq.g11548.t1",128.492710830693,-8.06111398399066,3.27711952845234,1.81505536644762e-06,2.63319566903695e-05,"Q96P65",1.17e-28,"Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155)","cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0016020; GO:0032870; GO:0042277"
"782","Pocillopora_acuta_HIv2___TS.g23115.t1",82.0184673278625,-10.4870427403544,3.92762674549471,1.87287673676721e-06,2.70352186832344e-05,"P10079",8.89e-84,"Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","","GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579"
"783","Pocillopora_acuta_HIv2___RNAseq.g936.t1",2339.96311251566,-3.07611129482018,0.767498252731261,1.87971425153099e-06,2.70798674642871e-05,"Q86TI4",2.51e-93,"WD repeat-containing protein 86","",""
"784","Pocillopora_acuta_HIv2___TS.g9513.t1",11530.1786131575,-3.74242818741844,3.73301971959814,1.89437231896937e-06,2.72367805383429e-05,"Q9VIK2",1.18e-56,"Carcinine transporter","carcinine import across plasma membrane [GO:1905130]; detection of light stimulus involved in visual perception [GO:0050908]; neurotransmitter uptake [GO:0001504]; positive phototaxis [GO:0046956]; visual perception [GO:0007601]","GO:0001504; GO:0005326; GO:0005886; GO:0007601; GO:0043679; GO:0046956; GO:0050908; GO:1905130; GO:1905131"
"785","Pocillopora_acuta_HIv2___RNAseq.g11877.t2b",2944.03655162024,3.66283992835838,1.01501714130256,1.90875456337301e-06,2.7416311821874e-05,"Q8IUL8",7.39e-55,"Cartilage intermediate layer protein 2 (CILP-2) [Cleaved into: Cartilage intermediate layer protein 2 C1; Cartilage intermediate layer protein 2 C2]","","GO:0005615; GO:0070062"
"786","Pocillopora_acuta_HIv2___RNAseq.g701.t1",129.222877659363,-8.26788594503997,3.51750996745913,2.0519693581785e-06,2.92466595394987e-05,"H2LRU7",3.96e-27,"Polycystin-2 (Polycystic kidney disease 2 protein homolog)","calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus [GO:0050982]; detection of nodal flow [GO:0003127]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; release of sequestered calcium ion into cytosol [GO:0051209]; Wnt signaling pathway [GO:0016055]","GO:0003127; GO:0005102; GO:0005245; GO:0005248; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005789; GO:0005886; GO:0005929; GO:0007166; GO:0015271; GO:0016020; GO:0016055; GO:0016323; GO:0030659; GO:0034703; GO:0050982; GO:0051209; GO:0051262; GO:0051290; GO:0051371; GO:0060170; GO:0070588; GO:0071277; GO:0071805; GO:0098662"
"787","Pocillopora_acuta_HIv2___RNAseq.g4030.t1",142.268472866387,-7.96740959202097,3.39427840691207,2.05438371765284e-06,2.92466595394987e-05,"Q6DCV0",5.29e-164,"WD repeat domain phosphoinositide-interacting protein 4 (WIPI-4) (WD repeat-containing protein 45)","autophagosome assembly [GO:0000045]; cellular response to starvation [GO:0009267]; positive regulation of autophagosome assembly [GO:2000786]","GO:0000045; GO:0000407; GO:0009267; GO:0032266; GO:1901981; GO:2000786"
"788","Pocillopora_acuta_HIv2___RNAseq.g702.t1",58.2086220298453,-10.1121392696641,3.66762618095969,2.06195177431045e-06,2.92981484059033e-05,"Q26627",2.92e-39,"Sperm receptor for egg jelly (suREJ)","detection of mechanical stimulus [GO:0050982]","GO:0005262; GO:0005509; GO:0005886; GO:0016020; GO:0030246; GO:0050982"
"789","Pocillopora_acuta_HIv2___TS.g25599.t1",10009.4862760367,6.38691212770124,2.57825120456407,2.07001699620232e-06,2.93824591099807e-05,NA,NA,NA,NA,NA
"790","Pocillopora_acuta_HIv2___RNAseq.g29841.t1",816.002237387024,-5.13519042541937,2.01902238291629,2.07640122060071e-06,2.94441835831065e-05,"O00339",8.25e-51,"Matrilin-2","axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; neuron migration [GO:0001764]; response to axon injury [GO:0048678]","GO:0001764; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0007411; GO:0008347; GO:0030198; GO:0031012; GO:0031104; GO:0048678; GO:0062023; GO:0120216"
"791","Pocillopora_acuta_HIv2___RNAseq.g18958.t1",1870.13484021893,3.77126416067944,1.09239335597011,2.1118350658632e-06,2.98880453939777e-05,NA,NA,NA,NA,NA
"792","Pocillopora_acuta_HIv2___RNAseq.g4383.t1",634.590364681193,-4.96609049267424,4.0574693641474,2.1568023962306e-06,3.04351120576385e-05,"D2GXS7",1.41e-15,"Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2)","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]","GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0030371; GO:0043161; GO:0043523; GO:0061630"
"793","Pocillopora_acuta_HIv2___RNAseq.g9603.t1",749.297124870208,-5.04652376325173,1.9587348629848,2.25084092627658e-06,3.16386425244552e-05,"P36514",2.08e-91,"UDP-glucuronosyltransferase 2C1 (UDPGT 2C1) (EC 2.4.1.17)","lipid metabolic process [GO:0006629]","GO:0005789; GO:0006629; GO:0015020"
"794","Pocillopora_acuta_HIv2___RNAseq.g26782.t1",73.0933474465787,-10.4021718420544,3.83785031533194,2.27505763593311e-06,3.19479938312004e-05,"Q9DER7",2.57e-97,"Tolloid-like protein 1 (EC 3.4.24.-) (Chicken tolloid-like protein 1) (Metalloprotease colloid)","cell differentiation [GO:0030154]; dorsal/ventral pattern formation [GO:0009953]; protein processing [GO:0016485]","GO:0004222; GO:0005509; GO:0005615; GO:0008270; GO:0009953; GO:0016485; GO:0030154"
"795","Pocillopora_acuta_HIv2___RNAseq.g9150.t1",479.913053914647,4.96546075048198,1.84929124596505,2.31618917199182e-06,3.24940447950434e-05,NA,NA,NA,NA,NA
"796","Pocillopora_acuta_HIv2___RNAseq.g25708.t1",635.875602112745,-1.20527317638641,2.17279874968636,2.40151688950761e-06,3.35609084925972e-05,"Q8IVV2",0,"Lipoxygenase homology domain-containing protein 1","sensory perception of sound [GO:0007605]","GO:0007605; GO:0032420"
"797","Pocillopora_acuta_HIv2___RNAseq.g28169.t1",119.66311298677,-5.39674731088182,1.51571903701777,2.42278148403926e-06,3.38253970899072e-05,"F6QEU4",1.29e-49,"E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0030371; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177"
"798","Pocillopora_acuta_HIv2___RNAseq.g28450.t1",209.330492281868,3.29630013464204,0.850025451688192,2.43048223046933e-06,3.39001880245983e-05,"P35033",1.19e-62,"Trypsin-3 (EC 3.4.21.4) (Trypsin III)","digestion [GO:0007586]; proteolysis [GO:0006508]","GO:0004252; GO:0005615; GO:0006508; GO:0007586; GO:0046872"
"799","Pocillopora_acuta_HIv2___RNAseq.g9863.t1",107.331067328028,-7.77215992739827,3.08539239291436,2.43630262444944e-06,3.39486331021548e-05,NA,NA,NA,NA,NA
"800","Pocillopora_acuta_HIv2___RNAseq.5685_t",266.65376562013,-5.18449389774653,3.48847367639774,2.46011125879207e-06,3.41816035035241e-05,NA,NA,NA,NA,NA
"801","Pocillopora_acuta_HIv2___TS.g24185.t1",681.196054409371,-1.46264316414617,2.64009517322554,2.51583483871164e-06,3.48888160183366e-05,NA,NA,NA,NA,NA
"802","Pocillopora_acuta_HIv2___RNAseq.g18951.t1",944.681077776357,-5.23459538079338,3.32564099429247,2.5294461451983e-06,3.50106445091703e-05,"Q3SYV5",2.73e-65,"Tetraspanin-33 (Tspan-33)","protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]","GO:0005737; GO:0005886; GO:0005912; GO:0051604; GO:0072659"
"803","Pocillopora_acuta_HIv2___RNAseq.g19787.t1",104.271855347264,-6.74885936685245,2.13679877578244,2.53961809013887e-06,3.51176252923219e-05,NA,NA,NA,NA,NA
"804","Pocillopora_acuta_HIv2___RNAseq.7292_t",196.49604090737,-1.07004029488122,1.94928083552496,2.65204378703408e-06,3.65673606631658e-05,"Q99PW8",0,"Kinesin-like protein KIF17 (MmKIF17)","anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based process [GO:0007017]; protein transport [GO:0015031]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192]","GO:0001750; GO:0001917; GO:0003777; GO:0005524; GO:0005815; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007017; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016192; GO:0016887; GO:0030030; GO:0031503; GO:0032391; GO:0032839; GO:0036064; GO:0042073; GO:0043005; GO:0098794; GO:0098971; GO:1990075"
"805","Pocillopora_acuta_HIv2___RNAseq.g17311.t1",2064.858451302,3.51362905108564,0.984625315631918,2.66401756802702e-06,3.66974762894694e-05,"A6QLN9",1.27e-13,"von Willebrand factor A domain-containing protein 1","translation [GO:0006412]","GO:0003735; GO:0005576; GO:0005604; GO:0005840; GO:0006412; GO:0062023"
"806","Pocillopora_acuta_HIv2___RNAseq.g26093.t1",292.704893782478,-1.26466874821607,2.25257715173746,2.71505933615078e-06,3.72940344141357e-05,NA,NA,NA,NA,NA
"807","Pocillopora_acuta_HIv2___RNAseq.g11768.t1",182.547353640695,-8.06497807906387,3.89967796454282,2.73659231556318e-06,3.74499337972649e-05,NA,NA,NA,NA,NA
"808","Pocillopora_acuta_HIv2___TS.g10198.t2",278.968072165855,-1.30414638725108,2.3870971289624,2.75747325458169e-06,3.76976305805951e-05,"Q9UMZ3",1.08e-40,"Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48)","regulation of fat cell differentiation [GO:0045598]","GO:0004725; GO:0009925; GO:0016324; GO:0043235; GO:0045598; GO:0120044"
"809","Pocillopora_acuta_HIv2___RNAseq.g25885.t1",338.278471721624,6.1194915720607,2.90636673290514,2.77518858438656e-06,3.78561632525897e-05,"Q8IZD6",8.86e-61,"Solute carrier family 22 member 15 (Fly-like putative transporter 1) (Flipt 1)","amino acid transport [GO:0006865]; monoatomic ion transport [GO:0006811]","GO:0005886; GO:0006811; GO:0006865; GO:0015199"
"810","Pocillopora_acuta_HIv2___RNAseq.g13940.t1",129.696031600665,-7.71615577101799,3.30380090338066,2.79080648129912e-06,3.79738710682131e-05,NA,NA,NA,NA,NA
"811","Pocillopora_acuta_HIv2___RNAseq.g1217.t1",278.804556139816,-4.53238803347756,5.84787251350289,2.81804299203751e-06,3.83084340571715e-05,"P29274",2.79e-14,"Adenosine receptor A2a","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; astrocyte activation [GO:0048143]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; central nervous system development [GO:0007417]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; inflammatory response [GO:0006954]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vascular permeability [GO:0043116]; neuron projection morphogenesis [GO:0048812]; phagocytosis [GO:0006909]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of urine volume [GO:0035810]; prepulse inhibition [GO:0060134]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of calcium ion transport [GO:0051924]; regulation of DNA-templated transcription [GO:0006355]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of norepinephrine secretion [GO:0014061]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; response to purine-containing compound [GO:0014074]; response to xenobiotic stimulus [GO:0009410]; sensory perception [GO:0007600]; synaptic transmission, cholinergic [GO:0007271]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; vasodilation [GO:0042311]","GO:0001609; GO:0001963; GO:0001973; GO:0001975; GO:0005516; GO:0005882; GO:0005886; GO:0006355; GO:0006909; GO:0006915; GO:0006954; GO:0006968; GO:0007188; GO:0007189; GO:0007205; GO:0007267; GO:0007271; GO:0007417; GO:0007596; GO:0007600; GO:0007626; GO:0008015; GO:0008285; GO:0008289; GO:0009410; GO:0014049; GO:0014057; GO:0014061; GO:0014074; GO:0016020; GO:0019899; GO:0030425; GO:0030673; GO:0031000; GO:0031802; GO:0032230; GO:0032279; GO:0035249; GO:0035810; GO:0042311; GO:0042734; GO:0042755; GO:0042802; GO:0043025; GO:0043116; GO:0043524; GO:0044877; GO:0045211; GO:0045938; GO:0046636; GO:0048143; GO:0048786; GO:0048812; GO:0050714; GO:0050728; GO:0051393; GO:0051881; GO:0051899; GO:0051924; GO:0051968; GO:0060079; GO:0060080; GO:0060134; GO:0097190; GO:0098978; GO:0099171; GO:1900273; GO:2001235"
"812","Pocillopora_acuta_HIv2___RNAseq.g1030.t1",175.971739544299,-7.79280810345085,3.44795981291929,2.8301195299999e-06,3.84364778233977e-05,"Q90X67",3.13e-30,"Suppressor of cytokine signaling 3 (SOCS-3)","intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein ubiquitination [GO:0016567]","GO:0005942; GO:0009968; GO:0016567; GO:0035556; GO:0046854; GO:0046935"
"813","Pocillopora_acuta_HIv2___RNAseq.g25805.t1",213.115870933737,-1.13390775862777,2.33128399663741,2.84620216518542e-06,3.85824443460561e-05,"O74549",2.16e-27,"NEDD8-conjugating enzyme ubc12 (EC 2.3.2.34) (RUB1-conjugating enzyme) (Ubiquitin carrier protein 12)","protein neddylation [GO:0045116]","GO:0005524; GO:0005634; GO:0005829; GO:0019788; GO:0045116; GO:0061654"
"814","Pocillopora_acuta_HIv2___RNAseq.g30774.t1",358.183784846663,-7.93689170567839,3.77005125431813,2.85536682329499e-06,3.86704360787816e-05,NA,NA,NA,NA,NA
"815","Pocillopora_acuta_HIv2___TS.g11855.t2",102.794813779928,-8.00889609283553,3.4741599879742,2.96198600943972e-06,3.99647067542315e-05,NA,NA,NA,NA,NA
"816","Pocillopora_acuta_HIv2___RNAseq.g7683.t1",792.420962683035,-4.34246282102472,3.95710629531889,2.96670461388883e-06,3.99910676004548e-05,"Q9ULH7",2.01e-40,"Myocardin-related transcription factor B (MRTF-B) (MKL/myocardin-like protein 2) (Megakaryoblastic leukemia 2)","muscle organ development [GO:0007517]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of striated muscle tissue development [GO:0045844]; positive regulation of transcription by RNA polymerase II [GO:0045944]; smooth muscle cell differentiation [GO:0051145]","GO:0003713; GO:0005634; GO:0007517; GO:0045296; GO:0045844; GO:0045944; GO:0051145; GO:1902895"
"817","Pocillopora_acuta_HIv2___TS.g4466.t2",150.34533257272,-7.89791982453843,3.80317875846327,2.96970728756442e-06,3.99942702116683e-05,"Q1RLY6",9.2e-175,"Kynurenine 3-monooxygenase (EC 1.14.13.9) (Kynurenine 3-hydroxylase)","'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; kynurenine metabolic process [GO:0070189]; NAD metabolic process [GO:0019674]; podocyte development [GO:0072015]; quinolinate biosynthetic process [GO:0019805]; response to yeast [GO:0001878]; tryptophan catabolic process [GO:0006569]","GO:0001878; GO:0004502; GO:0005741; GO:0006569; GO:0019674; GO:0019805; GO:0034354; GO:0043420; GO:0070189; GO:0071949; GO:0072015"
"818","Pocillopora_acuta_HIv2___RNAseq.g13196.t1",183.167377393119,3.62620743516046,1.01917340646049,3.20518634717802e-06,4.28860456295863e-05,NA,NA,NA,NA,NA
"819","Pocillopora_acuta_HIv2___TS.g15668.t1",900.817267723889,-4.80592032394515,1.7344233998854,3.29446138772505e-06,4.39991592909096e-05,"A2TF48",3.83e-07,"Myeloid differentiation primary response protein MyD88","defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 8 signaling pathway [GO:0034158]","GO:0002755; GO:0005634; GO:0005737; GO:0005886; GO:0006954; GO:0008063; GO:0032731; GO:0034142; GO:0034158; GO:0035325; GO:0043123; GO:0045087; GO:0050830; GO:0051607; GO:0070976; GO:1900227"
"820","Pocillopora_acuta_HIv2___RNAseq.g2214.t1c",148.01235283777,-7.60206973239123,3.26902034519985,3.3012466620264e-06,4.40491067523523e-05,NA,NA,NA,NA,NA
"821","Pocillopora_acuta_HIv2___RNAseq.g5063.t1",132.008536846297,-7.75325705657358,3.66780316580228,3.39422926018793e-06,4.51647948660149e-05,"Q8GYB1",4.56e-37,"Nudix hydrolase 15, mitochondrial (AtNUDT15) (EC 3.6.1.-) (Coenzyme A diphosphatase NUDT15)","coenzyme A biosynthetic process [GO:0015937]; nucleoside phosphate metabolic process [GO:0006753]; succinyl-CoA metabolic process [GO:0006104]","GO:0005739; GO:0006104; GO:0006753; GO:0008893; GO:0010945; GO:0015937; GO:0046872"
"822","Pocillopora_acuta_HIv2___RNAseq.g30215.t1",4238.85293381068,2.92717635227683,0.750050679794013,3.4209797205266e-06,4.54789068728831e-05,"Q9GLP1",1.48e-30,"Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain]","blood circulation [GO:0008015]; blood coagulation [GO:0007596]","GO:0005507; GO:0005576; GO:0007596; GO:0008015; GO:0031091"
"823","Pocillopora_acuta_HIv2___RNAseq.g28911.t1",5629.05905301619,2.9456646299318,0.757052094396936,3.50046621077876e-06,4.64076473626984e-05,"Q75N90",7.52e-85,"Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide]","anatomical structure morphogenesis [GO:0009653]","GO:0001527; GO:0005201; GO:0005509; GO:0005576; GO:0009653; GO:0031012"
"824","Pocillopora_acuta_HIv2___RNAseq.g26553.t1",96.4502692492265,-10.4659743667427,4.06711464001433,3.50724534891357e-06,4.64415925954246e-05,NA,NA,NA,NA,NA
"825","Pocillopora_acuta_HIv2___RNAseq.g7741.t1",144.532540952573,-7.79539911233674,3.61582584106545,3.58327891896161e-06,4.724571220042e-05,"Q8BH95",1.32e-42,"Enoyl-CoA hydratase, mitochondrial (mECH) (mECH1) (EC 4.2.1.17) (EC 5.3.3.8) (Enoyl-CoA hydratase 1) (ECHS1) (Short-chain enoyl-CoA hydratase) (SCEH)","fatty acid beta-oxidation [GO:0006635]","GO:0004165; GO:0004300; GO:0005739; GO:0005759; GO:0006635; GO:0043956; GO:0120092"
"826","Pocillopora_acuta_HIv2___RNAseq.g703.t1",1021.55520835017,3.86419345375021,1.27727996558627,3.87419812235919e-06,5.05743697128189e-05,NA,NA,NA,NA,NA
"827","Pocillopora_acuta_HIv2___TS.g5618.t1",10064.3811847063,5.38580158297742,1.8586447586047,3.92183971139004e-06,5.10580464316342e-05,"Q9UGM3",3.42e-55,"Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)","defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031]","GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062"
"828","Pocillopora_acuta_HIv2___TS.g26020.t2",54.2941816349516,-9.87943815697259,3.6398442997165,3.970911323995e-06,5.16504149193019e-05,NA,NA,NA,NA,NA
"829","Pocillopora_acuta_HIv2___RNAseq.g27846.t1",186.338223706541,-5.5673455495429,3.09024335983209,3.97996625833635e-06,5.17216819052803e-05,"Q17RP2",6.86e-62,"Tigger transposable element-derived protein 6","","GO:0003677; GO:0005634"
"830","Pocillopora_acuta_HIv2___RNAseq.g14608.t1",320.741677579826,-4.56742048379658,1.65682453423222,3.99651762319429e-06,5.18901534128206e-05,NA,NA,NA,NA,NA
"831","Pocillopora_acuta_HIv2___RNAseq.g28639.t1",192.271680732401,-5.38856297647956,3.96928172087643,4.00141651753611e-06,5.19071645826388e-05,"A0A1L8H0H2",2.61e-37,"DNA-binding protein RFX7 (Regulatory factor X 7)","positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0000979; GO:0003700; GO:0005634; GO:0045944"
"832","Pocillopora_acuta_HIv2___RNAseq.10171_t",13842.4547164277,3.97836048344464,1.37645991743315,4.07249081365703e-06,5.27345632307388e-05,"Q95218",1.53e-53,"Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin)","cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031]","GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0050829; GO:0050830"
"833","Pocillopora_acuta_HIv2___TS.g8082.t1",184.930661949782,-5.75844960852041,2.41144791815255,4.22772973240806e-06,5.44038103643685e-05,"Q60855",5.97e-07,"Receptor-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (Cell death protein RIP) (Receptor-interacting protein 1) (RIP-1)","amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to tumor necrosis factor [GO:0071356]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory response [GO:0006954]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of necroptotic process [GO:0060546]; peptidyl-serine autophosphorylation [GO:0036289]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA processing [GO:1903800]; positive regulation of necroptotic process [GO:0060545]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; regulation of reactive oxygen species metabolic process [GO:2000377]; ripoptosome assembly [GO:0097343]; ripoptosome assembly involved in necroptotic process [GO:1901026]; T cell apoptotic process [GO:0070231]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0001934; GO:0004672; GO:0004674; GO:0004706; GO:0005123; GO:0005524; GO:0005739; GO:0006915; GO:0006954; GO:0008625; GO:0030163; GO:0031264; GO:0031625; GO:0032757; GO:0032760; GO:0032991; GO:0033209; GO:0035591; GO:0036289; GO:0042327; GO:0042803; GO:0043065; GO:0043066; GO:0043123; GO:0043124; GO:0043235; GO:0043410; GO:0043525; GO:0044877; GO:0045651; GO:0045944; GO:0046330; GO:0046777; GO:0050729; GO:0051092; GO:0060545; GO:0060546; GO:0070105; GO:0070231; GO:0070266; GO:0070301; GO:0070513; GO:0071356; GO:0071363; GO:0097300; GO:0097342; GO:0097343; GO:0097527; GO:0106310; GO:1900119; GO:1901026; GO:1901224; GO:1903265; GO:1903800; GO:1990000; GO:2000377; GO:2001237; GO:2001238; GO:2001240"
"834","Pocillopora_acuta_HIv2___TS.g16611.t1",68.5021010470253,-10.1643611600477,3.90860231962672,4.24474351271217e-06,5.45741957047723e-05,"Q8N972",1.61e-170,"Zinc finger protein 709","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"835","Pocillopora_acuta_HIv2___RNAseq.g6071.t1",129.661178378612,-7.68239820166555,3.62822424799125,4.32265521634586e-06,5.55265408962935e-05,NA,NA,NA,NA,NA
"836","Pocillopora_acuta_HIv2___TS.g21616.t3a",735.605053854112,-3.70562353246989,1.14527001192663,4.36551408838303e-06,5.5959633193166e-05,"Q6R520",2.51e-51,"Calmodulin (CaM)","","GO:0005509; GO:0030234"
"837","Pocillopora_acuta_HIv2___RNAseq.g334.t1",1218.88336377857,-3.33700753233913,0.948944253086642,4.36797745264688e-06,5.5959633193166e-05,"F8WLE0",0,"Kinesin-like protein KIF28P (Kinesin-like protein 6)","cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384]","GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007005; GO:0007018; GO:0008017; GO:0016887; GO:0030705; GO:0031966; GO:0072384"
"838","Pocillopora_acuta_HIv2___RNAseq.665_t",411.692398983122,-1.01246311347492,1.77334033083325,4.4580291760241e-06,5.69116804960393e-05,"Q15319",1.61e-90,"POU domain, class 4, transcription factor 3 (Brain-specific homeobox/POU domain protein 3C) (Brain-3C) (Brn-3C)","axon extension [GO:0048675]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290]; sensory perception of sound [GO:0007605]; vestibulocochlear nerve development [GO:0021562]; visual perception [GO:0007601]","GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007601; GO:0007605; GO:0021562; GO:0031290; GO:0042472; GO:0042491; GO:0045944; GO:0048675; GO:0050885; GO:0051402; GO:1990837"
"839","Pocillopora_acuta_HIv2___RNAseq.g29941.t1",26708.5341789636,3.10382735955113,0.830224200267492,4.49162442010028e-06,5.72899961308029e-05,NA,NA,NA,NA,NA
"840","Pocillopora_acuta_HIv2___RNAseq.g9374.t1",382.09094034297,8.51683516949733,4.05643159123157,4.64050832175937e-06,5.89291592325967e-05,"Q6NXR0",6.95e-58,"Interferon-inducible GTPase 5 (EC 3.6.5.-) (Immunity-related GTPase cinema 1)","positive regulation of flagellated sperm motility [GO:1902093]","GO:0003924; GO:0005525; GO:0005811; GO:0016020; GO:0036126; GO:0097226; GO:1902093"
"841","Pocillopora_acuta_HIv2___RNAseq.g26722.t1",873.917258774888,-2.63577958702468,0.661197894200254,4.7191349811165e-06,5.9822584020043e-05,NA,NA,NA,NA,NA
"842","Pocillopora_acuta_HIv2___TS.g19253.t1",100.145407212621,-7.03313701975375,3.48133075860922,4.88279505569209e-06,6.14662730074242e-05,"P54886",0,"Delta-1-pyrroline-5-carboxylate synthase (P5CS) (Aldehyde dehydrogenase family 18 member A1) [Includes: Glutamate 5-kinase (GK) (EC 2.7.2.11) (Gamma-glutamyl kinase); Gamma-glutamyl phosphate reductase (GPR) (EC 1.2.1.41) (Glutamate-5-semialdehyde dehydrogenase) (Glutamyl-gamma-semialdehyde dehydrogenase)]","citrulline biosynthetic process [GO:0019240]; glutamate metabolic process [GO:0006536]; L-proline biosynthetic process [GO:0055129]; ornithine biosynthetic process [GO:0006592]; proline biosynthetic process [GO:0006561]; response to temperature stimulus [GO:0009266]","GO:0003723; GO:0004349; GO:0004350; GO:0005524; GO:0005739; GO:0005743; GO:0006536; GO:0006561; GO:0006592; GO:0009266; GO:0019240; GO:0042802; GO:0055129"
"843","Pocillopora_acuta_HIv2___TS.g19435.t1",970.051656199186,5.12810963762654,2.35504150099132,4.98581011838429e-06,6.2708484828096e-05,"Q70AG8",2.82e-26,"Alpha-(1,3)-fucosyltransferase 11 (EC 2.4.1.-) (Fucosyltransferase XI) (Fuc-TXI) (FucT-XI) (Galactoside 3-L-fucosyltransferase 11) (Fucosyltransferase 11)","protein glycosylation [GO:0006486]","GO:0000139; GO:0006486; GO:0032580; GO:0046920"
"844","Pocillopora_acuta_HIv2___RNAseq.g20518.t1",3244.62904135567,4.61004387843721,1.42955932957916,5.0099976417383e-06,6.29579547264142e-05,NA,NA,NA,NA,NA
"845","Pocillopora_acuta_HIv2___RNAseq.g26711.t1",1640.37593047741,-2.51553714485822,0.624286455534957,5.03334564709633e-06,6.31964509024317e-05,NA,NA,NA,NA,NA
"846","Pocillopora_acuta_HIv2___RNAseq.g8736.t1",714.256779080191,-1.12121574960062,1.81802357033406,5.06954477947076e-06,6.3595746478981e-05,NA,NA,NA,NA,NA
"847","Pocillopora_acuta_HIv2___RNAseq.g10278.t1",303.544186117648,-1.13952810257352,2.2406815292855,5.12838345780881e-06,6.42224574318153e-05,"Q3KR73",3.51e-165,"KAT8 regulatory NSL complex subunit 3 (NSL complex protein NSL3) (Non-specific lethal 3 homolog)","chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitochondrial transcription [GO:1903108]","GO:0000123; GO:0005634; GO:0005739; GO:0006325; GO:0044545; GO:0045944; GO:1903108"
"848","Pocillopora_acuta_HIv2___RNAseq.g13060.t1",7815.93678153804,-5.1496162484721,2.07238392648807,5.43272332943181e-06,6.75657009775595e-05,"O88572",1.08e-113,"Low-density lipoprotein receptor-related protein 6 (LRP-6)","anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesenchymal cell proliferation [GO:0010463]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of developmental process [GO:0051093]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of morphogenesis of an epithelium [GO:1905331]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:2000151]; negative regulation of planar cell polarity pathway involved in neural tube closure [GO:2000168]; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis [GO:2000164]; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis [GO:2000166]; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis [GO:2000149]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of stem cell proliferation [GO:2000648]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of anatomical structure morphogenesis [GO:0022603]; regulation of cell development [GO:0060284]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation [GO:0050678]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; ventricular septum morphogenesis [GO:0060412]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244]","GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003151; GO:0003344; GO:0003401; GO:0005041; GO:0005769; GO:0005783; GO:0005886; GO:0006355; GO:0007204; GO:0007268; GO:0007399; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0010463; GO:0010976; GO:0016020; GO:0017147; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021874; GO:0021915; GO:0021943; GO:0021987; GO:0022603; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0034185; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042475; GO:0042733; GO:0042813; GO:0043025; GO:0043065; GO:0045121; GO:0045202; GO:0045444; GO:0045599; GO:0045778; GO:0045780; GO:0045893; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050678; GO:0050680; GO:0051091; GO:0051093; GO:0051593; GO:0055008; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060412; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071542; GO:0072089; GO:0090009; GO:0090118; GO:0090244; GO:0090245; GO:0098609; GO:0110135; GO:1905331; GO:1990963; GO:2000051; GO:2000149; GO:2000151; GO:2000164; GO:2000166; GO:2000168; GO:2000648"
"849","Pocillopora_acuta_HIv2___RNAseq.g15935.t1",237.673397775777,6.08446523725861,2.6828470314637,5.59377715945305e-06,6.93897022592872e-05,NA,NA,NA,NA,NA
"850","Pocillopora_acuta_HIv2___RNAseq.g17443.t1",120.960900507032,-7.35909987660081,3.3223288283538,5.60536458855679e-06,6.94738589621983e-05,"Q5REY7",7.09e-132,"UBX domain-containing protein 7","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]","GO:0005654; GO:0031625; GO:0034098; GO:0043130; GO:0043161; GO:0061629"
"851","Pocillopora_acuta_HIv2___RNAseq.g4682.t1",270.940324536305,-1.00319780421679,1.84517567180721,5.61181000181074e-06,6.94941950909165e-05,NA,NA,NA,NA,NA
"852","Pocillopora_acuta_HIv2___RNAseq.g26035.t1",2844.02785962697,3.46691692593601,1.0406659784573,5.67581380620594e-06,7.0166641788857e-05,"B3EWZ7",2.34e-11,"Threonine-rich protein","","GO:0005576"
"853","Pocillopora_acuta_HIv2___RNAseq.g23499.t1",45.6032550073575,-9.81836575499638,3.6411413046792,6.0093116449662e-06,7.38455152171618e-05,NA,NA,NA,NA,NA
"854","Pocillopora_acuta_HIv2___RNAseq.g26270.t1a",2780.75438924398,4.8165204541975,1.58454449159142,6.01934889664227e-06,7.38455152171618e-05,"P55012",0,"Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (mNKCC1)","ammonium transmembrane transport [GO:0072488]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell volume homeostasis [GO:0006884]; cellular response to chemokine [GO:1990869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to potassium ion [GO:0035865]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hyperosmotic response [GO:0006972]; inorganic anion import across plasma membrane [GO:0098658]; intracellular chloride ion homeostasis [GO:0030644]; intracellular potassium ion homeostasis [GO:0030007]; intracellular sodium ion homeostasis [GO:0006883]; maintenance of blood-brain barrier [GO:0035633]; mammary duct terminal end bud growth [GO:0060763]; multicellular organism growth [GO:0035264]; negative regulation of vascular wound healing [GO:0061044]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of cell volume [GO:0045795]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of matrix metallopeptidase secretion [GO:1904464]; regulation of spontaneous synaptic transmission [GO:0150003]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; T cell chemotaxis [GO:0010818]","GO:0006813; GO:0006814; GO:0006821; GO:0006883; GO:0006884; GO:0006972; GO:0007214; GO:0008511; GO:0008519; GO:0010818; GO:0015079; GO:0016323; GO:0016324; GO:0030007; GO:0030644; GO:0035264; GO:0035633; GO:0035725; GO:0035865; GO:0042995; GO:0043025; GO:0044297; GO:0045795; GO:0050910; GO:0055064; GO:0055075; GO:0055078; GO:0060444; GO:0060763; GO:0061044; GO:0071222; GO:0071944; GO:0072488; GO:0098658; GO:0098719; GO:0150003; GO:1902476; GO:1904450; GO:1904464; GO:1990573; GO:1990869"
"855","Pocillopora_acuta_HIv2___RNAseq.g25184.t1",1197.80217612348,4.61143610292268,3.96563611580368,6.05447435978099e-06,7.41506495680544e-05,"P70191",5.24e-44,"TNF receptor-associated factor 5","apoptotic process [GO:0006915]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA stabilization [GO:0048255]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0005164; GO:0005737; GO:0005813; GO:0005829; GO:0006915; GO:0007165; GO:0008270; GO:0008284; GO:0009898; GO:0023019; GO:0031625; GO:0031996; GO:0033209; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0043123; GO:0048255; GO:0051092; GO:0070534; GO:0097400"
"856","Pocillopora_acuta_HIv2___RNAseq.g30624.t2a",46.9199198828432,-9.8402859917041,3.67156876893793,6.12688067936849e-06,7.49105681710784e-05,NA,NA,NA,NA,NA
"857","Pocillopora_acuta_HIv2___TS.g4055.t1",42.8677633033214,-6.12549410435651,2.14674040969707,6.17284039981361e-06,7.53451169138431e-05,NA,NA,NA,NA,NA
"858","Pocillopora_acuta_HIv2___TS.g8258.t1",75.7322744331064,7.17538386167691,3.33160106177021,6.26401379830199e-06,7.63291453905982e-05,"Q8NDA2",9.73e-30,"Hemicentin-2","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808]","GO:0005509; GO:0005576; GO:0005886; GO:0007156; GO:0008046; GO:0030424; GO:0032154; GO:0043025; GO:0050808; GO:0062023"
"859","Pocillopora_acuta_HIv2___RNAseq.g11916.t1",585.852403749978,-1.2138565246803,2.18748583015886,6.27092063248054e-06,7.63489865557227e-05,"Q9I8C7",6.31e-78,"Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10)","","GO:0004888; GO:0005262; GO:0005886; GO:0022848; GO:0043005; GO:0045202; GO:0045211; GO:1902495"
"860","Pocillopora_acuta_HIv2___RNAseq.g17573.t1",2170.58915866496,2.45860874282813,0.613632668202065,6.39765379721068e-06,7.78264630133349e-05,"Q28IU6",4.07e-11,"Homeobox protein Hox-D1","","GO:0000981; GO:0005634; GO:0043565"
"861","Pocillopora_acuta_HIv2___RNAseq.g24040.t1",1807.45892921878,4.56837901214151,2.08397942625547,6.55052117973364e-06,7.94855187446874e-05,"Q9BQG1",1.04e-25,"Synaptotagmin-3 (Synaptotagmin III) (SytIII)","calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; positive regulation of dendrite extension [GO:1903861]","GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005768; GO:0005886; GO:0017156; GO:0030154; GO:0030276; GO:0030658; GO:0070382; GO:1903861"
"862","Pocillopora_acuta_HIv2___RNAseq.g26958.t1",765.317738878119,-1.22022228262382,2.04892243055664,6.75184458745621e-06,8.15951963754611e-05,"A7RZS0",1.42e-48,"Biogenesis of lysosome-related organelles complex 1 subunit 2 (BLOC-1 subunit 2)","endosomal transport [GO:0016197]; lysosome localization [GO:0032418]","GO:0000930; GO:0005765; GO:0005813; GO:0016197; GO:0031083; GO:0032418; GO:0043015; GO:0099078"
"863","Pocillopora_acuta_HIv2___TS.g27239.t2",5362.68132109276,2.77908935420257,0.7308724629782,6.80644581304864e-06,8.21087841867686e-05,"Q08D11",1.95e-166,"Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II)","phosphatidylserine biosynthetic process [GO:0006659]","GO:0005789; GO:0006659; GO:0106245"
"864","Pocillopora_acuta_HIv2___RNAseq.g2263.t1b",1355.99328185568,-5.01481478299129,2.48662986767067,6.88948887456439e-06,8.29721624327221e-05,"P42893",6.72e-148,"Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71)","axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; blood vessel diameter maintenance [GO:0097746]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; gene expression [GO:0010467]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; neuron projection development [GO:0031175]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of blood pressure [GO:0008217]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to cadmium ion [GO:0046686]; response to hypoxia [GO:0001666]; response to muscle stretch [GO:0035994]; response to xenobiotic stimulus [GO:0009410]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492]","GO:0001666; GO:0001921; GO:0004175; GO:0004222; GO:0005768; GO:0005769; GO:0005886; GO:0007411; GO:0007507; GO:0008217; GO:0008270; GO:0009410; GO:0009897; GO:0010467; GO:0010613; GO:0010814; GO:0010815; GO:0010816; GO:0016020; GO:0016485; GO:0016486; GO:0030141; GO:0031175; GO:0031982; GO:0033093; GO:0034959; GO:0035050; GO:0035994; GO:0042447; GO:0042733; GO:0042802; GO:0042803; GO:0043583; GO:0043950; GO:0045745; GO:0046686; GO:0048471; GO:0060037; GO:0060385; GO:0070372; GO:0097492; GO:0097746; GO:1902287"
"865","Pocillopora_acuta_HIv2___RNAseq.g16001.t1",226.580039841484,-5.06266594531708,3.48434593681137,7.14768928254335e-06,8.56538341198898e-05,"Q9VX98",2.13e-61,"Density-regulated protein homolog","formation of translation preinitiation complex [GO:0001731]; positive regulation of ecdysone receptor signaling pathway [GO:0120142]; positive regulation of insulin receptor signaling pathway [GO:0046628]; translation reinitiation [GO:0002188]","GO:0001731; GO:0002188; GO:0003729; GO:0003743; GO:0032991; GO:0046628; GO:0048027; GO:0120142"
"866","Pocillopora_acuta_HIv2___TS.g11286.t1",2158.52113630256,4.9130627473798,1.83181419715166,7.18578044666268e-06,8.58968003144868e-05,"B3EWZ3",3.6e-28,"Coadhesin","","GO:0016020"
"867","Pocillopora_acuta_HIv2___RNAseq.g5445.t1",128.865940556453,-1.66575855600047,8.49959679654042,7.26284774250931e-06,8.67463499154869e-05,"Q96DM1",1.11e-69,"PiggyBac transposable element-derived protein 4","",""
"868","Pocillopora_acuta_HIv2___RNAseq.g16905.t1",276.179521322004,-5.99966679301006,2.70429519211591,7.37074524771945e-06,8.78899087081732e-05,"E7FAM5",1.96e-63,"E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177"
"869","Pocillopora_acuta_HIv2___TS.g568.t1",575.612194494433,4.98242595253981,2.30187593578235,7.63572099507108e-06,9.05271053054985e-05,"P28741",7.63e-61,"Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A)","anterior/posterior pattern specification [GO:0009952]; anterograde axonal transport [GO:0008089]; anterograde dendritic transport [GO:0098937]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; dentate gyrus development [GO:0021542]; determination of left/right symmetry [GO:0007368]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; forebrain development [GO:0030900]; heart development [GO:0007507]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; inner ear receptor cell stereocilium organization [GO:0060122]; keratinocyte proliferation [GO:0043616]; kidney development [GO:0001822]; microtubule anchoring at centrosome [GO:0034454]; motile cilium assembly [GO:0044458]; neural precursor cell proliferation [GO:0061351]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; positive regulation of axo-dendritic protein transport [GO:1905128]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of establishment or maintenance of cell polarity regulating cell shape [GO:2000771]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of receptor-mediated endocytosis [GO:0048260]; smoothened signaling pathway [GO:0007224]","GO:0001701; GO:0001822; GO:0001947; GO:0003341; GO:0003777; GO:0005524; GO:0005814; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007224; GO:0007368; GO:0007507; GO:0008017; GO:0008089; GO:0008544; GO:0009952; GO:0009953; GO:0010457; GO:0010838; GO:0016887; GO:0016939; GO:0019894; GO:0021542; GO:0021904; GO:0021915; GO:0030507; GO:0030900; GO:0031514; GO:0032391; GO:0032839; GO:0034454; GO:0036334; GO:0043005; GO:0043025; GO:0043616; GO:0044458; GO:0044877; GO:0048260; GO:0050679; GO:0060122; GO:0060271; GO:0061351; GO:0090316; GO:0098794; GO:0098937; GO:0098971; GO:0098978; GO:0120170; GO:1904115; GO:1905128; GO:1905515; GO:2000771"
"870","Pocillopora_acuta_HIv2___RNAseq.g20579.t1",130.793328055589,-2.84696202020268,5.3525542012707,7.89269211795643e-06,9.30398523179476e-05,"Q3ZAV0",1.8e-19,"Coiled-coil domain-containing protein 60","",""
"871","Pocillopora_acuta_HIv2___RNAseq.g25336.t1",3879.28098932196,-4.64792456726993,1.99588867033443,8.19264255216027e-06,9.61057436126895e-05,NA,NA,NA,NA,NA
"872","Pocillopora_acuta_HIv2___RNAseq.g26716.t1",935.049124170182,-2.47219655795142,0.633121052121539,8.40216426536449e-06,9.8403970796949e-05,NA,NA,NA,NA,NA
"873","Pocillopora_acuta_HIv2___RNAseq.g29210.t1",51.1667733145563,-7.18780253899828,2.67710770626603,8.49709081921526e-06,9.91944484335185e-05,NA,NA,NA,NA,NA
"874","Pocillopora_acuta_HIv2___RNAseq.g30806.t1",802.009611151024,3.77809789323258,0.99412127546036,8.64824722157182e-06,0.000100796331839496,"Q9NXG6",1.54e-55,"Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4)","regulation of erythrocyte differentiation [GO:0045646]","GO:0004656; GO:0005506; GO:0005509; GO:0005783; GO:0005789; GO:0016706; GO:0031418; GO:0045646; GO:0160082"
"875","Pocillopora_acuta_HIv2___TS.g18901.t1",82.7258345383486,-7.37909414706467,3.74952111270859,8.66172781128016e-06,0.000100872166716873,NA,NA,NA,NA,NA
"876","Pocillopora_acuta_HIv2___RNAseq.g20718.t1",515.313742037359,5.17362409171873,2.25785218757629,8.75612776462898e-06,0.000101807581983596,"Q9SCN0",9.13e-15,"Probable glycosyltransferase STELLO2 (EC 2.4.-.-)","plant-type cell wall cellulose biosynthetic process [GO:0052324]; regulation of plant-type cell wall cellulose biosynthetic process [GO:2001009]","GO:0000139; GO:0005794; GO:0016757; GO:0042802; GO:0052324; GO:2001009"
"877","Pocillopora_acuta_HIv2___RNAseq.g4879.t1",8387.62210612352,-5.08977068239278,2.28320045042381,8.8559135973328e-06,0.000102802515466952,"O93429",8.28e-60,"Serotransferrin","antibacterial humoral response [GO:0019731]; iron ion transport [GO:0006826]","GO:0005615; GO:0005769; GO:0005886; GO:0006826; GO:0019731; GO:0046872; GO:0055037"
"878","Pocillopora_acuta_HIv2___RNAseq.g26133.t1",48.1650983738402,-9.79393283059989,3.68683300211277,8.9690445449981e-06,0.000103948926521516,NA,NA,NA,NA,NA
"879","Pocillopora_acuta_HIv2___RNAseq.g16665.t1",2103.55166903586,4.73437256148878,1.74578716093206,9.03553367319549e-06,0.00010455196723928,"Q09YM8",9.73e-09,"Cortactin-binding protein 2 (CortBP2)","","GO:0005938; GO:0043197; GO:0090443"
"880","Pocillopora_acuta_HIv2___RNAseq.g4354.t1",70.7119686645363,-7.42621619544129,3.48330274338104,9.22562846384446e-06,0.000106411076635603,NA,NA,NA,NA,NA
"881","Pocillopora_acuta_HIv2___RNAseq.g4202.t1",32661.3244858288,2.82276683557086,0.766522399915237,9.39163249510804e-06,0.000108153321981881,"Q9U943",1.28e-76,"Apolipophorins [Cleaved into: Apolipophorin-2 (Apolipophorin II) (apoLp-2); Apolipophorin-1 (Apolipophorin I) (apoLp-1)]","Wnt signaling pathway [GO:0016055]","GO:0005319; GO:0005576; GO:0008289; GO:0016055"
"882","Pocillopora_acuta_HIv2___RNAseq.g11192.t1",127.800366897645,-7.27554122348429,3.71726477645648,9.4152912880967e-06,0.00010833951725619,NA,NA,NA,NA,NA
"883","Pocillopora_acuta_HIv2___RNAseq.g8581.t1",44.9465383223538,-9.70745563232503,3.73366785593754,9.50878167451884e-06,0.000109259869786876,NA,NA,NA,NA,NA
"884","Pocillopora_acuta_HIv2___TS.g14552.t1",1206.9654152097,-4.24663760112633,1.37032583771473,9.51038274762699e-06,0.000109259869786876,"P58365",0,"Cadherin-23 (Otocadherin)","adult locomotory behavior [GO:0008344]; auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; cell-cell adhesion [GO:0098609]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; righting reflex [GO:0060013]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]","GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0005911; GO:0006816; GO:0007156; GO:0007605; GO:0007626; GO:0008344; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060013; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098609; GO:0098683; GO:0098684"
"885","Pocillopora_acuta_HIv2___RNAseq.g24413.t1",2120.4187580133,2.95226539858586,0.826662242314725,9.52105964657965e-06,0.000109295719625498,"B2LT62",2.13e-19,"Toll-like receptor 2 (CD antigen CD282)","cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; toll-like receptor signaling pathway [GO:0002224]","GO:0002224; GO:0004888; GO:0005794; GO:0006954; GO:0030670; GO:0042497; GO:0045087; GO:0045121; GO:0061809; GO:0071726; GO:0071727"
"886","Pocillopora_acuta_HIv2___RNAseq.g7219.t1",2365.96211385938,5.16260788272841,1.72460899127254,9.56926968820767e-06,0.000109762027573541,"Q09YI1",3.67e-17,"Cortactin-binding protein 2 (CortBP2)","regulation of synapse organization [GO:0050807]","GO:0005938; GO:0043197; GO:0050807; GO:0090443; GO:0098978"
"887","Pocillopora_acuta_HIv2___TS.g10825.t1",23047.6843347451,2.33574346993334,0.594297349890339,9.74083157470583e-06,0.00011155295953804,"Q9NS62",1.96e-10,"Thrombospondin type-1 domain-containing protein 1 (Transmembrane molecule with thrombospondin module)","focal adhesion assembly [GO:0048041]","GO:0005576; GO:0005768; GO:0005829; GO:0005925; GO:0010008; GO:0048041; GO:0050840; GO:0071944"
"888","Pocillopora_acuta_HIv2___RNAseq.g25351.t1",48599.9596373917,2.50537894086459,0.65434172119363,9.91457932083311e-06,0.000113273677169455,"A6QLI0",1.15e-31,"Mammalian ependymin-related protein 1 (MERP-1)","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005576; GO:0005764; GO:0007160; GO:0008289; GO:0043202"
"889","Pocillopora_acuta_HIv2___RNAseq.g14729.t1",1792.45168228751,4.89534671129104,2.83735802262151,9.93237215791475e-06,0.000113297973889652,NA,NA,NA,NA,NA
"890","Pocillopora_acuta_HIv2___RNAseq.g20413.t2",268.659268004744,-4.47847454035502,3.64637901948557,1.00376593905588e-05,0.00011440875131997,"P49961",3.37e-43,"Ectonucleoside triphosphate diphosphohydrolase 1 (EC 3.6.1.5) (ATP diphosphohydrolase) (ATP-DPH) (ATPDase) (Ecto-ATP diphosphohydrolase 1) (Ecto-ATPDase 1) (Ecto-ATPase 1) (Ecto-apyrase) (Lymphoid cell activation antigen) (Nucleoside triphosphate diphosphohydrolase 1) (NTPDase1) (CD antigen CD39)","blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; nucleoside diphosphate catabolic process [GO:0009134]; platelet aggregation [GO:0070527]","GO:0003924; GO:0004050; GO:0004382; GO:0005524; GO:0005886; GO:0005901; GO:0007155; GO:0007596; GO:0009134; GO:0016020; GO:0016887; GO:0017110; GO:0017111; GO:0036384; GO:0043262; GO:0043273; GO:0045134; GO:0070062; GO:0070527; GO:0103023; GO:1990003"
"891","Pocillopora_acuta_HIv2___RNAseq.g22682.t1b",1326.13611977452,4.08047153981058,1.39664685487556,1.00508367050365e-05,0.000114468741812322,NA,NA,NA,NA,NA
"892","Pocillopora_acuta_HIv2___TS.g23133.t3",4216.88558149283,2.8648425451034,0.788146616518237,1.00836473920002e-05,0.00011466185210526,"Q61838",0,"Pregnancy zone protein (Alpha-2-macroglobulin) (Alpha-2-M) [Cleaved into: Alpha-2-macroglobulin 165 kDa subunit; Alpha-2-macroglobulin 35 kDa subunit]","embryo implantation [GO:0007566]","GO:0002020; GO:0004866; GO:0004867; GO:0005576; GO:0005615; GO:0007566; GO:0044877; GO:0048403; GO:0048406; GO:0062023"
"893","Pocillopora_acuta_HIv2___RNAseq.g26613.t1",376.897202416782,-1.15865081316625,2.07090765327349,1.01105714335502e-05,0.000114877694591414,"Q8BUG5",1.67e-101,"Calcyphosin-2 (Calcyphosine-2)","","GO:0005509"
"894","Pocillopora_acuta_HIv2___RNAseq.g9864.t1",245.22951242933,-1.52631574214192,3.17238285710889,1.01233423190909e-05,0.000114932514366822,NA,NA,NA,NA,NA
"895","Pocillopora_acuta_HIv2___RNAseq.2618_t",181.750869429989,-3.21147424218062,5.40493885448366,1.01510695901127e-05,0.000115156918079522,"Q9UHJ3",2.82e-10,"Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1)","cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; spermatogenesis [GO:0007283]","GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635"
"896","Pocillopora_acuta_HIv2___RNAseq.g14883.t1",216.59486890865,3.31335402866013,0.989217887197637,1.01967375659754e-05,0.000115584335544098,NA,NA,NA,NA,NA
"897","Pocillopora_acuta_HIv2___RNAseq.g21588.t1a",368.385709673478,4.74228025056755,2.47902093601577,1.02604831288303e-05,0.000116135789711485,"Q8BYW1",3.48e-08,"Rho GTPase-activating protein 25 (Rho-type GTPase-activating protein 25)","actin filament organization [GO:0007015]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis, engulfment [GO:0006911]; signal transduction [GO:0007165]","GO:0001891; GO:0005096; GO:0006911; GO:0007015; GO:0007165; GO:0051058"
"898","Pocillopora_acuta_HIv2___RNAseq.g12617.t1",93.7118160412986,-7.15108738818647,3.40021550206404,1.0297261041459e-05,0.000116450026351574,"Q54RB9",1.02e-13,"Calcium-binding mitochondrial carrier protein (Mitochondrial substrate carrier family protein O)","aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]","GO:0005313; GO:0005509; GO:0005739; GO:0005743; GO:0015183; GO:0015810; GO:0015813; GO:0042802; GO:0043490"
"899","Pocillopora_acuta_HIv2___RNAseq.g8914.t1",4734.09510362457,4.72764850795015,2.66172640755826,1.03961397003406e-05,0.000117476378613849,"O75096",0,"Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)","amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395"
"900","Pocillopora_acuta_HIv2___RNAseq.g21460.t2a",320.658590728494,-8.42838522899119,4.02138157465229,1.0505197911234e-05,0.000118616067594136,NA,NA,NA,NA,NA
"901","Pocillopora_acuta_HIv2___TS.g8967.t1",101.952342767167,6.79675204710369,4.41386089896612,1.05246103900859e-05,0.00011865001144365,"O05485",3.77e-29,"Extracellular protease (EC 3.4.24.-)","proteolysis [GO:0006508]","GO:0004222; GO:0006508; GO:0046872"
"902","Pocillopora_acuta_HIv2___RNAseq.g16328.t1",40.5521430511232,-9.53285768528439,3.58055444518208,1.07014352121994e-05,0.000120455687867123,NA,NA,NA,NA,NA
"903","Pocillopora_acuta_HIv2___RNAseq.g5707.t1",57.1293290731454,-9.95650747385463,3.93219849629419,1.0947073023421e-05,0.000123124777768866,"Q559T8",2.38e-06,"Probable serine/threonine-protein kinase DDB_G0272282 (EC 2.7.11.1)","intracellular signal transduction [GO:0035556]","GO:0004674; GO:0005524; GO:0035091; GO:0035556; GO:0106310"
"904","Pocillopora_acuta_HIv2___RNAseq.g20516.t1",130.085698469165,-3.4133435611583,3.96395789964622,1.15457899830716e-05,0.000129255655042684,NA,NA,NA,NA,NA
"905","Pocillopora_acuta_HIv2___RNAseq.18788_t",50.2841889209094,-9.59611096706639,3.78463378124048,1.15574729427336e-05,0.000129286379461484,"P31422",1.26e-121,"Metabotropic glutamate receptor 3 (mGluR3)","G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]","GO:0001641; GO:0005246; GO:0005886; GO:0007216; GO:0010467; GO:0014069; GO:0019233; GO:0030424; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0050804; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170"
"906","Pocillopora_acuta_HIv2___RNAseq.g25911.t1",427.104293769442,-4.03442037337059,2.65367221667768,1.17860601679973e-05,0.000131538251751477,NA,NA,NA,NA,NA
"907","Pocillopora_acuta_HIv2___TS.g5338.t1",2352.95724361698,5.34713903244736,2.55880498419433,1.18073966498176e-05,0.000131606038807237,"P45452",4.05e-45,"Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13)","bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; collagen catabolic process [GO:0030574]; endochondral ossification [GO:0001958]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; growth plate cartilage development [GO:0003417]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645]","GO:0001958; GO:0003417; GO:0004175; GO:0004222; GO:0004252; GO:0005509; GO:0005518; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0022617; GO:0030198; GO:0030282; GO:0030574; GO:0031012; GO:0060349; GO:1904645"
"908","Pocillopora_acuta_HIv2___RNAseq.g183.t1",340.729076017681,4.63795977653563,2.19184090236558,1.18103317458375e-05,0.000131606038807237,"B7WFQ1",7.31e-42,"Uncharacterized skeletal organic matrix protein 2 (Uncharacterized SOMP-2)","","GO:0016020"
"909","Pocillopora_acuta_HIv2___RNAseq.g6274.t1",113.9945549342,-3.88876723977939,1.27088379057447,1.2368072902844e-05,0.000137292253619905,"Q5F4A1",2.41e-54,"G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase)","apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]","GO:0004842; GO:0005634; GO:0005730; GO:0005737; GO:0006915; GO:0016567; GO:0046872"
"910","Pocillopora_acuta_HIv2___RNAseq.g30214.t1",394.110628099166,-4.26133082853496,1.46917105378475,1.2477378067123e-05,0.000138293330546259,"B2RQL2",6.59e-30,"Storkhead-box protein 1","cell division [GO:0051301]; cellular response to nitrosative stress [GO:0071500]; inner ear development [GO:0048839]; negative regulation of gene expression [GO:0010629]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of otic vesicle morphogenesis [GO:1904120]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of mitochondrial DNA metabolic process [GO:1901858]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of mitotic cell cycle [GO:0007346]; regulation of response to oxidative stress [GO:1902882]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0006357; GO:0007346; GO:0010628; GO:0010629; GO:0010800; GO:0010821; GO:0010971; GO:0033138; GO:0045787; GO:0048839; GO:0051301; GO:0051881; GO:0051897; GO:0071500; GO:1900087; GO:1901858; GO:1902882; GO:1904120"
"911","Pocillopora_acuta_HIv2___RNAseq.g24683.t1",108.883660724108,-6.14575643451015,2.94500195019702,1.25832926276355e-05,0.000139261560927462,"H3ZPL1",1.23e-48,"Aromatic-amino-acid aminotransferase 1 (ARAT-I) (AROAT) (EC 2.6.1.57)","biosynthetic process [GO:0009058]","GO:0009058; GO:0030170; GO:0080130"
"912","Pocillopora_acuta_HIv2___TS.g26640.t2",321.217153466364,-1.03022215847482,1.90297786089638,1.29376690038265e-05,0.000142847667535379,"P34568",1.94e-12,"Speckle-type POZ protein homolog (BTB and MATH domain-containing protein 43) (HIB homolog)","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162]","GO:0005634; GO:0005737; GO:0016567; GO:0016607; GO:0030162; GO:0031625; GO:0043161"
"913","Pocillopora_acuta_HIv2___RNAseq.g5755.t1",258.536958638658,-4.78321608666242,4.28707354854162,1.29566916280567e-05,0.000142948579487576,"Q9QX29",2e-47,"Short transient receptor potential channel 5 (TrpC5) (Capacitative calcium entry channel 2) (CCE2) (Transient receptor protein 5) (TRP-5) (mTRP5) (Trp-related protein 5)","calcium ion transmembrane transport [GO:0070588]; negative regulation of dendrite morphogenesis [GO:0050774]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane hyperpolarization [GO:1902630]","GO:0003779; GO:0005886; GO:0007204; GO:0008284; GO:0010800; GO:0015279; GO:0030182; GO:0030276; GO:0030425; GO:0030426; GO:0034703; GO:0034704; GO:0042805; GO:0043025; GO:0045666; GO:0045773; GO:0050774; GO:0051117; GO:0051402; GO:0051480; GO:0070588; GO:0070679; GO:0070782; GO:0098793; GO:1902630"
"914","Pocillopora_acuta_HIv2___RNAseq.g16526.t1",568.210053125228,4.96493883857928,2.32214892195011,1.3391788952358e-05,0.000147411594678011,"P47179",6.41e-12,"Cell wall protein DAN4 (Delayed anaerobic protein 4)","fungal-type cell wall organization [GO:0031505]","GO:0005199; GO:0005576; GO:0005886; GO:0009277; GO:0031505; GO:0071944; GO:0098552"
"915","Pocillopora_acuta_HIv2___RNAseq.g3423.t2",188.524505033016,-1.13439373613214,1.93425583342978,1.36125520293189e-05,0.000149273656218399,"Q80UG8",0,"Tubulin monoglutamylase TTLL4 (EC 6.3.2.-) (Protein monoglutamylase TTLL4) (Tubulin--tyrosine ligase-like protein 4)","microtubule cytoskeleton organization [GO:0000226]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222]","GO:0000226; GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0036064; GO:0046872; GO:0070739; GO:0070740; GO:0097731; GO:0120222"
"916","Pocillopora_acuta_HIv2___RNAseq.g5181.t1",400.629188017808,4.75293978589626,2.10748942807356,1.38046414224945e-05,0.000150886667255231,"Q9HCK4",3.69e-30,"Roundabout homolog 2","aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412]","GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609"
"917","Pocillopora_acuta_HIv2___RNAseq.g30322.t1",2426.55028242543,3.00800664706974,0.896585758389207,1.41696952377623e-05,0.000154330174637797,"P98064",1.04e-155,"Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain]","complement activation, lectin pathway [GO:0001867]; zymogen activation [GO:0031638]","GO:0001867; GO:0004252; GO:0005509; GO:0005615; GO:0005654; GO:0005829; GO:0031638; GO:0042803; GO:0048306"
"918","Pocillopora_acuta_HIv2___RNAseq.g12292.t1",44.2167118929873,-9.40479925696489,3.63568244435608,1.42688668689536e-05,0.000155060022834369,"Q7SIC1",4.31e-15,"Fucolectin","regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]","GO:0001868; GO:0005509; GO:0005576; GO:0010185; GO:0030246; GO:0042806; GO:0045088"
"919","Pocillopora_acuta_HIv2___TS.g17409.t1",258.305641564203,-1.12489184028508,1.93390404864316,1.43391686195604e-05,0.000155707008193185,"Q969V4",2.94e-141,"Tektin-1","cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]","GO:0005634; GO:0005879; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0160111"
"920","Pocillopora_acuta_HIv2___RNAseq.g15036.t2",215.571648799652,-5.70683323920743,3.3677387121369,1.44824654748772e-05,0.000157145071739402,"Q17RW2",3.49e-11,"Collagen alpha-1(XXIV) chain","extracellular matrix organization [GO:0030198]","GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0030020; GO:0030198; GO:0062023"
"921","Pocillopora_acuta_HIv2___RNAseq.g22119.t1",47.6485687071175,-9.44111453476717,3.7076379732913,1.46733270979203e-05,0.000159096704006237,NA,NA,NA,NA,NA
"922","Pocillopora_acuta_HIv2___RNAseq.g11254.t1",2215.16772567462,-4.78470746665669,2.92548075465379,1.5052135501415e-05,0.000162473199919751,NA,NA,NA,NA,NA
"923","Pocillopora_acuta_HIv2___RNAseq.g13234.t1",7877.73619950051,-4.81323125668932,3.36361366739634,1.5182386938825e-05,0.000163664904878556,NA,NA,NA,NA,NA
"924","Pocillopora_acuta_HIv2___RNAseq.g25079.t1",726.610847277969,-4.50289914317973,2.42370758902821,1.53997634831952e-05,0.00016548453121912,NA,NA,NA,NA,NA
"925","Pocillopora_acuta_HIv2___RNAseq.g4878.t1",2068.41975489463,4.11170370060049,3.42602154869952,1.59743593853911e-05,0.000171150469740961,"O97490",3.41e-67,"Melanotransferrin (Membrane-bound transferrin-like protein p97) (CD antigen CD228)","iron ion transport [GO:0006826]","GO:0005615; GO:0005769; GO:0005886; GO:0006826; GO:0046872; GO:0055037; GO:0098552"
"926","Pocillopora_acuta_HIv2___RNAseq.g28814.t1",142.643508793693,-6.97146337916294,4.24588063757597,1.59997566021575e-05,0.00017119168874376,NA,NA,NA,NA,NA
"927","Pocillopora_acuta_HIv2___TS.g9370.t1",3756.79217575597,3.2851025107622,1.07725874969137,1.68373420616974e-05,0.000179333811178491,"Q5R9H4",0,"APOBEC1 complementation factor (APOBEC1-stimulating protein)","mRNA processing [GO:0006397]; protein stabilization [GO:0050821]","GO:0003727; GO:0005737; GO:0005783; GO:0006397; GO:0030895; GO:0050821"
"928","Pocillopora_acuta_HIv2___TS.g23724.t1a",3514.2101435833,4.52556855132624,1.48637261484032,1.71734864205295e-05,0.000182779475781118,"B8RJM0",1.96e-36,"Uncharacterized skeletal organic matrix protein 3 (Uncharacterized SOMP-3)","","GO:0016020"
"929","Pocillopora_acuta_HIv2___RNAseq.g15293.t1",1839.70464286307,4.55560970233435,1.97527404388184,1.71919000213356e-05,0.000182840913168087,NA,NA,NA,NA,NA
"930","Pocillopora_acuta_HIv2___RNAseq.g19870.t1",593.27662889163,-2.72908395840902,4.20661373568702,1.72867707260058e-05,0.000183445232414489,"Q9Z0U4",7.43e-73,"Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932]","GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0043204; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430"
"931","Pocillopora_acuta_HIv2___TS.g16484.t1",154.454617079156,-3.45319763065609,4.27696613619078,1.77846990998386e-05,0.000187764881591289,"P31649",0,"Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13)","amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; creatine transmembrane transport [GO:0015881]; gamma-aminobutyric acid import [GO:0051939]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; taurine transmembrane transport [GO:0015734]","GO:0005283; GO:0005308; GO:0005332; GO:0005368; GO:0005369; GO:0005886; GO:0006836; GO:0006865; GO:0015185; GO:0015734; GO:0015881; GO:0016323; GO:0016597; GO:0035725; GO:0042995; GO:0051939; GO:0089718"
"932","Pocillopora_acuta_HIv2___RNAseq.30019_t",2423.82724239577,4.61491530452191,1.66843063748757,1.82367182815299e-05,0.000191837013253854,NA,NA,NA,NA,NA
"933","Pocillopora_acuta_HIv2___TS.g20447.t1",224.601958130723,3.50464977740229,1.2367403309033,1.85410305240442e-05,0.000194613545355425,NA,NA,NA,NA,NA
"934","Pocillopora_acuta_HIv2___RNAseq.g28398.t1",252.971186387421,-6.69326843259703,4.11095309014308,1.87499192137191e-05,0.000196378589071132,"Q9Y6H5",2.51e-30,"Synphilin-1 (Sph1) (Alpha-synuclein-interacting protein)","cell death [GO:0008219]; dopamine metabolic process [GO:0042417]; regulation of inclusion body assembly [GO:0090083]; regulation of neurotransmitter secretion [GO:0046928]","GO:0005654; GO:0005737; GO:0005829; GO:0008021; GO:0008219; GO:0031625; GO:0036464; GO:0042417; GO:0042734; GO:0042802; GO:0043025; GO:0046928; GO:0090083"
"935","Pocillopora_acuta_HIv2___TS.g16066.t1",41.2613579680828,-9.33211960519476,3.6534001268223,1.88955286333429e-05,0.000197496135604105,NA,NA,NA,NA,NA
"936","Pocillopora_acuta_HIv2___RNAseq.g28816.t1",119.345492272193,-4.43890804237539,1.86152759512228,1.89046970501576e-05,0.000197496135604105,"Q5I020",3.91e-74,"Proton-coupled zinc antiporter SLC30A8 (Solute carrier family 30 member 8) (Zinc transporter 8) (ZnT-8)","zinc ion import into organelle [GO:0062111]","GO:0005886; GO:0030658; GO:0030667; GO:0046872; GO:0062111; GO:0140826"
"937","Pocillopora_acuta_HIv2___RNAseq.g26331.t1",1081.697046677,4.08871469152543,2.06068355928116,1.90247360417514e-05,0.000198394940236404,"Q5ZMH1",0,"Septin-2","cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104]; regulation of exocytosis [GO:0017157]; smoothened signaling pathway [GO:0007224]","GO:0003924; GO:0005525; GO:0005737; GO:0005819; GO:0005940; GO:0007224; GO:0008021; GO:0008104; GO:0015630; GO:0017157; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0060090; GO:0060170; GO:0060271; GO:0061640"
"938","Pocillopora_acuta_HIv2___RNAseq.g9789.t1",220.438535080701,-6.7014419337882,4.26029685908355,1.93000113881693e-05,0.000200975784534544,"Q8C0S1",0,"DIS3-like exonuclease 1 (EC 3.1.13.1)","mRNA catabolic process [GO:0006402]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]","GO:0000175; GO:0000177; GO:0003723; GO:0005813; GO:0005829; GO:0005886; GO:0006396; GO:0006401; GO:0006402; GO:0008859; GO:0016075; GO:0019899"
"939","Pocillopora_acuta_HIv2___RNAseq.g5859.t1",52.25457011884,-9.72377704494641,4.00296251684459,1.94506674162182e-05,0.000202398887415957,"P16157",8.66e-29,"Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)","cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]","GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014"
"940","Pocillopora_acuta_HIv2___RNAseq.g623.t1",259.234238914522,-2.52396804905551,6.54115425373354,1.95175656143629e-05,0.000202949007222247,"F1MKX4",0,"Proteasome activator complex subunit 4 (Proteasome activator PA200)","DNA damage response [GO:0006974]; DNA repair [GO:0006281]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; sperm DNA condensation [GO:0035092]","GO:0005634; GO:0005829; GO:0006281; GO:0006974; GO:0010499; GO:0016504; GO:0016607; GO:0035092; GO:0070577; GO:0070628; GO:1990111"
"941","Pocillopora_acuta_HIv2___RNAseq.g3826.t1",12381.153714469,2.77026385764369,0.803614557131352,1.96506461318958e-05,0.000204186024175102,"Q9ER58",5.79e-23,"Testican-2 (SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2)","cellular response to leukemia inhibitory factor [GO:1990830]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]","GO:0005509; GO:0005539; GO:0005576; GO:0010811; GO:0030198; GO:0050840; GO:0062023; GO:1990830"
"942","Pocillopora_acuta_HIv2___RNAseq.g23210.t1",91.1601050956309,6.9054061422844,4.36527143473709,1.99044192683505e-05,0.00020652619820475,"A2AJ76",1.35e-106,"Hemicentin-2","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808]","GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0032154; GO:0043025; GO:0050808; GO:0062023"
"943","Pocillopora_acuta_HIv2___RNAseq.g20060.t1",4926.13035022732,-2.48661114094141,0.688071356607355,2.01389036393018e-05,0.000208510452568977,NA,NA,NA,NA,NA
"944","Pocillopora_acuta_HIv2___RNAseq.g22964.t1",1389.15835526996,-4.62397155044648,2.60268282723946,2.04723262063318e-05,0.000211659561292626,"Q6QNK2",6.08e-29,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020; GO:0016607"
"945","Pocillopora_acuta_HIv2___RNAseq.g28800.t1",5118.41942028873,2.51433739523645,0.694191051668756,2.05336926528383e-05,0.000212142378950466,"O42401",5.96e-15,"Matrilin-3","","GO:0005509; GO:0005576; GO:0062023"
"946","Pocillopora_acuta_HIv2___RNAseq.g3486.t1",1322.77803553658,3.08573855393351,0.986724038436886,2.14254979703221e-05,0.000220411381680469,"Q9VL06",2.54e-27,"E3 ubiquitin-protein ligase Ufd4 (EC 2.3.2.26) (Ubiquitin fusion-degradation 4-like)","negative regulation of ERK1 and ERK2 cascade [GO:0070373]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005634; GO:0006511; GO:0016607; GO:0032436; GO:0043161; GO:0046872; GO:0061630; GO:0070373; GO:0070534"
"947","Pocillopora_acuta_HIv2___RNAseq.g24766.t1",946.345253742189,2.88358628253527,0.862280099381326,2.16062700589972e-05,0.000221640489456266,"Q868Z9",1.25e-120,"Papilin","extracellular matrix organization [GO:0030198]","GO:0004867; GO:0005201; GO:0005576; GO:0005604; GO:0030198"
"948","Pocillopora_acuta_HIv2___RNAseq.g8794.t1",3354.94669077861,3.15448732140871,0.984735471362669,2.17444762180675e-05,0.000222427230564447,NA,NA,NA,NA,NA
"949","Pocillopora_acuta_HIv2___RNAseq.g15874.t1",70.7956442298273,-6.19136883718997,4.54168963305042,2.2215948388321e-05,0.000226289772879349,NA,NA,NA,NA,NA
"950","Pocillopora_acuta_HIv2___RNAseq.g4612.t1",81.1077759665498,-6.84940525461326,3.52734829773109,2.2420900272119e-05,0.000228056189547067,"Q7Z4Q2",9.58e-43,"HEAT repeat-containing protein 3","erythrocyte maturation [GO:0043249]; protein import into nucleus [GO:0006606]; ribosomal large subunit biogenesis [GO:0042273]","GO:0006606; GO:0042273; GO:0043249; GO:0051082"
"951","Pocillopora_acuta_HIv2___RNAseq.g26589.t1",6569.48131392173,2.33793737589324,0.635532028240099,2.27801166178674e-05,0.000230898112656506,"Q5VXJ0",5.57e-109,"Lipase member K (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 2)","cornification [GO:0070268]; lipid catabolic process [GO:0016042]","GO:0004465; GO:0005576; GO:0016042; GO:0043231; GO:0070268"
"952","Pocillopora_acuta_HIv2___RNAseq.g18425.t1",1910.41124896392,2.14946155697096,0.567510331836371,2.30744563399628e-05,0.00023339086468617,"Q0EEE2",1.85e-99,"Patched domain-containing protein 3 (RND-type protein RNDEu-3)","","GO:0005783; GO:0005789; GO:0005886; GO:0016020; GO:0097225"
"953","Pocillopora_acuta_HIv2___TS.g23740.t1",77.6023914050985,-1.07108161343213,2.01423388119685,2.45966626281172e-05,0.000246795069454252,NA,NA,NA,NA,NA
"954","Pocillopora_acuta_HIv2___RNAseq.g30961.t2",101.185827490747,-2.68070303957299,0.737339123710472,2.46059216163522e-05,0.000246795069454252,NA,NA,NA,NA,NA
"955","Pocillopora_acuta_HIv2___RNAseq.g8520.t1",75.4558839837935,-9.92925406053249,4.22591586060452,2.46214937238997e-05,0.000246795069454252,"Q96RW7",2.26e-24,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711"
"956","Pocillopora_acuta_HIv2___TS.g26333.t1",364.815535134934,-7.47098312134917,6.15442885383955,2.46775979262529e-05,0.000247161680745645,"Q9C0D5",1.07e-15,"Protein TANC1 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 1)","dendritic spine maintenance [GO:0097062]; myoblast fusion [GO:0007520]; regulation of postsynapse organization [GO:0099175]; visual learning [GO:0008542]","GO:0007520; GO:0008542; GO:0014069; GO:0030425; GO:0043025; GO:0043679; GO:0097062; GO:0098978; GO:0099175"
"957","Pocillopora_acuta_HIv2___RNAseq.g565.t1",2194.070175455,4.65528088033765,2.32528606368567,2.48777679359737e-05,0.000248846497528302,"Q13467",4.39e-52,"Frizzled-5 (Fz-5) (hFz5) (FzE5)","angiogenesis [GO:0001525]; anterior/posterior axis specification, embryo [GO:0008595]; apoptotic process involved in morphogenesis [GO:0060561]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; canonical Wnt signaling pathway [GO:0060070]; cellular response to molecule of bacterial origin [GO:0071219]; chorionic trophoblast cell differentiation [GO:0060718]; embryonic axis specification [GO:0000578]; embryonic camera-type eye morphogenesis [GO:0048596]; eye development [GO:0001654]; glandular epithelial cell maturation [GO:0002071]; intestinal epithelial cell maturation [GO:0060574]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type II interferon production [GO:0032729]; post-embryonic camera-type eye development [GO:0031077]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of chorionic trophoblast cell proliferation [GO:1901382]; regulation of mitophagy [GO:1901524]; Spemann organizer formation [GO:0060061]; synapse assembly [GO:0007416]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]; T cell differentiation in thymus [GO:0033077]","GO:0000139; GO:0000578; GO:0001525; GO:0001540; GO:0001654; GO:0002071; GO:0002726; GO:0004930; GO:0005886; GO:0005923; GO:0007416; GO:0008285; GO:0008289; GO:0008595; GO:0009986; GO:0017147; GO:0019901; GO:0030182; GO:0030424; GO:0030425; GO:0030669; GO:0031077; GO:0031625; GO:0031901; GO:0032729; GO:0032731; GO:0032760; GO:0033077; GO:0035567; GO:0042813; GO:0043204; GO:0044877; GO:0045202; GO:0045944; GO:0048471; GO:0048596; GO:0060061; GO:0060070; GO:0060561; GO:0060574; GO:0060670; GO:0060715; GO:0060716; GO:0060718; GO:0071219; GO:1901382; GO:1901524; GO:1903955; GO:2000810"
"958","Pocillopora_acuta_HIv2___RNAseq.g2420.t1",514.853497632878,-3.0905927575608,0.986152789347182,2.50766158333345e-05,0.000250662177894506,NA,NA,NA,NA,NA
"959","Pocillopora_acuta_HIv2___RNAseq.g29828.t1",957.537009005633,-4.21126214696274,3.22074139695073,2.54983109693286e-05,0.000254350048179565,"J7GQ11",1.39e-80,"L-tyrosine decarboxylase (TDC) (EC 4.1.1.25)","carboxylic acid metabolic process [GO:0019752]","GO:0004837; GO:0019752; GO:0030170; GO:0036468"
"960","Pocillopora_acuta_HIv2___TS.g26046.t2",86.2823929881733,-6.56524514909561,3.19149937784328,2.61668034983578e-05,0.00026012140604828,"Q922Q5",2.24e-152,"Adenosine 3'-phospho 5'-phosphosulfate transporter 2 (Solute carrier family 35 member B3)","3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; transmembrane transport [GO:0055085]","GO:0000139; GO:0005739; GO:0005789; GO:0015297; GO:0046963; GO:0046964; GO:0055085"
"961","Pocillopora_acuta_HIv2___RNAseq.g5401.t1",227.927050314172,-6.31303870888089,3.64327945057109,2.64472233152734e-05,0.000262728460186892,"O00750",0,"Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.137) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta)","autophagosome organization [GO:1905037]; cellular response to starvation [GO:0009267]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]","GO:0005524; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005942; GO:0009267; GO:0016303; GO:0030139; GO:0035005; GO:0035091; GO:0036092; GO:0043231; GO:0043491; GO:0048015; GO:1905037"
"962","Pocillopora_acuta_HIv2___RNAseq.g2419.t1",485.949602170474,-3.05392682915506,0.974867448214073,2.6896566645078e-05,0.000267008881231577,NA,NA,NA,NA,NA
"963","Pocillopora_acuta_HIv2___RNAseq.g13082.t1",57.2334389873204,-6.7377130450607,3.39145216483689,2.76909087558738e-05,0.000273954380468508,"Q5T280",8e-133,"Putative methyltransferase C9orf114 (EC 2.1.1.-) (Centromere protein 32) (CENP-32) (Kinetochore-associated protein) (SPOUT domain-containing methyltransferase 1)","cell division [GO:0051301]; maintenance of centrosome location [GO:0051661]; methylation [GO:0032259]; miRNA processing [GO:0035196]; post-transcriptional regulation of gene expression [GO:0010608]","GO:0000776; GO:0003723; GO:0005737; GO:0008168; GO:0010608; GO:0031616; GO:0032259; GO:0035196; GO:0035198; GO:0051301; GO:0051661; GO:0072686"
"964","Pocillopora_acuta_HIv2___TS.g26127.t2b",3433.77439236694,4.34232318093989,2.20797704088504,2.81769159550705e-05,0.000278191749060846,"Q27409",2.4e-33,"Adhesive plaque matrix protein (Foot protein 1) (MGFP-1) (MGFP1)","","GO:0005576"
"965","Pocillopora_acuta_HIv2___RNAseq.g17226.t1",291.104969011209,-6.93611726752003,7.97149457245005,2.84666340006631e-05,0.000280860432595902,"Q8WV93",9.39e-77,"AFG1-like ATPase (Lactation elevated protein 1) (EC 3.6.-.-) (Protein AFG1 homolog)","mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial protein catabolic process [GO:0035694]; mitochondrion organization [GO:0007005]","GO:0005524; GO:0005737; GO:0005739; GO:0006123; GO:0007005; GO:0016887; GO:0031966; GO:0035694"
"966","Pocillopora_acuta_HIv2___RNAseq.g29507.t1",985.759468535731,1.72345293880375,4.22077050261381,2.87323443083423e-05,0.000283095795692004,NA,NA,NA,NA,NA
"967","Pocillopora_acuta_HIv2___RNAseq.g16162.t1",1084.49910428811,-1.18093212800683,2.25313149339657,2.97818982198261e-05,0.000292126840759021,"P12256",5.72e-42,"Penicillin V acylase (PVA) (EC 3.5.1.11) (BspPVA) (Penicillin V amidase) (Penicillin amidohydrolase)","response to antibiotic [GO:0046677]","GO:0008953; GO:0046677"
"968","Pocillopora_acuta_HIv2___TS.g17632.t1",37.6214674462873,-9.16734288478501,3.70744108441945,3.16115622525172e-05,0.000308018451557186,"Q3T1H5",2.54e-07,"Tyrosyl-DNA phosphodiesterase 2 (Tyr-DNA phosphodiesterase 2) (EC 3.1.4.-) (5'-tyrosyl-DNA phosphodiesterase) (5'-Tyr-DNA phosphodiesterase) (TRAF and TNF receptor-associated protein)","double-strand break repair [GO:0006302]; neuron development [GO:0048666]","GO:0000287; GO:0003697; GO:0004518; GO:0005634; GO:0005730; GO:0005737; GO:0006302; GO:0016605; GO:0030145; GO:0036317; GO:0048666; GO:0070260"
"969","Pocillopora_acuta_HIv2___RNAseq.g13323.t1",686.059182187685,-4.22955562888798,2.71188024021223,3.28688095755739e-05,0.000318642400603955,"Q5RDU7",1.11e-66,"Protein yippee-like 5","cell population proliferation [GO:0008283]","GO:0000151; GO:0005634; GO:0005737; GO:0005813; GO:0008283; GO:0030496; GO:0046872; GO:0097431"
"970","Pocillopora_acuta_HIv2___RNAseq.g12272.t1",69.0793080890973,4.63046724202961,2.73912521595197,3.30136883896111e-05,0.000319618466443999,"P18052",2.13e-67,"Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28)","insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of focal adhesion assembly [GO:0051893]","GO:0004725; GO:0005925; GO:0007229; GO:0008286; GO:0016020; GO:0043235; GO:0044877; GO:0048714; GO:0050804; GO:0051893; GO:0097060; GO:0098685"
"971","Pocillopora_acuta_HIv2___RNAseq.g25338.t1",89.5428391617885,-4.23707341567048,3.14559744775023,3.41079829107426e-05,0.000329111317425605,NA,NA,NA,NA,NA
"972","Pocillopora_acuta_HIv2___TS.g29372.t2",2289.76798425546,4.40273635086828,2.31982333240465,3.41371200239687e-05,0.000329172869351122,"A0A0B5RUB0",2.18e-105,"Trimethylamine transporter (TMA transporter) (TMA-specific transporter)","","GO:0005886; GO:0022857"
"973","Pocillopora_acuta_HIv2___RNAseq.g14126.t1",93.2131367121753,-6.45373975449272,4.91123525530439,3.45055529862793e-05,0.00033228250225935,"Q8K2X3",7.77e-21,"CST complex subunit STN1 (Alpha-accessory factor of 44 kDa) (AAF-44) (AAF44) (Oligonucleotide/oligosaccharide-binding fold-containing protein 1) (Suppressor of cdc thirteen homolog)","negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of DNA replication [GO:0045740]; telomere capping [GO:0016233]; telomere maintenance via telomere lengthening [GO:0010833]","GO:0000781; GO:0001650; GO:0003697; GO:0005634; GO:0005654; GO:0010833; GO:0016233; GO:0032211; GO:0042162; GO:0043047; GO:0045111; GO:0045740; GO:1990879"
"974","Pocillopora_acuta_HIv2___RNAseq.g14257.t1",609.690712100481,4.17885855574746,1.7183423928562,3.45444564998408e-05,0.000332435807593943,"P61917",3.99e-30,"NPC intracellular cholesterol transporter 2 (EPI-1) (Epididymal secretory protein E1) (Niemann Pick type C2 protein homolog)","cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]","GO:0005615; GO:0005764; GO:0005783; GO:0008203; GO:0015485; GO:0030301; GO:0032367; GO:0033344"
"975","Pocillopora_acuta_HIv2___RNAseq.g8459.t1",49.7993375944743,1.3243329799424,2.80330714012677,3.46805905981977e-05,0.000333523977667774,NA,NA,NA,NA,NA
"976","Pocillopora_acuta_HIv2___RNAseq.g2094.t1b",284.077097040679,-4.20506424627376,1.47641452117459,3.50286339219817e-05,0.000336007780587195,"A7SDW5",0,"Eukaryotic translation initiation factor 3 subunit L (eIF3l)","formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]","GO:0001732; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290"
"977","Pocillopora_acuta_HIv2___RNAseq.g12481.t1",34.1116058001867,-9.18038404369564,3.70948369507693,3.52925054098904e-05,0.000338243120675089,"A0A2K5X3B6",1.03e-51,"Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1)","3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; flavonoid metabolic process [GO:0009812]","GO:0004062; GO:0005829; GO:0008146; GO:0009812; GO:0050427"
"978","Pocillopora_acuta_HIv2___RNAseq.g12955.t1",549.14848724659,2.53089507711772,0.733741993632126,3.56905736622531e-05,0.00034096991905603,NA,NA,NA,NA,NA
"979","Pocillopora_acuta_HIv2___TS.g186.t2",1622.80559521189,2.27844211593717,0.634913836877624,3.59647605973541e-05,0.000343136080000086,"Q6P2X9",7.06e-28,"Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12)","creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449]","GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0046449"
"980","Pocillopora_acuta_HIv2___RNAseq.g7833.t1",316.008295885859,-1.32961499841588,2.53041448308311,3.63778143738246e-05,0.000346163623094078,"Q86U44",0,"N6-adenosine-methyltransferase catalytic subunit (EC 2.1.1.348) (Methyltransferase-like protein 3) (hMETTL3) (N6-adenosine-methyltransferase 70 kDa subunit) (MT-A70)","cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; innate immune response [GO:0045087]; mRNA destabilization [GO:0061157]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oogenesis [GO:0048477]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]","GO:0000398; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006397; GO:0006974; GO:0007283; GO:0007623; GO:0008173; GO:0009048; GO:0016556; GO:0016604; GO:0016607; GO:0019827; GO:0021861; GO:0031053; GO:0034644; GO:0036396; GO:0042063; GO:0045087; GO:0045580; GO:0045727; GO:0045746; GO:0046982; GO:0048477; GO:0051445; GO:0060339; GO:0061157; GO:0098508; GO:1902036; GO:1903679; GO:1904047; GO:1990204"
"981","Pocillopora_acuta_HIv2___RNAseq.g25458.t1",285.361323981426,-7.29982340262003,5.82601759701101,3.7092864977221e-05,0.000352272619192728,"A7MCS3",1.35e-17,"UPF0764 protein C16orf89 homolog","","GO:0005576; GO:0005829; GO:0016020"
"982","Pocillopora_acuta_HIv2___RNAseq.g27673.t1",3815.81336061895,-4.1545289888685,2.32518582051072,3.7807986422566e-05,0.000358123585865091,"P63016",2.54e-98,"Paired box protein Pax-6 (Oculorhombin)","anterior/posterior pattern specification [GO:0009952]; astrocyte differentiation [GO:0048708]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; blood vessel development [GO:0001568]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; cell population proliferation [GO:0008283]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; cerebral cortex regionalization [GO:0021796]; chromatin remodeling [GO:0006338]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; cornea development in camera-type eye [GO:0061303]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; embryonic camera-type eye morphogenesis [GO:0048596]; epithelial cell development [GO:0002064]; establishment of mitotic spindle orientation [GO:0000132]; eye photoreceptor cell development [GO:0042462]; forebrain development [GO:0030900]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain-midbrain boundary formation [GO:0021905]; gene expression [GO:0010467]; glandular epithelial cell differentiation [GO:0002067]; glucose homeostasis [GO:0042593]; habenula development [GO:0021986]; hindbrain development [GO:0030902]; insulin metabolic process [GO:1901142]; interkinetic nuclear migration [GO:0022027]; iris morphogenesis [GO:0061072]; keratinocyte differentiation [GO:0030216]; lacrimal gland development [GO:0032808]; learned vocalization behavior or vocal learning [GO:0098598]; lens development in camera-type eye [GO:0002088]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neural precursor cell proliferation [GO:0061351]; neuroblast proliferation [GO:0007405]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; olfactory bulb mitral cell layer development [GO:0061034]; oligodendrocyte cell fate specification [GO:0021778]; pallium development [GO:0021543]; pancreatic A cell development [GO:0003322]; pancreatic A cell differentiation [GO:0003310]; pituitary gland development [GO:0021983]; positive regulation of cell fate specification [GO:0042660]; positive regulation of core promoter binding [GO:1904798]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamatergic neuron differentiation [GO:0120008]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron migration [GO:2001224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to organelle [GO:0033365]; regionalization [GO:0003002]; regulation of asymmetric cell division [GO:0009786]; regulation of cell migration [GO:0030334]; regulation of gene expression [GO:0010468]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of neuron projection development [GO:0010975]; regulation of timing of cell differentiation [GO:0048505]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ethanol [GO:0045471]; response to wounding [GO:0009611]; retina development in camera-type eye [GO:0060041]; rhombomere morphogenesis [GO:0021593]; salivary gland morphogenesis [GO:0007435]; sensory neuron migration [GO:1904937]; signal transduction involved in regulation of gene expression [GO:0023019]; smoothened signaling pathway [GO:0007224]; spinal cord development [GO:0021510]; telencephalon regionalization [GO:0021978]; transcription by RNA polymerase II [GO:0006366]; type B pancreatic cell differentiation [GO:0003309]; ventral spinal cord development [GO:0021517]","GO:0000122; GO:0000132; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0000981; GO:0001221; GO:0001227; GO:0001228; GO:0001568; GO:0001709; GO:0001755; GO:0001764; GO:0001933; GO:0002052; GO:0002064; GO:0002067; GO:0002088; GO:0003002; GO:0003309; GO:0003310; GO:0003322; GO:0003677; GO:0003680; GO:0003682; GO:0003690; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006357; GO:0006366; GO:0007224; GO:0007399; GO:0007405; GO:0007406; GO:0007409; GO:0007411; GO:0007420; GO:0007435; GO:0008283; GO:0009611; GO:0009786; GO:0009950; GO:0009952; GO:0009953; GO:0010467; GO:0010468; GO:0010628; GO:0010975; GO:0019901; GO:0021510; GO:0021517; GO:0021543; GO:0021549; GO:0021593; GO:0021772; GO:0021778; GO:0021796; GO:0021798; GO:0021902; GO:0021905; GO:0021978; GO:0021983; GO:0021986; GO:0021987; GO:0022027; GO:0023019; GO:0030154; GO:0030182; GO:0030216; GO:0030334; GO:0030858; GO:0030900; GO:0030902; GO:0031490; GO:0031625; GO:0032808; GO:0032869; GO:0033365; GO:0035035; GO:0042462; GO:0042593; GO:0042660; GO:0043010; GO:0043565; GO:0044344; GO:0045165; GO:0045471; GO:0045664; GO:0045665; GO:0045893; GO:0045944; GO:0048505; GO:0048596; GO:0048708; GO:0050680; GO:0050767; GO:0060041; GO:0061034; GO:0061072; GO:0061303; GO:0061351; GO:0070410; GO:0070412; GO:0071333; GO:0071380; GO:0071466; GO:0071837; GO:0098598; GO:0120008; GO:1901142; GO:1902895; GO:1904798; GO:1904937; GO:1990830; GO:1990837; GO:2000178; GO:2001224"
"983","Pocillopora_acuta_HIv2___RNAseq.g10529.t1",2425.59091314201,4.28260794289436,2.05288901626838,3.78839937676238e-05,0.000358608694931224,NA,NA,NA,NA,NA
"984","Pocillopora_acuta_HIv2___RNAseq.g17519.t1",1719.95496711286,1.08058068214725,1.94626640985696,3.80116312024801e-05,0.000359581578621761,"Q9VBW3",4.3e-76,"Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303"
"985","Pocillopora_acuta_HIv2___RNAseq.g6279.t1",62.0898809323004,-5.03853431846026,2.43214513392916,3.82858265988262e-05,0.000361702283426141,"Q5F4A1",3.47e-68,"G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase)","apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]","GO:0004842; GO:0005634; GO:0005730; GO:0005737; GO:0006915; GO:0016567; GO:0046872"
"986","Pocillopora_acuta_HIv2___RNAseq.g31061.t1",140.156502876075,-1.04002659353816,1.92464224367362,3.86731806229354e-05,0.000365123292774242,NA,NA,NA,NA,NA
"987","Pocillopora_acuta_HIv2___RNAseq.g20555.t1",53.4795269263418,-6.59573507305144,3.73391808861867,3.94031797711964e-05,0.000371530373018634,NA,NA,NA,NA,NA
"988","Pocillopora_acuta_HIv2___RNAseq.g7618.t1",326.496348298609,-3.5911969495824,3.93429901884987,4.04217776976431e-05,0.000380638406652805,NA,NA,NA,NA,NA
"989","Pocillopora_acuta_HIv2___TS.g19790.t1",184.727420450665,-2.11669416567151,5.44450288139862,4.09955451006384e-05,0.000385288865715162,"O95833",4.17e-29,"Chloride intracellular channel protein 3 (Glutaredoxin-like oxidoreductase CLIC3) (EC 1.8.-.-)","chloride transport [GO:0006821]; positive regulation of sprouting angiogenesis [GO:1903672]; signal transduction [GO:0007165]","GO:0005254; GO:0005634; GO:0005737; GO:0005886; GO:0006821; GO:0007165; GO:0016020; GO:0016604; GO:0019153; GO:0031012; GO:0034707; GO:0070062; GO:1903672"
"990","Pocillopora_acuta_HIv2___RNAseq.g434.t1",4373.17759770191,3.00106870893394,1.04010407429975,4.11447393309512e-05,0.000386439941352518,"P58421",0,"Frizzled-5 (Fz-5) (Xfz5)","camera-type eye development [GO:0043010]; neuron development [GO:0048666]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; Wnt signaling pathway [GO:0016055]","GO:0000139; GO:0004930; GO:0005886; GO:0016055; GO:0042127; GO:0043010; GO:0045595; GO:0048666"
"991","Pocillopora_acuta_HIv2___RNAseq.g22527.t1",411.940995574875,4.08059793182053,2.20461103023023,4.13001123202268e-05,0.000387647517585828,"Q9DER7",0,"Tolloid-like protein 1 (EC 3.4.24.-) (Chicken tolloid-like protein 1) (Metalloprotease colloid)","cell differentiation [GO:0030154]; dorsal/ventral pattern formation [GO:0009953]; protein processing [GO:0016485]","GO:0004222; GO:0005509; GO:0005615; GO:0008270; GO:0009953; GO:0016485; GO:0030154"
"992","Pocillopora_acuta_HIv2___RNAseq.g887.t1",291.753066340651,-3.89339620886414,1.86634309733101,4.20727976801988e-05,0.000393622862643205,NA,NA,NA,NA,NA
"993","Pocillopora_acuta_HIv2___RNAseq.g1273.t1",2144.39075430026,4.34688608720132,2.70433876536997,4.31206052799153e-05,0.000401866259515912,"Q8N2E2",1.77e-45,"von Willebrand factor D and EGF domain-containing protein","","GO:0005102; GO:0005576; GO:0009986"
"994","Pocillopora_acuta_HIv2___RNAseq.g12378.t1",643.772313607207,4.08789714050488,1.4798835125104,4.49851861718902e-05,0.00041762884004507,"P81546",8.83e-17,"Metalloproteinase inhibitor 1 (Tissue inhibitor of metalloproteinases 1) (TIMP-1)","cellular response to UV-A [GO:0071492]; negative regulation of catalytic activity [GO:0043086]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; positive regulation of cell population proliferation [GO:0008284]; regulation of integrin-mediated signaling pathway [GO:2001044]; response to cytokine [GO:0034097]; response to hormone [GO:0009725]","GO:0002020; GO:0005125; GO:0005615; GO:0008083; GO:0008191; GO:0008284; GO:0009725; GO:0010951; GO:0031012; GO:0034097; GO:0043086; GO:0046872; GO:0051045; GO:0071492; GO:2001044"
"995","Pocillopora_acuta_HIv2___RNAseq.g25648.t1",191.567774494503,-3.89271464527941,2.07172173267815,4.52071526036203e-05,0.000418911287710445,NA,NA,NA,NA,NA
"996","Pocillopora_acuta_HIv2___RNAseq.g7079.t1",72.9557720249617,6.49878323339179,3.13787494214239,4.52102129504981e-05,0.000418911287710445,NA,NA,NA,NA,NA
"997","Pocillopora_acuta_HIv2___RNAseq.g7895.t1",734.801675679575,1.12385809499096,2.07248720332877,4.57648239365421e-05,0.000423236837223878,"Q63722",8.99e-22,"Protein jagged-1 (Jagged1) (CD antigen CD339)","animal organ morphogenesis [GO:0009887]; animal organ regeneration [GO:0031100]; aorta morphogenesis [GO:0035909]; blood vessel remodeling [GO:0001974]; camera-type eye development [GO:0043010]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum morphogenesis [GO:0060411]; cell fate determination [GO:0001709]; ciliary body morphogenesis [GO:0061073]; distal tubule development [GO:0072017]; endocardial cushion cell development [GO:0061444]; inhibition of neuroepithelial cell differentiation [GO:0002085]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; loop of Henle development [GO:0072070]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of stem cell differentiation [GO:2000737]; nephron development [GO:0072006]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; podocyte development [GO:0072015]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of gene expression [GO:0010628]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; response to muramyl dipeptide [GO:0032495]; T cell mediated immunity [GO:0002456]; wound healing [GO:0042060]","GO:0001709; GO:0001953; GO:0001974; GO:0002011; GO:0002085; GO:0002456; GO:0003184; GO:0003215; GO:0005112; GO:0005509; GO:0005543; GO:0005886; GO:0005912; GO:0007219; GO:0009887; GO:0010628; GO:0016020; GO:0016324; GO:0022408; GO:0030182; GO:0030336; GO:0031100; GO:0032495; GO:0035909; GO:0042060; GO:0042127; GO:0042491; GO:0043010; GO:0045177; GO:0045596; GO:0045599; GO:0045602; GO:0045639; GO:0045665; GO:0045669; GO:0045747; GO:0045944; GO:0048018; GO:0048839; GO:0050678; GO:0060090; GO:0060411; GO:0061073; GO:0061101; GO:0061156; GO:0061309; GO:0061444; GO:0062043; GO:0072006; GO:0072015; GO:0072017; GO:0072070; GO:0097150; GO:2000737"
"998","Pocillopora_acuta_HIv2___TS.g9644.t2",110.413699532373,-5.11316588001749,2.71325394017689,4.64397543876265e-05,0.000428656418291404,"Q68EL3",2.24e-29,"BET1-like protein","protein transport [GO:0015031]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0000139; GO:0005484; GO:0005829; GO:0015031; GO:0031201; GO:0042147; GO:2000156"
"999","Pocillopora_acuta_HIv2___TS.g30914.t1",1235.88291131494,4.10907028017226,3.43635531092144,4.71605679088938e-05,0.000434477996327542,"Q64487",0,"Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)","heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling [GO:0099537]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]","GO:0004725; GO:0005102; GO:0007157; GO:0030182; GO:0042734; GO:0046426; GO:0050775; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099151; GO:0099537; GO:0099545; GO:0099560"
"1000","Pocillopora_acuta_HIv2___RNAseq.g8058.t1",175.466270740882,-3.8698522129104,3.6369426046546,4.9505202085147e-05,0.000454630630450518,"Q8K3X3",0,"GDP-mannose 4,6 dehydratase (EC 4.2.1.47) (GDP-D-mannose dehydratase) (GMD)","'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219]","GO:0005737; GO:0007219; GO:0008446; GO:0019673; GO:0042351; GO:0042802; GO:0070401"
"1001","Pocillopora_acuta_HIv2___RNAseq.g3776.t1",304.38140369965,-4.14691423071393,2.67278347563635,4.95533033610498e-05,0.000454783616633391,"Q95YM9",4.55e-06,"Fibroblast growth factor receptor (HrFGFR) (EC 2.7.10.1)","positive regulation of cell population proliferation [GO:0008284]","GO:0005007; GO:0005524; GO:0008284; GO:0016020; GO:0017134; GO:0043235"
"1002","Pocillopora_acuta_HIv2___RNAseq.g17469.t1",2827.33405261627,2.89405848685574,0.946707932078835,4.97220508010159e-05,0.000456042956744385,NA,NA,NA,NA,NA
"1003","Pocillopora_acuta_HIv2___RNAseq.g11497.t1",636.622673074196,3.47622920138163,1.16100049050816,5.06873052940108e-05,0.000463719913834644,"B0S6T2",9.93e-176,"Solute carrier family 15 member 2 (Peptide transporter 2) (PEPT2)","dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; peptide transport [GO:0015833]; peptidoglycan transport [GO:0015835]; protein transport [GO:0015031]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]; response to yeast [GO:0001878]; tripeptide import across plasma membrane [GO:0140207]","GO:0001878; GO:0005886; GO:0015031; GO:0015333; GO:0015833; GO:0015835; GO:0016324; GO:0030670; GO:0042937; GO:0045087; GO:0070424; GO:0071916; GO:0140206; GO:0140207"
"1004","Pocillopora_acuta_HIv2___RNAseq.g775.t1",686.76072988379,4.24720958614062,3.20217545716923,5.08586181505689e-05,0.000464575814913832,"Q924H0",2.76e-32,"Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor)","cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of MAPK cascade [GO:0043408]","GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0042277; GO:0043408"
"1005","Pocillopora_acuta_HIv2___RNAseq.g17719.t1",60.6723974892898,-1.01343484933138,1.8789921151872,5.08666633921256e-05,0.000464575814913832,"Q09575",9.25e-24,"Uncharacterized protein K02A2.6","DNA integration [GO:0015074]","GO:0003676; GO:0005737; GO:0008270; GO:0015074; GO:0019899; GO:0042575"
"1006","Pocillopora_acuta_HIv2___RNAseq.g9056.t1",1100.93738901822,4.08351762976333,2.48049465432508,5.14886383665599e-05,0.000469565993274856,"Q80T79",4.49e-83,"CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)","regulation of dendrite development [GO:0050773]","GO:0005886; GO:0050773"
"1007","Pocillopora_acuta_HIv2___RNAseq.g14094.t1",86.2705700482992,-6.24827439421253,4.26418844174452,5.17843157384566e-05,0.000471370889138474,"F1QMV3",2.74e-70,"Trafficking protein particle complex subunit 6b (TRAPP complex subunit 6B)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; nervous system development [GO:0007399]","GO:0005783; GO:0005801; GO:0005802; GO:0006888; GO:0007399; GO:0030008"
"1008","Pocillopora_acuta_HIv2___RNAseq.g727.t1",31.1027796244483,-8.9761424403908,3.6430763474576,5.21588244060854e-05,0.000474481280634981,NA,NA,NA,NA,NA
"1009","Pocillopora_acuta_HIv2___TS.g19792.t3c",397.742553976533,-1.23762533236552,2.0716959267925,5.26217338829646e-05,0.000478391426073664,"Q55E58",5.83e-18,"Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)","cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856]","GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310"
"1010","Pocillopora_acuta_HIv2___RNAseq.g23053.t1",1003.7088565745,-1.10828225831793,1.95662111223744,5.29899730250182e-05,0.000481134318790875,"Q924A2",2.47e-40,"Protein capicua homolog","brain development [GO:0007420]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; social behavior [GO:0035176]; transcription by RNA polymerase II [GO:0006366]","GO:0000122; GO:0000977; GO:0000981; GO:0003682; GO:0005634; GO:0006357; GO:0006366; GO:0007420; GO:0007612; GO:0007613; GO:0032991; GO:0035176; GO:0045892; GO:0048286"
"1011","Pocillopora_acuta_HIv2___TS.g12436.t1a",71.7747898860387,-6.13874355926303,4.52520580175407,5.33861667447518e-05,0.000484123834354915,NA,NA,NA,NA,NA
"1012","Pocillopora_acuta_HIv2___TS.g21741.t1",6778.30722367671,-3.73930181484783,2.6302620408578,5.46390067954347e-05,0.000494245524883782,NA,NA,NA,NA,NA
"1013","Pocillopora_acuta_HIv2___RNAseq.22092_t",343.233674107457,2.17526836581224,4.26041332854471,5.47984934907335e-05,0.000494451284996862,"Q9JME2",2.7e-41,"Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)","apoptotic process [GO:0006915]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0006915; GO:0007179; GO:0007585; GO:0008146; GO:0009791; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216"
"1014","Pocillopora_acuta_HIv2___RNAseq.g30304.t2",2520.38767280819,4.3163272801789,2.36273966012624,5.56644747586354e-05,0.000501014911579902,"D9IQ16",4.06e-39,"Galaxin","","GO:0005576"
"1015","Pocillopora_acuta_HIv2___RNAseq.g8859.t1b",69.873321900024,-6.30184636864903,4.18723833789106,5.60283504245984e-05,0.00050366318243716,NA,NA,NA,NA,NA
"1016","Pocillopora_acuta_HIv2___RNAseq.g1838.t1",74.0163059089429,-6.12969282742948,4.59607687804028,5.64668823529368e-05,0.000506975162230216,"Q8WWC4",3.3e-13,"m-AAA protease-interacting protein 1, mitochondrial (Matrix AAA peptidase-interacting protein 1)","calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein insertion into mitochondrial membrane [GO:0051204]","GO:0005743; GO:0005759; GO:0032979; GO:0036444; GO:0043022; GO:0051204; GO:0051560"
"1017","Pocillopora_acuta_HIv2___RNAseq.g12372.t1",1892.12047322306,4.03416006304539,1.99941266139224,5.68243423865883e-05,0.000509236238091458,"H9JW44",1.09e-95,"Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41)","chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]","GO:0000272; GO:0004099; GO:0005615; GO:0006032; GO:0046872"
"1018","Pocillopora_acuta_HIv2___RNAseq.g1942.t1",243.380270176727,-1.42136318701716,2.96075023982905,5.72304748080239e-05,0.000512254296936393,NA,NA,NA,NA,NA
"1019","Pocillopora_acuta_HIv2___TS.g5112.t1",7861.55930595759,-2.93840328974779,1.03214233744887,5.77456164228064e-05,0.000516212976476806,NA,NA,NA,NA,NA
"1020","Pocillopora_acuta_HIv2___RNAseq.g19452.t1",173.485215914209,-3.86260209201146,3.72171159334832,5.78179421520908e-05,0.000516540281215467,"Q8BX94",3.58e-45,"Oxysterol-binding protein-related protein 2 (ORP-2) (OSBP-related protein 2)","intracellular cholesterol transport [GO:0032367]; plasma membrane organization [GO:0007009]; protein homotetramerization [GO:0051289]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]","GO:0005546; GO:0005811; GO:0005829; GO:0005886; GO:0007009; GO:0008526; GO:0009898; GO:0015485; GO:0032367; GO:0051289; GO:0097038; GO:0098831; GO:0098978; GO:0099509; GO:0120020"
"1021","Pocillopora_acuta_HIv2___RNAseq.g1239.t1",1155.76204457354,-2.22889607103658,3.13590697045893,5.85713173488698e-05,0.000522303042006198,"Q552Z6",1.81e-12,"GTP-binding protein A","","GO:0005525"
"1022","Pocillopora_acuta_HIv2___RNAseq.g27066.t1",7657.02166339574,2.37726293529804,0.707551773173344,6.05131897011668e-05,0.000538954911230096,NA,NA,NA,NA,NA
"1023","Pocillopora_acuta_HIv2___RNAseq.g15163.t1",1240.28670083128,3.52429969620495,3.47407239279441,6.17266380381759e-05,0.000549424056974877,"Q9W740",2.52e-25,"Noggin-2","cartilage development [GO:0051216]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell differentiation [GO:0045596]; osteoblast differentiation [GO:0001649]","GO:0001649; GO:0005615; GO:0009953; GO:0030514; GO:0045596; GO:0051216"
"1024","Pocillopora_acuta_HIv2___RNAseq.g24675.t1",35.5676223044538,-8.85557699878646,3.73334143438149,6.26995242937074e-05,0.00055739761486428,"Q9GYF0",1.77e-06,"Cholesterol uptake protein 1","cholesterol import [GO:0070508]; RNA transport [GO:0050658]","GO:0003725; GO:0005764; GO:0005768; GO:0005794; GO:0005886; GO:0015485; GO:0031410; GO:0050658; GO:0051033; GO:0070508"
"1025","Pocillopora_acuta_HIv2___RNAseq.g28652.t1",962.258919711437,4.15821322476366,2.49986202278684,6.29922204525734e-05,0.000559116659753043,NA,NA,NA,NA,NA
"1026","Pocillopora_acuta_HIv2___TS.g15585.t1",3589.91101719033,3.87712809254236,2.48611256559258,6.34456490069253e-05,0.000561958277548174,"Q5VST9",4.7e-15,"Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)","protein localization to M-band [GO:0036309]; regulation of small GTPase mediated signal transduction [GO:0051056]; sarcomere organization [GO:0045214]","GO:0004674; GO:0005085; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005829; GO:0005886; GO:0008307; GO:0010314; GO:0016604; GO:0030016; GO:0030018; GO:0030506; GO:0031430; GO:0031432; GO:0032266; GO:0036309; GO:0042383; GO:0043325; GO:0045214; GO:0046872; GO:0051056; GO:0070273; GO:0106310"
"1027","Pocillopora_acuta_HIv2___RNAseq.g26727.t1",2428.7531099245,-2.52550154361669,0.78726639108198,6.39847241773808e-05,0.000566386199817403,NA,NA,NA,NA,NA
"1028","Pocillopora_acuta_HIv2___RNAseq.g28109.t1",2232.43567180149,3.93292396230729,2.50382669416444,6.41757571799152e-05,0.00056772975648336,"P37889",1.21e-71,"Fibulin-2 (FIBL-2)","positive regulation of cell-substrate adhesion [GO:0010811]","GO:0005509; GO:0005576; GO:0010811; GO:0050840; GO:0062023"
"1029","Pocillopora_acuta_HIv2___TS.g305.t1",340.354574462484,-1.11982884047201,1.79830203091573,6.59973035102417e-05,0.000582419156785928,"O75899",4.3e-126,"Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]","GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712"
"1030","Pocillopora_acuta_HIv2___RNAseq.g17949.t2",747.49311440671,-3.22858979714895,1.40752111053402,6.92770832374685e-05,0.000608393279870518,NA,NA,NA,NA,NA
"1031","Pocillopora_acuta_HIv2___TS.g4835.t2",2307.74808167478,2.54911095460013,0.803953629390608,6.9580277248796e-05,0.000610314815116182,"O94854",9.82e-08,"Microtubule-actin cross-linking factor 1, isoforms 6/7 (Uncharacterized protein KIAA0754)","intermediate filament cytoskeleton organization [GO:0045104]","GO:0005509; GO:0005737; GO:0005856; GO:0008017; GO:0045104"
"1032","Pocillopora_acuta_HIv2___RNAseq.g8690.t1",1186.97644649534,-3.70714413052707,3.27796126282967,6.99633713033163e-05,0.000613293404708246,"Q6VFT5",3.36e-59,"Forkhead box protein L2","anatomical structure morphogenesis [GO:0009653]; apoptotic DNA fragmentation [GO:0006309]; cell differentiation [GO:0030154]; extraocular skeletal muscle development [GO:0002074]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA-templated transcription [GO:0045893]","GO:0000978; GO:0000981; GO:0001541; GO:0002074; GO:0003677; GO:0003700; GO:0005634; GO:0006309; GO:0009653; GO:0030154; GO:0043028; GO:0043065; GO:0043280; GO:0045893"
"1033","Pocillopora_acuta_HIv2___RNAseq.g24012.t1",616.503792806688,-1.36588846681679,2.38381513919896,7.21235711388111e-05,0.000629188982479954,NA,NA,NA,NA,NA
"1034","Pocillopora_acuta_HIv2___TS.g3218.t1",667.006638835375,4.06986189542241,2.49472410415795,7.25335756413482e-05,0.000632003396431603,NA,NA,NA,NA,NA
"1035","Pocillopora_acuta_HIv2___RNAseq.g26675.t1",11803.2317031444,2.44764220774697,0.761692688418433,7.39259069440515e-05,0.000642586729590602,NA,NA,NA,NA,NA
"1036","Pocillopora_acuta_HIv2___RNAseq.g24500.t1",60.1286021470813,-6.42912638623765,2.75750933187373,7.56680800798696e-05,0.000655076023075279,NA,NA,NA,NA,NA
"1037","Pocillopora_acuta_HIv2___RNAseq.g20345.t1",226.895174944419,-1.30368307616462,2.40871770204207,7.60070460089464e-05,0.000657515498488876,NA,NA,NA,NA,NA
"1038","Pocillopora_acuta_HIv2___RNAseq.g4959.t1",1090.4585784368,-2.85436549532898,1.01981918455512,7.7824735351589e-05,0.000670832522124782,"Q9QXE4",6.14e-15,"Tumor protein p53-inducible nuclear protein 1 (Stress-induced protein) (Thymus-expressed acidic protein) (TEAP) (p53-dependent damage-inducible nuclear protein 1) (p53DINP1)","apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; autophagosome assembly [GO:0000045]; cellular response to ethanol [GO:0071361]; cellular response to hydroperoxide [GO:0071447]; cellular response to methyl methanesulfonate [GO:0072703]; cellular response to UV [GO:0034644]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of myofibroblast differentiation [GO:1904761]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; response to heat [GO:0009408]","GO:0000045; GO:0005634; GO:0005776; GO:0005829; GO:0006915; GO:0008285; GO:0009408; GO:0010508; GO:0010628; GO:0010629; GO:0016209; GO:0016605; GO:0030336; GO:0031410; GO:0034644; GO:0043065; GO:0045893; GO:0048102; GO:0048147; GO:0071361; GO:0071447; GO:0072703; GO:1904761"
"1039","Pocillopora_acuta_HIv2___RNAseq.g758.t1",3358.4593161405,2.5213848731154,0.807327722843834,7.99130349775865e-05,0.000686786772380162,NA,NA,NA,NA,NA
"1040","Pocillopora_acuta_HIv2___TS.g800.t1",356.420590991389,-3.19475895819014,1.57955125151455,8.03815610352151e-05,0.000689584162997243,"O95185",5.64e-06,"Netrin receptor UNC5C (Protein unc-5 homolog 3) (Protein unc-5 homolog C)","anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; chemorepulsion of axon [GO:0061643]; dorsal root ganglion development [GO:1990791]; ectopic germ cell programmed cell death [GO:0035234]; positive regulation of apoptotic process [GO:0043065]; positive regulation of developmental process [GO:0051094]; positive regulation of reproductive process [GO:2000243]; regulation of neuron migration [GO:2001222]","GO:0005042; GO:0005043; GO:0005886; GO:0006915; GO:0007411; GO:0007420; GO:0009986; GO:0015631; GO:0019901; GO:0030027; GO:0030175; GO:0030425; GO:0030426; GO:0033564; GO:0035234; GO:0043025; GO:0043065; GO:0045202; GO:0051094; GO:0061643; GO:1990791; GO:2000243; GO:2001222"
"1041","Pocillopora_acuta_HIv2___TS.g24030.t1",4457.23889416617,4.20726747993412,1.9700797679344,8.0579331914863e-05,0.00069046176351693,"O35136",1.02e-41,"Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2) (Neural cell adhesion molecule RB-8) (R4B12)","axonal fasciculation [GO:0007413]; cell adhesion [GO:0007155]","GO:0007155; GO:0007413; GO:0016604; GO:0030424; GO:0042802; GO:0097060; GO:0098552"
"1042","Pocillopora_acuta_HIv2___RNAseq.g26200.t1",29175.7743379683,2.49664196608494,0.788011794838062,8.07180945712313e-05,0.000691241278791172,"P02466",3.84e-151,"Collagen alpha-2(I) chain (Alpha-2 type I collagen)","blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096"
"1043","Pocillopora_acuta_HIv2___RNAseq.g20665.t1",3005.83945632987,-3.57222731647928,3.25418107833739,8.10273980504055e-05,0.000693479458817198,"Q09596",7.51e-40,"Probable glutathione S-transferase 5 (EC 2.5.1.18) (GST class-sigma)","innate immune response [GO:0045087]","GO:0004364; GO:0045087"
"1044","Pocillopora_acuta_HIv2___TS.g28196.t1",42.2064226824668,-8.90105831999768,4.02629172085902,8.14022034678344e-05,0.000695863753521723,"Q1ZXD6",1.41e-17,"Probable serine/threonine-protein kinase roco5 (EC 2.7.11.1) (Ras of complex proteins and C-terminal of roc 5)","signal transduction [GO:0007165]; sorocarp development [GO:0030587]","GO:0004672; GO:0004674; GO:0005085; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0007165; GO:0030587; GO:0106310"
"1045","Pocillopora_acuta_HIv2___RNAseq.g30377.t2",463.558343261751,2.28848256281652,3.7995794333622,8.35369255931622e-05,0.000712008303936062,"O15973",9.93e-16,"Rhodopsin, GQ-coupled (GQ-rhodopsin)","cellular response to light stimulus [GO:0071482]; phototransduction [GO:0007602]; visual perception [GO:0007601]","GO:0005886; GO:0007601; GO:0007602; GO:0008020; GO:0071482"
"1046","Pocillopora_acuta_HIv2___TS.g10300.t1",391.287719790513,-4.23814952219135,3.12828933757027,8.51577566632753e-05,0.000722841427451652,"Q0P5L5",2.74e-154,"Formylglycine-generating enzyme (FGE) (EC 1.8.3.7) (C-alpha-formylglycine-generating enzyme 1) (Sulfatase-modifying factor 1)","post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158]","GO:0005783; GO:0005788; GO:0018158; GO:0043687; GO:0120147; GO:1903135"
"1047","Pocillopora_acuta_HIv2___RNAseq.g14375.t1",4079.04011946024,3.74259698423301,2.83932625300744,8.6067966789733e-05,0.000728856599324765,"A6H584",7.12e-09,"Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain)","cell adhesion [GO:0007155]","GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023"
"1048","Pocillopora_acuta_HIv2___RNAseq.g31038.t1",1101.92807608059,-4.00047789167036,1.76129237883341,8.68956301757238e-05,0.000734146258680881,"P50549",1.41e-68,"ETS translocation variant 1 (Ets-related protein 81)","axon guidance [GO:0007411]; mechanosensory behavior [GO:0007638]; muscle organ development [GO:0007517]; peripheral nervous system neuron development [GO:0048935]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]","GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0007411; GO:0007517; GO:0007638; GO:0045944; GO:0048935; GO:1990837"
"1049","Pocillopora_acuta_HIv2___RNAseq.g22295.t2",213.56297169106,-4.44305177729081,3.17474943952477,8.87855643344846e-05,0.000748365036441716,"P79942",5.16e-78,"Nocturnin (EC 3.1.3.-) (Carbon catabolite repression 4-like protein) (Rhythmic message 1) (RM1)","circadian rhythm [GO:0007623]; NADP metabolic process [GO:0006739]","GO:0004535; GO:0005634; GO:0005739; GO:0006739; GO:0007623; GO:0019178; GO:0046872; GO:0048471; GO:0102757"
"1050","Pocillopora_acuta_HIv2___RNAseq.g28208.t1",170.155080228177,-4.03944092744012,3.82680835882051,9.13946731494981e-05,0.000768118856731168,NA,NA,NA,NA,NA
"1051","Pocillopora_acuta_HIv2___RNAseq.g10158.t1",1479.44456660291,-3.13221368670166,3.97890151945225,9.61737019656354e-05,0.000803614341554564,"Q812E0",2.04e-137,"Cytoplasmic polyadenylation element-binding protein 2 (CPE-BP2) (CPE-binding protein 2) (mCPEB-2)","cellular response to arsenic-containing substance [GO:0071243]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of cytoplasmic translational elongation [GO:1900248]; negative regulation of translational elongation [GO:0045900]; regulation of translation at synapse, modulating synaptic transmission [GO:0099547]","GO:0000900; GO:0003730; GO:0005095; GO:0005634; GO:0005737; GO:0005840; GO:0008135; GO:0008187; GO:0032869; GO:0034599; GO:0035925; GO:0043005; GO:0043022; GO:0043023; GO:0043024; GO:0045202; GO:0045900; GO:0071243; GO:0071456; GO:0098978; GO:0099547; GO:1900248; GO:1990124; GO:2000766"
"1052","Pocillopora_acuta_HIv2___RNAseq.g16095.t1",188.282424293033,-3.65120630207534,2.7646438871111,9.76016943252575e-05,0.000814135471003763,"P86733",5.24e-23,"BPTI/Kunitz domain-containing protein","","GO:0004867; GO:0005576; GO:0005615"
"1053","Pocillopora_acuta_HIv2___RNAseq.g26340.t1",1514.87206485343,-3.08860695950824,2.97263963903124,9.84424628191776e-05,0.000820202639525682,"Q8WPW2",3.9e-154,"Pyridoxal 5'-phosphate synthase subunit SNZERR (PLP synthase subunit SNZERR) (EC 4.3.3.6) (Ethylene response protein) (PDX1)","amino acid metabolic process [GO:0006520]; pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615]","GO:0006520; GO:0008615; GO:0036381; GO:0042823"
"1054","Pocillopora_acuta_HIv2___RNAseq.g24353.t1",120.74700534995,3.65350781308021,1.74532929262034,9.98353008254053e-05,0.000830028919924304,NA,NA,NA,NA,NA
"1055","Pocillopora_acuta_HIv2___RNAseq.g4031.t1c",874.900395188356,-1.42504671619011,2.20741614196592,0.000101564742782863,0.000841370240327223,"Q5R4J5",3.68e-42,"Synaptotagmin-1 (Synaptotagmin I) (SytI)","calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903235]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]","GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0019905; GO:0030154; GO:0030276; GO:0030424; GO:0030672; GO:0031045; GO:0042584; GO:0048488; GO:0048791; GO:0071277; GO:1903235"
"1056","Pocillopora_acuta_HIv2___RNAseq.g17517.t1",1733.32182958728,3.98152411686429,1.94852806732884,0.000102655041298777,0.000848527921872331,"Q9VBW3",2.87e-73,"Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303"
"1057","Pocillopora_acuta_HIv2___TS.g16941.t1",108.856139701982,-1.40201688324132,2.35530770324784,0.000102768226840215,0.000848527921872331,NA,NA,NA,NA,NA
"1058","Pocillopora_acuta_HIv2___RNAseq.g19325.t1",242.890544148897,-1.0774779343929,1.86926418947995,0.000102780760448031,0.000848527921872331,"Q567I9",3.97e-109,"Cytochrome b5 domain-containing protein 1","cilium movement [GO:0003341]; regulation of cilium beat frequency [GO:0003356]","GO:0003341; GO:0003356; GO:0005737; GO:0005856; GO:0042995; GO:0046872"
"1059","Pocillopora_acuta_HIv2___RNAseq.g13877.t1",169.236130838179,-1.14489317312048,2.04246291097135,0.000102927823925226,0.000848773115880539,"A0JPQ7",4.86e-29,"Uncharacterized protein C19orf47 homolog","","GO:0005634"
"1060","Pocillopora_acuta_HIv2___TS.g7278.t1",68.8518742448097,1.56208324520608,2.91577448476753,0.000103718017867412,0.000853828918858419,"Q9Y4B6",1.28e-18,"DDB1- and CUL4-associated factor 1 (HIV-1 Vpr-binding protein) (VprBP) (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1) (Vpr-interacting protein)","B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]","GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043687; GO:0045732; GO:0080008; GO:0106310; GO:1990244; GO:1990756"
"1061","Pocillopora_acuta_HIv2___RNAseq.g6896.t1",870.17172066181,-3.50754416962333,2.75612308479577,0.000104319093680754,0.000857954961797028,"Q5BK26",0,"Patatin-like phospholipase domain-containing protein 7 (EC 3.1.1.-) (EC 3.1.1.5) (Liver NTE-related protein 1) (NTE-related esterase)","phosphatidylcholine catabolic process [GO:0034638]","GO:0004622; GO:0005783; GO:0005789; GO:0005811; GO:0034638"
"1062","Pocillopora_acuta_HIv2___RNAseq.g1970.t1",1578.77647794326,2.32367223889845,3.37454760403753,0.00010556985869587,0.000866607512018763,"B3EWY6",3.2e-87,"Skeletal aspartic acid-rich protein 1","","GO:0005576"
"1063","Pocillopora_acuta_HIv2___TS.g24066.t1",6081.75958151818,2.27236467624306,0.712818520657562,0.000109710959209108,0.000896981370589127,"P27393",8.24e-154,"Collagen alpha-2(IV) chain","extracellular matrix organization [GO:0030198]","GO:0005581; GO:0005604; GO:0005615; GO:0030020; GO:0030198"
"1064","Pocillopora_acuta_HIv2___RNAseq.g7754.t1",235.063684751222,-1.01201363299521,1.70837399376779,0.000109766110753786,0.000896981370589127,NA,NA,NA,NA,NA
"1065","Pocillopora_acuta_HIv2___RNAseq.g14354.t1",755.049483355471,3.23367424426078,4.94503720158178,0.000110161405223452,0.000899703311774148,NA,NA,NA,NA,NA
"1066","Pocillopora_acuta_HIv2___RNAseq.g30565.t1",41.697831037724,-5.90794310287633,3.50707919063204,0.000111231450270054,0.000907929851414254,"Q96DX5",7.26e-34,"Ankyrin repeat and SOCS box protein 9 (ASB-9)","intracellular signal transduction [GO:0035556]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]","GO:0005739; GO:0005829; GO:0016567; GO:0031466; GO:0035556; GO:0043161; GO:0045732; GO:1990756"
"1067","Pocillopora_acuta_HIv2___TS.g25584.t1",120.839747336801,1.06517855125261,1.79800081952338,0.000112503430479264,0.000916244154533827,"Q7Z407",1.85e-20,"CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)","regulation of dendrite development [GO:0050773]","GO:0005886; GO:0050773"
"1068","Pocillopora_acuta_HIv2___RNAseq.g12376.t1",1045.73785985076,3.75453198678198,1.76568868690228,0.000114324196285417,0.000929089948784687,"H9JW44",5.86e-96,"Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41)","chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]","GO:0000272; GO:0004099; GO:0005615; GO:0006032; GO:0046872"
"1069","Pocillopora_acuta_HIv2___RNAseq.g12049.t1",62.8991078524264,-1.0354681653863,1.91378004581996,0.000114337673453868,0.000929089948784687,"P00389",0,"NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4)","response to hormone [GO:0009725]","GO:0003958; GO:0005789; GO:0005829; GO:0009725; GO:0010181; GO:0050660; GO:0050661"
"1070","Pocillopora_acuta_HIv2___TS.g15832.t1",7865.30278436561,2.46920800611594,0.827823818262245,0.000121364437379741,0.000980131335712214,"P02466",7.07e-153,"Collagen alpha-2(I) chain (Alpha-2 type I collagen)","blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096"
"1071","Pocillopora_acuta_HIv2___RNAseq.g8876.t1",28.7330248390001,-8.54304721714774,3.68503081782909,0.000122897556556875,0.000989749586881207,"Q91770",1.98e-20,"Homeobox protein not2 (Xnot-2) (Xnot2)","negative regulation of DNA-templated transcription [GO:0045892]; notochord formation [GO:0014028]","GO:0000981; GO:0003677; GO:0005634; GO:0014028; GO:0045892"
"1072","Pocillopora_acuta_HIv2___RNAseq.g8587.t1",456.761246394455,2.77278605172307,3.82013917741802,0.000123916095816841,0.000996288165589095,"Q19269",2.14e-45,"Zinc metalloproteinase nas-14 (EC 3.4.24.-) (Nematode astacin 14)","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"1073","Pocillopora_acuta_HIv2___RNAseq.g8670.t1",5976.07967302424,3.19828205619244,1.32750711594381,0.000124507544247063,0.00100031869686516,"P02752",1.2e-55,"Riboflavin-binding protein (RBP) [Cleaved into: Riboflavin-binding protein, plasma form; Riboflavin-binding protein, yolk major form; Riboflavin-binding protein, yolk minor form]","negative regulation of sensory perception of bitter taste [GO:1904661]; negative regulation of sensory perception of sweet taste [GO:1904657]; riboflavin transport [GO:0032218]","GO:0009897; GO:0032217; GO:0032218; GO:0038023; GO:1902444; GO:1904657; GO:1904661"
"1074","Pocillopora_acuta_HIv2___RNAseq.g6972.t1",41.9246463005393,-5.7938617161554,3.6567337867147,0.000124555722694563,0.00100031869686516,NA,NA,NA,NA,NA
"1075","Pocillopora_acuta_HIv2___RNAseq.g2626.t1",237.041366217848,5.69051302814439,2.2676242913625,0.0001246384152025,0.00100042732380075,NA,NA,NA,NA,NA
"1076","Pocillopora_acuta_HIv2___RNAseq.g15885.t1",54.5100177919839,-5.75760444240056,2.89476141630985,0.000124959016719753,0.00100118566274317,"Q15649",3.56e-26,"Zinc finger HIT domain-containing protein 3 (HNF-4a coactivator) (Thyroid hormone receptor interactor 3) (Thyroid receptor-interacting protein 3) (TR-interacting protein 3) (TRIP-3)","box C/D snoRNP assembly [GO:0000492]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of DNA-templated transcription [GO:0006355]; snoRNA localization [GO:0048254]","GO:0000463; GO:0000492; GO:0005634; GO:0005737; GO:0006355; GO:0046872; GO:0046966; GO:0048254; GO:0070761"
"1077","Pocillopora_acuta_HIv2___RNAseq.g15236.t1",339.408054364753,3.80130780951967,2.33425060635168,0.000125235576585775,0.00100243905906843,"Q2TBT8",6.44e-19,"RING finger protein 151","protein ubiquitination [GO:0016567]","GO:0008270; GO:0016567; GO:0061630"
"1078","Pocillopora_acuta_HIv2___RNAseq.g26979.t1",16227.093016946,2.27873315118381,0.724006320487525,0.000127320029947943,0.00101743475865583,"P83205",3.33e-135,"Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain]","cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis involved in protein catabolic process [GO:0051603]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590]","GO:0004175; GO:0004197; GO:0005518; GO:0005615; GO:0005764; GO:0006590; GO:0009897; GO:0016324; GO:0030574; GO:0030855; GO:0042470; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0051603; GO:0097067; GO:1904090"
"1079","Pocillopora_acuta_HIv2___RNAseq.g7248.t1",34.8871881954713,-8.60714265475365,3.92059017726659,0.000130836691523619,0.00104282746345749,"Q8WU66",9.09e-34,"Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)","hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505]","GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170"
"1080","Pocillopora_acuta_HIv2___RNAseq.g26700.t1",3564.82512470245,-2.85109773642727,1.08280694505229,0.000130858119895972,0.00104282746345749,"E9PUL5",2.16e-08,"Proline-rich transmembrane protein 2 (Dispanin subfamily B member 3) (DSPB3)","negative regulation of short-term synaptic potentiation [GO:1905513]; negative regulation of SNARE complex assembly [GO:0035544]; neuromuscular process controlling posture [GO:0050884]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]","GO:0005886; GO:0008021; GO:0016020; GO:0017075; GO:0017124; GO:0030672; GO:0031629; GO:0031982; GO:0035544; GO:0042734; GO:0043005; GO:0043197; GO:0043679; GO:0050884; GO:0098793; GO:0098839; GO:0098978; GO:0150037; GO:1905513"
"1081","Pocillopora_acuta_HIv2___RNAseq.g28803.t1b",11712.5269697605,2.24046662097318,0.710158675585822,0.000131085859260153,0.00104406710811611,"P02466",4.64e-152,"Collagen alpha-2(I) chain (Alpha-2 type I collagen)","blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096"
"1082","Pocillopora_acuta_HIv2___TS.g7149.t2",312.848616037606,-2.39034343926723,3.57716390706445,0.000132067886821696,0.00105130980461696,"Q8CDT7",1.55e-28,"Ciliary-associated calcium-binding coiled-coil protein 1","","GO:0005509; GO:0005737; GO:0005813; GO:0036126"
"1083","Pocillopora_acuta_HIv2___RNAseq.g7645.t1",1667.13017235351,-3.74485189635384,1.72930235286757,0.000134037915790843,0.00106474260465297,"Q9BYK8",0,"3'-5' exoribonuclease HELZ2 (EC 3.1.13.1) (ATP-dependent RNA helicase PRIC285) (EC 3.6.4.13) (Helicase with zinc finger 2, transcriptional coactivator) (Helicase with zinc finger domain 2) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein)","positive regulation of transcription by RNA polymerase II [GO:0045944]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]","GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0008859; GO:0016020; GO:0016887; GO:0030374; GO:0035194; GO:0043186; GO:0045944; GO:0046872"
"1084","Pocillopora_acuta_HIv2___RNAseq.g10777.t1",187.45508411074,-1.13242358640651,1.91672580868611,0.000135480938152456,0.0010725759657565,"Q8CAQ8",1.39e-70,"MICOS complex subunit Mic60 (Mitochondrial inner membrane protein) (Mitofilin)","cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560]; neuron cellular homeostasis [GO:0070050]","GO:0005739; GO:0005743; GO:0005758; GO:0042407; GO:0043209; GO:0051560; GO:0061617; GO:0070050"
"1085","Pocillopora_acuta_HIv2___TS.g15232.t1a",167.812907590762,-1.48565225389899,2.73304463843714,0.000137004202941665,0.00108285726303183,NA,NA,NA,NA,NA
"1086","Pocillopora_acuta_HIv2___RNAseq.g26031.t1a",11043.6237038499,-3.07564727927596,4.91351753417192,0.000137372505370465,0.00108407882487095,"Q505H7",1.53e-11,"Protein IWS1 homolog (IWS1-like protein)","mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]","GO:0005634; GO:0006397; GO:0008380; GO:0051028"
"1087","Pocillopora_acuta_HIv2___RNAseq.g5711.t2",347.776168613039,-1.37401482187436,2.62357664232688,0.000137817162022536,0.00108690699645254,"Q8CGF6",1.7e-111,"WD repeat-containing protein 47 (Neuronal enriched MAP interacting protein) (Nemitin)","adult locomotory behavior [GO:0008344]; anterior commissure morphogenesis [GO:0021960]; autophagy [GO:0006914]; brain development [GO:0007420]; cerebral cortex development [GO:0021987]; cerebral cortex radial glia-guided migration [GO:0021801]; corpus callosum development [GO:0022038]; detection of hot stimulus involved in thermoception [GO:0120168]; locomotory behavior [GO:0007626]; microtubule cytoskeleton organization [GO:0000226]; motor behavior [GO:0061744]; negative regulation of microtubule depolymerization [GO:0007026]; neural precursor cell proliferation [GO:0061351]; neuron projection development [GO:0031175]; neuronal stem cell population maintenance [GO:0097150]","GO:0000226; GO:0005737; GO:0005874; GO:0006914; GO:0007026; GO:0007420; GO:0007626; GO:0008344; GO:0021801; GO:0021960; GO:0021987; GO:0022038; GO:0030424; GO:0030425; GO:0030426; GO:0031175; GO:0043005; GO:0043025; GO:0044877; GO:0061351; GO:0061744; GO:0097150; GO:0120168"
"1088","Pocillopora_acuta_HIv2___RNAseq.12371_t",4891.91865740084,-2.54131046757504,0.876640384889696,0.000141037560387756,0.00110988426194152,NA,NA,NA,NA,NA
"1089","Pocillopora_acuta_HIv2___RNAseq.g26015.t1",107.96012525571,-1.05720929163541,1.75517818485208,0.000141966020818507,0.00111597637234722,NA,NA,NA,NA,NA
"1090","Pocillopora_acuta_HIv2___RNAseq.g3515.t1",95.7288092904257,3.46537365623755,3.03591786251755,0.000142759986766639,0.0011216080655039,"Q9UBC2",2.99e-08,"Epidermal growth factor receptor substrate 15-like 1 (Eps15-related protein) (Eps15R)","endocytosis [GO:0006897]; endosomal transport [GO:0016197]","GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006897; GO:0016020; GO:0016197; GO:0030132; GO:0045296"
"1091","Pocillopora_acuta_HIv2___RNAseq.g14741.t1",196.94047861251,-2.98740514572386,3.67958610543194,0.00014415463101751,0.00113072265891392,"Q92733",8.99e-40,"Proline-rich protein PRCC (Papillary renal cell carcinoma translocation-associated gene protein)","regulation of cell cycle [GO:0051726]","GO:0005634; GO:0005654; GO:0016607; GO:0051726"
"1092","Pocillopora_acuta_HIv2___RNAseq.g4399.t2",947.117373759097,-2.06472506889346,3.78418998486596,0.000144908611224187,0.0011355406493349,"Q14114",1.03e-27,"Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2)","ammon gyrus development [GO:0021541]; cellular response to cholesterol [GO:0071397]; cellular response to growth factor stimulus [GO:0071363]; chemical synaptic transmission [GO:0007268]; cytokine-mediated signaling pathway [GO:0019221]; dendrite morphogenesis [GO:0048813]; endocytosis [GO:0006897]; layer formation in cerebral cortex [GO:0021819]; lipid metabolic process [GO:0006629]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of dendrite development [GO:1900006]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; proteolysis [GO:0006508]; reelin-mediated signaling pathway [GO:0038026]; regulation of apoptotic process [GO:0042981]; regulation of innate immune response [GO:0045088]; response to xenobiotic stimulus [GO:0009410]; retinoid metabolic process [GO:0001523]; signal transduction [GO:0007165]; ventral spinal cord development [GO:0021517]","GO:0001523; GO:0001540; GO:0004888; GO:0005041; GO:0005509; GO:0005615; GO:0005875; GO:0005886; GO:0005901; GO:0006508; GO:0006629; GO:0006897; GO:0007165; GO:0007268; GO:0008035; GO:0009410; GO:0009986; GO:0016020; GO:0019221; GO:0019894; GO:0021517; GO:0021541; GO:0021819; GO:0030229; GO:0030424; GO:0030425; GO:0034185; GO:0038024; GO:0038025; GO:0038026; GO:0042981; GO:0043025; GO:0043235; GO:0045088; GO:0045202; GO:0048306; GO:0048813; GO:0050731; GO:0050804; GO:0061003; GO:0071363; GO:0071397; GO:1900006"
"1093","Pocillopora_acuta_HIv2___RNAseq.g23414.t1",258.40787731036,-3.2377630460392,1.77298990872876,0.000146139459273823,0.00114319152998192,"P35404",3.73e-12,"5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (Serotonin receptor 1B)","adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; bone remodeling [GO:0046849]; cellular response to alkaloid [GO:0071312]; cellular response to xenobiotic stimulus [GO:0071466]; chemical synaptic transmission [GO:0007268]; negative regulation of serotonin secretion [GO:0014063]; regulation of behavior [GO:0050795]; vasoconstriction [GO:0042310]","GO:0004993; GO:0005886; GO:0007198; GO:0007268; GO:0014063; GO:0042310; GO:0045202; GO:0046849; GO:0050795; GO:0071312; GO:0071466"
"1094","Pocillopora_acuta_HIv2___RNAseq.g25250.t1",302.114740379049,-1.16705698946424,2.00773168624515,0.000146765286086613,0.00114746653943609,"Q66J85",3.32e-39,"AN1-type zinc finger protein 3 homolog","","GO:0003677; GO:0008270"
"1095","Pocillopora_acuta_HIv2___RNAseq.g21418.t1",788.438671528168,3.34989197517028,1.61596470631176,0.000151799314207131,0.00117917576836302,"P16241",2.72e-76,"POU domain protein CF1A (Chorion factor 1A) (CF1-A) (Protein drifter) (Ventral veins lacking protein)","brain development [GO:0007420]; brain segmentation [GO:0035284]; dendrite morphogenesis [GO:0048813]; motor neuron axon guidance [GO:0008045]; peripheral nervous system development [GO:0007422]; positive regulation of antimicrobial peptide biosynthetic process [GO:0002807]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of dendrite morphogenesis [GO:0048814]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0002807; GO:0005634; GO:0006357; GO:0007420; GO:0007422; GO:0008045; GO:0035284; GO:0045944; GO:0048813; GO:0048814"
"1096","Pocillopora_acuta_HIv2___TS.g15792.t1",1425.84151006973,1.84831977719958,4.16660418298418,0.000152193714377484,0.00118004266433944,"B3EWY7",1.02e-70,"Acidic skeletal organic matrix protein (Acidic SOMP)","","GO:0005576"
"1097","Pocillopora_acuta_HIv2___RNAseq.g13857.t1",2577.46422040318,2.53891736203651,3.46465141919714,0.000152842471635964,0.00118409936247594,"O19006",6.6e-91,"Bone morphogenetic protein 2 (BMP-2)","cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]; positive regulation of odontoblast differentiation [GO:1901331]","GO:0001503; GO:0005125; GO:0005615; GO:0008083; GO:0030154; GO:0051216; GO:1901331"
"1098","Pocillopora_acuta_HIv2___RNAseq.g14731.t1",2676.28324034623,2.89406023720651,1.17902315386417,0.000154202945803165,0.00119272267812673,NA,NA,NA,NA,NA
"1099","Pocillopora_acuta_HIv2___RNAseq.g17678.t1",25.3077056700698,-8.52211244710992,3.69331583065335,0.000154765890907302,0.00119643711709418,"Q7RTR2",2.35e-22,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223"
"1100","Pocillopora_acuta_HIv2___RNAseq.g26886.t1",80.7576063521977,3.30126413089326,1.33425562782921,0.000155624610520923,0.00120243288812748,NA,NA,NA,NA,NA
"1101","Pocillopora_acuta_HIv2___RNAseq.g9662.t1",1449.54985538158,-3.85590298567163,1.37563642047225,0.000155819360395672,0.0012032948364992,NA,NA,NA,NA,NA
"1102","Pocillopora_acuta_HIv2___TS.g5415.t1",30.9487271906282,-5.87479604926878,2.32197943512066,0.00015685852820334,0.00121002760103099,"Q9P126",5.14e-19,"C-type lectin domain family 1 member B (C-type lectin-like receptor 2) (CLEC-2)","cell surface receptor signaling pathway [GO:0007166]; defense response [GO:0006952]; platelet formation [GO:0030220]; signal transduction [GO:0007165]","GO:0004888; GO:0005886; GO:0006952; GO:0007165; GO:0007166; GO:0009986; GO:0030220; GO:0030246"
"1103","Pocillopora_acuta_HIv2___RNAseq.g5342.t1",1956.29110885674,3.5465065461934,3.30489736157546,0.000159724451263958,0.00122885875695845,"P78504",9.12e-17,"Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339)","angiogenesis [GO:0001525]; aorta morphogenesis [GO:0035909]; aortic valve morphogenesis [GO:0003180]; blood vessel remodeling [GO:0001974]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum morphogenesis [GO:0060411]; cell fate determination [GO:0001709]; ciliary body morphogenesis [GO:0061073]; distal tubule development [GO:0072017]; endocardial cushion cell development [GO:0061444]; endothelial cell differentiation [GO:0045446]; hemopoiesis [GO:0030097]; inhibition of neuroepithelial cell differentiation [GO:0002085]; inner ear auditory receptor cell differentiation [GO:0042491]; keratinocyte differentiation [GO:0030216]; loop of Henle development [GO:0072070]; morphogenesis of an epithelial sheet [GO:0002011]; myoblast differentiation [GO:0045445]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of stem cell differentiation [GO:2000737]; nephron development [GO:0072006]; nervous system development [GO:0007399]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; podocyte development [GO:0072015]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of reproductive process [GO:2000241]; response to muramyl dipeptide [GO:0032495]; T cell mediated immunity [GO:0002456]","GO:0001525; GO:0001709; GO:0001953; GO:0001974; GO:0002011; GO:0002085; GO:0002456; GO:0003180; GO:0003184; GO:0003215; GO:0005112; GO:0005198; GO:0005509; GO:0005543; GO:0005576; GO:0005886; GO:0005912; GO:0007219; GO:0007399; GO:0008083; GO:0016020; GO:0016324; GO:0022408; GO:0030097; GO:0030216; GO:0030336; GO:0032495; GO:0035909; GO:0042127; GO:0042491; GO:0045445; GO:0045446; GO:0045599; GO:0045602; GO:0045639; GO:0045665; GO:0045669; GO:0045747; GO:0045944; GO:0050678; GO:0060090; GO:0060411; GO:0061073; GO:0061101; GO:0061156; GO:0061309; GO:0061444; GO:0062043; GO:0072006; GO:0072015; GO:0072017; GO:0072070; GO:0097150; GO:2000241; GO:2000737"
"1104","Pocillopora_acuta_HIv2___RNAseq.g3666.t1a",167.700938232003,-1.01299330871552,1.75357316900771,0.000159901576499278,0.00122956746543623,"Q6GPQ3",2.23e-17,"Major facilitator superfamily domain-containing protein 8","","GO:0005765; GO:0022857"
"1105","Pocillopora_acuta_HIv2___RNAseq.g1033.t1",2322.63113884992,-2.0978764427017,0.66086332531699,0.000162441510394986,0.00124777164437232,NA,NA,NA,NA,NA
"1106","Pocillopora_acuta_HIv2___RNAseq.g8980.t1",106.101495155826,3.47836061085379,2.36677606657635,0.000162552641502909,0.00124796253009452,"B8EIZ7",8.19e-180,"Trimethylamine monooxygenase (TMA monooxygenase) (Tmm) (EC 1.14.13.148)","","GO:0004499; GO:0034899; GO:0047822; GO:0050660; GO:0050661"
"1107","Pocillopora_acuta_HIv2___RNAseq.g30759.t1",401.229753927853,-3.70407031889035,1.84634656990781,0.00016344823269504,0.00125358703400109,NA,NA,NA,NA,NA
"1108","Pocillopora_acuta_HIv2___RNAseq.g27609.t1",647.195843838856,-3.41923332212617,1.99668596308939,0.000164236629218084,0.00125821960011142,"Q01062",0,"cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; cAMP-mediated signaling [GO:0019933]; cardiac septum development [GO:0003279]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; coronary vasculature development [GO:0060976]; establishment of endothelial barrier [GO:0061028]; heart development [GO:0007507]; heart valve development [GO:0003170]; intracellular signal transduction [GO:0035556]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of cGMP-mediated signaling [GO:0010752]; regulation of mitochondrion organization [GO:0010821]; regulation of nitric oxide mediated signal transduction [GO:0010749]; response to hydrogen sulfide [GO:1904880]; ventricular septum development [GO:0003281]","GO:0000122; GO:0000287; GO:0003170; GO:0003279; GO:0003281; GO:0004115; GO:0004118; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007193; GO:0007507; GO:0008270; GO:0010628; GO:0010749; GO:0010752; GO:0010754; GO:0010821; GO:0019933; GO:0019934; GO:0030424; GO:0030425; GO:0030552; GO:0030553; GO:0030911; GO:0035556; GO:0035904; GO:0036004; GO:0036006; GO:0042301; GO:0042734; GO:0042802; GO:0042803; GO:0043116; GO:0043117; GO:0043949; GO:0043951; GO:0046069; GO:0047555; GO:0048471; GO:0050729; GO:0060976; GO:0061028; GO:0071222; GO:0071260; GO:0071320; GO:0071321; GO:0071560; GO:0090324; GO:0097011; GO:0097060; GO:0097457; GO:0106072; GO:1904613; GO:1904880"
"1109","Pocillopora_acuta_HIv2___RNAseq.g2255.t1",2924.51760305112,-3.63919689628225,1.9526796865899,0.000165372375011915,0.00126624988468625,NA,NA,NA,NA,NA
"1110","Pocillopora_acuta_HIv2___RNAseq.g614.t1",2049.65500897357,3.45811602151735,1.86218991887892,0.000168382670426697,0.00128453952798088,"Q61321",2.37e-90,"Homeobox protein SIX4 (Sine oculis homeobox homolog 4) (Skeletal muscle-specific ARE-binding protein AREC3)","embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic skeletal system morphogenesis [GO:0048704]; fungiform papilla morphogenesis [GO:0061197]; generation of neurons [GO:0048699]; inner ear morphogenesis [GO:0042472]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; male sex differentiation [GO:0046661]; metanephric mesenchyme development [GO:0072075]; myoblast migration [GO:0051451]; myotome development [GO:0061055]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of satellite cell differentiation [GO:1902725]; olfactory placode formation [GO:0030910]; pharyngeal system development [GO:0060037]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ureteric bud formation [GO:0072107]; protein localization to nucleus [GO:0034504]; regulation of branch elongation involved in ureteric bud branching [GO:0072095]; regulation of epithelial cell proliferation [GO:0050678]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; regulation of transcription by RNA polymerase II [GO:0006357]; sarcomere organization [GO:0045214]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle tissue development [GO:0007519]; thymus development [GO:0048538]; tongue development [GO:0043586]; trigeminal ganglion development [GO:0061551]","GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0007519; GO:0008582; GO:0008584; GO:0010468; GO:0030238; GO:0030910; GO:0032880; GO:0034504; GO:0042472; GO:0043066; GO:0043524; GO:0043565; GO:0043586; GO:0045214; GO:0045892; GO:0045893; GO:0045944; GO:0046661; GO:0048538; GO:0048699; GO:0048701; GO:0048704; GO:0050678; GO:0051451; GO:0060037; GO:0061055; GO:0061197; GO:0061551; GO:0072075; GO:0072095; GO:0072107; GO:0090190; GO:0098528; GO:1902725"
"1111","Pocillopora_acuta_HIv2___RNAseq.g26608.t1",1585.09370711908,-2.44978651781069,0.8598964792555,0.000169323080395762,0.00129103270155208,"P22735",5.1e-173,"Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1)","cell envelope organization [GO:0043163]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]; protein modification process [GO:0036211]","GO:0001533; GO:0003810; GO:0005829; GO:0005886; GO:0010838; GO:0016020; GO:0018149; GO:0030216; GO:0031424; GO:0036211; GO:0042802; GO:0043163; GO:0045787; GO:0046872; GO:0070062"
"1112","Pocillopora_acuta_HIv2___RNAseq.g25208.t1",3909.7379627209,1.9080937435686,0.577153954727436,0.000169542740813714,0.00129202645054244,"A7ISW1",2.32e-79,"Glutaminyl-peptide cyclotransferase (EC 2.3.2.5) (Glutaminyl cyclase) (QC) (Glutaminyl-tRNA cyclotransferase)","peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [GO:0017186]","GO:0005576; GO:0008270; GO:0016603; GO:0017186"
"1113","Pocillopora_acuta_HIv2___RNAseq.g20764.t1",109.580587839618,-2.99115259713211,1.25004201804998,0.00017027872288891,0.00129626918308694,"A1R8N8",1.83e-10,"D-inositol 3-phosphate glycosyltransferase (EC 2.4.1.250) (N-acetylglucosamine-inositol-phosphate N-acetylglucosaminyltransferase) (GlcNAc-Ins-P N-acetylglucosaminyltransferase)","mycothiol biosynthetic process [GO:0010125]","GO:0000287; GO:0008375; GO:0010125; GO:0102710"
"1114","Pocillopora_acuta_HIv2___RNAseq.g715.t1",367.339410568285,3.23660279393445,1.7147788168189,0.000176940377331449,0.00134415211014815,"Q9JHA8",9.6e-26,"von Willebrand factor A domain-containing protein 7 (Protein G7c)","","GO:0005576"
"1115","Pocillopora_acuta_HIv2___RNAseq.g16215.t1",550.147465141243,2.5922423512374,0.950200490455441,0.00017751192545669,0.00134778608388744,NA,NA,NA,NA,NA
"1116","Pocillopora_acuta_HIv2___TS.g17638.t1",2636.16298133553,-2.71132948162721,4.55526841091182,0.000177605834362525,0.00134779159927574,NA,NA,NA,NA,NA
"1117","Pocillopora_acuta_HIv2___TS.g958.t1",61.2580426743589,-2.95825707097455,4.1686540260267,0.000181302966431403,0.00137153039040994,NA,NA,NA,NA,NA
"1118","Pocillopora_acuta_HIv2___RNAseq.g26735.t1",923.096739732059,2.97024315759188,1.40956323770441,0.000181650647835667,0.00137272464487727,NA,NA,NA,NA,NA
"1119","Pocillopora_acuta_HIv2___TS.g370.t2",1450.61376741721,2.14566360497757,0.687841493514045,0.000186089721428653,0.00140114613781574,NA,NA,NA,NA,NA
"1120","Pocillopora_acuta_HIv2___RNAseq.g9118.t1",3898.31463056834,3.52999515361495,2.41940627730262,0.000187263191502979,0.00140851523759703,"Q13219",0,"Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A)","cell surface receptor signaling pathway [GO:0007166]; female pregnancy [GO:0007565]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to dexamethasone [GO:0071548]; response to follicle-stimulating hormone [GO:0032354]","GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0007166; GO:0007565; GO:0008237; GO:0008270; GO:0030163; GO:0032354; GO:0071548"
"1121","Pocillopora_acuta_HIv2___RNAseq.g9423.t1",299.739005122343,-2.38363007294439,0.799967780267798,0.000188612283211956,0.00141718860487155,NA,NA,NA,NA,NA
"1122","Pocillopora_acuta_HIv2___RNAseq.g4516.t1",3380.31050688834,-3.58754389518566,3.15424685759457,0.000189400810869729,0.00142237452150559,"G8HTB6",3.67e-25,"ZP domain-containing protein","","GO:0016020"
"1123","Pocillopora_acuta_HIv2___RNAseq.g15474.t1",42.8208233604579,-4.59034339230563,2.19592182033759,0.000189961909229498,0.00142510843106611,NA,NA,NA,NA,NA
"1124","Pocillopora_acuta_HIv2___RNAseq.g19855.t1",2206.24934791836,-3.26754540443004,2.07143478134699,0.000193997056557191,0.00145159600557145,"Q87NG3",7.74e-106,"Glycine betaine transporter 1","amino acid transport [GO:0006865]","GO:0005886; GO:0006865; GO:0022857"
"1125","Pocillopora_acuta_HIv2___TS.g4252.t1",88.8407182957697,-1.58540327298769,2.59074201512631,0.000194094764572399,0.00145159600557145,NA,NA,NA,NA,NA
"1126","Pocillopora_acuta_HIv2___RNAseq.g11214.t1",286.003491976719,-2.51177848833835,4.59202928696328,0.00019512957341006,0.00145782755671648,"P61752",1.54e-17,"Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I)","chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; positive regulation of vasoconstriction [GO:0045907]","GO:0001696; GO:0004969; GO:0004993; GO:0005886; GO:0007187; GO:0007268; GO:0030425; GO:0030594; GO:0045202; GO:0045907"
"1127","Pocillopora_acuta_HIv2___RNAseq.g7909.t1",68.1348379078686,-4.79369106818616,6.01416052361766,0.000201358601826897,0.0015004898592603,"C0HK24",3.03e-08,"L-rhamnose-binding lectin ELEL-1","","GO:0030246"
"1128","Pocillopora_acuta_HIv2___RNAseq.g1510.t1",67.9421519896673,-3.78832797036156,2.73347515441747,0.000203441982347826,0.00151367532545214,"Q27084",7.16e-78,"Tachylectin-2 (Lectin L10c)","innate immune response [GO:0045087]","GO:0005576; GO:0030246; GO:0045087"
"1129","Pocillopora_acuta_HIv2___RNAseq.g2094.t1a",59.9956099768579,-1.28103002353891,2.65703445207045,0.000203887322296177,0.00151620885845342,"Q5RCY5",1.26e-63,"Single-strand DNA endonuclease ASTE1 (EC 3.1.-.-) (Protein asteroid homolog 1)","double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]","GO:0000014; GO:0000724; GO:0006303; GO:1990599"
"1130","Pocillopora_acuta_HIv2___RNAseq.g15904.t1",2168.24234252399,-1.50856624111965,3.03578828043458,0.000205318526776009,0.00152528360107252,NA,NA,NA,NA,NA
"1131","Pocillopora_acuta_HIv2___RNAseq.g21477.t1",251.626015782724,3.41334117386604,2.66146282180633,0.000205834967853515,0.00152833520278914,"P24821",6.13e-40,"Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)","bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to wounding [GO:0009611]","GO:0001558; GO:0001649; GO:0002009; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0005925; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009611; GO:0009612; GO:0010628; GO:0014012; GO:0016020; GO:0030155; GO:0030334; GO:0042475; GO:0045471; GO:0045545; GO:0050727; GO:0060447; GO:0060739; GO:0060740; GO:0062023; GO:0071300; GO:0071305; GO:0071774; GO:0071799; GO:0090733; GO:0098966"
"1132","Pocillopora_acuta_HIv2___RNAseq.g82.t1",64.9391617500023,-5.24462556942245,3.86839423857815,0.000211650849513047,0.0015682980980311,"Q9NRG9",6.33e-136,"Aladin (Adracalin)","fertilization [GO:0009566]; learning [GO:0007612]; microtubule bundle formation [GO:0001578]; mitotic spindle assembly [GO:0090307]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; regulation of nucleocytoplasmic transport [GO:0046822]","GO:0000922; GO:0001578; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005813; GO:0005829; GO:0006913; GO:0007612; GO:0009566; GO:0015031; GO:0016020; GO:0031965; GO:0046822; GO:0051028; GO:0072686; GO:0090307"
"1133","Pocillopora_acuta_HIv2___RNAseq.g8820.t1",1129.70986215374,3.36507158136878,2.59958601254134,0.000212355299728827,0.00157271226588723,"Q3SYW2",2.58e-53,"Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment]","complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]","GO:0004252; GO:0005576; GO:0006508; GO:0006956; GO:0006958; GO:0009617; GO:0045087; GO:0046872"
"1134","Pocillopora_acuta_HIv2___TS.g15614.t1",252.814842680518,-3.16782760561315,2.95631937480924,0.000212772486106992,0.00157418989209797,"Q54HT5",2.43e-07,"Putative uncharacterized protein DDB_G0289245","",""
"1135","Pocillopora_acuta_HIv2___RNAseq.11267_t",1417.79626460539,-1.81642148984031,3.45148323147627,0.00021333179204236,0.00157752098164658,"Q05A36",4.03e-116,"RNA-binding E3 ubiquitin-protein ligase MEX3C (EC 2.3.2.27) (RING finger and KH domain-containing protein 2) (RING-type E3 ubiquitin transferase MEX3C)","chondrocyte hypertrophy [GO:0003415]; energy homeostasis [GO:0097009]; regulation of fat cell differentiation [GO:0045598]","GO:0003415; GO:0003723; GO:0005634; GO:0005737; GO:0045598; GO:0046872; GO:0061630; GO:0097009"
"1136","Pocillopora_acuta_HIv2___RNAseq.g19051.t1",23.5398908061935,-8.37853881696348,3.72142584952847,0.000216582027212655,0.00159991953095191,NA,NA,NA,NA,NA
"1137","Pocillopora_acuta_HIv2___RNAseq.g1763.t1",844.616833144935,3.18395297700602,1.7839837326284,0.000217454582425262,0.00160390774104997,"Q4LAL6",3.91e-36,"Homeobox protein aristaless-like 4","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0001228; GO:0005634; GO:0006357"
"1138","Pocillopora_acuta_HIv2___RNAseq.g9335.t1",5254.4169357378,-1.88304800958456,5.55044349439727,0.000217692510715198,0.00160484427878931,NA,NA,NA,NA,NA
"1139","Pocillopora_acuta_HIv2___RNAseq.g15290.t1",2980.34601632217,3.85008031211467,1.7922489894581,0.000224802196768984,0.00165472721326544,"P00734",3.01e-53,"Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain]","acute-phase response [GO:0006953]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; blood coagulation [GO:0007596]; cell surface receptor signaling pathway [GO:0007166]; cytolysis by host of symbiont cells [GO:0051838]; fibrinolysis [GO:0042730]; G protein-coupled receptor signaling pathway [GO:0007186]; ligand-gated ion channel signaling pathway [GO:1990806]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of platelet activation [GO:0010544]; negative regulation of proteolysis [GO:0045861]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]; platelet activation [GO:0030168]; positive regulation of blood coagulation [GO:0030194]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid kinase activity [GO:0090218]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; proteolysis [GO:0006508]; regulation of blood coagulation [GO:0030193]; regulation of cell shape [GO:0008360]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to wounding [GO:0009611]","GO:0001530; GO:0001934; GO:0004252; GO:0005102; GO:0005509; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0006508; GO:0006953; GO:0007166; GO:0007186; GO:0007596; GO:0008083; GO:0008201; GO:0008284; GO:0008360; GO:0009611; GO:0010544; GO:0030168; GO:0030193; GO:0030194; GO:0030307; GO:0032024; GO:0032967; GO:0042730; GO:0045861; GO:0046427; GO:0048712; GO:0051281; GO:0051480; GO:0051838; GO:0051897; GO:0051918; GO:0061844; GO:0062023; GO:0070053; GO:0070062; GO:0070945; GO:0072562; GO:0090218; GO:1900016; GO:1900182; GO:1900738; GO:1990806; GO:2000379"
"1140","Pocillopora_acuta_HIv2___RNAseq.g24097.t1",153.212837031582,-1.00189526818781,1.8813921969228,0.000227042484663806,0.00167036749652965,"Q5F364",0,"Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)","cyclic nucleotide transport [GO:0070729]; glutathione transmembrane transport [GO:0034775]; lipid transport [GO:0006869]; xenobiotic transport [GO:0042908]","GO:0005524; GO:0006869; GO:0008559; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042908; GO:0070729"
"1141","Pocillopora_acuta_HIv2___RNAseq.g11343.t1",2459.01675963391,-2.50838773900446,0.943953868631272,0.000227785152692747,0.00167497938411179,NA,NA,NA,NA,NA
"1142","Pocillopora_acuta_HIv2___RNAseq.g8748.t1",27.7479687232215,-8.21791393832849,3.80102466452942,0.000231218871483077,0.0016985016542058,NA,NA,NA,NA,NA
"1143","Pocillopora_acuta_HIv2___RNAseq.g627.t1",1143.28191094706,-2.30244550448359,0.80068324949516,0.000232022654129176,0.00170267664602963,"Q5F3Z9",5.19e-57,"Zinc finger CCCH domain-containing protein 14","regulation of mRNA stability [GO:0043488]","GO:0005634; GO:0005737; GO:0008143; GO:0016607; GO:0043488; GO:0046872"
"1144","Pocillopora_acuta_HIv2___RNAseq.g6924.t1",223.007489333949,3.25742944468314,2.09166886071281,0.000232923764593608,0.00170745216884495,NA,NA,NA,NA,NA
"1145","Pocillopora_acuta_HIv2___RNAseq.g2185.t1b",2655.89435504385,-3.34744828384678,3.3106777364479,0.000233027556782351,0.00170745216884495,"Q00223",2.33e-33,"Putative gastrointestinal growth factor xP4 (TFF p4.1)","","GO:0005576; GO:0008083"
"1146","Pocillopora_acuta_HIv2___RNAseq.g11537.t1",24.1249821700645,-8.34301305105168,3.84845790121451,0.000234034678893831,0.00171309594914999,NA,NA,NA,NA,NA
"1147","Pocillopora_acuta_HIv2___TS.g19260.t1",36.0768785823353,-8.22028343885866,3.97008188443449,0.000236072845581067,0.00172626776465346,"A7SLX5",0,"2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 (EC 2.5.1.108) (Diphthamide biosynthesis protein 1) (Diphtheria toxin resistance protein 1) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 1)","protein histidyl modification to diphthamide [GO:0017183]","GO:0017183; GO:0032991; GO:0046872; GO:0051539; GO:0090560"
"1148","Pocillopora_acuta_HIv2___TS.g14217.t2",79.3250448038697,3.37123829119163,2.61657753853925,0.000238054012662648,0.00173987531033479,"Q28DL4",2.16e-19,"TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6)","intracellular signaling cassette [GO:0141124]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]","GO:0004842; GO:0005164; GO:0005634; GO:0005811; GO:0005938; GO:0008270; GO:0042981; GO:0043122; GO:0070534; GO:0141124"
"1149","Pocillopora_acuta_HIv2___RNAseq.g20561.t1b",138.612186869492,-3.67855542560669,3.09561581792526,0.000242959168802936,0.00177125071449882,"Q9ULJ7",2.78e-80,"Ankyrin repeat domain-containing protein 50","endocytic recycling [GO:0032456]; protein transport [GO:0015031]","GO:0005768; GO:0015031; GO:0032456"
"1150","Pocillopora_acuta_HIv2___TS.g1359.t1",25529.286334581,2.47815105729161,0.914519090594498,0.000244963600963871,0.00178316734994536,"B8V7R6",0,"Collagen alpha chain","","GO:0005201; GO:0005576; GO:0005581"
"1151","Pocillopora_acuta_HIv2___TS.g1376.t2",280.402569190165,-1.06984531186057,1.672816089696,0.00024625175786051,0.00178984192245951,"A8XI14",1.34e-28,"Sugar transporter SWEET1","carbohydrate transport [GO:0008643]","GO:0000139; GO:0005794; GO:0005886; GO:0008643; GO:0016020; GO:0051119"
"1152","Pocillopora_acuta_HIv2___RNAseq.g20216.t1",23.4456244826826,1.16125431832276,2.26114881291853,0.000247901637844025,0.00180002474386344,"Q80TR8",3.48e-35,"DDB1- and CUL4-associated factor 1 (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1)","B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]","GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0008180; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043687; GO:0045732; GO:0080008; GO:0106310; GO:1990244; GO:1990756"
"1153","Pocillopora_acuta_HIv2___RNAseq.g6231.t1",198.906719907403,1.46396494268142,2.59108574268307,0.000249953233077532,0.00181310108487132,NA,NA,NA,NA,NA
"1154","Pocillopora_acuta_HIv2___RNAseq.g18027.t1",1566.63734852305,2.42735614512207,0.89194401215459,0.000250352938615503,0.00181418081369471,NA,NA,NA,NA,NA
"1155","Pocillopora_acuta_HIv2___RNAseq.g13581.t1",1030.77615703046,-2.86071278070914,3.31982871854589,0.000250531329153611,0.00181456441906752,"Q5EAU9",3.56e-54,"Regulator of microtubule dynamics protein 3 (RMD-3) (Protein FAM82A2) (Protein FAM82C)","","GO:0000922; GO:0005634; GO:0005741"
"1156","Pocillopora_acuta_HIv2___RNAseq.g19647.t1",77.8397591748566,-3.20688589119695,3.51120274040819,0.000250978013926898,0.00181688988660594,"Q7T105",2.63e-65,"Mesoderm induction early response protein 1 (Early response 1) (Er1) (Mi-er1) (Xmi-er1)","chromatin remodeling [GO:0006338]; regulation of DNA-templated transcription [GO:0006355]","GO:0003677; GO:0005634; GO:0006338; GO:0006355; GO:0017053"
"1157","Pocillopora_acuta_HIv2___RNAseq.g243.t1",69.7075816177688,-3.23429417673493,1.37563684873892,0.000251279838570344,0.00181816487497822,"P0CI65",5.9e-38,"Nephrocystin-3","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"1158","Pocillopora_acuta_HIv2___RNAseq.g25186.t1",446.619209424149,2.07329971793224,3.345593402498,0.000252194704672387,0.00182296062387877,"P70191",7.73e-42,"TNF receptor-associated factor 5","apoptotic process [GO:0006915]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA stabilization [GO:0048255]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0005164; GO:0005737; GO:0005813; GO:0005829; GO:0006915; GO:0007165; GO:0008270; GO:0008284; GO:0009898; GO:0023019; GO:0031625; GO:0031996; GO:0033209; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0043123; GO:0048255; GO:0051092; GO:0070534; GO:0097400"
"1159","Pocillopora_acuta_HIv2___RNAseq.g12374.t1",3131.42127049564,3.80143544504726,1.7612071125638,0.0002539656995985,0.00183392904592746,"Q9VH14",3.51e-17,"Tissue inhibitor of metalloproteinase","basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; delamination [GO:0060232]; imaginal disc-derived wing expansion [GO:0048526]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; oogenesis [GO:0048477]; phototaxis [GO:0042331]; tracheal outgrowth, open tracheal system [GO:0007426]; tracheal pit formation in open tracheal system [GO:0035202]; ventral cord development [GO:0007419]; wing disc morphogenesis [GO:0007472]","GO:0002020; GO:0005615; GO:0007155; GO:0007419; GO:0007426; GO:0007472; GO:0008191; GO:0008270; GO:0030425; GO:0031012; GO:0035202; GO:0042331; GO:0048477; GO:0048526; GO:0051045; GO:0060232; GO:0071711"
"1160","Pocillopora_acuta_HIv2___RNAseq.g23004.t1",645.619041811558,-2.68272138494392,1.1453533294706,0.000255496067894323,0.00184130300250298,"Q6GPD0",6.04e-171,"Rho GTPase-activating protein 32 (Rho-type GTPase-activating protein 32) (Rho/Cdc42/Rac GTPase-activating protein RICS)","signal transduction [GO:0007165]","GO:0005096; GO:0005737; GO:0005886; GO:0007165; GO:0014069; GO:1901981"
"1161","Pocillopora_acuta_HIv2___RNAseq.g25761.t1",1143.87904687794,2.57273208064203,1.00933725086846,0.000255962166196069,0.00184374341228085,"A6NMZ7",1.41e-45,"Collagen alpha-6(VI) chain","cell adhesion [GO:0007155]","GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023"
"1162","Pocillopora_acuta_HIv2___RNAseq.15128_t",61.342460158374,-1.19035843982154,2.32759012027961,0.000257302725920995,0.00185247716661089,NA,NA,NA,NA,NA
"1163","Pocillopora_acuta_HIv2___TS.g2757.t1",150.917679634835,-3.02312517060783,3.48983296791174,0.000262248064078901,0.00188620387808912,"Q9BSF4",1.86e-33,"Mitochondrial import inner membrane translocase subunit Tim29 (TIM29)","protein insertion into mitochondrial inner membrane [GO:0045039]","GO:0005743; GO:0005758; GO:0042721; GO:0045039; GO:0140318"
"1164","Pocillopora_acuta_HIv2___RNAseq.g22638.t1",17813.0516537474,2.41770323775597,0.90968773764325,0.000265595347889803,0.00190743352129002,"P08120",0,"Collagen alpha-1(IV) chain (Collagen type IV alpha 1)","basement membrane organization [GO:0071711]; cardiac muscle cell development [GO:0055013]; dorsal closure [GO:0007391]; extracellular matrix organization [GO:0030198]; intestinal epithelial structure maintenance [GO:0060729]; post-embryonic digestive tract morphogenesis [GO:0048621]","GO:0005201; GO:0005587; GO:0005604; GO:0005615; GO:0007391; GO:0030020; GO:0030198; GO:0048621; GO:0055013; GO:0060729; GO:0062023; GO:0071711"
"1165","Pocillopora_acuta_HIv2___RNAseq.g687.t1",352.086281235166,-1.13817062191447,2.18161715735787,0.000268315244888428,0.0019231475233232,"Q9H9S5",1.16e-146,"Ribitol 5-phosphate transferase FKRP (EC 2.7.8.-) (Fukutin-related protein) (Ribitol-5-phosphate transferase)","adult walking behavior [GO:0007628]; basement membrane organization [GO:0071711]; bone mineralization [GO:0030282]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; connective tissue development [GO:0061448]; connective tissue replacement [GO:0097709]; creatine metabolic process [GO:0006600]; diaphragm development [GO:0060539]; filtration diaphragm assembly [GO:0036058]; glial cell differentiation [GO:0010001]; glycolytic process [GO:0006096]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; localization of cell [GO:0051674]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; muscle contraction [GO:0006936]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; oxygen metabolic process [GO:0072592]; pentitol metabolic process [GO:0019519]; pentose metabolic process [GO:0019321]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; protein import [GO:0017038]; protein O-linked mannosylation [GO:0035269]; protein processing [GO:0016485]; protein tetramerization [GO:0051262]; reelin-mediated signaling pathway [GO:0038026]; reproductive process [GO:0022414]; respiratory system process [GO:0003016]; response to activity [GO:0014823]; response to alcohol [GO:0097305]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle tissue regeneration [GO:0043403]","GO:0000139; GO:0001701; GO:0001764; GO:0002162; GO:0003007; GO:0003016; GO:0005615; GO:0005654; GO:0005791; GO:0005794; GO:0005829; GO:0006096; GO:0006600; GO:0006629; GO:0006936; GO:0006954; GO:0007420; GO:0007628; GO:0009410; GO:0010001; GO:0014823; GO:0016485; GO:0016780; GO:0017038; GO:0019321; GO:0019519; GO:0022414; GO:0030282; GO:0035269; GO:0035437; GO:0036058; GO:0038026; GO:0042383; GO:0042802; GO:0043010; GO:0043236; GO:0043403; GO:0043491; GO:0046872; GO:0050905; GO:0051262; GO:0051384; GO:0051674; GO:0060539; GO:0061448; GO:0071711; GO:0072592; GO:0097305; GO:0097709; GO:0098528; GO:0098723"
"1166","Pocillopora_acuta_HIv2___RNAseq.g23455.t1",86.4851502214077,3.34483539430924,1.82321886865254,0.000270228816578083,0.00193303145548239,"P27401",5.78e-07,"Pro-Pol polyprotein (Pr125Pol) [Cleaved into: Protease/Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (EC 3.4.23.-) (p87Pro-RT-RNaseH); Protease/Reverse transcriptase (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.4.23.-) (p65Pro-RT); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p42In)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; proteolysis [GO:0006508]; symbiont entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]","GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0006508; GO:0015074; GO:0030430; GO:0042025; GO:0043657; GO:0044423; GO:0044826; GO:0046718; GO:0046872; GO:0075713; GO:0075732"
"1167","Pocillopora_acuta_HIv2___RNAseq.g28025.t1",909.958746722603,-2.36939872880019,0.853684410755956,0.000270797472467235,0.00193614169143158,"Q9JLB4",4.52e-24,"Cubilin (Intrinsic factor-cobalamin receptor)","cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584]","GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0051649; GO:0070062"
"1168","Pocillopora_acuta_HIv2___RNAseq.g29951.t1",553.480578933693,2.32462633234384,0.797927959228109,0.000272580357307374,0.00194792603166692,NA,NA,NA,NA,NA
"1169","Pocillopora_acuta_HIv2___RNAseq.g23588.t1",1186.7343084127,2.45067569509182,0.89613203462696,0.000273405604145979,0.00195285859672466,"Q01484",3.68e-69,"Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)","atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]","GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008093; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259"
"1170","Pocillopora_acuta_HIv2___RNAseq.g5494.t1",338.00767677427,-2.76188455545381,1.39077095166502,0.000273676725224454,0.0019538302831424,"Q3SZV6",2.06e-26,"Mitochondrial import inner membrane translocase subunit Tim21 (TIM21-like protein, mitochondrial)","mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981]; protein import into mitochondrial matrix [GO:0030150]","GO:0005744; GO:0030150; GO:0032981; GO:0033617"
"1171","Pocillopora_acuta_HIv2___RNAseq.g6299.t1",72.0797018030765,-2.8178470951975,1.100624365418,0.000278563106230845,0.00198284289789515,NA,NA,NA,NA,NA
"1172","Pocillopora_acuta_HIv2___RNAseq.g28270.t1",299.79990274016,-6.33053606315945,5.43955658503132,0.000280040236549404,0.00199041866410348,"O08734",1.42e-26,"Bcl-2 homologous antagonist/killer (Apoptosis regulator BAK)","animal organ regeneration [GO:0031100]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell negative selection [GO:0002352]; blood vessel remodeling [GO:0001974]; calcium ion transport into cytosol [GO:0060402]; cellular response to mechanical stimulus [GO:0071260]; cellular response to UV [GO:0034644]; endocrine pancreas development [GO:0031018]; epithelial cell proliferation [GO:0050673]; establishment of localization in cell [GO:0051649]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fibroblast apoptotic process [GO:0044346]; homeostasis of number of cells [GO:0048872]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; leukocyte homeostasis [GO:0001776]; limb morphogenesis [GO:0035108]; mitochondrial fusion [GO:0008053]; myeloid cell homeostasis [GO:0002262]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of proteolysis [GO:0045862]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; post-embryonic camera-type eye morphogenesis [GO:0048597]; regulation of cell cycle [GO:0051726]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; response to ethanol [GO:0045471]; response to fungus [GO:0009620]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to mycotoxin [GO:0010046]; response to organic cyclic compound [GO:0014070]; response to UV-C [GO:0010225]; response to xenobiotic stimulus [GO:0009410]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068]","GO:0001776; GO:0001782; GO:0001783; GO:0001836; GO:0001974; GO:0002262; GO:0002352; GO:0005739; GO:0005741; GO:0005783; GO:0005829; GO:0008053; GO:0008285; GO:0008630; GO:0009410; GO:0009620; GO:0010046; GO:0010225; GO:0010248; GO:0010332; GO:0010524; GO:0010629; GO:0014070; GO:0015288; GO:0031018; GO:0031072; GO:0031100; GO:0031334; GO:0031966; GO:0032471; GO:0033137; GO:0034644; GO:0035108; GO:0042542; GO:0042802; GO:0042803; GO:0043065; GO:0044325; GO:0044346; GO:0044877; GO:0045471; GO:0045862; GO:0046872; GO:0046902; GO:0046930; GO:0046982; GO:0048597; GO:0048872; GO:0050673; GO:0051087; GO:0051400; GO:0051649; GO:0051726; GO:0051881; GO:0060068; GO:0060402; GO:0070059; GO:0070242; GO:0071260; GO:0090200; GO:0090201; GO:0097145; GO:0097192; GO:1900103; GO:1901029; GO:1901030; GO:1902262"
"1173","Pocillopora_acuta_HIv2___RNAseq.g802.t1",510.719432962993,3.32025759028111,1.49356336754412,0.000282712742507622,0.0020064558918696,"Q90Z00",1.16e-08,"Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)","anatomical structure homeostasis [GO:0060249]; cardiac muscle tissue development [GO:0048738]; cartilage development [GO:0051216]; cell migration in hindbrain [GO:0021535]; dorsal/ventral pattern formation [GO:0009953]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; liver development [GO:0001889]; mesoderm development [GO:0007498]; negative regulation of endodermal cell fate specification [GO:0042664]; olfactory nerve formation [GO:0021628]; olfactory placode morphogenesis [GO:0071699]; pectoral fin development [GO:0033339]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAP kinase activity [GO:0043406]; post-anal tail morphogenesis [GO:0036342]; posterior lateral line development [GO:0048916]; response to ethanol [GO:0045471]; skin morphogenesis [GO:0043589]","GO:0001889; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007498; GO:0008201; GO:0008284; GO:0008543; GO:0009953; GO:0017134; GO:0018108; GO:0021535; GO:0021628; GO:0031101; GO:0031410; GO:0033339; GO:0036342; GO:0042664; GO:0043235; GO:0043406; GO:0043589; GO:0045471; GO:0045597; GO:0048738; GO:0048916; GO:0051216; GO:0060249; GO:0071699"
"1174","Pocillopora_acuta_HIv2___RNAseq.g27067.t1",1363.7001598054,1.13792473959415,1.91329424642651,0.000285477164503037,0.00202408907224114,NA,NA,NA,NA,NA
"1175","Pocillopora_acuta_HIv2___RNAseq.g14426.t1",202.977365817956,-3.17852747403929,2.17814537474353,0.000289710306145042,0.00205108657272731,"Q9H0C5",2.86e-16,"BTB/POZ domain-containing protein 1 (Hepatitis C virus NS5A-transactivated protein 8) (HCV NS5A-transactivated protein 8)","muscle organ development [GO:0007517]; neurogenesis [GO:0022008]; protein ubiquitination [GO:0016567]; regulation of protein binding [GO:0043393]","GO:0000932; GO:0005654; GO:0005829; GO:0007517; GO:0016567; GO:0022008; GO:0032991; GO:0036464; GO:0042802; GO:0043393; GO:0097602"
"1176","Pocillopora_acuta_HIv2___RNAseq.g7076.t1",1274.53713067447,3.52724602254572,1.51679449388979,0.000296367042252799,0.00209207071700561,NA,NA,NA,NA,NA
"1177","Pocillopora_acuta_HIv2___RNAseq.g15832.t1",1352.41797806265,3.3894295209199,2.19647044375059,0.000296963498264218,0.00209423697654493,"B3EWZ5",2.52e-152,"MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1)","","GO:0005576; GO:0016020"
"1178","Pocillopora_acuta_HIv2___RNAseq.g15951.t1",127.817149844781,1.00795286089828,1.7490730043359,0.000298889331451238,0.0021047396738611,NA,NA,NA,NA,NA
"1179","Pocillopora_acuta_HIv2___RNAseq.g2577.t1",2312.20319626339,2.78787327555219,1.24098440740164,0.000300130608768607,0.00211245212906527,"B2RVL6",9.01e-80,"Zinc finger CCHC domain-containing protein 24","","GO:0003676; GO:0008270"
"1180","Pocillopora_acuta_HIv2___RNAseq.g11589.t1",43.6256406216019,-4.39866457991901,1.76862449676764,0.000302012840053682,0.00212466620551384,"Q86YH6",1.29e-83,"All trans-polyprenyl-diphosphate synthase PDSS2 (All-trans-decaprenyl-diphosphate synthase subunit 2) (EC 2.5.1.91) (Candidate tumor suppressor protein) (Decaprenyl pyrophosphate synthase subunit 2) (Decaprenyl-diphosphate synthase subunit 2) (Solanesyl-diphosphate synthase subunit 2)","cerebellum development [GO:0021549]; isoprenoid biosynthetic process [GO:0008299]; regulation of body fluid levels [GO:0050878]; ubiquinone biosynthetic process [GO:0006744]","GO:0004659; GO:0005759; GO:0005829; GO:0006744; GO:0008299; GO:0021549; GO:0032478; GO:0046982; GO:0050878; GO:0052923; GO:0097269; GO:1990234"
"1181","Pocillopora_acuta_HIv2___RNAseq.g15155.t1",1418.71685129792,1.87655536708993,0.601359590773537,0.000307235512540788,0.00215825859805243,NA,NA,NA,NA,NA
"1182","Pocillopora_acuta_HIv2___RNAseq.g9066.t1",473.905013300093,1.98780555731253,0.650324224979998,0.000308268880719739,0.00216446654889821,NA,NA,NA,NA,NA
"1183","Pocillopora_acuta_HIv2___RNAseq.g3788.t1",210.873224673444,-2.51545843478512,2.73257921610266,0.000309179543923351,0.00216875505495022,"Q6DG32",1.12e-98,"Solute carrier family 25 member 36-A","mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleotide import into mitochondrion [GO:1990519]","GO:0000002; GO:0005739; GO:0005743; GO:0015218; GO:1990519"
"1184","Pocillopora_acuta_HIv2___TS.g23178.t1",7125.51468368757,2.60608845419624,1.06948529725725,0.000309803744169721,0.00217102778860021,"A0MSJ1",4.25e-146,"Collagen alpha-1(XXVII) chain B","bone mineralization [GO:0030282]; extracellular matrix organization [GO:0030198]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501]","GO:0001501; GO:0005581; GO:0005615; GO:0030020; GO:0030198; GO:0030282; GO:0046872; GO:0048570; GO:0062023"
"1185","Pocillopora_acuta_HIv2___TS.g435.t1",746.467681055603,-2.48736251137283,0.973709966381474,0.000311585016330278,0.00218245311196181,NA,NA,NA,NA,NA
"1186","Pocillopora_acuta_HIv2___RNAseq.g25867.t1",750.997782165744,-2.75663143751395,3.07855876912392,0.000314852292169926,0.00220320442861433,"Q0VCA2",7.31e-30,"Arrestin domain-containing protein 3","protein transport [GO:0015031]","GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005886; GO:0015031"
"1187","Pocillopora_acuta_HIv2___RNAseq.g20669.t1",343.77235351548,-1.06224081229072,1.67188590729145,0.000316576333758703,0.00221312715876553,"P46428",2.23e-31,"Glutathione S-transferase (EC 2.5.1.18) (GST class-sigma)","","GO:0004364"
"1188","Pocillopora_acuta_HIv2___RNAseq.g19687.t1",82.4098037014261,-1.39949511638121,2.24397299431526,0.000319250337095981,0.00222751417064943,NA,NA,NA,NA,NA
"1189","Pocillopora_acuta_HIv2___RNAseq.g7585.t1",4729.51343393641,-2.18579440040787,0.771330210212334,0.000319667339577858,0.00222827392754416,"Q5T089",9.66e-06,"MORN repeat-containing protein 1","",""
"1190","Pocillopora_acuta_HIv2___TS.g8275.t1",401.495413003185,-1.74825953095843,3.99144580900972,0.000321256013797287,0.00223826925990557,"P08059",0,"Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI)","gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]","GO:0004347; GO:0005125; GO:0005615; GO:0005829; GO:0006094; GO:0006096; GO:0048029; GO:0051156; GO:0097367"
"1191","Pocillopora_acuta_HIv2___RNAseq.g2037.t1",67.5959589518068,2.68919835097806,1.00264363104863,0.000321915075368518,0.00224178124705356,"Q6JEL3",3.36e-34,"Kelch-like protein 10","cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286]","GO:0000902; GO:0005737; GO:0007286; GO:0008584; GO:0009566; GO:0016567; GO:0048808; GO:0048873"
"1192","Pocillopora_acuta_HIv2___RNAseq.g28255.t1",1346.05577356654,-2.49066334758191,1.0146433461041,0.000329154523598931,0.00228999087510098,"Q6DIR8",0,"Paladin","","GO:0005829"
"1193","Pocillopora_acuta_HIv2___RNAseq.g12286.t1",225.884972465831,-2.86711727079627,1.16026260247208,0.000332523364257273,0.00231120516127688,"Q9I928",1.2e-13,"Fucolectin-4","regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]","GO:0001868; GO:0005509; GO:0005615; GO:0010185; GO:0030246; GO:0042806; GO:0045088"
"1194","Pocillopora_acuta_HIv2___RNAseq.g12892.t1",323.703214811455,2.71075537439264,2.99673596500011,0.000341066566900027,0.00236376944113176,"Q2KHZ8",1.26e-164,"Lysosomal acid glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase) (EC 3.2.1.46) (Lysosomal glycosylceramidase)","autophagy [GO:0006914]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; lipid glycosylation [GO:0030259]; lysosome organization [GO:0007040]; regulation of TOR signaling [GO:0032006]","GO:0004336; GO:0004348; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006680; GO:0006914; GO:0007040; GO:0008203; GO:0030259; GO:0032006; GO:0046527; GO:0050295"
"1195","Pocillopora_acuta_HIv2___RNAseq.g28910.t1",2807.76704565131,3.32181454551033,1.97355585885245,0.00034566301849493,0.00238761695296594,"O00339",4.12e-72,"Matrilin-2","axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; neuron migration [GO:0001764]; response to axon injury [GO:0048678]","GO:0001764; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0007411; GO:0008347; GO:0030198; GO:0031012; GO:0031104; GO:0048678; GO:0062023; GO:0120216"
"1196","Pocillopora_acuta_HIv2___RNAseq.g20688.t1",4154.69321679724,-1.93744969773145,0.645117926010988,0.00034989176911581,0.00241194607281697,"Q8WU66",2.96e-18,"Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)","hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505]","GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170"
"1197","Pocillopora_acuta_HIv2___RNAseq.5656_t",23.6643379102425,-5.66066998870861,2.77998419951606,0.000354852118179564,0.00244408620826153,NA,NA,NA,NA,NA
"1198","Pocillopora_acuta_HIv2___RNAseq.g1863.t1",1426.30050883794,-2.67368319645582,1.19901528208143,0.00035648075968595,0.00245063579282204,"Q8TD57",0,"Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b)","cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]","GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0008569; GO:0016887; GO:0030286; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729"
"1199","Pocillopora_acuta_HIv2___RNAseq.g23886.t1",1411.88130779252,3.25612129754305,1.73408726541336,0.000367754357226617,0.00251975320839687,"P07942",0,"Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta)","cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]","GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005788; GO:0007155; GO:0021812; GO:0030335; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043257; GO:0043259; GO:0045785; GO:0048471; GO:0050679; GO:0051149; GO:0062023; GO:0070062; GO:0098637; GO:0110011; GO:2001046"
"1200","Pocillopora_acuta_HIv2___TS.g26218.t1",5184.38010298222,-1.76743489824987,0.568483295846654,0.000369176490012315,0.00252829959826616,NA,NA,NA,NA,NA
"1201","Pocillopora_acuta_HIv2___RNAseq.g16037.t1",1991.33855410664,2.44395428656429,0.985726588734297,0.000370654966279908,0.00253722358365953,"Q96AY4",4.01e-24,"Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1202","Pocillopora_acuta_HIv2___RNAseq.g16772.t1",257.697434426489,3.17079017065946,2.47893648069737,0.000372280201924127,0.00254593893174022,NA,NA,NA,NA,NA
"1203","Pocillopora_acuta_HIv2___TS.g30706.t1",241.33656049606,1.01985604516468,1.95869057876632,0.000375841778347171,0.00256908104064909,"P33450",4.31e-16,"Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito]","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of establishment of planar polarity [GO:0090175]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]","GO:0001736; GO:0001737; GO:0005509; GO:0005739; GO:0005886; GO:0007156; GO:0007157; GO:0007164; GO:0007446; GO:0007447; GO:0007476; GO:0008285; GO:0009888; GO:0010629; GO:0016324; GO:0016327; GO:0016336; GO:0016339; GO:0032880; GO:0035159; GO:0035209; GO:0035220; GO:0035332; GO:0040008; GO:0042067; GO:0043065; GO:0044331; GO:0045296; GO:0045317; GO:0045570; GO:0045571; GO:0045926; GO:0046621; GO:0048105; GO:0090175; GO:0090176; GO:0090251; GO:0098609"
"1204","Pocillopora_acuta_HIv2___RNAseq.g4073.t1",505.37798999216,2.73660380012432,3.14889879917061,0.000381996166907215,0.00260376652127519,"P17124",1.31e-44,"Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I)","chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; positive regulation of vasoconstriction [GO:0045907]","GO:0001696; GO:0004969; GO:0004993; GO:0005886; GO:0007187; GO:0007268; GO:0030425; GO:0030594; GO:0045202; GO:0045907"
"1205","Pocillopora_acuta_HIv2___RNAseq.g20678.t1b",6419.05717657914,-1.87054248633441,0.618408957572685,0.000385575470442341,0.0026256890793211,"Q6DK93",4.71e-19,"Cornifelin homolog","",""
"1206","Pocillopora_acuta_HIv2___RNAseq.g19367.t1",1104.62737374208,-2.67766749524116,1.2439177700986,0.000391545896070991,0.00266283134369859,"Q9WU20",0,"Methylenetetrahydrofolate reductase (NADPH) (EC 1.5.1.53)","methionine biosynthetic process [GO:0009086]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]","GO:0004489; GO:0009086; GO:0035999; GO:0046653; GO:0050660; GO:0050661; GO:0071949; GO:0106313"
"1207","Pocillopora_acuta_HIv2___RNAseq.g27039.t1",5675.97667964296,3.34559367038434,1.51349223641927,0.00039158201521342,0.00266283134369859,"P51029",9.02e-25,"Protein Wnt-8b","canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]; Wnt signaling pathway [GO:0016055]","GO:0001654; GO:0005109; GO:0005125; GO:0005615; GO:0009880; GO:0016055; GO:0021854; GO:0021879; GO:0030182; GO:0030900; GO:0043049; GO:0045165; GO:0060070; GO:0060898; GO:0070654; GO:0071679"
"1208","Pocillopora_acuta_HIv2___TS.g4251.t1b",497.781081653622,-1.09662132686511,1.78122402923925,0.000394475459243535,0.00267872912793356,NA,NA,NA,NA,NA
"1209","Pocillopora_acuta_HIv2___RNAseq.g7809.t1",1634.90870211496,-2.54535818759497,1.11028762964463,0.000397479207286339,0.00269604627581372,NA,NA,NA,NA,NA
"1210","Pocillopora_acuta_HIv2___RNAseq.g29617.t1",448.989736755592,-3.12687727872549,2.12212720933086,0.000404095697084549,0.00273378866353177,"Q5ZMH1",8.79e-168,"Septin-2","cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104]; regulation of exocytosis [GO:0017157]; smoothened signaling pathway [GO:0007224]","GO:0003924; GO:0005525; GO:0005737; GO:0005819; GO:0005940; GO:0007224; GO:0008021; GO:0008104; GO:0015630; GO:0017157; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0060090; GO:0060170; GO:0060271; GO:0061640"
"1211","Pocillopora_acuta_HIv2___TS.g23932.t1",273.508241549708,-1.70242085833424,3.19886150490917,0.000411203494254562,0.00277667943085807,"P52784",0,"ATP-dependent 6-phosphofructokinase, muscle type (ATP-PFK) (PFK-M) (EC 2.7.1.11) (6-phosphofructokinase type A) (Phosphofructo-1-kinase isozyme A) (PFK-A) (Phosphohexokinase)","canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]","GO:0003872; GO:0005524; GO:0005945; GO:0006002; GO:0016020; GO:0016208; GO:0030388; GO:0042802; GO:0046872; GO:0048029; GO:0061621; GO:0070095"
"1212","Pocillopora_acuta_HIv2___TS.g15692.t1",21.425933578978,-8.05038756341297,3.86033385831836,0.000415471081615969,0.00280157283193165,NA,NA,NA,NA,NA
"1213","Pocillopora_acuta_HIv2___RNAseq.g29895.t1",397.987178506803,3.12444280612761,1.19980580838818,0.000415785139729945,0.00280238409182382,"P57102",3.63e-27,"Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND)","cardiac muscle cell differentiation [GO:0055007]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cardiogenic plate morphogenesis [GO:0003142]; determination of intestine left/right asymmetry [GO:0071908]; embryonic heart tube formation [GO:0003144]; embryonic pectoral fin morphogenesis [GO:0035118]; embryonic viscerocranium morphogenesis [GO:0048703]; heart contraction [GO:0060047]; heart development [GO:0007507]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; noradrenergic neuron differentiation [GO:0003357]; polarized epithelial cell differentiation [GO:0030859]; proepicardium development [GO:0003342]; regulation of transcription by RNA polymerase II [GO:0006357]; sympathetic nervous system development [GO:0048485]; thyroid gland development [GO:0030878]","GO:0000977; GO:0000981; GO:0001947; GO:0003007; GO:0003142; GO:0003144; GO:0003342; GO:0003357; GO:0005634; GO:0006357; GO:0007507; GO:0010002; GO:0030859; GO:0030878; GO:0035051; GO:0035118; GO:0046983; GO:0048485; GO:0048703; GO:0055007; GO:0060047; GO:0071908"
"1214","Pocillopora_acuta_HIv2___RNAseq.g15784.t1",122.293115182267,-1.87141072974864,3.21902209477605,0.000419476183759991,0.00282236734650825,"Q8K301",0,"Probable ATP-dependent RNA helicase DDX52 (EC 3.6.4.13) (ATP-dependent RNA helicase ROK1-like) (DEAD box protein 52)","maturation of SSU-rRNA [GO:0030490]","GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016887; GO:0030490"
"1215","Pocillopora_acuta_HIv2___RNAseq.g12745.t1",1468.13090961765,2.43178772955905,1.00398163147685,0.000419530544454697,0.00282236734650825,"Q9Y5Z4",1.25e-35,"Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL)","","GO:0005576; GO:0005737; GO:0005739; GO:0020037; GO:0035578; GO:0070062"
"1216","Pocillopora_acuta_HIv2___RNAseq.g24688.t1",1510.13690624933,3.00752528910673,1.90553606558907,0.000426297162755528,0.00285990823844896,"Q9ULB1",6.92e-34,"Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha)","adult behavior [GO:0030534]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; learning [GO:0007612]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]","GO:0005246; GO:0005509; GO:0005730; GO:0005783; GO:0005886; GO:0007158; GO:0007268; GO:0007269; GO:0007411; GO:0007416; GO:0007612; GO:0009986; GO:0030534; GO:0031965; GO:0031982; GO:0033130; GO:0035176; GO:0038023; GO:0042297; GO:0042734; GO:0042995; GO:0043025; GO:0050839; GO:0050885; GO:0051965; GO:0051968; GO:0071625; GO:0090129; GO:0097104; GO:0097109; GO:0097116; GO:0097118; GO:0097119; GO:2000463"
"1217","Pocillopora_acuta_HIv2___TS.g24743.t1",131.030297610325,2.64964622543993,1.1383810671547,0.000428400215095739,0.00287002348825603,"Q8NDA2",7.89e-19,"Hemicentin-2","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808]","GO:0005509; GO:0005576; GO:0005886; GO:0007156; GO:0008046; GO:0030424; GO:0032154; GO:0043025; GO:0050808; GO:0062023"
"1218","Pocillopora_acuta_HIv2___RNAseq.g16781.t1",2783.43402669958,3.034341406293,3.37306319304717,0.000431620277498915,0.00288758357712503,NA,NA,NA,NA,NA
"1219","Pocillopora_acuta_HIv2___RNAseq.g10855.t1",430.375091833424,2.88509965966059,1.51755279573055,0.000434987192708168,0.00290473442074374,"Q8HYN8",5.31e-09,"Adrenocorticotropic hormone receptor (ACTH receptor) (ACTH-R) (Adrenocorticotropin receptor) (Melanocortin receptor 2) (MC2-R)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; regulation of metabolic process [GO:0019222]","GO:0004930; GO:0004978; GO:0005737; GO:0005886; GO:0007189; GO:0019222"
"1220","Pocillopora_acuta_HIv2___RNAseq.g11391.t1",1682.58469282923,2.86175037757502,2.6443310688341,0.000440575101602427,0.00293739053548328,NA,NA,NA,NA,NA
"1221","Pocillopora_acuta_HIv2___RNAseq.g29952.t1",1303.87918489441,2.85969153162951,1.47639223790881,0.000440689813467832,0.00293739053548328,NA,NA,NA,NA,NA
"1222","Pocillopora_acuta_HIv2___RNAseq.g20712.t1",452.795435298219,-1.00706279813882,1.71084261258161,0.000441998073295075,0.00294339785089317,"Q08CS6",7.06e-17,"DBH-like monooxygenase protein 2 homolog (EC 1.14.17.-)","dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]","GO:0004500; GO:0005507; GO:0005615; GO:0006589; GO:0030667; GO:0042420; GO:0042421"
"1223","Pocillopora_acuta_HIv2___RNAseq.g2519.t1",2787.3644931296,-1.83447772980934,4.0407641061666,0.000445549640412367,0.00296440177851899,"O75899",1.2e-86,"Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]","GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712"
"1224","Pocillopora_acuta_HIv2___TS.g22351.t2",823.990219553825,1.52467469676117,3.05481771540953,0.000445562048292332,0.00296440177851899,"P04927",6.84e-11,"S-antigen protein","","GO:0020003"
"1225","Pocillopora_acuta_HIv2___TS.g28207.t1",188.339515035872,-2.24487609608506,3.15785665593733,0.000450390022503895,0.00299239379214347,"A0A8V1ABE9",2.07e-122,"D-serine dehydratase (EC 4.3.1.18) (D-serine deaminase)","D-serine catabolic process [GO:0036088]","GO:0005737; GO:0008270; GO:0008721; GO:0030170; GO:0030425; GO:0036088"
"1226","Pocillopora_acuta_HIv2___TS.g23176.t1",24.8894874951279,-7.9007094390919,3.91722357080792,0.000452359793269957,0.00300410103299203,NA,NA,NA,NA,NA
"1227","Pocillopora_acuta_HIv2___TS.g3265.t1",667.550514401953,3.1732606109571,1.66797261715989,0.000455758895001489,0.00302389754922089,"Q64487",3.22e-154,"Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)","heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling [GO:0099537]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]","GO:0004725; GO:0005102; GO:0007157; GO:0030182; GO:0042734; GO:0046426; GO:0050775; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099151; GO:0099537; GO:0099545; GO:0099560"
"1228","Pocillopora_acuta_HIv2___TS.g12121.t1",3563.48809330222,2.83588019819896,4.37107136419832,0.000456856187871793,0.00302839958816573,"F4JKH6",2.72e-13,"Protein REDUCED CHLOROPLAST COVERAGE 2 (Protein TPR-domain suppressor of STIMPY)","chloroplast localization [GO:0019750]","GO:0003729; GO:0005634; GO:0005829; GO:0005886; GO:0019750"
"1229","Pocillopora_acuta_HIv2___RNAseq.11667_t",93.157064543126,-2.1563384628799,5.25058593817255,0.000459807689974208,0.00304377960081782,NA,NA,NA,NA,NA
"1230","Pocillopora_acuta_HIv2___TS.g3883.t1",1043.08603250223,2.17079732733821,0.790368973771361,0.00046002562012544,0.00304382917177235,"P50238",1.41e-43,"Cysteine-rich protein 1 (CRP-1) (Cysteine-rich heart protein) (CRHP) (hCRHP) (Cysteine-rich intestinal protein) (CRIP)","cellular response to antibiotic [GO:0071236]; cellular response to UV-B [GO:0071493]; heart development [GO:0007507]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; prostate gland stromal morphogenesis [GO:0060741]; regulation of gene expression [GO:0010468]; response to zinc ion [GO:0010043]","GO:0005737; GO:0006955; GO:0007507; GO:0008270; GO:0008630; GO:0010043; GO:0010468; GO:0042277; GO:0060741; GO:0071236; GO:0071493"
"1231","Pocillopora_acuta_HIv2___RNAseq.g5347.t1",2005.24813127323,1.47962327367168,2.63681594980338,0.000461792614689698,0.00305412363002825,"Q5XJN2",6.82e-53,"Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (Gamma-interferon-inducible protein IP-30)","cell redox homeostasis [GO:0045454]; hematopoietic stem cell proliferation [GO:0071425]; immune system process [GO:0002376]","GO:0002376; GO:0005576; GO:0005764; GO:0016667; GO:0016671; GO:0045454; GO:0047134; GO:0071425"
"1232","Pocillopora_acuta_HIv2___RNAseq.g27887.t1",63.4878315257775,3.66647583186148,1.47215793202378,0.000462333764409646,0.00305490889375108,"Q9P215",3.62e-21,"Pogo transposable element with KRAB domain","regulation of DNA-templated transcription [GO:0006355]","GO:0003677; GO:0005634; GO:0005654; GO:0006355"
"1233","Pocillopora_acuta_HIv2___RNAseq.g22361.t1",523.476698097692,2.96863193834738,2.25975538564691,0.000466083418632766,0.00307827879776453,"A0A1U8QWA2",0,"Glycine betaine reductase ATRR (Nonribosomal peptide synthetase-like protein ATRR) [Includes: Carboxylic acid reductase (EC 1.2.1.-); Aldehyde reductase (EC 1.1.1.-)]","secondary metabolite biosynthetic process [GO:0044550]; small molecule metabolic process [GO:0044281]","GO:0016491; GO:0031177; GO:0044281; GO:0044550"
"1234","Pocillopora_acuta_HIv2___RNAseq.g22120.t1",26.0358264448358,-5.32534922072243,3.62821352969885,0.000481505662897852,0.0031714471348609,"Q9CXI3",3.56e-117,"DBH-like monooxygenase protein 1 (EC 1.14.17.-) (DBH-related protein) (Monooxygenase X)","dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]","GO:0004500; GO:0005507; GO:0005615; GO:0005789; GO:0006589; GO:0030667; GO:0042420; GO:0042421"
"1235","Pocillopora_acuta_HIv2___RNAseq.g14748.t1",2261.5533321687,2.04012463206369,0.725299901123019,0.000489755954171755,0.00321553795784851,"P13234",5.81e-135,"Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR) (Calspermin)","adaptive immune response [GO:0002250]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; myeloid dendritic cell differentiation [GO:0043011]; neuron-neuron synaptic transmission [GO:0007270]; nucleocytoplasmic transport [GO:0006913]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein export from nucleus [GO:0046827]; postsynapse to nucleus signaling pathway [GO:0099527]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; signal transduction [GO:0007165]","GO:0002250; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006913; GO:0006954; GO:0007165; GO:0007270; GO:0007616; GO:0009931; GO:0035556; GO:0043011; GO:0045893; GO:0046827; GO:0098794; GO:0098978; GO:0098982; GO:0099170; GO:0099527; GO:0106310"
"1236","Pocillopora_acuta_HIv2___TS.g25624.t1",436.653625393772,4.29609397159621,3.619355918147,0.000492088684315537,0.00322777293771732,NA,NA,NA,NA,NA
"1237","Pocillopora_acuta_HIv2___RNAseq.g11345.t1",1518.01744178848,-1.09841619027887,1.67691972321713,0.000492288931181167,0.00322777293771732,"P28289",4.12e-83,"Tropomodulin-1 (Erythrocyte tropomodulin) (E-Tmod)","actin filament organization [GO:0007015]; adult locomotory behavior [GO:0008344]; lens fiber cell development [GO:0070307]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]","GO:0003779; GO:0005523; GO:0005829; GO:0005856; GO:0005865; GO:0005884; GO:0006936; GO:0007015; GO:0008344; GO:0016020; GO:0030016; GO:0030017; GO:0030239; GO:0030863; GO:0051694; GO:0070307"
"1238","Pocillopora_acuta_HIv2___RNAseq.g12619.t1",190.023160077095,-1.89179484916132,4.21604558776801,0.000496736856922027,0.00325398636708342,"Q8LGG8",2.57e-09,"Universal stress protein A-like protein","","GO:0005829; GO:0005886; GO:0016208"
"1239","Pocillopora_acuta_HIv2___RNAseq.g805.t1",877.333875088288,3.16812368645221,1.69174901690404,0.000497654335741091,0.00325704629509463,"D3ZB51",2.71e-09,"Protein turtle homolog B (Immunoglobulin superfamily member 9B)","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; synaptic membrane adhesion [GO:0099560]","GO:0007156; GO:0007399; GO:0014069; GO:0019900; GO:0030425; GO:0043005; GO:0043025; GO:0045211; GO:0060077; GO:0097151; GO:0098982; GO:0099560; GO:0099629"
"1240","Pocillopora_acuta_HIv2___RNAseq.g3016.t1",1002.55051305483,-3.08359367358911,1.61426483576986,0.000500162734633725,0.00327198271991958,"P07756",0,"Carbamoyl-phosphate synthase [ammonia], mitochondrial (EC 6.3.4.16) (Carbamoyl-phosphate synthetase I) (CPSase I)","'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; carbamoyl phosphate biosynthetic process [GO:0070409]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucagon stimulus [GO:0071377]; cellular response to oleic acid [GO:0071400]; glutamine metabolic process [GO:0006541]; hepatocyte differentiation [GO:0070365]; homocysteine metabolic process [GO:0050667]; liver development [GO:0001889]; midgut development [GO:0007494]; monoatomic anion homeostasis [GO:0055081]; nitric oxide metabolic process [GO:0046209]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to cAMP [GO:0051591]; response to dexamethasone [GO:0071548]; response to food [GO:0032094]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to growth hormone [GO:0060416]; response to lipopolysaccharide [GO:0032496]; response to oleic acid [GO:0034201]; response to starvation [GO:0042594]; response to steroid hormone [GO:0048545]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; triglyceride catabolic process [GO:0019433]; urea cycle [GO:0000050]; vasodilation [GO:0042311]","GO:0000050; GO:0001889; GO:0004087; GO:0004088; GO:0004175; GO:0005509; GO:0005524; GO:0005543; GO:0005730; GO:0005737; GO:0005739; GO:0005743; GO:0005886; GO:0006207; GO:0006541; GO:0007494; GO:0009410; GO:0009636; GO:0010043; GO:0014075; GO:0016595; GO:0019433; GO:0030955; GO:0032094; GO:0032496; GO:0032991; GO:0033762; GO:0034201; GO:0036094; GO:0042311; GO:0042594; GO:0042645; GO:0043200; GO:0044344; GO:0044877; GO:0046209; GO:0046872; GO:0048545; GO:0050667; GO:0051384; GO:0051591; GO:0055081; GO:0060416; GO:0070365; GO:0070409; GO:0071242; GO:0071320; GO:0071377; GO:0071400; GO:0071548; GO:0072341"
"1241","Pocillopora_acuta_HIv2___RNAseq.g16302.t1a",98.93323474434,3.03420162741526,1.70096011160411,0.000504084013817969,0.00329316674609896,NA,NA,NA,NA,NA
"1242","Pocillopora_acuta_HIv2___RNAseq.g26455.t1",2244.83015482519,2.39589621628863,2.51339680432347,0.000506610405132208,0.00330668452158495,NA,NA,NA,NA,NA
"1243","Pocillopora_acuta_HIv2___RNAseq.g28585.t1",244.392613219257,2.83398824224019,2.55427539746746,0.000521687335161671,0.00339131937787794,NA,NA,NA,NA,NA
"1244","Pocillopora_acuta_HIv2___TS.g28685.t1",239.649795067491,3.29574248112841,1.5419570075751,0.000528835139067831,0.00343007688407045,NA,NA,NA,NA,NA
"1245","Pocillopora_acuta_HIv2___RNAseq.g764.t1",3728.93005945397,2.3093879766526,0.948232346709125,0.000530342394987447,0.00343831125105264,NA,NA,NA,NA,NA
"1246","Pocillopora_acuta_HIv2___RNAseq.g18763.t1",1126.26146301497,2.12113913590459,0.775384760595286,0.000532376626541583,0.00344686460443037,"P50430",3.56e-139,"Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)","anterior head development [GO:0097065]; autophagy [GO:0006914]; colon epithelial cell migration [GO:0061580]; dermatan sulfate catabolic process [GO:0030209]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]","GO:0003943; GO:0004065; GO:0005764; GO:0006914; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030209; GO:0043627; GO:0043890; GO:0046872; GO:0051597; GO:0061580; GO:0097065"
"1247","Pocillopora_acuta_HIv2___RNAseq.g6037.t1",834.39555573937,2.53559600921352,1.19622857226378,0.000537467828664807,0.00347360798650928,NA,NA,NA,NA,NA
"1248","Pocillopora_acuta_HIv2___RNAseq.g22262.t1",54.6132730203529,2.6855092768733,4.44188126556818,0.000540597532277771,0.00348915783438897,"P54422",4.68e-26,"Glutathione hydrolase proenzyme (EC 3.4.19.13) (Gamma-glutamyltranspeptidase proenzyme) (EC 2.3.2.2) [Cleaved into: Glutathione hydrolase large chain; Glutathione hydrolase small chain]","glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; proteolysis [GO:0006508]","GO:0005576; GO:0006508; GO:0006750; GO:0006751; GO:0036374; GO:0103068"
"1249","Pocillopora_acuta_HIv2___TS.g1462.t1",972.093848949411,1.1141471088388,1.83547536309369,0.000545099010656696,0.00351664232387977,"P98133",0,"Fibrillin-1 (MP340) [Cleaved into: Asprosin]","anatomical structure morphogenesis [GO:0009653]","GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0008201; GO:0009653; GO:0031012"
"1250","Pocillopora_acuta_HIv2___RNAseq.g706.t1",4411.72644151322,2.85179598356657,2.82069933838327,0.000549114409657267,0.00353938984905647,NA,NA,NA,NA,NA
"1251","Pocillopora_acuta_HIv2___RNAseq.g618.t1",549.372576804797,-2.36897632924021,2.80555328327415,0.00055046970578983,0.00354654513342722,"Q9Y3B3",9.19e-42,"Transmembrane emp24 domain-containing protein 7 (p24 family protein gamma-3) (p24gamma3) (p27)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]","GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0030126; GO:0030127; GO:0030133; GO:0030134; GO:0033116; GO:0038024"
"1252","Pocillopora_acuta_HIv2___RNAseq.g19308.t1",60.1177448583493,2.31573132152102,0.861527979408761,0.000552287039617407,0.00355666951960204,NA,NA,NA,NA,NA
"1253","Pocillopora_acuta_HIv2___RNAseq.g28746.t1",1193.65422691206,-3.17430222236247,1.71233999172213,0.000552963374579981,0.00355944025363811,"A8MY62",2.07e-49,"Putative beta-lactamase-like 1","",""
"1254","Pocillopora_acuta_HIv2___RNAseq.g28504.t1",1178.74503629064,3.17438747646346,2.15224888357285,0.000568542840283556,0.00365160019620842,"O89029",2.03e-13,"Matrilin-4 (MAT-4)","extracellular matrix organization [GO:0030198]; response to axon injury [GO:0048678]","GO:0005509; GO:0005576; GO:0030198; GO:0048678; GO:0062023; GO:0120216"
"1255","Pocillopora_acuta_HIv2___RNAseq.g26117.t1b",157.327138404517,-3.46982121210275,4.13029940609561,0.000569692463816763,0.00365735987423243,NA,NA,NA,NA,NA
"1256","Pocillopora_acuta_HIv2___RNAseq.g9553.t1b",710.800425580721,2.01561252370252,0.720557218773623,0.000570054500376855,0.00365806046736949,"A0A411L030",9.6e-39,"Proline hydroxylase buaE (EC 1.14.11.-) (2-oxoglutarate-dependent dioxygenase buaE) (Burnettramic acids biosynthesis cluster protein E)","antibiotic biosynthetic process [GO:0017000]; small molecule biosynthetic process [GO:0044283]","GO:0017000; GO:0044283; GO:0046872; GO:0051213"
"1257","Pocillopora_acuta_HIv2___RNAseq.g29506.t1",560.385379456574,-1.9876086003504,3.09008503722038,0.00057128696713696,0.00366434354442084,"Q9BSR8",2e-87,"Protein YIPF4 (YIP1 family member 4)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; vesicle fusion with Golgi apparatus [GO:0048280]","GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006888; GO:0043231; GO:0048280"
"1258","Pocillopora_acuta_HIv2___TS.g27153.t2",357.955992596386,-2.83065026758904,1.36426174455911,0.000572920778546699,0.0036731942113916,"A6H8I2",0,"Small G protein signaling modulator 3 homolog (RUN and TBC1 domain-containing protein 3)","",""
"1259","Pocillopora_acuta_HIv2___RNAseq.g8148.t1",2320.13158146332,3.40378680496231,1.75761567003207,0.000578447403880108,0.00370698416026667,"Q96RW7",0,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711"
"1260","Pocillopora_acuta_HIv2___RNAseq.g13823.t1",2705.40623241689,2.72371496563779,2.56816871477126,0.00058254889715202,0.00372831294177293,"B3EWY9",0,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020"
"1261","Pocillopora_acuta_HIv2___RNAseq.g11960.t1",114.827699348794,-2.86416538681919,1.27280183002549,0.000586581278787808,0.0037508008914177,"Q1RLX4",9.93e-70,"Trafficking protein particle complex subunit 11 (Protein foie gras)","Golgi organization [GO:0007030]; lipid homeostasis [GO:0055088]; liver development [GO:0001889]; protein N-linked glycosylation [GO:0006487]; protein secretion [GO:0009306]; regulation of response to endoplasmic reticulum stress [GO:1905897]; retina development in camera-type eye [GO:0060041]; vesicle-mediated transport [GO:0016192]","GO:0001889; GO:0005794; GO:0006487; GO:0007030; GO:0009306; GO:0016192; GO:0055088; GO:0060041; GO:1905897"
"1262","Pocillopora_acuta_HIv2___RNAseq.g2586.t1c",338.049591336376,-2.23860669757698,0.875621658089102,0.000590597303816377,0.00377175010803823,NA,NA,NA,NA,NA
"1263","Pocillopora_acuta_HIv2___RNAseq.g18025.t1",231.886845394456,2.02556696120467,0.729213295516061,0.000594199664298815,0.00379113539674374,NA,NA,NA,NA,NA
"1264","Pocillopora_acuta_HIv2___TS.g1350.t1",11229.3611067898,2.43601809602803,1.08398639924308,0.000596990482274869,0.00380726205274414,"P02466",8.4e-152,"Collagen alpha-2(I) chain (Alpha-2 type I collagen)","blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096"
"1265","Pocillopora_acuta_HIv2___RNAseq.g3724.t1",2912.48215599092,-2.08799364488192,0.792800159337887,0.000600713011796401,0.00382762687340226,"P14207",2.02e-53,"Folate receptor beta (FR-beta) (Folate receptor 2) (Folate receptor, fetal/placental) (Placental folate-binding protein) (FBP)","cell adhesion [GO:0007155]; folic acid transport [GO:0015884]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; inflammatory response [GO:0006954]; positive regulation of cell population proliferation [GO:0008284]; sperm-egg recognition [GO:0035036]","GO:0005542; GO:0005576; GO:0005886; GO:0006954; GO:0007155; GO:0007342; GO:0008284; GO:0009897; GO:0009986; GO:0015884; GO:0035036; GO:0038023; GO:0061714"
"1266","Pocillopora_acuta_HIv2___TS.g16387.t1",1616.47444472284,-2.26718011836848,0.912104205356951,0.000601392860939733,0.00383027139613928,"Q24UI6",7.04e-55,"Translation initiation factor IF-2","","GO:0003743; GO:0003924; GO:0005525; GO:0005737"
"1267","Pocillopora_acuta_HIv2___RNAseq.g7450.t1",126.099581119041,-2.8155067839749,1.96221958054671,0.000604384177175282,0.00384243532250732,NA,NA,NA,NA,NA
"1268","Pocillopora_acuta_HIv2___RNAseq.g6836.t1",25.2147696725998,-7.73103171180336,4.08316733363929,0.000605554579239189,0.0038466145955712,"Q8WU66",5.46e-17,"Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)","hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505]","GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170"
"1269","Pocillopora_acuta_HIv2___TS.g30131.t1",1929.24112474161,2.34977195611177,1.0248597612087,0.000607235445272105,0.00385559854276371,"P24369",3.4e-74,"Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP)","bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; neutrophil chemotaxis [GO:0030593]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein stabilization [GO:0050821]","GO:0000413; GO:0003755; GO:0005654; GO:0005737; GO:0005788; GO:0005790; GO:0006457; GO:0016018; GO:0030593; GO:0032991; GO:0034663; GO:0040018; GO:0042470; GO:0043231; GO:0044829; GO:0048471; GO:0050821; GO:0060348; GO:0061077; GO:0070063"
"1270","Pocillopora_acuta_HIv2___RNAseq.g23492.t1",61.1243654153646,2.92290596401845,2.07091116645432,0.000608936091910405,0.00386300510236496,NA,NA,NA,NA,NA
"1271","Pocillopora_acuta_HIv2___RNAseq.g1930.t1",1599.4340437655,-2.40013464458297,1.06482547451842,0.000621667988776711,0.00393514476571831,"P52160",2.39e-29,"Transcriptional regulator Myc-A (c-Myc-A) (zc-Myc)","hematopoietic stem cell differentiation [GO:0060218]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of vasculature development [GO:1901342]; vasculature development [GO:0001944]","GO:0000978; GO:0000981; GO:0001944; GO:0003677; GO:0005634; GO:0006357; GO:0008284; GO:0046983; GO:0060218; GO:1901342"
"1272","Pocillopora_acuta_HIv2___TS.g13806.t1a",492.285474633909,-2.51122642020902,1.45826741160971,0.000622247486032169,0.00393708995536714,"Q9P2G9",0,"Kelch-like protein 8","protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005654; GO:0006511; GO:0016567; GO:0031463"
"1273","Pocillopora_acuta_HIv2___RNAseq.g18501.t1",113.7136644653,-4.84600229104134,2.5190460963993,0.0006310203349868,0.00398745198574392,"Q13490",1.05e-31,"Baculoviral IAP repeat-containing protein 2 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 1) (C-IAP1) (IAP homolog B) (Inhibitor of apoptosis protein 2) (hIAP-2) (hIAP2) (RING finger protein 48) (RING-type E3 ubiquitin transferase BIRC2) (TNFR2-TRAF-signaling complex protein 2)","apoptotic process [GO:0006915]; canonical NF-kappaB signal transduction [GO:0007249]; cell surface receptor signaling pathway [GO:0007166]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; non-canonical NF-kappaB signal transduction [GO:0038061]; placenta development [GO:0001890]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0000209; GO:0001666; GO:0001741; GO:0001890; GO:0003713; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0007166; GO:0007249; GO:0008270; GO:0009898; GO:0016740; GO:0031398; GO:0033209; GO:0034121; GO:0035631; GO:0038061; GO:0039535; GO:0042127; GO:0042802; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0043130; GO:0043161; GO:0044877; GO:0045088; GO:0045471; GO:0045595; GO:0050727; GO:0051087; GO:0051591; GO:0051726; GO:0060544; GO:0060546; GO:0061630; GO:0070266; GO:0070424; GO:0098770; GO:1901222; GO:1902443; GO:1902523; GO:1902524; GO:1902527; GO:2000116; GO:2000377"
"1274","Pocillopora_acuta_HIv2___RNAseq.g21280.t1",1104.52950906445,3.13475637328492,1.90919911776997,0.000641790519072634,0.00404481833022509,NA,NA,NA,NA,NA
"1275","Pocillopora_acuta_HIv2___RNAseq.g2851.t1",58.5546497026431,-2.09007725370443,3.32654735629017,0.000644866739354183,0.00405890013838943,NA,NA,NA,NA,NA
"1276","Pocillopora_acuta_HIv2___RNAseq.g25436.t1",482.642446992219,2.71462321483916,2.41724981270969,0.000646617452662523,0.00406814912366713,NA,NA,NA,NA,NA
"1277","Pocillopora_acuta_HIv2___RNAseq.g28678.t1",1207.91590211953,-2.71256532017639,2.21113672774191,0.000655504616627681,0.00411935206542067,"D3UW23",0,"Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (Rhiminopeptidase A)","proteolysis [GO:0006508]","GO:0004177; GO:0005886; GO:0006508; GO:0008237; GO:0008270"
"1278","Pocillopora_acuta_HIv2___RNAseq.g2221.t1",740.328647264728,-2.86848737869112,1.97372451655802,0.000656916135241909,0.00412576421195786,"Q76KP1",5.51e-61,"N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 (NGalNAc-T1) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase IV) (Beta4GalNAc-T4) (Beta4GalNAcT4)","","GO:0008376; GO:0032580; GO:0033842"
"1279","Pocillopora_acuta_HIv2___RNAseq.g22142.t1",72.1082421324344,2.91928827116604,1.90214296439502,0.000667346605799814,0.00417495731240853,NA,NA,NA,NA,NA
"1280","Pocillopora_acuta_HIv2___RNAseq.g12528.t1",624.351712648832,-2.24916298495107,3.00315446278509,0.000672925532919416,0.00420803930313292,"Q91ZM9",1.15e-07,"Docking protein 5 (Downstream of tyrosine kinase 5)","cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; neuron differentiation [GO:0030182]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386]","GO:0005737; GO:0007169; GO:0007265; GO:0030182; GO:0043410; GO:0051386"
"1281","Pocillopora_acuta_HIv2___RNAseq.10263_t",3036.53535946797,2.56160162030553,1.44101571243952,0.000673743214496699,0.00421133182993961,"Q8IWU5",1.83e-153,"Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form]","bone development [GO:0060348]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; liver regeneration [GO:0097421]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelin production [GO:1904472]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of hepatocyte proliferation [GO:2000345]; response to wounding [GO:0009611]","GO:0001822; GO:0002063; GO:0003094; GO:0004065; GO:0005509; GO:0005539; GO:0005576; GO:0005615; GO:0005783; GO:0005795; GO:0005886; GO:0008449; GO:0009611; GO:0009986; GO:0010575; GO:0014846; GO:0030177; GO:0030201; GO:0032836; GO:0035860; GO:0040037; GO:0048706; GO:0051216; GO:0060348; GO:0060384; GO:0090263; GO:0097421; GO:1904472; GO:2000345"
"1282","Pocillopora_acuta_HIv2___RNAseq.g10557.t1",571.935275930207,2.64023564309556,1.0026482719818,0.000679299615844858,0.00424056523244714,"Q7T2H2",5.67e-28,"Fibroblast growth factor receptor-like 1","negative regulation of cell population proliferation [GO:0008285]","GO:0005007; GO:0005886; GO:0008201; GO:0008285; GO:0017134"
"1283","Pocillopora_acuta_HIv2___RNAseq.g9084.t1",3736.00912665436,2.90713894076682,1.40221173412562,0.000692686119785967,0.00431110672830647,"Q8SQ75",1.5e-56,"Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment]","complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]","GO:0004252; GO:0005601; GO:0006508; GO:0006958; GO:0009617; GO:0045087; GO:0046872; GO:0070062"
"1284","Pocillopora_acuta_HIv2___TS.g8131.t1",198.189302709465,1.07841496058243,2.09579348369083,0.000694290363433298,0.004319232609333,"Q8C419",2.94e-67,"Metabotropic glycine receptor (mGlyR) (G-protein coupled receptor 158)","brain development [GO:0007420]; cognition [GO:0050890]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of neurotransmitter secretion [GO:0001956]; protein localization to plasma membrane [GO:0072659]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synapse organization [GO:0050807]","GO:0001956; GO:0004888; GO:0005634; GO:0005886; GO:0007186; GO:0007420; GO:0008047; GO:0008277; GO:0016020; GO:0042734; GO:0042995; GO:0045211; GO:0050807; GO:0050890; GO:0072659; GO:0098839; GO:0160079"
"1285","Pocillopora_acuta_HIv2___RNAseq.g2273.t1",3039.3243582818,-1.86650029602888,0.668846349638262,0.000703583038373227,0.00436765024336066,"P54145",6.92e-138,"Putative ammonium transporter 1","ammonium homeostasis [GO:0097272]; ammonium transmembrane transport [GO:0072488]","GO:0005886; GO:0008519; GO:0072488; GO:0097272"
"1286","Pocillopora_acuta_HIv2___TS.g19616.t2b",636.782212174969,-1.60446225929013,2.35525034074196,0.000709328740100713,0.00439388903503928,NA,NA,NA,NA,NA
"1287","Pocillopora_acuta_HIv2___RNAseq.g4013.t1",171.118611476062,-1.08536962879221,1.80084332662554,0.000719558531232782,0.0044477327332269,NA,NA,NA,NA,NA
"1288","Pocillopora_acuta_HIv2___RNAseq.820_t",2229.99269376669,1.87280077453894,0.670853867163949,0.000720188185698124,0.00444972316016132,"Q91821",0,"Maternal embryonic leucine zipper kinase (MELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase)","apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; hemopoiesis [GO:0030097]; neural precursor cell proliferation [GO:0061351]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]","GO:0004674; GO:0004715; GO:0005509; GO:0005524; GO:0005886; GO:0005938; GO:0006915; GO:0008283; GO:0008289; GO:0030097; GO:0043065; GO:0046777; GO:0061351; GO:0106310"
"1289","Pocillopora_acuta_HIv2___RNAseq.g5896.t1",3440.59614231845,2.25437790138856,2.36453405202972,0.000723851361791455,0.00447011291880539,"Q9I8W5",8.72e-24,"Probable N-acetyltransferase camello (EC 2.3.1.-) (Xcml)","gastrulation with mouth forming second [GO:0001702]; negative regulation of cell adhesion [GO:0007162]","GO:0000139; GO:0001702; GO:0005794; GO:0007162; GO:0008080"
"1290","Pocillopora_acuta_HIv2___RNAseq.g28577.t1",46.9812007729321,2.99424199137308,2.37015879471899,0.000728794074128724,0.0044971320342141,"G5EBQ8",3.6e-107,"Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)","cell wall chitin biosynthetic process [GO:0006038]; chitin biosynthetic process [GO:0006031]; positive regulation of nematode larval development [GO:0061063]","GO:0004100; GO:0005886; GO:0006031; GO:0006038; GO:0030428; GO:0061063; GO:0071944"
"1291","Pocillopora_acuta_HIv2___RNAseq.g237.t1",386.013334923639,-2.35227937923947,1.04669819146138,0.00073398218414125,0.00451859368732133,"A0JM23",2.01e-36,"Nephrocystin-3","cilium assembly [GO:0060271]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]","GO:0005929; GO:0016055; GO:0060271; GO:0090090; GO:2000095"
"1292","Pocillopora_acuta_HIv2___RNAseq.g23361.t1",51.9369832263055,-1.30999755824903,2.52022102736785,0.000734146513081107,0.00451859368732133,"Q26614",5.37e-07,"Fibroblast growth factor receptor (SpFGFR) (EC 2.7.10.1)","","GO:0005007; GO:0005524; GO:0005886; GO:0017134; GO:0043235"
"1293","Pocillopora_acuta_HIv2___TS.g1340.t1b",4631.38078039568,1.95257579511089,0.729772980019247,0.000735367509316185,0.00452418360474236,"Q28668",6.52e-72,"Collagen alpha-2(I) chain (Alpha-2 type I collagen)","extracellular matrix organization [GO:0030198]","GO:0005581; GO:0005615; GO:0030020; GO:0030198; GO:0046872; GO:0062023"
"1294","Pocillopora_acuta_HIv2___RNAseq.g1315.t1",470.976544572365,1.99011042152131,3.01855813013709,0.000744743776629451,0.00457408661790589,"Q0V9P1",3.74e-22,"Histamine N-methyltransferase (HMT) (EC 2.1.1.8)","histamine catabolic process [GO:0001695]; methylation [GO:0032259]","GO:0001695; GO:0005737; GO:0032259; GO:0046539"
"1295","Pocillopora_acuta_HIv2___TS.g14240.t1",40.6435769702235,2.88463424979852,1.27595924975357,0.000745601576452719,0.00457546932618249,NA,NA,NA,NA,NA
"1296","Pocillopora_acuta_HIv2___RNAseq.g26271.t1",456.897978789053,-2.5528787942438,1.64808448130304,0.000758127425341846,0.00464248733283,"P68373",0,"Tubulin alpha-1C chain (EC 3.6.5.-) (Alpha-tubulin 6) (Alpha-tubulin isotype M-alpha-6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain]","microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]","GO:0000226; GO:0000278; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005874; GO:0005881; GO:0016787; GO:0045121; GO:0046872"
"1297","Pocillopora_acuta_HIv2___RNAseq.g8922.t1",605.533010139431,2.22039676651637,2.77389272206674,0.000758640622794287,0.00464366397295665,"Q00685",0,"Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3 gamma chain]","complement activation, classical pathway [GO:0006958]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]","GO:0004866; GO:0005615; GO:0006954; GO:0006958; GO:0045087"
"1298","Pocillopora_acuta_HIv2___RNAseq.g7074.t1",133.808489773768,2.81524127784733,1.41761971734184,0.000759943296134389,0.00464966998108621,NA,NA,NA,NA,NA
"1299","Pocillopora_acuta_HIv2___TS.g29599.t2",283.253432583366,-1.59172090510138,2.28754945991114,0.000769439304141522,0.00469783456948205,"Q8IYQ7",0,"Threonine synthase-like 1 (TSH1)","","GO:0005737"
"1300","Pocillopora_acuta_HIv2___TS.g2746.t1",2190.07588565629,-2.13970426220663,0.885144146529845,0.000772016965824144,0.00471158371041368,NA,NA,NA,NA,NA
"1301","Pocillopora_acuta_HIv2___RNAseq.g9734.t1",321.144709954626,2.61416969290279,2.10494415805812,0.000774271039418239,0.00472135595031426,NA,NA,NA,NA,NA
"1302","Pocillopora_acuta_HIv2___RNAseq.g30593.t1",319.597733468068,1.69014866336472,2.44162677316582,0.000789695674822049,0.00479922615152358,"Q2HJI8",3.45e-51,"Ras-related protein Rab-8B","endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; protein secretion [GO:0009306]","GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0006887; GO:0008021; GO:0009306; GO:0010008; GO:0019003; GO:0030140; GO:0030670; GO:0032456; GO:0045335"
"1303","Pocillopora_acuta_HIv2___RNAseq.g15577.t1",225.946430385387,-2.02724078916384,0.769182658076192,0.000794654102456302,0.00482328029287787,"P05123",1.79e-103,"Creatine kinase M-type (EC 2.7.3.2) (Creatine kinase M chain) (Creatine phosphokinase M-type) (CPK-M) (M-CK)","phosphocreatine biosynthetic process [GO:0046314]; response to heat [GO:0009408]","GO:0004111; GO:0005524; GO:0005615; GO:0005737; GO:0009408; GO:0046314"
"1304","Pocillopora_acuta_HIv2___RNAseq.g763.t1",97.7345988190866,-2.95569297577162,1.64826941977381,0.000804509992123635,0.00487349716402162,"O70277",2.65e-20,"Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22)","negative regulation of translation [GO:0017148]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252]","GO:0000209; GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0017148; GO:0030371; GO:0030425; GO:0034141; GO:0042802; GO:0043161; GO:0061630; GO:0070534; GO:0098794; GO:0098978; GO:0140252"
"1305","Pocillopora_acuta_HIv2___TS.g22883.t1",2589.67808780979,2.58015124215372,1.95484028431713,0.000805465966420186,0.00487662609388931,NA,NA,NA,NA,NA
"1306","Pocillopora_acuta_HIv2___RNAseq.g11124.t1",8118.19874141245,2.03182653218577,0.787588810642589,0.000806168082218828,0.00487883478711846,NA,NA,NA,NA,NA
"1307","Pocillopora_acuta_HIv2___TS.g18665.t1",106.168312872365,-4.46232783945712,3.31623424384385,0.000809980306787407,0.0048978073400389,NA,NA,NA,NA,NA
"1308","Pocillopora_acuta_HIv2___TS.g18622.t1b",4572.98017033914,3.38243611792493,1.74956122386046,0.000822388464066329,0.00496660824394796,"A2ASQ1",1.54e-86,"Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]","cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; enzyme-linked receptor protein signaling pathway [GO:0007167]; motor neuron apoptotic process [GO:0097049]; negative regulation of P-type sodium:potassium-exchanging transporter activity [GO:1903407]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; neuromuscular junction development [GO:0007528]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of motor neuron apoptotic process [GO:2000673]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; regulation of synaptic activity [GO:0060025]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]","GO:0001932; GO:0001934; GO:0002162; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0007009; GO:0007167; GO:0007268; GO:0007416; GO:0007528; GO:0007623; GO:0009986; GO:0015031; GO:0030154; GO:0030548; GO:0032092; GO:0033691; GO:0035022; GO:0035374; GO:0036122; GO:0042030; GO:0042383; GO:0043083; GO:0043087; GO:0043113; GO:0043395; GO:0043547; GO:0044295; GO:0044325; GO:0045202; GO:0045887; GO:0045944; GO:0048018; GO:0050431; GO:0050731; GO:0050807; GO:0051491; GO:0055117; GO:0060025; GO:0061098; GO:0062023; GO:0070507; GO:0071340; GO:0086036; GO:0097049; GO:0098978; GO:1902667; GO:1903277; GO:1903407; GO:1904395; GO:2000541; GO:2000673"
"1309","Pocillopora_acuta_HIv2___RNAseq.g14769.t1",2602.28641466178,2.82036905402545,2.08499394404293,0.00082603511465979,0.00498446887711273,"Q61555",0,"Fibrillin-2 [Cleaved into: Placensin]","anatomical structure morphogenesis [GO:0009653]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583]","GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0009653; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023"
"1310","Pocillopora_acuta_HIv2___RNAseq.g21967.t1",1724.85187375922,1.92530210663041,0.714976180431075,0.000829625684291578,0.00500404749691134,"P53634",5.21e-171,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; T cell mediated cytotoxicity [GO:0001913]","GO:0001913; GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0005788; GO:0005813; GO:0006508; GO:0006955; GO:0008234; GO:0008239; GO:0016020; GO:0016505; GO:0019902; GO:0030134; GO:0031404; GO:0031642; GO:0033116; GO:0035578; GO:0042802; GO:0043231; GO:0051087; GO:0051603; GO:0062023; GO:0070062; GO:1903052; GO:1903980; GO:2001235"
"1311","Pocillopora_acuta_HIv2___RNAseq.g15938.t1",191.513469864645,2.33829242289381,1.00549321893909,0.000832396464800125,0.00501866713917007,NA,NA,NA,NA,NA
"1312","Pocillopora_acuta_HIv2___RNAseq.g20666.t1",917.510474861776,-3.01256110480447,1.63360477454758,0.000838024252739548,0.00504838933428772,"P46434",7.02e-34,"Glutathione S-transferase 1 (EC 2.5.1.18)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749"
"1313","Pocillopora_acuta_HIv2___TS.g28827.t1",585.91619590565,2.14097136731822,0.871288750827289,0.000844634636989637,0.00508303563751189,NA,NA,NA,NA,NA
"1314","Pocillopora_acuta_HIv2___RNAseq.g24449.t1",114.361387954748,-1.30532345527104,2.14734917348291,0.000845083290961576,0.00508303563751189,NA,NA,NA,NA,NA
"1315","Pocillopora_acuta_HIv2___RNAseq.g11156.t1",598.963172983968,1.95847827284413,2.48576721378234,0.000853710854094494,0.00512580896372883,NA,NA,NA,NA,NA
"1316","Pocillopora_acuta_HIv2___RNAseq.g16844.t1",101.446831546233,-2.81437017362226,2.314886140788,0.000877035308117517,0.00525276964663013,"Q96PQ7",3.95e-24,"Kelch-like protein 5","","GO:0003779; GO:0005737; GO:0005829; GO:0005856"
"1317","Pocillopora_acuta_HIv2___RNAseq.g8915.t1",1709.59092303431,-2.52152406894803,1.30047168895481,0.000877482631424409,0.00525327350203752,"P10079",9.58e-16,"Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","","GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579"
"1318","Pocillopora_acuta_HIv2___TS.g4253.t1",277.454642673524,-1.06836191190703,1.6700951753089,0.000890535111462251,0.00532040473035522,NA,NA,NA,NA,NA
"1319","Pocillopora_acuta_HIv2___RNAseq.g20160.t1",1122.97064399026,-1.81994362278943,3.0183111219097,0.000900643343601513,0.00537191972035145,NA,NA,NA,NA,NA
"1320","Pocillopora_acuta_HIv2___RNAseq.g9715.t1",184.285875622447,-2.53664245765143,1.42072036500444,0.000912979107407433,0.00543429210269182,NA,NA,NA,NA,NA
"1321","Pocillopora_acuta_HIv2___RNAseq.g26701.t1",1070.5255059844,-2.36452991581157,1.4562340827908,0.000915716468771726,0.00544610320901079,"Q8CQD9",2.31e-10,"Accumulation-associated protein","","GO:0005576"
"1322","Pocillopora_acuta_HIv2___RNAseq.g9334.t1",6238.79877234631,-1.87172736135396,0.695723994017379,0.000928676521193222,0.00551411215210951,"P16621",0,"Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR)","axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; hematopoietic stem cell homeostasis [GO:0061484]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; negative regulation of insulin receptor signaling pathway [GO:0046627]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic assembly at neuromuscular junction [GO:0051124]","GO:0004725; GO:0005001; GO:0005158; GO:0005925; GO:0007155; GO:0007283; GO:0007399; GO:0007411; GO:0007412; GO:0008045; GO:0008201; GO:0008594; GO:0009925; GO:0009986; GO:0030424; GO:0031252; GO:0031290; GO:0032093; GO:0045467; GO:0046627; GO:0048477; GO:0048675; GO:0048841; GO:0051124; GO:0051491; GO:0060269; GO:0061484; GO:0120034; GO:1903386"
"1323","Pocillopora_acuta_HIv2___RNAseq.g9589.t2",2396.75766737527,2.98936446595039,1.90403265763673,0.000930236143635572,0.00552110610650181,"Q91994",3.89e-37,"Homeobox protein OTX1 B (zOtx1) (Orthodenticle homolog 1 B)","inner ear morphogenesis [GO:0042472]; lateral semicircular canal development [GO:0060875]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal pigment epithelium development [GO:0003406]","GO:0000978; GO:0000981; GO:0003406; GO:0005634; GO:0006357; GO:0042472; GO:0060875"
"1324","Pocillopora_acuta_HIv2___RNAseq.g14505.t1",13007.13582953,-1.6521379962892,0.579779812154478,0.000932225881913604,0.00552837849774431,"P12716",0,"Actin, cytoplasmic (EC 3.6.4.-) [Cleaved into: Actin, cytoplasmic, intermediate form]","","GO:0005524; GO:0005737; GO:0005856; GO:0016787"
"1325","Pocillopora_acuta_HIv2___RNAseq.g11563.t1",510.933175310693,-1.2836763660119,1.99992272570729,0.000939447557913042,0.00556208329007542,"Q28BR5",0,"Presequence protease, mitochondrial (EC 3.4.24.-) (Pitrilysin metalloproteinase 1)","proteolysis [GO:0006508]","GO:0004222; GO:0005759; GO:0006508; GO:0046872"
"1326","Pocillopora_acuta_HIv2___RNAseq.g21911.t1",606.500147466504,2.19452213232372,0.929294852170392,0.000941171916997339,0.00557001252350635,NA,NA,NA,NA,NA
"1327","Pocillopora_acuta_HIv2___RNAseq.g9068.t1",271.676330149337,2.8823566981118,1.48817732080267,0.000942294978790619,0.00557437814855931,"P04186",2.84e-55,"Complement factor B (EC 3.4.21.47) (C3/C5 convertase) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment]","B cell proliferation [GO:0042100]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]","GO:0004252; GO:0005576; GO:0006508; GO:0006956; GO:0006957; GO:0009617; GO:0042100"
"1328","Pocillopora_acuta_HIv2___RNAseq.g8488.t1",2529.15127212934,-2.18843506548774,0.929429679288788,0.000944429449385266,0.00558472099587428,"P23098",0,"Dynein beta chain, ciliary","cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]","GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0008569; GO:0030030; GO:0030286; GO:0031514; GO:0045505; GO:0051959"
"1329","Pocillopora_acuta_HIv2___RNAseq.g15699.t1",865.146250204035,1.71662580573025,0.609079621534403,0.000945795163142316,0.00558783332363594,"P54357",2.63e-35,"Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain)","actin filament-based movement [GO:0030048]","GO:0005509; GO:0005829; GO:0016460; GO:0017022; GO:0030048; GO:0031475; GO:0031476; GO:0031477; GO:0032036"
"1330","Pocillopora_acuta_HIv2___RNAseq.g3099.t1",443.207179018389,-2.65499237758483,1.6869883214988,0.000970590194695905,0.00571139811882896,NA,NA,NA,NA,NA
"1331","Pocillopora_acuta_HIv2___TS.g10811.t1",491.89720636027,-1.28190423194249,2.05137534799281,0.00097460648340659,0.00573036917723289,"Q9JLG8",0,"Calpain-15 (EC 3.4.22.-) (Small optic lobes homolog)","proteolysis [GO:0006508]","GO:0004198; GO:0005737; GO:0006508; GO:0046872"
"1332","Pocillopora_acuta_HIv2___RNAseq.g23898.t1",814.369081255654,2.37519512332793,2.03803539183503,0.000975246179458144,0.00573180038182958,"Q9JHA8",2.31e-27,"von Willebrand factor A domain-containing protein 7 (Protein G7c)","","GO:0005576"
"1333","Pocillopora_acuta_HIv2___TS.g24890.t1",159.555559772517,3.07622261678377,1.3232751381101,0.000977381541080839,0.00574201730714592,"Q5ZJP7",1.09e-37,"BTB/POZ domain-containing protein KCTD7","membrane hyperpolarization [GO:0060081]; protein homooligomerization [GO:0051260]","GO:0005829; GO:0005886; GO:0051260; GO:0060081"
"1334","Pocillopora_acuta_HIv2___TS.g12320.t1",73.6609249231075,1.40672746961431,3.1895298519884,0.000981180040601737,0.00575848949313109,"Q60HG8",4.27e-14,"Alpha-crystallin B chain (Alpha(B)-crystallin)","negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; protein refolding [GO:0042026]; response to heat [GO:0009408]","GO:0005212; GO:0005576; GO:0005634; GO:0005737; GO:0005764; GO:0009408; GO:0032991; GO:0042026; GO:0042803; GO:0043066; GO:0045892; GO:0046872; GO:0051082"
"1335","Pocillopora_acuta_HIv2___RNAseq.g30994.t1a",1228.79079190103,-2.48932710102532,2.95334714012785,0.000981379742849013,0.00575848949313109,"B0JZG0",0,"Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2)","sodium ion transport [GO:0006814]","GO:0005886; GO:0006814; GO:0015293"
"1336","Pocillopora_acuta_HIv2___RNAseq.g14607.t1",1821.93583211297,-2.80177655566482,2.23489445002232,0.000990795134531323,0.00580902343974911,NA,NA,NA,NA,NA
"1337","Pocillopora_acuta_HIv2___TS.g6576.t2",502.264756076173,2.0244266229135,0.801608966384794,0.00100098910518815,0.00586166251718274,"Q9VY77",1.21e-67,"LIM domain-containing protein jub","cytoskeleton organization [GO:0007010]; follicle cell of egg chamber development [GO:0030707]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; regulation of DNA-templated transcription [GO:0006355]; response to hypoxia [GO:0001666]","GO:0000278; GO:0000932; GO:0001666; GO:0003714; GO:0005634; GO:0005667; GO:0005912; GO:0006355; GO:0007010; GO:0030707; GO:0035331; GO:0045179; GO:0045572; GO:0046872; GO:0071539; GO:0140311"
"1338","Pocillopora_acuta_HIv2___RNAseq.g15972.t1",1348.21796755039,2.87481264775041,1.78696674275892,0.00100402598794682,0.00587468927575356,NA,NA,NA,NA,NA
"1339","Pocillopora_acuta_HIv2___TS.g15602.t1",134.775287682405,1.43462508291545,2.31446412746763,0.00100714196148652,0.00588815736901418,NA,NA,NA,NA,NA
"1340","Pocillopora_acuta_HIv2___RNAseq.g4068.t1",231.0319046947,-2.88483175993017,2.83346562673946,0.00100757268470808,0.00588829547944147,"Q9BQA1",1.73e-59,"Methylosome protein WDR77 (Androgen receptor cofactor p44) (Methylosome protein 50) (MEP-50) (WD repeat-containing protein 77) (p44/Mep50)","epithelial cell proliferation involved in prostate gland development [GO:0060767]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; oocyte axis specification [GO:0007309]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; protein polyubiquitination [GO:0000209]; regulation of transcription by RNA polymerase II [GO:0006357]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; spliceosomal snRNP assembly [GO:0000387]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000209; GO:0000387; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006357; GO:0006511; GO:0007309; GO:0008284; GO:0008327; GO:0030374; GO:0031465; GO:0034709; GO:0048026; GO:0060528; GO:0060767; GO:0060770; GO:1990756"
"1341","Pocillopora_acuta_HIv2___RNAseq.g25248.t1a",397.797339458725,-1.32591955285096,2.09995495733093,0.00100875096639038,0.00589047599600991,"Q7SXM7",0,"U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31)","mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; retina development in camera-type eye [GO:0060041]; spliceosomal tri-snRNP complex assembly [GO:0000244]","GO:0000244; GO:0000381; GO:0000398; GO:0005634; GO:0005687; GO:0005690; GO:0015030; GO:0016607; GO:0030622; GO:0046540; GO:0060041; GO:0071005; GO:0071011; GO:0071339; GO:0097526"
"1342","Pocillopora_acuta_HIv2___RNAseq.g21032.t1",1708.35825151064,2.00507929578145,0.789179528843591,0.00101215429875942,0.00590790951463126,"A4ZNR5",8.21e-14,"Protein naked cuticle homolog 2-like (Naked-2-like) (Protein naked cuticle homolog 2-B) (Naked-2B)","negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]","GO:0005509; GO:0005737; GO:0005886; GO:0016055; GO:0030178; GO:0090090"
"1343","Pocillopora_acuta_HIv2___RNAseq.g8890.t1",29.9877935858864,-1.45883451541938,2.68906701982634,0.00101916589261988,0.00594614444998673,"Q7ZTV5",4.87e-16,"Follicle-stimulating hormone receptor (FSH-R) (Follitropin receptor)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of protein kinase A signaling [GO:0010738]","GO:0004963; GO:0005886; GO:0007186; GO:0007189; GO:0008528; GO:0008584; GO:0009755; GO:0010738; GO:0016020; GO:0042699; GO:0043235; GO:0051897; GO:0070374; GO:0071372"
"1344","Pocillopora_acuta_HIv2___RNAseq.g8916.t1",2710.00133414159,3.00081910367814,2.03910174296076,0.0010231084139086,0.00596462720627733,"Q9QYP1",0,"Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)","amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001932; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395"
"1345","Pocillopora_acuta_HIv2___TS.g4588.t1",1270.79567156701,-1.69290695647509,3.08517697915496,0.00103562844299407,0.00603275465141613,"Q6BEB4",3.66e-59,"Transcription factor Sp5","bone morphogenesis [GO:0060349]; cellular response to organic cyclic compound [GO:0071407]; post-anal tail morphogenesis [GO:0036342]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0036342; GO:0046872; GO:0060349; GO:0071407"
"1346","Pocillopora_acuta_HIv2___TS.g12990.t1",319.323234430846,-1.41512964106404,2.54470302310449,0.00104180566577002,0.00606385398378171,"P57769",1.16e-43,"Sorting nexin-16","early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622]","GO:0005764; GO:0005769; GO:0005770; GO:0006622; GO:0008333; GO:0010008; GO:0031901; GO:0031902; GO:0035091; GO:0042802; GO:0045022"
"1347","Pocillopora_acuta_HIv2___RNAseq.g13718.t1",929.284439213473,-2.3921609202369,2.63041981462069,0.00104990461059192,0.00610117327746144,"Q7TN83",7.64e-08,"Synaptotagmin-16 (Synaptotagmin 14-like protein) (Synaptotagmin XIV-related protein)","","GO:0005543; GO:0016020; GO:0042802"
"1348","Pocillopora_acuta_HIv2___TS.g23144.t1",1933.98573877367,2.90257623605892,2.09879549999036,0.00105204484463207,0.00610625065519992,"Q00685",6.8e-149,"Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3 gamma chain]","complement activation, classical pathway [GO:0006958]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]","GO:0004866; GO:0005615; GO:0006954; GO:0006958; GO:0045087"
"1349","Pocillopora_acuta_HIv2___RNAseq.g9955.t1",485.428905626887,-1.9754112710899,2.67288727576601,0.00105828000114881,0.00613505488441541,"Q9VNJ5",4.89e-33,"Protein dispatched","germ cell migration [GO:0008354]; patched ligand maturation [GO:0007225]; segment polarity determination [GO:0007367]; smoothened signaling pathway [GO:0007224]; wing disc pattern formation [GO:0035222]","GO:0005886; GO:0007224; GO:0007225; GO:0007367; GO:0008354; GO:0016020; GO:0022857; GO:0035222; GO:0035230"
"1350","Pocillopora_acuta_HIv2___RNAseq.g24174.t1",754.986216723705,-2.06180601272018,2.26128135849346,0.00106833378690251,0.00619085732922992,"Q4G5Y1",2.7e-97,"Kelch domain-containing protein 2 (Endothelial differentiation inhibitory protein TNG)","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0005634; GO:0016567; GO:0016604; GO:0031462; GO:0031965; GO:0043161; GO:0140627; GO:1990756"
"1351","Pocillopora_acuta_HIv2___RNAseq.g25727.t1",445.280596568869,-2.41583093455754,1.36243261029591,0.00107173983123365,0.00620810769682161,"Q54271",1.52e-53,"Phosphonopyruvate decarboxylase (PnPy decarboxylase) (EC 4.1.1.82)","antibiotic biosynthetic process [GO:0017000]; organic phosphonate biosynthetic process [GO:0032923]","GO:0000287; GO:0017000; GO:0030976; GO:0032923; GO:0033980"
"1352","Pocillopora_acuta_HIv2___RNAseq.g2884.t1",1112.13170716239,2.03916322252795,3.49290729945891,0.00109061258131659,0.00630984815046525,"A9Y006",1.15e-87,"Aquaporin-3 (Aquaglyceroporin-3)","glycerol transmembrane transport [GO:0015793]; polyol transmembrane transport [GO:0015791]; water transport [GO:0006833]","GO:0005886; GO:0006833; GO:0015166; GO:0015204; GO:0015250; GO:0015254; GO:0015791; GO:0015793; GO:0016323"
"1353","Pocillopora_acuta_HIv2___RNAseq.g13818.t1",1420.88291894327,2.42534445297742,1.64269971620452,0.0010919819067551,0.00631524442195353,"O95084",4.31e-42,"Serine protease 23 (EC 3.4.21.-) (Putative secreted protein Zsig13)","proteolysis [GO:0006508]","GO:0004252; GO:0005634; GO:0005788; GO:0006508; GO:0070062"
"1354","Pocillopora_acuta_HIv2___RNAseq.g6284.t1",124.919317252501,-1.88051164289881,0.706290614223847,0.00110623171472775,0.00638489047159704,"A4YI89",5.39e-12,"3-hydroxypropionyl-coenzyme A dehydratase (3-hydroxypropionyl-CoA dehydratase) (EC 4.2.1.116)","fatty acid metabolic process [GO:0006631]","GO:0006631; GO:0043956"
"1355","Pocillopora_acuta_HIv2___RNAseq.g26743.t1",533.321382848229,-2.37707499282495,1.74040126193548,0.00111879303973831,0.00644967019799716,"P27545",1.95e-75,"Ceramide synthase 1 (CerS1) (Longevity assurance gene 1 protein homolog 1) (Protein UOG-1) (Sphingoid base N-stearoyltransferase CERS1) (EC 2.3.1.299)","brain development [GO:0007420]; ceramide biosynthetic process [GO:0046513]; negative regulation of glucose import [GO:0046325]","GO:0005783; GO:0005789; GO:0007420; GO:0016410; GO:0043231; GO:0046325; GO:0046513; GO:0050291"
"1356","Pocillopora_acuta_HIv2___RNAseq.26508_t",840.771081085752,2.4006203101079,2.79511425310312,0.00112173170854704,0.00646403483363522,"Q9JJS0",3.3e-27,"Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You)","chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of smoothened signaling pathway [GO:0045880]; signal transduction [GO:0007165]","GO:0003413; GO:0005509; GO:0005615; GO:0007165; GO:0008289; GO:0009986; GO:0019897; GO:0042802; GO:0045669; GO:0045778; GO:0045880; GO:0097108; GO:1902732"
"1357","Pocillopora_acuta_HIv2___RNAseq.g27047.t1",2115.7622800643,2.50723886780883,2.43622626623094,0.00112817143942077,0.00649338308785593,"P51028",5.66e-55,"Protein Wnt-8a","anterior/posterior pattern specification [GO:0009952]; brain segmentation [GO:0035284]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell migration involved in gastrulation [GO:0042074]; cell proliferation involved in pronephros development [GO:0039015]; central nervous system development [GO:0007417]; determination of dorsal identity [GO:0048263]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; endoderm development [GO:0007492]; eye development [GO:0001654]; hindbrain development [GO:0030902]; mesoderm development [GO:0007498]; mesoderm formation [GO:0001707]; mesodermal cell fate commitment [GO:0001710]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neural crest cell fate specification [GO:0014036]; neural plate anterior/posterior regionalization [GO:0021999]; neural plate pattern specification [GO:0060896]; neuron differentiation [GO:0030182]; notochord development [GO:0030903]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; post-anal tail morphogenesis [GO:0036342]; regulation of anterior head development [GO:2000742]; regulation of cell population proliferation [GO:0042127]; somitogenesis [GO:0001756]; Spemann organizer formation [GO:0060061]; spinal cord anterior/posterior patterning [GO:0021512]; Wnt signaling pathway [GO:0016055]","GO:0000578; GO:0001654; GO:0001707; GO:0001710; GO:0001756; GO:0005109; GO:0005125; GO:0005615; GO:0007398; GO:0007417; GO:0007492; GO:0007498; GO:0009950; GO:0009952; GO:0009953; GO:0009986; GO:0010628; GO:0014036; GO:0016055; GO:0021512; GO:0021999; GO:0030182; GO:0030902; GO:0030903; GO:0035284; GO:0036342; GO:0039015; GO:0042074; GO:0042127; GO:0045165; GO:0045743; GO:0048263; GO:0060061; GO:0060070; GO:0060896; GO:0090090; GO:0090263; GO:0097189; GO:2000742"
"1358","Pocillopora_acuta_HIv2___RNAseq.g13205.t1",1874.07141110417,2.49963330084524,1.27593057564322,0.0011319030003562,0.00651226929083215,NA,NA,NA,NA,NA
"1359","Pocillopora_acuta_HIv2___RNAseq.g17611.t1",44238.8316123337,1.84836958351184,0.708377741261182,0.00113236590741494,0.00651234214109331,NA,NA,NA,NA,NA
"1360","Pocillopora_acuta_HIv2___TS.g27519.t1",742.015542841422,-1.52206266575968,2.57215636876491,0.00113402664190964,0.00651930101294951,"Q9VVU5",8.47e-19,"COP9 signalosome complex subunit 1b (Dch1-2) (Signalosome subunit 1b)","female germ-line stem cell population maintenance [GO:0036099]; germ cell development [GO:0007281]; germarium-derived cystoblast division [GO:0048142]; male germ-line cyst encapsulation [GO:0048140]; protein deneddylation [GO:0000338]; protein stabilization [GO:0050821]","GO:0000338; GO:0005737; GO:0007281; GO:0008180; GO:0036099; GO:0048140; GO:0048142; GO:0050821"
"1361","Pocillopora_acuta_HIv2___RNAseq.953_t",1081.97867628544,-2.2437900583519,2.40405010288745,0.00113780824203377,0.00653065810030811,"Q87PP5",5.95e-102,"Glycine betaine/proline/choline/ectoine transporter VP1456","amino acid transport [GO:0006865]","GO:0005886; GO:0006865; GO:0022857"
"1362","Pocillopora_acuta_HIv2___TS.g14962.t1",1936.99986158019,-2.15405694932985,0.980528874608433,0.00113831458575164,0.00653097269667265,"Q6NS52",0,"Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (Diglyceride kinase beta) (DGK-beta)","diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of postsynapse organization [GO:0099175]; response to bacterium [GO:0009617]","GO:0004143; GO:0005509; GO:0005524; GO:0005737; GO:0005886; GO:0006654; GO:0007205; GO:0009617; GO:0035556; GO:0046339; GO:0046473; GO:0046834; GO:0050804; GO:0098685; GO:0098978; GO:0099147; GO:0099175"
"1363","Pocillopora_acuta_HIv2___RNAseq.g682.t1",2333.47091477811,2.80410290032967,1.73737822301744,0.00116327260653293,0.00666359405183852,"O55005",1.77e-28,"Roundabout homolog 1","aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hypoxia [GO:0071456]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; coronary vasculature development [GO:0060976]; endocardial cushion formation [GO:0003272]; heart development [GO:0007507]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; kidney development [GO:0001822]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; neuron projection extension [GO:1990138]; olfactory bulb interneuron development [GO:0021891]; oligodendrocyte development [GO:0014003]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; regulation of dendrite morphogenesis [GO:0048814]; Roundabout signaling pathway [GO:0035385]; spinal cord development [GO:0021510]; synapse organization [GO:0050808]; ventricular septum development [GO:0003281]; ventricular septum morphogenesis [GO:0060412]","GO:0001822; GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0003281; GO:0005737; GO:0005886; GO:0007156; GO:0007411; GO:0007507; GO:0008046; GO:0008285; GO:0009986; GO:0010628; GO:0010629; GO:0014003; GO:0016199; GO:0021510; GO:0021836; GO:0021891; GO:0030275; GO:0030336; GO:0030424; GO:0030425; GO:0030673; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043025; GO:0045747; GO:0048814; GO:0050772; GO:0050808; GO:0050925; GO:0051964; GO:0060412; GO:0060763; GO:0060976; GO:0070100; GO:0071456; GO:1900748; GO:1990138"
"1364","Pocillopora_acuta_HIv2___RNAseq.g27433.t1",732.86833028706,2.38655533467572,1.40931482251937,0.00116467422675389,0.0066689817956327,NA,NA,NA,NA,NA
"1365","Pocillopora_acuta_HIv2___RNAseq.10616_t",908.191368335668,2.21411420240366,1.03890221830357,0.00116858418298724,0.00668861096655968,"J9VG42",9.96e-06,"Transcription factor MBS1 (Mbp1/Swi4-like protein 1)","","GO:0001228; GO:0003677; GO:0090575"
"1366","Pocillopora_acuta_HIv2___RNAseq.g9223.t1",116.611128183097,-1.87345849601451,3.42401643423646,0.00117733227906486,0.00672814464021892,"Q684M4",3.34e-167,"Kelch-like ECH-associated protein 1","cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; in utero embryonic development [GO:0001701]; negative regulation of response to oxidative stress [GO:1902883]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of DNA-templated transcription [GO:0006355]; regulation of epidermal cell differentiation [GO:0045604]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0001701; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005884; GO:0006355; GO:0006511; GO:0010506; GO:0016234; GO:0016567; GO:0030496; GO:0031463; GO:0034451; GO:0034599; GO:0042802; GO:0045604; GO:0061629; GO:0071353; GO:0097718; GO:1902883; GO:1990756"
"1367","Pocillopora_acuta_HIv2___RNAseq.g2827.t1",2015.11450619594,-1.24285634093752,2.11756155058675,0.00118012138295281,0.00673875865891413,"O43581",9.75e-12,"Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII)","calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; regulation of synaptic vesicle endocytosis [GO:1900242]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle fusion [GO:0006906]; vesicle-mediated cholesterol transport [GO:0090119]","GO:0000149; GO:0001778; GO:0001786; GO:0005509; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0005886; GO:0006906; GO:0006909; GO:0008021; GO:0019905; GO:0030276; GO:0030424; GO:0030670; GO:0030672; GO:0031045; GO:0032009; GO:0036465; GO:0042734; GO:0045202; GO:0045956; GO:0046850; GO:0048791; GO:0050764; GO:0050796; GO:0070062; GO:0070092; GO:0090119; GO:0090385; GO:0098686; GO:1900242; GO:1990926; GO:1990927"
"1368","Pocillopora_acuta_HIv2___RNAseq.g4028.t1",1336.23793996349,-1.77810186245722,2.85689985070594,0.00120495944140934,0.00686432979934802,"O43581",5.45e-110,"Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII)","calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; regulation of synaptic vesicle endocytosis [GO:1900242]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle fusion [GO:0006906]; vesicle-mediated cholesterol transport [GO:0090119]","GO:0000149; GO:0001778; GO:0001786; GO:0005509; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0005886; GO:0006906; GO:0006909; GO:0008021; GO:0019905; GO:0030276; GO:0030424; GO:0030670; GO:0030672; GO:0031045; GO:0032009; GO:0036465; GO:0042734; GO:0045202; GO:0045956; GO:0046850; GO:0048791; GO:0050764; GO:0050796; GO:0070062; GO:0070092; GO:0090119; GO:0090385; GO:0098686; GO:1900242; GO:1990926; GO:1990927"
"1369","Pocillopora_acuta_HIv2___RNAseq.g8087.t1",1383.60419693104,2.96107099656306,1.83112173115437,0.00120793806426801,0.00687588199983174,"Q8R151",5.27e-143,"NFX1-type zinc finger-containing protein 1","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607"
"1370","Pocillopora_acuta_HIv2___RNAseq.g16484.t1",2367.06412104972,2.77216947384442,2.14747734167243,0.0012137289269486,0.00689879368294839,"Q9VBW3",7.07e-96,"Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303"
"1371","Pocillopora_acuta_HIv2___RNAseq.g27337.t1",784.209680573377,2.96352073216168,2.01816737647667,0.00121387098472785,0.00689879368294839,"Q6PBD4",1.72e-41,"Transcription factor HES-4 (Hairy and enhancer of split 4) (Protein hairy-2)","eye photoreceptor cell development [GO:0042462]; floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neurogenesis [GO:0050768]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest formation [GO:0014029]; Notch signaling pathway [GO:0007219]; photoreceptor cell maintenance [GO:0045494]; prechordal plate formation [GO:0021501]","GO:0000122; GO:0002088; GO:0005634; GO:0007219; GO:0007517; GO:0014029; GO:0021501; GO:0033504; GO:0042462; GO:0043066; GO:0043565; GO:0045494; GO:0045892; GO:0046982; GO:0048642; GO:0050768"
"1372","Pocillopora_acuta_HIv2___RNAseq.g16050.t1",1242.56235257443,-2.28920026484526,1.12566267817173,0.00122506798964609,0.0069542321044902,"Q04859",0,"Serine/threonine-protein kinase MAK (EC 2.7.11.1) (Male germ cell-associated kinase) (Protein kinase RCK)","cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary transport [GO:0042073]; negative regulation of non-motile cilium assembly [GO:1902856]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]","GO:0001750; GO:0001917; GO:0003713; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005929; GO:0005930; GO:0006468; GO:0030496; GO:0031514; GO:0032391; GO:0035556; GO:0042073; GO:0045494; GO:0046777; GO:0046872; GO:0060271; GO:0072686; GO:0106310; GO:1902856; GO:1905515"
"1373","Pocillopora_acuta_HIv2___RNAseq.g23638.t1",1021.22070160144,2.46811176281242,1.38381561771541,0.00123329425479171,0.00698995615254987,"Q4R8M9",7.1e-20,"Gametocyte-specific factor 1 (Protein FAM112B)","cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","GO:0005737; GO:0007283; GO:0030154; GO:0046872"
"1374","Pocillopora_acuta_HIv2___RNAseq.g31347.t1",3829.18725638947,1.73063444955828,0.642448952930385,0.001241630566982,0.00703169323446656,"P81439",1.3e-28,"Equistatin (EI) (Cysteine proteinase inhibitor)","","GO:0004869; GO:0005615"
"1375","Pocillopora_acuta_HIv2___RNAseq.g27596.t1",285.237795323668,-1.00629480504525,1.62781969481647,0.00124581683514876,0.00704988055696073,NA,NA,NA,NA,NA
"1376","Pocillopora_acuta_HIv2___RNAseq.g16553.t1",159.761145956839,-1.29839657048731,2.07185698268387,0.0012517375714587,0.00707784684659057,"Q5U584",4.28e-62,"SH3 domain-binding protein 5-like (SH3BP-5-like)","intracellular signal transduction [GO:0035556]","GO:0005085; GO:0035556"
"1377","Pocillopora_acuta_HIv2___RNAseq.g13070.t1",903.146272180001,-1.95953536058461,0.794838486951665,0.00126243005916109,0.00712716173915147,"A7SKE9",6.57e-147,"Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4)","formation of cytoplasmic translation initiation complex [GO:0001732]","GO:0001732; GO:0003723; GO:0003743; GO:0005852; GO:0016282; GO:0033290"
"1378","Pocillopora_acuta_HIv2___TS.g13222.t1b",83516.7658841999,1.99379400160411,0.85150963569783,0.00126435294556154,0.00713523254178782,"P18709",1.42e-50,"Vitellogenin-A2 (VTG A2) [Cleaved into: Lipovitellin I; Lipovitellin II; Phosvitin]","","GO:0005319; GO:0045735"
"1379","Pocillopora_acuta_HIv2___RNAseq.g12278.t1",173.362676067824,3.48038491566839,3.0242388431801,0.00128964548573845,0.00726620700871253,"P18052",5.24e-63,"Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28)","insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of focal adhesion assembly [GO:0051893]","GO:0004725; GO:0005925; GO:0007229; GO:0008286; GO:0016020; GO:0043235; GO:0044877; GO:0048714; GO:0050804; GO:0051893; GO:0097060; GO:0098685"
"1380","Pocillopora_acuta_HIv2___RNAseq.g22283.t1",4427.24165739326,-1.85312519296711,0.738485212268419,0.00129274425285269,0.0072784168443991,"Q76B49",4.79e-46,"CD63 antigen (CD antigen CD63)","cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]","GO:0002092; GO:0005576; GO:0005765; GO:0005886; GO:0007160; GO:0009986; GO:0015031; GO:0016477; GO:0031902; GO:0032585; GO:0035646; GO:0042470; GO:0048757; GO:0097487; GO:1900746; GO:2001046"
"1381","Pocillopora_acuta_HIv2___RNAseq.g6413.t1",17.443379719631,-1.09253874470373,2.34645064005787,0.00130039708540057,0.00731580841821621,NA,NA,NA,NA,NA
"1382","Pocillopora_acuta_HIv2___RNAseq.g15584.t1",1587.90694979045,-2.22262266855636,1.43831734197049,0.00133775964444812,0.00749975019275099,"P05123",0,"Creatine kinase M-type (EC 2.7.3.2) (Creatine kinase M chain) (Creatine phosphokinase M-type) (CPK-M) (M-CK)","phosphocreatine biosynthetic process [GO:0046314]; response to heat [GO:0009408]","GO:0004111; GO:0005524; GO:0005615; GO:0005737; GO:0009408; GO:0046314"
"1383","Pocillopora_acuta_HIv2___RNAseq.g1800.t1",103.53093248477,-1.55458488652781,2.5275459638825,0.00134167799733724,0.00751880300406273,"E7FAM5",2.92e-50,"E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177"
"1384","Pocillopora_acuta_HIv2___RNAseq.g22369.t1",1789.89550639446,1.9838363898172,0.82871817875551,0.00134260945333902,0.00752110888191156,"Q58D55",0,"Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)","carbohydrate metabolic process [GO:0005975]","GO:0004565; GO:0005764; GO:0005773; GO:0005975"
"1385","Pocillopora_acuta_HIv2___RNAseq.g9373.t1",462.526492373285,2.01998769677839,5.72848671793588,0.00134603939051537,0.0075374036950888,"Q32KW9",1.23e-49,"Interferon-inducible GTPase 5 (EC 3.6.5.-) (Immunity-related GTPase cinema 1)","positive regulation of flagellated sperm motility [GO:1902093]","GO:0003924; GO:0005525; GO:0005811; GO:0016020; GO:0036126; GO:0097226; GO:1902093"
"1386","Pocillopora_acuta_HIv2___RNAseq.g10514.t1",251.700966660513,-1.52068469693143,2.43387126372058,0.0013542988415955,0.0075748563205094,"Q92547",0,"DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1)","broken chromosome clustering [GO:0141112]; chromosome organization [GO:0051276]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein localization to site of double-strand break [GO:1990166]; response to ionizing radiation [GO:0010212]","GO:0000076; GO:0000077; GO:0000724; GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0005886; GO:0006259; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0035825; GO:0035861; GO:0042802; GO:0043539; GO:0051276; GO:0070532; GO:0090734; GO:0097680; GO:0097681; GO:0140031; GO:0140463; GO:0141112; GO:1990166"
"1387","Pocillopora_acuta_HIv2___RNAseq.g25936.t1",4149.59914181813,2.92845929452035,2.07026098006087,0.00135796539608702,0.00758656295442357,NA,NA,NA,NA,NA
"1388","Pocillopora_acuta_HIv2___RNAseq.g12306.t1",727.113927494196,1.16465052186372,1.97518538626118,0.00136610707952094,0.00762910146648295,"B7ZCC9",1.01e-57,"Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; neurogenesis [GO:0022008]","GO:0004930; GO:0005886; GO:0007166; GO:0007189; GO:0022008"
"1389","Pocillopora_acuta_HIv2___RNAseq.g28794.t1",4693.2014611543,2.45308438445675,1.51873799203372,0.00139334452191799,0.0077722079309764,"P02466",2e-164,"Collagen alpha-2(I) chain (Alpha-2 type I collagen)","blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096"
"1390","Pocillopora_acuta_HIv2___RNAseq.g3088.t1",1522.71637747625,2.03658746021117,1.69705848350216,0.00143660932232829,0.0079858252260401,"Q6AZT7",0,"Nephrocystin-3","cilium assembly [GO:0060271]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]","GO:0005929; GO:0016055; GO:0060027; GO:0060271; GO:0090090; GO:2000095"
"1391","Pocillopora_acuta_HIv2___RNAseq.g17948.t1",6554.25297373893,1.73923934715086,0.664361077927288,0.00145012910315588,0.00805478776806705,NA,NA,NA,NA,NA
"1392","Pocillopora_acuta_HIv2___TS.g7609.t1b",211.460256392235,-2.2666628055406,2.66696742956512,0.00145420968818166,0.00807125438597834,"Q5RB83",2.6e-75,"Phosphoserine phosphatase (PSP) (PSPase) (EC 3.1.3.3) (O-phosphoserine phosphohydrolase)","L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]","GO:0000287; GO:0005829; GO:0006563; GO:0006564; GO:0036424"
"1393","Pocillopora_acuta_HIv2___RNAseq.g28858.t1",1376.33822861957,-2.43522021641364,1.31806116670761,0.00146194408444459,0.00810795983029394,"Q3SXB8",1.44e-06,"Collectin-11 (Collectin kidney protein 1) (CL-K1)","antimicrobial humoral response [GO:0019730]; complement activation, lectin pathway [GO:0001867]; developmental process [GO:0032502]","GO:0001867; GO:0003677; GO:0005509; GO:0005537; GO:0005581; GO:0005615; GO:0019730; GO:0032502; GO:0042806; GO:0070492; GO:0120153"
"1394","Pocillopora_acuta_HIv2___RNAseq.g3142.t1a",165.535663324294,-1.00849314163139,1.57650999012518,0.0014703093779668,0.00814264381657414,"Q7T2B9",6.59e-14,"Myotrophin","regulation of barbed-end actin filament capping [GO:2000812]","GO:0005634; GO:0005737; GO:0048471; GO:2000812"
"1395","Pocillopora_acuta_HIv2___RNAseq.g13856.t1",416.501011933529,-2.04159542829857,2.56687351776336,0.0014947538086214,0.00826457151678133,"D3Z902",4.81e-56,"F-box/WD repeat-containing protein 7","DNA damage response [GO:0006974]; DNA repair [GO:0006281]; lung development [GO:0030324]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; Notch signaling pathway [GO:0007219]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein K63-linked ubiquitination [GO:0070534]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculogenesis [GO:0001570]","GO:0001570; GO:0005634; GO:0005694; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0006281; GO:0006974; GO:0007062; GO:0007219; GO:0010629; GO:0010992; GO:0016567; GO:0019005; GO:0030324; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0031648; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0048471; GO:0048511; GO:0050816; GO:0050821; GO:0070374; GO:0070534; GO:0090049; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2001205"
"1396","Pocillopora_acuta_HIv2___RNAseq.g20910.t1",16.2540859568451,-1.00051801998189,2.03670453504552,0.00150796548718707,0.00832079003225911,NA,NA,NA,NA,NA
"1397","Pocillopora_acuta_HIv2___TS.g22239.t1",25.6625567158209,-1.07640512332568,1.96872349126111,0.00150801369799088,0.00832079003225911,NA,NA,NA,NA,NA
"1398","Pocillopora_acuta_HIv2___RNAseq.g12927.t1",81.9520341217083,-2.64407530943549,1.5622848784884,0.00152359001839046,0.00839634959242936,NA,NA,NA,NA,NA
"1399","Pocillopora_acuta_HIv2___RNAseq.g21518.t1",1281.13793582765,1.63391679496025,2.84301663014365,0.00152377061893724,0.00839634959242936,"Q8JZQ5",0,"Diamine oxidase [copper-containing] (Diamine oxidase) (EC 1.4.3.22) (Amine oxidase copper domain-containing protein 1) (Histaminase)","amine metabolic process [GO:0009308]; cellular response to copper ion starvation [GO:0035874]; putrescine metabolic process [GO:0009445]; response to antibiotic [GO:0046677]","GO:0005507; GO:0005615; GO:0005886; GO:0005923; GO:0008131; GO:0008201; GO:0009308; GO:0009445; GO:0035874; GO:0046677; GO:0048038; GO:0050232; GO:0052597; GO:0052598; GO:0052599; GO:0052600; GO:0097159"
"1400","Pocillopora_acuta_HIv2___TS.g24662.t1",21.0156364379834,-3.15970274491034,3.02106069216357,0.00152381206306188,0.00839634959242936,"P97686",4.39e-08,"Neuronal cell adhesion molecule (Nr-CAM) (Ankyrin-binding cell adhesion molecule NrCAM) (Neuronal surface protein Bravo) (rBravo) (NgCAM-related cell adhesion molecule) (Ng-CAM-related)","angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; clustering of voltage-gated sodium channels [GO:0045162]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuronal action potential propagation [GO:0019227]; protein localization [GO:0008104]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; retinal ganglion cell axon guidance [GO:0031290]","GO:0001525; GO:0005576; GO:0005886; GO:0007155; GO:0007156; GO:0007411; GO:0007417; GO:0008104; GO:0010975; GO:0019227; GO:0030424; GO:0030506; GO:0031290; GO:0033268; GO:0043194; GO:0045162; GO:0045202; GO:0045211; GO:0070593; GO:0086080; GO:0098609; GO:0098632; GO:0098839; GO:0098978; GO:0099175"
"1401","Pocillopora_acuta_HIv2___RNAseq.g28818.t1",1048.18105913842,1.83751220228664,0.73683773048943,0.0015246304499289,0.00839765987348498,"Q6XYQ8",5.38e-20,"Synaptotagmin-10 (Synaptotagmin X) (SytX)","calcium-ion regulated exocytosis [GO:0017156]; chemical synaptic transmission [GO:0007268]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; sensory perception of smell [GO:0007608]","GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0007268; GO:0007608; GO:0017156; GO:0030276; GO:0030658; GO:0042803; GO:0045956; GO:0046982; GO:0070382; GO:0098793; GO:0098978"
"1402","Pocillopora_acuta_HIv2___RNAseq.19150_t",1429.28441585307,2.40407672853448,2.14590185735551,0.00152771048323515,0.00841142155672372,NA,NA,NA,NA,NA
"1403","Pocillopora_acuta_HIv2___RNAseq.g19600.t1",907.261226942243,-2.17834183938767,1.46279086522912,0.00153190507376727,0.00843130707266736,"Q6P8Y1",2.6e-98,"Calcyphosin-like protein","","GO:0005509; GO:0005737"
"1404","Pocillopora_acuta_HIv2___TS.g4840.t1",26.7177972799547,2.96663969838949,1.92933854420796,0.0015375213039505,0.00845675400469623,"Q7ZWG6",8.43e-25,"Proton-coupled folate transporter (Solute carrier family 46 member 1)","transmembrane transport [GO:0055085]","GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085"
"1405","Pocillopora_acuta_HIv2___RNAseq.g9309.t1",27.5165488014735,-3.10035793924201,2.78324461959235,0.00157345227839677,0.00864352972074852,"Q0R4F1",0,"ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1)","DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitochondrial genome maintenance [GO:0000002]; telomere maintenance [GO:0000723]","GO:0000002; GO:0000723; GO:0003677; GO:0005524; GO:0005634; GO:0005739; GO:0006281; GO:0006310; GO:0016887; GO:0043139"
"1406","Pocillopora_acuta_HIv2___RNAseq.g30102.t1",193.291378289905,-3.87713666559862,5.34723476814287,0.0015791177338259,0.00867135873274784,"O16616",6.42e-13,"E3 ubiquitin-protein ligase trim-21 (EC 2.3.2.27)","protein ubiquitination [GO:0016567]","GO:0005737; GO:0008270; GO:0016567; GO:0016740"
"1407","Pocillopora_acuta_HIv2___RNAseq.g29611.t1",28007.0215218009,1.51696408996071,0.552298659037667,0.00159627956767401,0.0087622723593309,NA,NA,NA,NA,NA
"1408","Pocillopora_acuta_HIv2___RNAseq.g15220.t1",887.67403368448,-1.6846991541624,2.76881401715949,0.00159773749419597,0.00876694807133934,NA,NA,NA,NA,NA
"1409","Pocillopora_acuta_HIv2___RNAseq.21012_t",36.489976006713,2.6660952773096,1.38464617848215,0.00159891890706822,0.00877010355397603,"Q8CHN8",1.18e-40,"Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain]","complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; zymogen activation [GO:0031638]","GO:0001867; GO:0004252; GO:0005509; GO:0005615; GO:0006956; GO:0008233; GO:0031638; GO:0042803; GO:0048306"
"1410","Pocillopora_acuta_HIv2___TS.g29156.t1",96.8200384455112,-2.48815632017851,2.40245494297444,0.00160420371695997,0.00879575533059478,NA,NA,NA,NA,NA
"1411","Pocillopora_acuta_HIv2___RNAseq.g9756.t1",1987.64126929979,1.71810098901,0.66940103476828,0.0016205167360903,0.00887846745106445,"Q5ZJF4",2.94e-91,"Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Glutathione-dependent peroxiredoxin) (Lysophosphatidylcholine acyltransferase 5) (LPC acyltransferase 5) (LPCAT-5) (Lyso-PC acyltransferase 5) (EC 2.3.1.23) (Non-selenium glutathione peroxidase) (NSGPx)","cell redox homeostasis [GO:0045454]; lipid catabolic process [GO:0016042]","GO:0004623; GO:0005615; GO:0005739; GO:0005764; GO:0005829; GO:0016042; GO:0045454; GO:0047184; GO:0051920"
"1412","Pocillopora_acuta_HIv2___RNAseq.g842.t1",667.519968577847,2.3180644734395,1.52915143106446,0.00162548608057114,0.00889895180521613,NA,NA,NA,NA,NA
"1413","Pocillopora_acuta_HIv2___RNAseq.g21055.t1",1810.23198076969,2.27687270138878,1.2340051205821,0.00165103513569602,0.00902174998213347,"Q6P1B1",0,"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)","bradykinin catabolic process [GO:0010815]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508]","GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0043069; GO:0070006"
"1414","Pocillopora_acuta_HIv2___RNAseq.g28809.t1",745.50663997748,2.09873420101978,1.02444341126911,0.00167885179264965,0.00915645261270154,NA,NA,NA,NA,NA
"1415","Pocillopora_acuta_HIv2___RNAseq.g27793.t1",505.80329188519,-1.68736694242437,2.34896129950894,0.0016843140754431,0.00917586394998457,"Q9N293",8.75e-35,"Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5)","lipid metabolic process [GO:0006629]; protein O-linked glycosylation [GO:0006493]","GO:0000139; GO:0006493; GO:0006629; GO:0008499"
"1416","Pocillopora_acuta_HIv2___RNAseq.g27206.t1",1311.00459748368,-1.74748947033634,1.84899921014233,0.00169643825662974,0.00923843484333303,"Q86U86",0,"Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D)","chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368]","GO:0000228; GO:0000278; GO:0000776; GO:0000785; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0006357; GO:0006368; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0045582; GO:0045597; GO:0045663; GO:0070316; GO:2000045; GO:2000781; GO:2000819"
"1417","Pocillopora_acuta_HIv2___TS.g7609.t1a",37.417393894475,-2.30513511584441,2.35887285246055,0.0017043582161102,0.00927458135358089,NA,NA,NA,NA,NA
"1418","Pocillopora_acuta_HIv2___RNAseq.g14360.t1",1548.37344868615,2.77204457416013,1.95617523045798,0.00171554051179113,0.00932490716367789,NA,NA,NA,NA,NA
"1419","Pocillopora_acuta_HIv2___TS.g18770.t2",1578.70198555442,-1.27991290335671,2.12763890243775,0.00174820229050195,0.00948106409067124,NA,NA,NA,NA,NA
"1420","Pocillopora_acuta_HIv2___RNAseq.g6073.t1",17.8806840183318,-1.09380252999249,2.32584060249185,0.00177277044962984,0.00960350254061647,NA,NA,NA,NA,NA
"1421","Pocillopora_acuta_HIv2___RNAseq.g9098.t1",2116.3987309538,2.0122388973289,2.48572556980563,0.00180352407761112,0.00974819591127325,"O60235",1.87e-36,"Transmembrane protease serine 11D (EC 3.4.21.-) (Airway trypsin-like protease) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain]","proteolysis [GO:0006508]; respiratory gaseous exchange by respiratory system [GO:0007585]","GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0007585; GO:0008233; GO:0070062"
"1422","Pocillopora_acuta_HIv2___RNAseq.g12088.t1",135.026335841181,2.38818677070321,2.84108712743999,0.00180794513822563,0.00976844171807826,"Q9EQD2",2.18e-33,"Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor)","cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of MAPK cascade [GO:0043408]","GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0042277; GO:0043408"
"1423","Pocillopora_acuta_HIv2___TS.g1420.t1b",141.813401693939,-2.40573887012201,1.27392855888229,0.00182433424449178,0.00983891194078614,NA,NA,NA,NA,NA
"1424","Pocillopora_acuta_HIv2___TS.g24259.t1",62.744234372737,-2.64695489946083,1.89944179751237,0.00183329286248273,0.0098685329225717,"Q8R3W5",4.44e-13,"tRNA-splicing endonuclease subunit Sen15 (tRNA-intron endonuclease Sen15)","mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]","GO:0003676; GO:0005730; GO:0006388; GO:0006397"
"1425","Pocillopora_acuta_HIv2___RNAseq.g5388.t1",1054.28576452956,2.06730103374743,2.03048774119908,0.00183696699601333,0.00988463193092885,"D3YXG0",8.08e-06,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]","GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711"
"1426","Pocillopora_acuta_HIv2___RNAseq.g30952.t1",104.092184356208,-1.95644095096114,2.56610967020977,0.00184210714054943,0.00990860456709072,"Q9Z1K5",4.83e-30,"E3 ubiquitin-protein ligase ARIH1 (EC 2.3.2.31) (Protein ariadne-1 homolog) (ARI-1) (UbcH7-binding protein) (UbcM4-interacting protein 77) (Ubiquitin-conjugating enzyme E2-binding protein 1)","protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0006511; GO:0008270; GO:0015030; GO:0016567; GO:0016604; GO:0019005; GO:0031462; GO:0031463; GO:0031464; GO:0031624; GO:0031625; GO:0061630; GO:0097413"
"1427","Pocillopora_acuta_HIv2___TS.g19590.t1",522.382671885679,-2.08142528146101,0.963043349168069,0.00184467744973055,0.00991874149922033,"Q8VEE0",5.75e-98,"Ribulose-phosphate 3-epimerase (EC 5.1.3.1) (Ribulose-5-phosphate-epimerase)","carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]","GO:0004750; GO:0005829; GO:0005975; GO:0006098; GO:0009052; GO:0030246; GO:0046872; GO:0048029"
"1428","Pocillopora_acuta_HIv2___RNAseq.g21912.t1",1446.16922174492,-2.26469926337555,2.54977015109375,0.00186441615473219,0.0100174276604927,"Q504H8",1e-48,"Homeobox protein HMX3 (Homeobox protein H6 family member 3) (Homeobox protein Nkx-5.1)","cell differentiation [GO:0030154]; inner ear morphogenesis [GO:0042472]; otolith development [GO:0048840]; posterior lateral line development [GO:0048916]; posterior lateral line neuromast primordium migration [GO:0048920]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0021510; GO:0030154; GO:0042472; GO:0048840; GO:0048916; GO:0048920"
"1429","Pocillopora_acuta_HIv2___RNAseq.g949.t1",537.975017112117,-1.93914736539213,0.867423917063415,0.00187977835647986,0.010092469988168,"Q5RBX7",1.35e-34,"Signal recognition particle 14 kDa protein (SRP14)","SRP-dependent cotranslational protein targeting to membrane [GO:0006614]","GO:0005786; GO:0006614; GO:0008312; GO:0030942"
"1430","Pocillopora_acuta_HIv2___TS.g28689.t1",160.346030570493,1.09430227763941,2.12013758084732,0.00188320201215697,0.0101070997787898,NA,NA,NA,NA,NA
"1431","Pocillopora_acuta_HIv2___RNAseq.g28339.t1",1279.96101528552,-1.16024123472217,1.90988416698163,0.001904785722279,0.0102153580597121,NA,NA,NA,NA,NA
"1432","Pocillopora_acuta_HIv2___RNAseq.g26011.t1",154.81058003676,-2.26795386565191,2.17960332958834,0.00191158119535813,0.0102480023757079,NA,NA,NA,NA,NA
"1433","Pocillopora_acuta_HIv2___RNAseq.g13672.t1",133.713372981856,-2.5768786219918,2.97922414427143,0.00191345984692944,0.0102535517846905,"P43166",2.26e-47,"Carbonic anhydrase 7 (EC 4.2.1.1) (Carbonate dehydratase VII) (Carbonic anhydrase VII) (CA-VII)","neuron cellular homeostasis [GO:0070050]; one-carbon metabolic process [GO:0006730]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]","GO:0004089; GO:0005737; GO:0005829; GO:0006730; GO:0008270; GO:0032230; GO:0032849; GO:0051453; GO:0070050; GO:2001225"
"1434","Pocillopora_acuta_HIv2___TS.g4401.t1",256.948979317925,2.00604822975662,1.75473156314214,0.00192567010744137,0.0103120668026775,NA,NA,NA,NA,NA
"1435","Pocillopora_acuta_HIv2___RNAseq.g2410.t1",569.26919791403,-2.09779677839684,1.29712954640957,0.00193781355271008,0.0103732550800883,"P70187",0,"Hippocampus abundant transcript 1 protein (Major facilitator superfamily domain-containing 14A)","acrosome assembly [GO:0001675]; sperm mitochondrion organization [GO:0030382]; spermatid development [GO:0007286]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]","GO:0001675; GO:0007283; GO:0007286; GO:0007289; GO:0016020; GO:0022857; GO:0030382"
"1436","Pocillopora_acuta_HIv2___RNAseq.g17508.t1b",2272.76926165412,2.7542000828804,1.96039480983139,0.00195011542329969,0.0104313866429759,"Q8CG08",2.54e-19,"Collagen triple helix repeat-containing protein 1","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0031012; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0090090; GO:0090103; GO:0090177"
"1437","Pocillopora_acuta_HIv2___RNAseq.g4746.t1",3648.60232233247,2.04540859669408,0.982894698284068,0.00196761633200653,0.0105172219608804,NA,NA,NA,NA,NA
"1438","Pocillopora_acuta_HIv2___RNAseq.g8098.t1",11539.4189961409,1.9197132520602,0.851982288511848,0.00197253903912308,0.0105396396977748,"Q95029",1.75e-127,"Cathepsin L1 (EC 3.4.22.15) (Cysteine proteinase 1) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain]","digestion [GO:0007586]; immune response [GO:0006955]; positive regulation of apoptotic signaling pathway [GO:2001235]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]","GO:0004197; GO:0005615; GO:0005764; GO:0005770; GO:0006508; GO:0006955; GO:0007586; GO:0008233; GO:0008234; GO:0008656; GO:0044754; GO:0045169; GO:0051603; GO:2001235"
"1439","Pocillopora_acuta_HIv2___RNAseq.g3840.t1",611.166561274037,-2.27810595135465,1.43051880317292,0.00198834040524242,0.0106083938109282,"O75366",0,"Advillin (p92)","actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480]","GO:0003779; GO:0005546; GO:0005737; GO:0005884; GO:0005925; GO:0007015; GO:0007399; GO:0008154; GO:0010592; GO:0010976; GO:0015629; GO:0030027; GO:0030424; GO:0042995; GO:0043005; GO:0051014; GO:0051015; GO:0051016; GO:0060271; GO:0071933; GO:1900480"
"1440","Pocillopora_acuta_HIv2___RNAseq.g24307.t1",336.818402277547,2.10361328297143,1.04975089881954,0.00200693108021071,0.0106948274587065,NA,NA,NA,NA,NA
"1441","Pocillopora_acuta_HIv2___RNAseq.g242.t1",25.2777026865998,-1.48693754924487,3.42671098422308,0.00200822035749902,0.0106948274587065,NA,NA,NA,NA,NA
"1442","Pocillopora_acuta_HIv2___RNAseq.g10739.t1",289.757265145104,-1.40801913683903,2.23765405801784,0.00200823778884449,0.0106948274587065,"A0A0C2SRU0",1.49e-78,"Decarboxylase iboD (EC 4.1.1.-) (Ibotenic acid biosynthesis cluster protein D)","phospholipid biosynthetic process [GO:0008654]","GO:0004609; GO:0008654"
"1443","Pocillopora_acuta_HIv2___RNAseq.g18294.t1b",206.959235047174,-2.06312720370591,2.05851991019484,0.00201566932845859,0.010730453134643,NA,NA,NA,NA,NA
"1444","Pocillopora_acuta_HIv2___RNAseq.g18290.t1",953.967303461302,2.53903221620928,1.91731556604633,0.00202872305900039,0.0107920008552341,NA,NA,NA,NA,NA
"1445","Pocillopora_acuta_HIv2___RNAseq.g22722.t1",716.088092866138,-1.15521997631936,1.82069647636793,0.00203356480856719,0.0108137799232044,"G5EDU6",2.38e-50,"Transcription factor ovo-like homolog lin-48 (Abnormal cell lineage protein 48)","animal organ morphogenesis [GO:0009887]; epidermal cell differentiation [GO:0009913]; hindgut morphogenesis [GO:0007442]; nematode male tail tip morphogenesis [GO:0045138]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to salt stress [GO:0009651]","GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007442; GO:0009651; GO:0009887; GO:0009913; GO:0045138; GO:0046872"
"1446","Pocillopora_acuta_HIv2___RNAseq.g9554.t1",665.832549353688,2.13351413611565,2.55021580750535,0.00204262341712599,0.0108460004057674,"Q9UDT6",4.44e-10,"CAP-Gly domain-containing linker protein 2 (Cytoplasmic linker protein 115) (CLIP-115) (Cytoplasmic linker protein 2) (Williams-Beuren syndrome chromosomal region 3 protein) (Williams-Beuren syndrome chromosomal region 4 protein)","cytoplasmic microtubule organization [GO:0031122]","GO:0005634; GO:0005875; GO:0005938; GO:0008017; GO:0031122; GO:0035371; GO:0051010"
"1447","Pocillopora_acuta_HIv2___RNAseq.g13027.t1",552.978205740474,1.9321586823156,1.78525909928474,0.00204696624456066,0.010865071472046,NA,NA,NA,NA,NA
"1448","Pocillopora_acuta_HIv2___RNAseq.g31256.t1",180.948442550252,-1.16722056944393,1.87424801684364,0.00206779668990561,0.0109498055471562,"Q5BJN5",1.38e-47,"Mitochondrial intermembrane space import and assembly protein 40 (Coiled-coil-helix-coiled-coil-helix domain-containing protein 4)","'de novo' post-translational protein folding [GO:0051084]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to oxidative stress [GO:0034599]; establishment of protein localization to mitochondrion [GO:0072655]; mitochondrial DNA repair [GO:0043504]; mitochondrial respiratory chain complex assembly [GO:0033108]; peptidyl-cysteine oxidation [GO:0018171]; positive regulation of cellular respiration [GO:1901857]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation by protein folding [GO:0022417]; regulation of protein export from nucleus [GO:0046825]","GO:0005739; GO:0005758; GO:0015035; GO:0018171; GO:0022417; GO:0033108; GO:0034599; GO:0043504; GO:0045041; GO:0046825; GO:0051084; GO:0072655; GO:1901857; GO:1990830"
"1449","Pocillopora_acuta_HIv2___TS.g5006.t1b",819.971019769495,2.02204887731796,1.00950198357586,0.00206862840882389,0.0109498055471562,"Q90Z00",2.94e-45,"Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)","anatomical structure homeostasis [GO:0060249]; cardiac muscle tissue development [GO:0048738]; cartilage development [GO:0051216]; cell migration in hindbrain [GO:0021535]; dorsal/ventral pattern formation [GO:0009953]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; liver development [GO:0001889]; mesoderm development [GO:0007498]; negative regulation of endodermal cell fate specification [GO:0042664]; olfactory nerve formation [GO:0021628]; olfactory placode morphogenesis [GO:0071699]; pectoral fin development [GO:0033339]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAP kinase activity [GO:0043406]; post-anal tail morphogenesis [GO:0036342]; posterior lateral line development [GO:0048916]; response to ethanol [GO:0045471]; skin morphogenesis [GO:0043589]","GO:0001889; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007498; GO:0008201; GO:0008284; GO:0008543; GO:0009953; GO:0017134; GO:0018108; GO:0021535; GO:0021628; GO:0031101; GO:0031410; GO:0033339; GO:0036342; GO:0042664; GO:0043235; GO:0043406; GO:0043589; GO:0045471; GO:0045597; GO:0048738; GO:0048916; GO:0051216; GO:0060249; GO:0071699"
"1450","Pocillopora_acuta_HIv2___RNAseq.g10479.t1",249.833793516816,-1.51995899808913,2.29699896399917,0.00210224987038945,0.0111014757668174,"Q5ZJJ8",3.48e-152,"Ubiquitin-like domain-containing CTD phosphatase 1 (EC 3.1.3.16) (Nuclear proteasome inhibitor UBLCP1)","regulation of proteasome assembly [GO:0090364]","GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0017018; GO:0046872; GO:0090364; GO:1904855"
"1451","Pocillopora_acuta_HIv2___RNAseq.g8978.t1",118.626825157533,1.27787655352621,1.90905026666937,0.00215009906073198,0.0113440119981408,"B8EIZ7",6.75e-177,"Trimethylamine monooxygenase (TMA monooxygenase) (Tmm) (EC 1.14.13.148)","","GO:0004499; GO:0034899; GO:0047822; GO:0050660; GO:0050661"
"1452","Pocillopora_acuta_HIv2___TS.g26912.t1",3498.5357432004,1.64369116485064,0.652933583242005,0.00215053103559887,0.0113440119981408,"P50460",1.34e-21,"Cysteine and glycine-rich protein 2 (Beta-cysteine-rich protein) (Beta-CRP) (Cysteine-rich protein 2) (CRP2)","muscle tissue development [GO:0060537]; sarcomere organization [GO:0045214]","GO:0005634; GO:0005737; GO:0008307; GO:0030018; GO:0042805; GO:0045214; GO:0046872; GO:0060537"
"1453","Pocillopora_acuta_HIv2___RNAseq.g16773.t1",517.173950836484,1.68698099126525,2.42179763749289,0.00215341310947972,0.0113550737205668,NA,NA,NA,NA,NA
"1454","Pocillopora_acuta_HIv2___RNAseq.g26860.t1",579.249932008465,-2.41427572152666,1.71463310462274,0.00215500311845284,0.0113593167293374,NA,NA,NA,NA,NA
"1455","Pocillopora_acuta_HIv2___RNAseq.g14837.t1",1136.33667680131,2.43943923634845,2.20890461059267,0.0021665530152676,0.0114035745315977,"Q9CR40",1.04e-41,"Kelch-like protein 28 (BTB/POZ domain-containing protein 5)","",""
"1456","Pocillopora_acuta_HIv2___TS.g23673.t1",128.018589930355,2.4001959827477,1.37231723697242,0.00216819662859478,0.011408074221897,"Q8IX30",1.31e-09,"Signal peptide, CUB and EGF-like domain-containing protein 3","positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of osteoblast differentiation [GO:0045669]; signal transduction [GO:0007165]","GO:0005509; GO:0005615; GO:0005886; GO:0007165; GO:0009986; GO:0030513; GO:0036122; GO:0042802; GO:0045669; GO:0070700"
"1457","Pocillopora_acuta_HIv2___RNAseq.g12293.t1",2187.86841419271,-2.04182093925497,0.998463149630775,0.00220973248553031,0.0116181645476956,"O14522",2.01e-135,"Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho)","cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; signal transduction [GO:0007165]","GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0035335; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0050807; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:0098839; GO:0098978; GO:1904893; GO:1990264"
"1458","Pocillopora_acuta_HIv2___RNAseq.g12419.t1",232.644070027198,-2.22534097251664,1.53823998851949,0.0022113839149791,0.0116222861415432,"Q66KE8",7.41e-90,"Coiled-coil domain-containing protein 78 (xCCDC78)","cell projection organization [GO:0030030]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]","GO:0005737; GO:0005814; GO:0030030; GO:0098535; GO:0098536"
"1459","Pocillopora_acuta_HIv2___TS.g29999.t1a",389.426937178768,-1.85282067770457,0.816733927529342,0.00223051633215026,0.0117146652971029,"Q9DBN9",5.38e-165,"Probable ATP-dependent RNA helicase DDX59 (EC 3.6.4.13) (DEAD box protein 59) (Zinc finger HIT domain-containing protein 5)","","GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005737; GO:0016887; GO:0046872"
"1460","Pocillopora_acuta_HIv2___RNAseq.g24896.t1",966.600333200339,2.46891803242375,2.0461650826192,0.00226740117913846,0.0118868034269876,"P51512",1.58e-53,"Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP)","chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]","GO:0001501; GO:0001958; GO:0004222; GO:0005615; GO:0005796; GO:0005886; GO:0006508; GO:0008047; GO:0008270; GO:0009986; GO:0016485; GO:0030198; GO:0030574; GO:0031012; GO:0035988; GO:0048701; GO:0070006; GO:0097094"
"1461","Pocillopora_acuta_HIv2___RNAseq.g4954.t1",467.379911644555,-2.08869717027349,2.12259267089644,0.0022960041774788,0.0120171776241975,"Q9NXC2",1.49e-115,"Glucose-fructose oxidoreductase domain-containing protein 1 (EC 1.-.-.-)","","GO:0000166; GO:0005576; GO:0016491"
"1462","Pocillopora_acuta_HIv2___RNAseq.g28195.t1",4609.47300551703,2.02069133714183,1.03977314333332,0.00235671116462209,0.0123015049747723,"O96790",9.75e-24,"Serine protease inhibitor dipetalogastin (Dipetalin)","negative regulation of coagulation [GO:0050819]","GO:0004867; GO:0005576; GO:0050819"
"1463","Pocillopora_acuta_HIv2___RNAseq.g24761.t1",3524.0390642244,-2.64910941532483,1.88961733810552,0.00237696012820755,0.0123937820095148,"P79134",7.56e-108,"Annexin A6 (Annexin VI) (Annexin-6)","apoptotic signaling pathway [GO:0097190]; biomineral tissue development [GO:0031214]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; growth plate cartilage chondrocyte differentiation [GO:0003418]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of sequestering of calcium ion [GO:0051283]; regulation of muscle contraction [GO:0006937]","GO:0001725; GO:0001786; GO:0003418; GO:0005262; GO:0005509; GO:0005544; GO:0005737; GO:0005886; GO:0005925; GO:0006816; GO:0006937; GO:0008201; GO:0012506; GO:0016020; GO:0019899; GO:0030061; GO:0031214; GO:0031982; GO:0035374; GO:0038024; GO:0042383; GO:0042470; GO:0042584; GO:0048306; GO:0048471; GO:0051015; GO:0051283; GO:0051560; GO:0070509; GO:0070588; GO:0097190"
"1464","Pocillopora_acuta_HIv2___TS.g14528.t1a",288.453628603143,1.62910708665229,2.39382163393088,0.0023978631352975,0.0124847704783812,"Q92626",1.01e-22,"Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment]","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070062; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"1465","Pocillopora_acuta_HIv2___TS.g2835.t1",79.4348268517831,-1.41273665426048,2.01249421072036,0.0024216567060758,0.01259505307324,"Q5F4A1",3.58e-61,"G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase)","apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]","GO:0004842; GO:0005634; GO:0005730; GO:0005737; GO:0006915; GO:0016567; GO:0046872"
"1466","Pocillopora_acuta_HIv2___RNAseq.g18716.t1",619.555710014511,1.52491873899192,2.43415772192658,0.00242263031155091,0.0125955876442388,"Q96PM5",8.02e-24,"RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING finger protein 199) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363) (p53-induced RING-H2 protein) (hPirh2)","error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630; GO:0070987; GO:0072344"
"1467","Pocillopora_acuta_HIv2___RNAseq.g16948.t1",2941.74848879862,-2.09122915706159,1.10913099404249,0.00242802638113692,0.0126191065672887,"P42325",2.16e-121,"Neurocalcin homolog (DrosNCa)","negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]","GO:0005509; GO:0045938; GO:1902848"
"1468","Pocillopora_acuta_HIv2___RNAseq.g3780.t1",5713.7004064335,1.57473233631454,0.623786989913418,0.00245599117179588,0.0127461271291193,"Q2VWQ2",5.25e-13,"Protein kinase C-binding protein NELL1 (NEL-like protein 1)","generation of neurons [GO:0048699]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]","GO:0005080; GO:0005509; GO:0005615; GO:0005635; GO:0005737; GO:0008201; GO:0010468; GO:0030501; GO:0033689; GO:0042177; GO:0042802; GO:0043065; GO:0045667; GO:0045669; GO:0045778; GO:0048471; GO:0048699"
"1469","Pocillopora_acuta_HIv2___RNAseq.g28209.t1",2192.24727625233,-2.24581696401046,2.04826528350693,0.00246298262184076,0.0127778266292341,NA,NA,NA,NA,NA
"1470","Pocillopora_acuta_HIv2___TS.g15590.t1",303.51019977438,3.24761957734985,2.14323069163015,0.00247139042779618,0.0128168487442251,"Q96RW7",2.07e-06,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711"
"1471","Pocillopora_acuta_HIv2___RNAseq.g8004.t1",599.105525428108,-2.0266369667347,1.06424728654923,0.00254009855295072,0.0131496010987399,"Q96EV8",1.8e-25,"Dysbindin (Biogenesis of lysosome-related organelles complex 1 subunit 8) (BLOC-1 subunit 8) (Dysbindin-1) (Dystrobrevin-binding protein 1) (Hermansky-Pudlak syndrome 7 protein) (HPS7 protein)","actin cytoskeleton organization [GO:0030036]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; blood coagulation [GO:0007596]; cilium assembly [GO:0060271]; dendrite morphogenesis [GO:0048813]; kidney development [GO:0001822]; melanosome organization [GO:0032438]; memory [GO:0007613]; negative regulation of dendritic spine morphogenesis [GO:0061002]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; platelet dense granule organization [GO:0060155]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; protein transmembrane transport [GO:0071806]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of dopamine secretion [GO:0014059]; regulation of synaptic vesicle exocytosis [GO:2000300]; retina development in camera-type eye [GO:0060041]","GO:0001822; GO:0001934; GO:0001956; GO:0002092; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0007596; GO:0007613; GO:0008089; GO:0010008; GO:0010628; GO:0014059; GO:0014069; GO:0015630; GO:0016528; GO:0030036; GO:0030424; GO:0030426; GO:0030496; GO:0030672; GO:0031083; GO:0031175; GO:0032438; GO:0033162; GO:0042383; GO:0043005; GO:0043025; GO:0043197; GO:0045211; GO:0048490; GO:0048812; GO:0048813; GO:0060041; GO:0060155; GO:0060159; GO:0060271; GO:0061002; GO:0061646; GO:0071806; GO:0098685; GO:0098686; GO:0098978; GO:1904115; GO:2000300"
"1472","Pocillopora_acuta_HIv2___RNAseq.g17731.t1",199.78662059948,-2.08580693566492,1.23594895086336,0.00255022216958243,0.013189007396741,"Q7RTR2",1.44e-83,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223"
"1473","Pocillopora_acuta_HIv2___RNAseq.g25237.t1",576.469052137045,-1.93619800922375,1.78681194392511,0.00255044618975972,0.013189007396741,"Q43469",2.49e-124,"Delta(8)-fatty-acid desaturase (EC 1.14.19.29) (Delta(8)-sphingolipid desaturase) (Sphingolipid 8-(E/Z)-desaturase)","sphingolipid metabolic process [GO:0006665]","GO:0006665; GO:0016020; GO:0046872; GO:0052631"
"1474","Pocillopora_acuta_HIv2___RNAseq.g10385.t1",500.556338227262,1.90093426688185,0.893357101882432,0.00255842646620404,0.0132164474885448,"Q8N441",3.27e-39,"Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5) (FGFR-5)","cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; diaphragm development [GO:0060539]; heart valve morphogenesis [GO:0003179]; negative regulation of cell population proliferation [GO:0008285]; skeletal system development [GO:0001501]; ventricular septum morphogenesis [GO:0060412]","GO:0001501; GO:0003179; GO:0005007; GO:0005794; GO:0005886; GO:0008201; GO:0008285; GO:0017134; GO:0030133; GO:0042802; GO:0044291; GO:0060412; GO:0060539; GO:0098742"
"1475","Pocillopora_acuta_HIv2___RNAseq.g21957.t1",266.022006239229,-2.47416653094385,2.25598481768647,0.00255971414899041,0.0132180312213486,"Q6UVY6",1.84e-14,"DBH-like monooxygenase protein 1 (EC 1.14.17.-) (Monooxygenase X)","dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]","GO:0004500; GO:0005507; GO:0005615; GO:0005789; GO:0006589; GO:0030667; GO:0042420; GO:0042421"
"1476","Pocillopora_acuta_HIv2___RNAseq.g9839.t1",3421.84144561209,1.41693788284467,0.538794650881152,0.00257749159456004,0.0132955914492569,"O42412",1.77e-54,"Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase)","hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403]","GO:0004800; GO:0005886; GO:0010008; GO:0033798; GO:0042403; GO:0042446"
"1477","Pocillopora_acuta_HIv2___TS.g9744.t1",42.2436684971209,-2.38099739663496,2.06252311839481,0.00259234542479346,0.0133674453562255,NA,NA,NA,NA,NA
"1478","Pocillopora_acuta_HIv2___RNAseq.g24672.t1",86.6084520670653,-2.42849112837845,1.55681362858112,0.00260386122406303,0.013422041605434,"Q8U3Y2",4.89e-77,"Glyoxylate reductase (EC 1.1.1.26)","","GO:0005737; GO:0047964; GO:0051287"
"1479","Pocillopora_acuta_HIv2___RNAseq.26564_t",6653.23248307922,-2.17380195066002,2.39549014334398,0.00265315283627666,0.0136275577499665,"P58197",8.9e-87,"Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2)","anterior neuropore closure [GO:0021506]; basement membrane organization [GO:0071711]; bone morphogenesis [GO:0060349]; cell population proliferation [GO:0008283]; cellular response to iron ion [GO:0071281]; cornea development in camera-type eye [GO:0061303]; embryonic body morphogenesis [GO:0010172]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; embryonic pattern specification [GO:0009880]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermis morphogenesis [GO:0048730]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; fibroblast migration [GO:0010761]; forebrain neuron development [GO:0021884]; forelimb morphogenesis [GO:0035136]; inner ear morphogenesis [GO:0042472]; keratinocyte development [GO:0003334]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lens morphogenesis in camera-type eye [GO:0002089]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neural tube closure [GO:0001843]; neuron apoptotic process [GO:0051402]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; outflow tract morphogenesis [GO:0003151]; positive regulation of bone mineralization [GO:0030501]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; retina layer formation [GO:0010842]; roof of mouth development [GO:0060021]; Schwann cell development [GO:0014044]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366]; trigeminal nerve development [GO:0021559]","GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0001228; GO:0001822; GO:0001843; GO:0002089; GO:0003151; GO:0003334; GO:0003404; GO:0003409; GO:0003677; GO:0003682; GO:0003700; GO:0003713; GO:0003714; GO:0005634; GO:0005905; GO:0006355; GO:0006357; GO:0006366; GO:0007173; GO:0007399; GO:0007423; GO:0007605; GO:0008283; GO:0008285; GO:0009880; GO:0010172; GO:0010628; GO:0010761; GO:0010763; GO:0010842; GO:0010944; GO:0014032; GO:0014044; GO:0021506; GO:0021559; GO:0021623; GO:0021884; GO:0030501; GO:0032496; GO:0035115; GO:0035136; GO:0042059; GO:0042127; GO:0042472; GO:0042802; GO:0043066; GO:0043524; GO:0043525; GO:0043565; GO:0043588; GO:0045595; GO:0045664; GO:0045892; GO:0045893; GO:0045944; GO:0048485; GO:0048596; GO:0048701; GO:0048705; GO:0048730; GO:0051402; GO:0060021; GO:0060235; GO:0060325; GO:0060349; GO:0061029; GO:0061303; GO:0070172; GO:0071281; GO:0071711; GO:0072210; GO:0140536; GO:1990837; GO:2000378"
"1480","Pocillopora_acuta_HIv2___RNAseq.g3523.t1",2327.91634013368,1.87966823216358,1.57985063229323,0.00265627376831652,0.0136387446875861,"Q6DIV6",1.08e-72,"Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter)","beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836]","GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800"
"1481","Pocillopora_acuta_HIv2___RNAseq.g30027.t1",1878.08236006063,2.18543721835924,2.18731521896636,0.00268279455893538,0.013745639567992,"O97563",8.09e-19,"Metalloproteinase inhibitor 4 (Tissue inhibitor of metalloproteinases 4) (TIMP-4)","negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; response to cytokine [GO:0034097]; response to hormone [GO:0009725]","GO:0002020; GO:0005615; GO:0008191; GO:0009725; GO:0031012; GO:0034097; GO:0046872; GO:0051045"
"1482","Pocillopora_acuta_HIv2___RNAseq.g28606.t1",1750.27220872435,-1.13405828391564,1.87491752314468,0.00272865199918785,0.0139558778346015,NA,NA,NA,NA,NA
"1483","Pocillopora_acuta_HIv2___RNAseq.g3097.t1",290.125582934751,-2.08539333504305,1.71500441859797,0.00275387843460708,0.0140699744536054,NA,NA,NA,NA,NA
"1484","Pocillopora_acuta_HIv2___RNAseq.g11722.t1",37.352150895933,2.28069260795494,1.75766418726498,0.00277503580828916,0.0141730642412057,NA,NA,NA,NA,NA
"1485","Pocillopora_acuta_HIv2___TS.g21212.t1",71.0531706971678,-2.36543836957818,1.39798457008062,0.00283632949402894,0.014462765087659,NA,NA,NA,NA,NA
"1486","Pocillopora_acuta_HIv2___RNAseq.g26959.t1",415.376553593932,-2.03134424027342,1.40274453016759,0.00284113600769568,0.0144748824287814,"Q6GPV5",6.93e-50,"E3 ubiquitin-protein ligase RNF181 (EC 2.3.2.27) (RING finger protein 181)","protein ubiquitination [GO:0016567]","GO:0016567; GO:0046872; GO:0061630"
"1487","Pocillopora_acuta_HIv2___RNAseq.g13617.t2",2007.47700811452,-1.91939980286917,1.38778187540866,0.00285255227546407,0.0145202288025644,"Q17RD7",2.94e-77,"Synaptotagmin-16 (Chr14Syt) (Synaptotagmin 14-like protein) (Synaptotagmin XIV-related protein)","","GO:0005543; GO:0042802"
"1488","Pocillopora_acuta_HIv2___RNAseq.g24836.t1",441.333049861554,-1.65205850611552,0.69235649352483,0.00289833104751901,0.0147371711897836,NA,NA,NA,NA,NA
"1489","Pocillopora_acuta_HIv2___RNAseq.g1638.t1",309.477082151102,1.90758137345237,2.03725771808115,0.00290258720228958,0.0147515886486003,"P10079",2.53e-115,"Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","","GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579"
"1490","Pocillopora_acuta_HIv2___RNAseq.g12682.t1",2977.74264656386,-1.89988384673255,0.980477271580394,0.0029046896138288,0.0147570883647418,"O35598",5.45e-143,"Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c)","adherens junction organization [GO:0034332]; amyloid-beta formation [GO:0034205]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; epidermal growth factor receptor ligand maturation [GO:0038004]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; negative regulation of gene expression [GO:0010629]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; nucleocytoplasmic transport [GO:0006913]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein catabolic process at postsynapse [GO:0140249]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of postsynapse organization [GO:0099175]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; signaling receptor ligand precursor processing [GO:0140448]","GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0005802; GO:0005886; GO:0005912; GO:0006468; GO:0006509; GO:0006913; GO:0007162; GO:0007219; GO:0007220; GO:0008021; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010629; GO:0010820; GO:0014069; GO:0016485; GO:0017124; GO:0019901; GO:0030136; GO:0030307; GO:0030424; GO:0030425; GO:0034205; GO:0034332; GO:0034612; GO:0038004; GO:0042117; GO:0042169; GO:0042803; GO:0043025; GO:0043065; GO:0043197; GO:0045211; GO:0046872; GO:0046930; GO:0046931; GO:0051089; GO:0061001; GO:0062023; GO:0070573; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0098696; GO:0098794; GO:0098978; GO:0099173; GO:0099175; GO:0140249; GO:0140448; GO:1901342; GO:1902945"
"1491","Pocillopora_acuta_HIv2___TS.g24829.t1a",2915.50267882844,-1.46126955674555,0.576426351166875,0.00292594376876384,0.0148546334402949,NA,NA,NA,NA,NA
"1492","Pocillopora_acuta_HIv2___RNAseq.g29143.t2",4185.18788079436,1.47985400508856,0.587461908195215,0.00299557664360012,0.0151602591228244,"Q9HCK4",1.34e-91,"Roundabout homolog 2","aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412]","GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609"
"1493","Pocillopora_acuta_HIv2___RNAseq.g10180.t1",3100.04406047856,-1.96634346738508,1.22347594476258,0.00300790447554972,0.0152013732824427,"P42583",1.46e-41,"Homeobox protein Nkx-2.5 (xNKx-2.5) (Homeobox protein NK-2 homolog E)","","GO:0000978; GO:0000981; GO:0005634; GO:0032991; GO:0032993"
"1494","Pocillopora_acuta_HIv2___RNAseq.g31081.t1",2788.55766565212,2.58240351982175,2.06520360452336,0.00301254861546487,0.0152195260824603,"Q29121",9.66e-164,"Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form]","protein O-linked glycosylation [GO:0006493]","GO:0004653; GO:0005576; GO:0005794; GO:0006493; GO:0030145; GO:0030246; GO:0032580"
"1495","Pocillopora_acuta_HIv2___RNAseq.g12410.t1",6201.14923901467,-1.88943059427905,0.934825669843489,0.00303272430988243,0.0153161048946017,"P43006",6.62e-159,"Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2)","adult behavior [GO:0030534]; cellular response to cocaine [GO:0071314]; D-aspartate import across plasma membrane [GO:0070779]; glutathione biosynthetic process [GO:0006750]; L-aspartate import across plasma membrane [GO:0140009]; L-aspartate transmembrane transport [GO:0070778]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; monoatomic anion transmembrane transport [GO:0098656]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neurotransmitter reuptake [GO:0098810]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; telencephalon development [GO:0021537]; visual behavior [GO:0007632]","GO:0005313; GO:0005314; GO:0005886; GO:0006750; GO:0007399; GO:0007632; GO:0008509; GO:0009410; GO:0009416; GO:0009611; GO:0009986; GO:0015175; GO:0015501; GO:0015813; GO:0016020; GO:0021537; GO:0030424; GO:0030534; GO:0030673; GO:0031982; GO:0033229; GO:0035264; GO:0042734; GO:0043197; GO:0043198; GO:0043200; GO:0044297; GO:0044306; GO:0045121; GO:0045202; GO:0046326; GO:0046872; GO:0070207; GO:0070778; GO:0070779; GO:0071314; GO:0097449; GO:0098656; GO:0098712; GO:0098796; GO:0098810; GO:0098978; GO:0140009"
"1496","Pocillopora_acuta_HIv2___RNAseq.g28041.t1",212.401682139925,-1.51577663612895,2.12851692570042,0.00305324293513057,0.0154035946333201,NA,NA,NA,NA,NA
"1497","Pocillopora_acuta_HIv2___RNAseq.g13338.t1",132.811231156371,-1.54499017864404,2.10647575009671,0.0030565091211976,0.0154146959306144,"P86854",4.98e-19,"Perlucin-like protein","","GO:0005576; GO:0030246; GO:0038023"
"1498","Pocillopora_acuta_HIv2___RNAseq.g20762.t1",86.4979593293527,-1.76499073418557,2.00099048195315,0.00311715893415529,0.0156877476769736,"A1R8N8",2.28e-12,"D-inositol 3-phosphate glycosyltransferase (EC 2.4.1.250) (N-acetylglucosamine-inositol-phosphate N-acetylglucosaminyltransferase) (GlcNAc-Ins-P N-acetylglucosaminyltransferase)","mycothiol biosynthetic process [GO:0010125]","GO:0000287; GO:0008375; GO:0010125; GO:0102710"
"1499","Pocillopora_acuta_HIv2___TS.g29496.t1",1258.16864349179,2.00707753439735,1.39369961999999,0.00312939818744078,0.0157274549628712,NA,NA,NA,NA,NA
"1500","Pocillopora_acuta_HIv2___RNAseq.g25873.t1",50.5071965629293,2.31011322822024,1.40482728599256,0.0031554295581441,0.0158472684475682,"Q9VLR9",1.91e-13,"Metallophosphoesterase 1 homolog (EC 3.1.-.-) (Post-GPI attachment to proteins 5 ortholog)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506]","GO:0005793; GO:0006506; GO:0006888; GO:0008081; GO:0016020; GO:0046872"
"1501","Pocillopora_acuta_HIv2___RNAseq.g26575.t1",441.940946214695,-2.05267148387348,1.79862185418267,0.00319818604119405,0.0160175079293043,"P97603",7.05e-08,"Neogenin","axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; intracellular iron ion homeostasis [GO:0006879]; multicellular organismal-level iron ion homeostasis [GO:0060586]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; protein secretion [GO:0009306]; regulation of axon regeneration [GO:0048679]; regulation of DNA-templated transcription [GO:0006355]; trans-synaptic signaling, modulating synaptic transmission [GO:0099550]","GO:0001764; GO:0005886; GO:0006355; GO:0006879; GO:0007411; GO:0007520; GO:0009306; GO:0009986; GO:0016020; GO:0030426; GO:0030513; GO:0038023; GO:0039706; GO:0043025; GO:0044295; GO:0045296; GO:0048679; GO:0048681; GO:0050709; GO:0060586; GO:0070700; GO:0097708; GO:0098609; GO:0098797; GO:0098839; GO:0098978; GO:0099550"
"1502","Pocillopora_acuta_HIv2___RNAseq.g19159.t1",4254.38174929535,2.60711350798839,1.84414394668991,0.00320230010131937,0.0160325609780143,"Q8BLQ7",4.17e-90,"Cationic amino acid transporter 4 (CAT-4) (CAT4) (Solute carrier family 7 member 4)","amino acid transport [GO:0006865]; carboxylic acid transmembrane transport [GO:1905039]","GO:0005886; GO:0006865; GO:0015171; GO:1905039"
"1503","Pocillopora_acuta_HIv2___TS.g6518.t1",277.043664034136,1.36744572581942,2.02490027112004,0.0032327746706642,0.0161515899262476,NA,NA,NA,NA,NA
"1504","Pocillopora_acuta_HIv2___RNAseq.g21479.t1",86.7028971796023,1.49266697840387,2.12794586629666,0.00323509276486059,0.0161575903836131,"P24821",8.17e-40,"Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)","bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to wounding [GO:0009611]","GO:0001558; GO:0001649; GO:0002009; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0005925; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009611; GO:0009612; GO:0010628; GO:0014012; GO:0016020; GO:0030155; GO:0030334; GO:0042475; GO:0045471; GO:0045545; GO:0050727; GO:0060447; GO:0060739; GO:0060740; GO:0062023; GO:0071300; GO:0071305; GO:0071774; GO:0071799; GO:0090733; GO:0098966"
"1505","Pocillopora_acuta_HIv2___RNAseq.g9253.t1",161.304064460142,2.27589833351754,1.76444788695432,0.003236568372741,0.0161593803739475,"Q64487",8.98e-10,"Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)","heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling [GO:0099537]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]","GO:0004725; GO:0005102; GO:0007157; GO:0030182; GO:0042734; GO:0046426; GO:0050775; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099151; GO:0099537; GO:0099545; GO:0099560"
"1506","Pocillopora_acuta_HIv2___RNAseq.g8443.t1",118.552428314398,-1.34111340619053,1.88032543219154,0.0032523941836926,0.0162319038110753,"Q24133",1.59e-86,"DnaJ protein homolog 1 (DROJ1)","chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]","GO:0005829; GO:0006457; GO:0009408; GO:0042691; GO:0050821; GO:0051082; GO:0051085; GO:0051087; GO:0140297"
"1507","Pocillopora_acuta_HIv2___RNAseq.g25798.t1",502.490244617237,-1.73964127257647,1.58624334276151,0.00325333857496594,0.0162319038110753,"P76482",1.58e-10,"Uncharacterized protein YfbL","proteolysis [GO:0006508]","GO:0006508; GO:0008235; GO:0016020"
"1508","Pocillopora_acuta_HIv2___RNAseq.g2445.t1",2116.81954437018,1.9328643526859,1.02983188081347,0.00326555006042997,0.016270381010699,"Q9HCI5",9.11e-15,"Melanoma-associated antigen E1 (Alpha-dystrobrevin-associated MAGE Protein) (DAMAGE) (Hepatocellular carcinoma-associated protein 1) (MAGE-E1 antigen)","negative regulation of transcription by RNA polymerase II [GO:0000122]","GO:0000122; GO:0005634; GO:0005886; GO:0030425; GO:0045211; GO:0048471"
"1509","Pocillopora_acuta_HIv2___RNAseq.g15527.t1",321.710751027024,-1.00569508273918,1.56610300219124,0.00327472096483292,0.0163104559350356,"Q5R5U3",2.04e-169,"Zinc finger protein 271","","GO:0003677; GO:0005634; GO:0046872"
"1510","Pocillopora_acuta_HIv2___RNAseq.g29942.t1",7120.04692307367,2.29408314607044,2.27250472295182,0.0033023617732121,0.016425502299773,NA,NA,NA,NA,NA
"1511","Pocillopora_acuta_HIv2___RNAseq.1286_t",1420.6844537146,-1.52391500650608,0.624614914160852,0.00331518840626933,0.0164779673911614,"Q95108",1.33e-38,"Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2)","cell redox homeostasis [GO:0045454]","GO:0005739; GO:0015035; GO:0045454"
"1512","Pocillopora_acuta_HIv2___RNAseq.g17193.t1",432.085193715848,-1.23647585340386,1.86034617040344,0.0033371121372759,0.0165641695104868,NA,NA,NA,NA,NA
"1513","Pocillopora_acuta_HIv2___RNAseq.g16108.t1",274.876509956482,-1.14920760859983,1.75121418061937,0.00334369103802223,0.0165854414176795,"Q9DG67",0,"DNA repair and recombination protein RAD54B (EC 3.6.4.-) (RAD54 homolog B)","double-strand break repair via homologous recombination [GO:0000724]; reciprocal meiotic recombination [GO:0007131]","GO:0000724; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0007131; GO:0015616; GO:0016787; GO:0140658"
"1514","Pocillopora_acuta_HIv2___RNAseq.g30425.t2",973.470836468521,-1.56212424368405,2.26462405107503,0.00334603460875334,0.0165913762704862,"Q5TZA2",0,"Rootletin (Ciliary rootlet coiled-coil protein)","cellular homeostasis [GO:0019725]; centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098]; ciliary basal body organization [GO:0032053]; epithelial structure maintenance [GO:0010669]; establishment of localization in cell [GO:0051649]; establishment of organelle localization [GO:0051656]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]","GO:0001917; GO:0003779; GO:0005198; GO:0005200; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0007098; GO:0008104; GO:0010457; GO:0010669; GO:0015629; GO:0019725; GO:0019894; GO:0032053; GO:0033365; GO:0035253; GO:0045494; GO:0045724; GO:0051649; GO:0051656; GO:0070062; GO:0097729; GO:0120219; GO:1903566"
"1515","Pocillopora_acuta_HIv2___RNAseq.g17217.t1",833.157247816079,-1.01544599914132,1.52095125834983,0.00337779423891403,0.0167144768633775,NA,NA,NA,NA,NA
"1516","Pocillopora_acuta_HIv2___RNAseq.g25038.t1",453.448692552547,1.45287706957925,2.11454280998948,0.0033852883609274,0.0167458313448885,NA,NA,NA,NA,NA
"1517","Pocillopora_acuta_HIv2___RNAseq.g11932.t1",608.698896528797,-1.43477790998065,1.95737476136416,0.00339251363829616,0.0167758349621592,"Q5I0D1",1.73e-148,"Glyoxalase domain-containing protein 4","","GO:0005739"
"1518","Pocillopora_acuta_HIv2___RNAseq.g23618.t1",134.379815296173,-2.32520428140584,1.88197677119144,0.00339532579456278,0.016784002834093,NA,NA,NA,NA,NA
"1519","Pocillopora_acuta_HIv2___TS.g5148.t1",1566.5342192108,-1.41767622991498,1.94254191623313,0.00342079476258277,0.0168925829450315,"P52209",0,"6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)","D-gluconate catabolic process [GO:0046177]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]","GO:0004616; GO:0005634; GO:0005829; GO:0006098; GO:0009051; GO:0019322; GO:0046177; GO:0050661; GO:0070062"
"1520","Pocillopora_acuta_HIv2___TS.g23962.t1",316.365215382108,-1.78907649222004,0.844609557589052,0.00342345874502224,0.0168994216858868,NA,NA,NA,NA,NA
"1521","Pocillopora_acuta_HIv2___RNAseq.g20774.t1",197.140174013224,-1.98663707264309,1.2493326021445,0.00344813637450023,0.0169927920002628,"A1R8N8",8.97e-12,"D-inositol 3-phosphate glycosyltransferase (EC 2.4.1.250) (N-acetylglucosamine-inositol-phosphate N-acetylglucosaminyltransferase) (GlcNAc-Ins-P N-acetylglucosaminyltransferase)","mycothiol biosynthetic process [GO:0010125]","GO:0000287; GO:0008375; GO:0010125; GO:0102710"
"1522","Pocillopora_acuta_HIv2___RNAseq.g11673.t1",4278.69044370854,-1.64543468748741,0.722960877510047,0.003464936019824,0.0170697665499776,"P70030",1.8e-91,"POU domain, class 3, transcription factor 2-B (Transcription factor POU3-B) (XlPOU3B)","brain development [GO:0007420]","GO:0000981; GO:0003677; GO:0005634; GO:0007420"
"1523","Pocillopora_acuta_HIv2___RNAseq.g17242.t1",281.121555175781,-1.00959303730453,1.54337438763461,0.00347910690139442,0.0171162592591051,NA,NA,NA,NA,NA
"1524","Pocillopora_acuta_HIv2___RNAseq.g24660.t1",1374.35171462858,-1.15312707287332,1.72264174802933,0.00350249031854269,0.0172137342736668,"Q5XIL0",1.81e-09,"E3 ubiquitin-protein ligase RNF167 (EC 2.3.2.27) (RING finger protein 167)","cellular response to leucine starvation [GO:1990253]; lysosome localization [GO:0032418]; negative regulation of cell cycle [GO:0045786]; negative regulation of TORC1 signaling [GO:1904262]; organelle localization [GO:0051640]; positive regulation of TORC1 signaling [GO:1904263]; protein K29-linked ubiquitination [GO:0035519]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of synaptic transmission, glutamatergic [GO:0051966]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000209; GO:0004842; GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0005886; GO:0006511; GO:0008270; GO:0032418; GO:0035519; GO:0036020; GO:0045786; GO:0051640; GO:0051966; GO:0061630; GO:0070534; GO:1904262; GO:1904263; GO:1990253"
"1525","Pocillopora_acuta_HIv2___RNAseq.g6737.t1",2988.27370964141,1.61408108400226,0.695738125398254,0.00352768195413582,0.0173198885894842,"P41969",3.1e-30,"ETS domain-containing protein Elk-1","cellular response to gamma radiation [GO:0071480]; cellular response to lipid [GO:0071396]; cellular response to testosterone stimulus [GO:0071394]; gene expression [GO:0010467]; hippocampal neuron apoptotic process [GO:0110088]; liver development [GO:0001889]; lung development [GO:0030324]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to light stimulus [GO:0009416]","GO:0000978; GO:0000981; GO:0001228; GO:0001889; GO:0003682; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0009416; GO:0010467; GO:0030324; GO:0030374; GO:0030425; GO:0031966; GO:0043025; GO:0043679; GO:0045471; GO:0045893; GO:0045944; GO:0061629; GO:0071394; GO:0071396; GO:0071480; GO:0071774; GO:0110088"
"1526","Pocillopora_acuta_HIv2___RNAseq.g2258.t1",1914.01503713316,-1.68326784617125,1.58386667433314,0.00354259017672254,0.0173753897307951,"O15992",0,"Arginine kinase (AK) (EC 2.7.3.3)","phosphocreatine biosynthetic process [GO:0046314]","GO:0004054; GO:0004111; GO:0005524; GO:0046314"
"1527","Pocillopora_acuta_HIv2___RNAseq.g14417.t1",293.973079284975,1.83196779059718,1.72190254752411,0.00355934255939213,0.0174516375522196,NA,NA,NA,NA,NA
"1528","Pocillopora_acuta_HIv2___TS.g21857.t1",165.622742328238,-1.95344921863239,1.15083634532365,0.00357399910308174,0.0175116270416579,"Q7Z443",2.58e-49,"Polycystin-1-like protein 3 (Polycystin-1L3) (PC1-like 3 protein) (Polycystic kidney disease protein 1-like 3)","cellular response to acidic pH [GO:0071468]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of mechanical stimulus [GO:0050982]; monoatomic cation transport [GO:0006812]; sensory perception of sour taste [GO:0050915]","GO:0001581; GO:0005262; GO:0005886; GO:0006812; GO:0016020; GO:0030246; GO:0034703; GO:0043235; GO:0050915; GO:0050982; GO:0070062; GO:0071468"
"1529","Pocillopora_acuta_HIv2___RNAseq.g25971.t1",356.616030347835,-1.00373950518088,1.59995149921938,0.00360492639440514,0.017647932598062,NA,NA,NA,NA,NA
"1530","Pocillopora_acuta_HIv2___TS.g26429.t1",534.234509372186,-2.01613343117562,1.75706434625841,0.00361744225415672,0.0176945163219895,NA,NA,NA,NA,NA
"1531","Pocillopora_acuta_HIv2___RNAseq.g25874.t1",16.8711622162434,1.64231855741625,4.38177238717756,0.00363169085982859,0.0177522056764315,"Q9UR07",5.1e-30,"Transposon Tf2-11 polyprotein (Retrotransposable element Tf2 155 kDa protein)","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; proteolysis [GO:0006508]","GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004519; GO:0005634; GO:0006310; GO:0006508; GO:0015074; GO:0046872"
"1532","Pocillopora_acuta_HIv2___RNAseq.g17416.t1",5807.49046974574,1.73660590374684,0.803840359585646,0.00363448173492567,0.0177598458830962,"Q8CAL5",1.62e-40,"Glypican-5 [Cleaved into: Secreted glypican-5]","cell migration [GO:0016477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of protein localization to membrane [GO:1905475]","GO:0005576; GO:0005796; GO:0005886; GO:0009986; GO:0016477; GO:0062023; GO:0090263; GO:0098552; GO:1905475"
"1533","Pocillopora_acuta_HIv2___RNAseq.g12614.t2",522.335970739427,-1.48025114326879,1.94924007856563,0.00364731511968276,0.0178105219078634,"A2AL36",3.89e-109,"Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110)","aorta development [GO:0035904]; axoneme assembly [GO:0035082]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; female germ-line stem cell asymmetric division [GO:0048132]; kidney development [GO:0001822]; ventricular septum development [GO:0003281]","GO:0001822; GO:0003279; GO:0003281; GO:0005813; GO:0005829; GO:0005930; GO:0034451; GO:0035082; GO:0035904; GO:0048132; GO:0048471; GO:0060976; GO:0070840; GO:0072687; GO:0090543; GO:0090619; GO:0097431; GO:0120103"
"1534","Pocillopora_acuta_HIv2___RNAseq.g28252.t1",5381.46974038774,2.29164169715687,1.95399765277732,0.00367118155125626,0.0179149696212451,"P30531",0,"Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1)","amino acid transport [GO:0006865]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid reuptake [GO:0051936]; inorganic anion import across plasma membrane [GO:0098658]; memory [GO:0007613]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; transport across blood-brain barrier [GO:0150104]","GO:0005332; GO:0005886; GO:0006865; GO:0007268; GO:0007613; GO:0008306; GO:0009636; GO:0009744; GO:0009986; GO:0010288; GO:0014054; GO:0014074; GO:0015185; GO:0015378; GO:0016020; GO:0030424; GO:0032229; GO:0032355; GO:0035725; GO:0042220; GO:0042734; GO:0042802; GO:0043025; GO:0045211; GO:0046872; GO:0050808; GO:0051592; GO:0051936; GO:0051939; GO:0098658; GO:0098719; GO:0098982; GO:0150104; GO:1902476"
"1535","Pocillopora_acuta_HIv2___RNAseq.g25739.t1",677.434318998229,2.03777555431461,1.92927749180301,0.00369276834748797,0.0180020901173125,"P52800",2.26e-12,"Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L)","adherens junction organization [GO:0034332]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; keratinocyte proliferation [GO:0043616]; lymph vessel development [GO:0001945]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of neuron projection development [GO:0010977]; nephric duct morphogenesis [GO:0072178]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell population proliferation [GO:0008284]; presynapse assembly [GO:0099054]; regulation of chemotaxis [GO:0050920]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; T cell costimulation [GO:0031295]; venous blood vessel morphogenesis [GO:0048845]","GO:0001945; GO:0002042; GO:0005102; GO:0005886; GO:0005912; GO:0007155; GO:0007411; GO:0008284; GO:0009887; GO:0010839; GO:0010977; GO:0030425; GO:0031295; GO:0034332; GO:0042734; GO:0043616; GO:0046875; GO:0048013; GO:0048514; GO:0048845; GO:0050920; GO:0072178; GO:0098685; GO:0098839; GO:0098978; GO:0099054; GO:0099072; GO:0099149; GO:1903849; GO:2000727"
"1536","Pocillopora_acuta_HIv2___RNAseq.g5279.t1",280.941136210132,2.18370390597342,1.0734895491506,0.00371514783046204,0.0180989889591792,NA,NA,NA,NA,NA
"1537","Pocillopora_acuta_HIv2___RNAseq.g30836.t1",893.512611702344,-1.09446636351098,1.73936726756807,0.00374701604370078,0.0182358142853594,"Q9QWN8",9.69e-61,"Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41)","actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; adult behavior [GO:0030534]; cellular response to ethanol [GO:0071361]; cerebellar Purkinje cell layer morphogenesis [GO:0021692]; multicellular organism growth [GO:0035264]; postsynapse organization [GO:0099173]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of postsynaptic specialization assembly [GO:0099150]; synapse assembly [GO:0007416]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005200; GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0007416; GO:0008021; GO:0008091; GO:0016079; GO:0016081; GO:0016192; GO:0016324; GO:0016363; GO:0017158; GO:0021692; GO:0030036; GO:0030054; GO:0030534; GO:0030864; GO:0033010; GO:0035264; GO:0042995; GO:0043025; GO:0048471; GO:0051015; GO:0051693; GO:0071361; GO:0098688; GO:0098793; GO:0098918; GO:0098978; GO:0099150; GO:0099173; GO:0099186; GO:0099189"
"1538","Pocillopora_acuta_HIv2___RNAseq.g942.t1",2094.46903772343,1.18126501049739,1.91667920709061,0.00375383166391382,0.0182628392824923,"Q90481",1.26e-37,"Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A)","cell differentiation [GO:0030154]; endocrine pancreas development [GO:0031018]; floor plate development [GO:0033504]; floor plate formation [GO:0021508]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; ventral spinal cord interneuron differentiation [GO:0021514]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008045; GO:0008347; GO:0014044; GO:0021508; GO:0021514; GO:0021529; GO:0021530; GO:0030154; GO:0031018; GO:0033504; GO:0045893"
"1539","Pocillopora_acuta_HIv2___RNAseq.g17071.t1",6072.9740389316,1.5011710939912,0.621760029498421,0.00375612859813162,0.0182678695505635,NA,NA,NA,NA,NA
"1540","Pocillopora_acuta_HIv2___RNAseq.g27566.t1",2397.19026154867,1.88059270433676,1.01900887193644,0.00381167410737507,0.0185317829543103,"B3EWZ9",0,"Hephaestin-like protein (EC 1.-.-.-)","copper ion transport [GO:0006825]","GO:0005507; GO:0005576; GO:0006825; GO:0016020; GO:0016491"
"1541","Pocillopora_acuta_HIv2___TS.g9271.t1",348.035711989756,1.37635431522078,1.96548991721862,0.00381595300958965,0.0185463522616615,NA,NA,NA,NA,NA
"1542","Pocillopora_acuta_HIv2___TS.g23869.t1",114.476451354839,-1.06893434167633,1.66687454728319,0.00382025201502348,0.0185602183903334,"Q4UMH6",9.68e-57,"Putative ankyrin repeat protein RF_0381","guanosine tetraphosphate metabolic process [GO:0015969]","GO:0015969"
"1543","Pocillopora_acuta_HIv2___TS.g1918.t1",1647.6018770717,1.61667016718238,0.708313873301286,0.00382137239812035,0.0185602183903334,"P53199",5.91e-08,"Sterol-4-alpha-carboxylate 3-dehydrogenase ERG26, decarboxylating (EC 1.1.1.170) (C-3 sterol dehydrogenase ERG26) (C-4 decarboxylase ERG26) (Ergosterol biosynthetic protein 26)","ergosterol biosynthetic process [GO:0006696]","GO:0000252; GO:0005783; GO:0005789; GO:0006696; GO:0047012; GO:0103066; GO:0103067"
"1544","Pocillopora_acuta_HIv2___RNAseq.g17093.t1",549.0524577421,-1.91266634428707,1.11578043319481,0.00383398812901049,0.0186089947308751,"Q9H706",2.63e-09,"GRB2-associated and regulator of MAPK protein 1 (GRB2-associated and regulator of MAPK1)","cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]","GO:0005886; GO:0007173; GO:0008284; GO:0051781; GO:0070064; GO:0070374; GO:0071364"
"1545","Pocillopora_acuta_HIv2___RNAseq.g31383.t1",305.369015172424,-1.93963138753434,1.23750343911188,0.00383922140822911,0.0186281443973921,"Q9SY73",4.23e-66,"NADPH-dependent pterin aldehyde reductase (EC 1.1.1.-)","folic acid-containing compound metabolic process [GO:0006760]","GO:0005829; GO:0006760; GO:0016616"
"1546","Pocillopora_acuta_HIv2___RNAseq.g18380.t1",396.631973087688,2.56807501572264,1.77248200526036,0.00387903942013239,0.0187961226709531,NA,NA,NA,NA,NA
"1547","Pocillopora_acuta_HIv2___RNAseq.g19800.t1",83.1305005530481,-1.10271379157806,1.85663206636408,0.00389560939501255,0.0188637744524478,"Q96AY4",1.89e-49,"Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1548","Pocillopora_acuta_HIv2___RNAseq.g11533.t2c",63.9602247010522,-1.14538919123842,2.34811424968059,0.00390542935878589,0.0188923512526686,"Q505D9",8.52e-16,"Tripartite motif-containing protein 67","negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]","GO:0005737; GO:0005856; GO:0008270; GO:0010976; GO:0046580; GO:2000060"
"1549","Pocillopora_acuta_HIv2___RNAseq.g12347.t1",220.765062937396,-1.99979499160731,1.60195500601403,0.00390839126511444,0.0188940411960612,"P53349",1.16e-128,"Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1)","apoptotic mitochondrial changes [GO:0008637]; camera-type eye development [GO:0043010]; epithelial cell morphogenesis [GO:0003382]; eyelid development in camera-type eye [GO:0061029]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of actin filament bundle assembly [GO:0032232]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]; protein polyubiquitination [GO:0000209]; regulation of cell migration [GO:0030334]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]; wound healing [GO:0042060]","GO:0000165; GO:0000209; GO:0002011; GO:0003382; GO:0004672; GO:0004674; GO:0004706; GO:0004708; GO:0004709; GO:0004842; GO:0005524; GO:0005737; GO:0005829; GO:0006511; GO:0007179; GO:0007254; GO:0008092; GO:0008270; GO:0008432; GO:0008637; GO:0030054; GO:0030334; GO:0030838; GO:0031434; GO:0031941; GO:0032232; GO:0042060; GO:0043010; GO:0043065; GO:0043410; GO:0043507; GO:0044877; GO:0045893; GO:0045944; GO:0046330; GO:0046625; GO:0050434; GO:0051019; GO:0061029; GO:0090263; GO:0106310"
"1550","Pocillopora_acuta_HIv2___RNAseq.g28795.t1",11904.6298542831,1.91386155653934,1.13395589882306,0.00392158612592241,0.0189451642369211,NA,NA,NA,NA,NA
"1551","Pocillopora_acuta_HIv2___TS.g24153.t1",229.374719532268,-1.04838548981297,1.61873095465919,0.00394678142523139,0.0190327993779926,NA,NA,NA,NA,NA
"1552","Pocillopora_acuta_HIv2___TS.g7845.t1",624.395249472847,1.80456699237365,0.946421071366784,0.00398245985934691,0.0191943683457493,NA,NA,NA,NA,NA
"1553","Pocillopora_acuta_HIv2___TS.g12846.t1",763.407221878272,1.50561250980919,2.03962028821958,0.00405115385680931,0.0194864946408014,"Q9JMH4",7.32e-06,"Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen homolog]","extracellular matrix organization [GO:0030198]; hemidesmosome assembly [GO:0031581]","GO:0005581; GO:0005604; GO:0005615; GO:0016020; GO:0030020; GO:0030056; GO:0030198; GO:0031581"
"1554","Pocillopora_acuta_HIv2___RNAseq.g23634.t1",3369.65392602801,-2.16735326872846,1.87433868800221,0.00405980241623915,0.0195129040070051,"C3ZAH2",1.28e-88,"Acireductone dioxygenase (Acireductone dioxygenase (Fe(2+)-requiring)) (ARD') (Fe-ARD) (EC 1.13.11.54) (Acireductone dioxygenase (Ni(2+)-requiring)) (ARD) (Ni-ARD) (EC 1.13.11.53)","L-methionine salvage from methylthioadenosine [GO:0019509]; methionine metabolic process [GO:0006555]","GO:0005506; GO:0005634; GO:0005737; GO:0006555; GO:0010308; GO:0010309; GO:0016151; GO:0019509"
"1555","Pocillopora_acuta_HIv2___RNAseq.g11410.t1",981.941658430094,-1.19298006768991,1.70234082789368,0.00406069144504185,0.0195129040070051,"Q6Q759",2.1e-100,"Sperm-associated antigen 17 (Projection protein PF6 homolog)","axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283]","GO:0001669; GO:0002177; GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0007283; GO:0031514; GO:0044458; GO:1904158; GO:1905198; GO:1990716; GO:1990953"
"1556","Pocillopora_acuta_HIv2___TS.g11680.t1",5027.48802736602,2.26775738269337,2.14577168832305,0.00407063795000006,0.0195366939140857,NA,NA,NA,NA,NA
"1557","Pocillopora_acuta_HIv2___RNAseq.g25270.t1",1919.36235294777,1.42578864603019,1.91230370025482,0.00407182774013385,0.0195366939140857,"H9JW44",4.16e-64,"Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41)","chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]","GO:0000272; GO:0004099; GO:0005615; GO:0006032; GO:0046872"
"1558","Pocillopora_acuta_HIv2___RNAseq.g15128.t1",520.563712725987,-1.12294519816904,1.68656515855029,0.00410194860085009,0.0196654241175657,"P51892",0,"DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1)","cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]","GO:0003677; GO:0003910; GO:0005524; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0046872; GO:0051301; GO:0071897"
"1559","Pocillopora_acuta_HIv2___RNAseq.g4502.t1",264.524049981882,-1.17120682381626,1.57155894489862,0.00412115945794644,0.019734946348402,"Q66H61",0,"Glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS)","brain development [GO:0007420]; glutaminyl-tRNA aminoacylation [GO:0006425]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of stress-activated MAPK cascade [GO:0032873]","GO:0004819; GO:0004860; GO:0005524; GO:0005737; GO:0005829; GO:0006425; GO:0007420; GO:0017101; GO:0019901; GO:0032873; GO:0032991; GO:0045892; GO:2001234"
"1560","Pocillopora_acuta_HIv2___RNAseq.g23870.t1",356.272724314354,-1.05292988464759,1.55988524031715,0.00412190769624741,0.019734946348402,"Q9VY28",3.89e-33,"Small ribosomal subunit protein mS25 (28S ribosomal protein S25, mitochondrial) (MRP-S25) (S25mt)","mitochondrial translation [GO:0032543]","GO:0003735; GO:0005739; GO:0005763; GO:0032543"
"1561","Pocillopora_acuta_HIv2___RNAseq.g10854.t2",1353.64991330021,-1.04456638609752,1.66444736675142,0.00414695339112312,0.0198482904861697,"Q2KIH7",0,"Phenylalanine-4-hydroxylase (PAH) (EC 1.14.16.1) (Phe-4-monooxygenase)","L-phenylalanine catabolic process [GO:0006559]; tyrosine biosynthetic process [GO:0006571]","GO:0004505; GO:0005506; GO:0006559; GO:0006571"
"1562","Pocillopora_acuta_HIv2___RNAseq.g8441.t1",394.780397911369,2.53236810434559,1.75130905524849,0.00417320856917961,0.0199488159851065,NA,NA,NA,NA,NA
"1563","Pocillopora_acuta_HIv2___RNAseq.g12289.t1",169.185864836578,-1.78770348251062,2.01297663212309,0.00417347325573371,0.0199488159851065,"P16621",3.7e-13,"Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR)","axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; hematopoietic stem cell homeostasis [GO:0061484]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; negative regulation of insulin receptor signaling pathway [GO:0046627]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic assembly at neuromuscular junction [GO:0051124]","GO:0004725; GO:0005001; GO:0005158; GO:0005925; GO:0007155; GO:0007283; GO:0007399; GO:0007411; GO:0007412; GO:0008045; GO:0008201; GO:0008594; GO:0009925; GO:0009986; GO:0030424; GO:0031252; GO:0031290; GO:0032093; GO:0045467; GO:0046627; GO:0048477; GO:0048675; GO:0048841; GO:0051124; GO:0051491; GO:0060269; GO:0061484; GO:0120034; GO:1903386"
"1564","Pocillopora_acuta_HIv2___RNAseq.g15574.t1",34.1673831055947,-1.80592316328319,2.48005185520437,0.00417841057487507,0.0199592240934587,"P24722",4.44e-50,"Creatine kinase, testis isozyme (EC 2.7.3.2)","phosphocreatine biosynthetic process [GO:0046314]","GO:0004111; GO:0005524; GO:0046314"
"1565","Pocillopora_acuta_HIv2___RNAseq.g25709.t3",975.148066046963,2.09919103200406,1.99819003011724,0.00425900916849302,0.0203106853323716,NA,NA,NA,NA,NA
"1566","Pocillopora_acuta_HIv2___RNAseq.g25665.t1",117.634957674554,-1.18000426620545,1.72010533204457,0.00427922363959257,0.0204003595000221,NA,NA,NA,NA,NA
"1567","Pocillopora_acuta_HIv2___RNAseq.g4955.t2",727.131161895092,1.86566408802407,1.12059453172838,0.00430604443787178,0.0205079442704569,"O14841",0,"5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Pyroglutamase)","glutathione metabolic process [GO:0006749]","GO:0005524; GO:0005829; GO:0006749; GO:0017168; GO:0042802"
"1568","Pocillopora_acuta_HIv2___TS.g9126.t1",399.880056416913,-1.14595994138117,1.7499633613479,0.00431496814446208,0.0205436798029952,"Q6DFR2",0,"E3 ubiquitin-protein ligase CBL-B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase CBL-B) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B)","cell surface receptor signaling pathway [GO:0007166]; protein ubiquitination [GO:0016567]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]","GO:0001784; GO:0004842; GO:0005509; GO:0005737; GO:0007166; GO:0016567; GO:2000583"
"1569","Pocillopora_acuta_HIv2___RNAseq.g12045.t1",2823.08197055924,1.79821305360744,1.04025501495976,0.00433696006782128,0.0206144562671597,"Q8IVN8",6.21e-24,"Somatomedin-B and thrombospondin type-1 domain-containing protein (RPE-spondin)","","GO:0005576; GO:0062023"
"1570","Pocillopora_acuta_HIv2___RNAseq.g848.t1",611.913336827958,-1.25874220490973,1.6492835799753,0.00434693492233696,0.0206415189483525,"Q5NVP8",2.01e-51,"Protein lin-52 homolog","regulation of DNA-templated transcription [GO:0006355]","GO:0006355; GO:0070176"
"1571","Pocillopora_acuta_HIv2___TS.g13017.t1",482.057190142572,1.75425516802324,2.05891516836066,0.00435604084825799,0.0206779700785046,"Q95LD9",2.8e-43,"Aryl hydrocarbon receptor (Ah receptor) (AhR)","cAMP-mediated signaling [GO:0019933]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; cellular response to molecule of bacterial origin [GO:0071219]; circadian regulation of gene expression [GO:0032922]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of inflammatory response [GO:0050728]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adaptive immune response [GO:0002819]; regulation of B cell proliferation [GO:0030888]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; xenobiotic metabolic process [GO:0006805]","GO:0001094; GO:0001223; GO:0002819; GO:0002841; GO:0004879; GO:0005634; GO:0005737; GO:0005829; GO:0006805; GO:0009410; GO:0009636; GO:0017025; GO:0019933; GO:0030888; GO:0032922; GO:0034753; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0050728; GO:0051879; GO:0061629; GO:0070888; GO:0071219; GO:0071320; GO:1904322; GO:1904613; GO:1990837"
"1572","Pocillopora_acuta_HIv2___RNAseq.g24029.t1",216.491270403315,-1.23581975824456,2.5561837392602,0.00436323629215192,0.0207053312761435,"H1AFJ5",6.19e-57,"Amiloride-sensitive sodium channel subunit alpha (Alpha-NaCH) (Epithelial Na(+) channel subunit alpha) (Alpha-ENaC) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA)","sodium ion transmembrane transport [GO:0035725]","GO:0001669; GO:0005737; GO:0015280; GO:0016324; GO:0031514; GO:0034706; GO:0035725"
"1573","Pocillopora_acuta_HIv2___RNAseq.g7172.t1",427.374765933611,1.82689020114338,1.65168763363599,0.00444908074542964,0.0210505410212281,"O50224",3.48e-08,"ATP-dependent DNA helicase RecG (EC 3.6.4.12)","DNA recombination [GO:0006310]; DNA repair [GO:0006281]","GO:0003677; GO:0003678; GO:0005524; GO:0006281; GO:0006310; GO:0016887"
"1574","Pocillopora_acuta_HIv2___RNAseq.g3778.t1",847.937059955879,-1.92771431035045,1.50194805606289,0.00445952492200387,0.0210930570542394,"Q9UDY8",6.11e-11,"Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase)","B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]","GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006952; GO:0008233; GO:0009620; GO:0031398; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0032991; GO:0036094; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043066; GO:0043123; GO:0043280; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0051092; GO:0051168; GO:0051603; GO:2000321"
"1575","Pocillopora_acuta_HIv2___RNAseq.g2110.t1",395.297756840887,1.31008546178811,2.38680206150991,0.00450942052601779,0.0213081537041233,"Q67XX3",2.98e-08,"Arginine-specific demethylase JMJ22 (EC 1.14.11.-) (Arginine-specific histone demethylase JMJ22) (F-box protein JMJ22) (Jumonji domain-containing protein 22) (AtJMJ22) (Protein JUMONJI 22) ([histone H4]-dimethyl-L-arginine(3) monodemethylase JMJ22)","epigenetic regulation of gene expression [GO:0040029]; gibberellic acid mediated signaling pathway [GO:0009740]; gibberellin mediated signaling pathway [GO:0010476]; positive regulation of seed germination [GO:0010030]; regulation of photomorphogenesis [GO:0010099]; response to red light [GO:0010114]","GO:0000976; GO:0000987; GO:0005634; GO:0009740; GO:0010030; GO:0010099; GO:0010114; GO:0010476; GO:0016491; GO:0040029; GO:0046872"
"1576","Pocillopora_acuta_HIv2___RNAseq.g7667.t1",654.3126396625,-1.9218318692877,1.78833212514393,0.00455461216814751,0.021486598304007,"Q8IV36",0,"Protein HID1 (Down-regulated in multiple cancers 1) (HID1 domain-containing protein) (Protein hid-1 homolog)","","GO:0000138; GO:0005737; GO:0005794; GO:0005797; GO:0005829; GO:0005881; GO:0016020; GO:0070062; GO:0098548"
"1577","Pocillopora_acuta_HIv2___RNAseq.g15948.t1",179.21690453972,2.1033274300776,1.67981841359773,0.00456608946079233,0.0215267007695242,"Q923Y9",9.89e-08,"Trace amine-associated receptor 1 (TaR-1) (Trace amine receptor 1)","G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cAMP-mediated signaling [GO:0043950]","GO:0001594; GO:0004930; GO:0005886; GO:0007186; GO:0008227; GO:0043950"
"1578","Pocillopora_acuta_HIv2___RNAseq.g24762.t1",15.282830436932,-2.36780284643251,2.77139918699504,0.0045882454557654,0.0216170626293781,NA,NA,NA,NA,NA
"1579","Pocillopora_acuta_HIv2___RNAseq.g21181.t1",523.598782675193,-1.89390095829945,1.5536949316254,0.00459269376230004,0.0216239331308294,"Q6DJG6",3.73e-22,"BRISC and BRCA1-A complex member 1 (Mediator of RAP80 interactions and targeting subunit of 40 kDa) (New component of the BRCA1-A complex)","cell division [GO:0051301]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212]","GO:0005634; GO:0005737; GO:0006302; GO:0007095; GO:0010212; GO:0045739; GO:0051301; GO:0070531; GO:0070552; GO:0140861"
"1580","Pocillopora_acuta_HIv2___RNAseq.g4791.t1",744.783624613668,1.83549822249361,1.94093658802434,0.00462605136025544,0.0217597420730844,"O18806",1.36e-09,"Coagulation factor VIII (Procoagulant component)","acute-phase response [GO:0006953]; blood coagulation, intrinsic pathway [GO:0007597]","GO:0005507; GO:0005615; GO:0006953; GO:0007597; GO:0016491"
"1581","Pocillopora_acuta_HIv2___RNAseq.g14359.t1",471.491197269295,1.87472129559383,1.92342768742911,0.00465887892140673,0.0218856851962413,NA,NA,NA,NA,NA
"1582","Pocillopora_acuta_HIv2___TS.g5226.t1",327.575763277583,2.19359629038624,1.759372118504,0.00471490690401885,0.0221129745329859,NA,NA,NA,NA,NA
"1583","Pocillopora_acuta_HIv2___RNAseq.g12223.t1",1942.75963931324,-1.8661158469433,2.06818144990927,0.00474534674739626,0.0222341092822609,"P25228",3.56e-96,"Ras-related protein Rab-3","cytoskeletal matrix organization at active zone [GO:0048789]; exocytosis [GO:0006887]; maintenance of presynaptic active zone structure [GO:0048790]; neurotransmitter secretion [GO:0007269]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; symbiont entry into host cell [GO:0046718]; vesicle-mediated transport [GO:0016192]","GO:0000287; GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0006887; GO:0007269; GO:0008021; GO:0009306; GO:0016192; GO:0031489; GO:0031630; GO:0031982; GO:0032482; GO:0045202; GO:0046718; GO:0046928; GO:0048172; GO:0048786; GO:0048789; GO:0048790"
"1584","Pocillopora_acuta_HIv2___RNAseq.g24899.t1",1384.37364325167,1.41511062071881,1.94468927196508,0.00475135612589601,0.0222510047087251,"Q9R0S3",1.48e-79,"Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP)","collagen catabolic process [GO:0030574]; drinking behavior [GO:0042756]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508]","GO:0001822; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008270; GO:0030198; GO:0030574; GO:0031012; GO:0042756; GO:0098552"
"1585","Pocillopora_acuta_HIv2___TS.g9052.t1",367.026110219639,1.870995728982,1.19937803737027,0.00475202942099364,0.0222510047087251,NA,NA,NA,NA,NA
"1586","Pocillopora_acuta_HIv2___RNAseq.g1994.t1",344.815468679523,-2.37288640201561,1.3352286608168,0.00478018921120475,0.022368378114159,NA,NA,NA,NA,NA
"1587","Pocillopora_acuta_HIv2___TS.g13467.t1",1087.05815970966,-1.84890260290849,1.21744272349154,0.00483225366335344,0.0226003961086342,NA,NA,NA,NA,NA
"1588","Pocillopora_acuta_HIv2___TS.g23602.t1",770.124420251313,1.76809777455945,0.964179670758694,0.00483289720436986,0.0226003961086342,"Q2PZL6",0,"Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)","branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]","GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307; GO:0098609"
"1589","Pocillopora_acuta_HIv2___RNAseq.g4919.t1",187.632811836304,-3.34833621156817,2.65896447002568,0.00484787308365932,0.0226557790895148,"Q01484",1.12e-24,"Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)","atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]","GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008093; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259"
"1590","Pocillopora_acuta_HIv2___RNAseq.g26474.t1a",14692.8901996415,-1.82635337212872,1.02605742383777,0.00486907109194618,0.0227416656310317,"P09057",9.03e-160,"Ornithine decarboxylase (ODC) (EC 4.1.1.17)","cell population proliferation [GO:0008283]; kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process [GO:0009446]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]","GO:0001822; GO:0004586; GO:0005737; GO:0005829; GO:0006595; GO:0008283; GO:0008284; GO:0009446; GO:0009615; GO:0033387; GO:0042176; GO:0042803; GO:0048471"
"1591","Pocillopora_acuta_HIv2___RNAseq.g4128.t2",1313.59585907275,-1.6432347139243,0.794984814782895,0.0049401292795325,0.0230348258862534,"B2RX14",0,"Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11)","interleukin-6-mediated signaling pathway [GO:0070102]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; positive regulation of interleukin-6 production [GO:0032755]; pre-miRNA processing [GO:0031054]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; retrotransposon silencing by mRNA destabilization [GO:0141008]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]","GO:0001556; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0010586; GO:0010587; GO:0019827; GO:0031054; GO:0031123; GO:0031664; GO:0032755; GO:0035198; GO:0036464; GO:0050265; GO:0070102; GO:0070569; GO:0071076; GO:0141008; GO:1990074"
"1592","Pocillopora_acuta_HIv2___RNAseq.g562.t1",543.010904142639,1.94735793673818,1.54842722599905,0.0049699008549046,0.02315125473924,"Q8CHL0",1.31e-52,"Frizzled-5 (Fz-5)","angiogenesis [GO:0001525]; anterior/posterior axis specification, embryo [GO:0008595]; apoptotic process involved in morphogenesis [GO:0060561]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; canonical Wnt signaling pathway [GO:0060070]; cellular response to molecule of bacterial origin [GO:0071219]; chorionic trophoblast cell differentiation [GO:0060718]; embryonic axis specification [GO:0000578]; embryonic camera-type eye development [GO:0031076]; embryonic camera-type eye morphogenesis [GO:0048596]; eye development [GO:0001654]; glandular epithelial cell maturation [GO:0002071]; intestinal epithelial cell maturation [GO:0060574]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type II interferon production [GO:0032729]; post-embryonic camera-type eye development [GO:0031077]; presynapse assembly [GO:0099054]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of chorionic trophoblast cell proliferation [GO:1901382]; Spemann organizer formation [GO:0060061]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]; T cell differentiation in thymus [GO:0033077]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055]","GO:0000139; GO:0000578; GO:0001525; GO:0001540; GO:0001654; GO:0001944; GO:0002071; GO:0002726; GO:0004930; GO:0005769; GO:0005794; GO:0005886; GO:0005923; GO:0008285; GO:0008289; GO:0008595; GO:0009986; GO:0016055; GO:0017147; GO:0019901; GO:0030424; GO:0030425; GO:0031076; GO:0031077; GO:0031625; GO:0032729; GO:0032731; GO:0032760; GO:0033077; GO:0035567; GO:0042813; GO:0043204; GO:0044877; GO:0045202; GO:0045944; GO:0048471; GO:0048596; GO:0060061; GO:0060070; GO:0060561; GO:0060574; GO:0060670; GO:0060715; GO:0060716; GO:0060718; GO:0071219; GO:0098978; GO:0099054; GO:1901382; GO:2000810"
"1593","Pocillopora_acuta_HIv2___RNAseq.g24815.t1",21.0544099274968,-1.14743451275483,2.07120513994866,0.00497177093985413,0.0231525096181746,"Q9NUC0",1.31e-06,"SERTA domain-containing protein 4","","GO:0005634"
"1594","Pocillopora_acuta_HIv2___TS.g14050.t1",158.666925752811,-1.73139736881039,0.885543457406558,0.00497516837559802,0.0231608739570807,NA,NA,NA,NA,NA
"1595","Pocillopora_acuta_HIv2___TS.g23568.t2d",533.682088671004,-2.31561592443843,2.3681862782822,0.00501119273001422,0.0233210666682895,"Q04073",1.56e-152,"DNA-binding protein P3A2","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357"
"1596","Pocillopora_acuta_HIv2___TS.g23391.t1",270.085511781274,2.04007745254068,1.8492075860232,0.00503271973070704,0.0233911498023607,"Q923L3",1.44e-86,"CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1)","conditioned place preference [GO:1990708]; female gonad development [GO:0008585]; glucose homeostasis [GO:0042593]; male gonad development [GO:0008584]; mammary gland branching involved in pregnancy [GO:0060745]; memory [GO:0007613]; oviduct epithelium development [GO:0035846]; startle response [GO:0001964]","GO:0001964; GO:0007613; GO:0008584; GO:0008585; GO:0016020; GO:0035846; GO:0042593; GO:0060745; GO:1990708"
"1597","Pocillopora_acuta_HIv2___RNAseq.g5089.t1",120.491178273966,-1.78681823734613,1.78483550423186,0.00504835888600837,0.0234487677993658,"Q1RMU2",3.22e-20,"Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD)","innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-18-mediated signaling pathway [GO:2000493]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of mitotic cell cycle [GO:0007346]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; Wnt signaling pathway [GO:0016055]","GO:0004843; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006508; GO:0007346; GO:0008270; GO:0010803; GO:0016055; GO:0016579; GO:0032088; GO:0036064; GO:0045087; GO:0046329; GO:0048471; GO:0050727; GO:0050728; GO:0061578; GO:0070266; GO:0070536; GO:0090090; GO:0097542; GO:1901223; GO:1902017; GO:1903753; GO:1990108; GO:2000493; GO:2001238; GO:2001242"
"1598","Pocillopora_acuta_HIv2___RNAseq.g1336.t1",15.7247237686746,-1.58379121333386,2.59880771029101,0.00506044295147916,0.0234973505137061,"Q55E58",6.49e-20,"Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)","cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856]","GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310"
"1599","Pocillopora_acuta_HIv2___RNAseq.g6698.t1",263.576088505531,1.225856589352,1.81904147522618,0.0050832676868735,0.0235806234198006,NA,NA,NA,NA,NA
"1600","Pocillopora_acuta_HIv2___TS.g26909.t1",252.60490560428,-1.06959524921932,1.61460337558608,0.00511358239212538,0.0237060434999043,NA,NA,NA,NA,NA
"1601","Pocillopora_acuta_HIv2___RNAseq.g25282.t1",3864.94043646493,-1.32165634119031,0.548289832883486,0.00512767452625834,0.0237637565997439,NA,NA,NA,NA,NA
"1602","Pocillopora_acuta_HIv2___RNAseq.6617_t",379.729722087825,1.66274273727593,3.19351782865406,0.00514457278950082,0.0238191744005569,NA,NA,NA,NA,NA
"1603","Pocillopora_acuta_HIv2___RNAseq.g4762.t1",147.479458524692,-1.57484287531878,1.93698656942031,0.00518253512161614,0.0239795866919565,NA,NA,NA,NA,NA
"1604","Pocillopora_acuta_HIv2___TS.g20588.t1",2606.30839091533,1.21825258975417,1.85534475927568,0.005187389651186,0.0239943728540947,NA,NA,NA,NA,NA
"1605","Pocillopora_acuta_HIv2___TS.g28604.t1",2013.84859828296,2.21574692543154,1.75294182493414,0.0051903591519619,0.0240004331118852,"O54962",1.64e-17,"Barrier-to-autointegration factor (LAP2-binding protein 1) [Cleaved into: Barrier-to-autointegration factor, N-terminally processed]","chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; DNA integration [GO:0015074]; establishment of integrated proviral latency [GO:0075713]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of innate immune response [GO:0045824]; negative regulation of protein ADP-ribosylation [GO:0010836]; negative regulation of type I interferon production [GO:0032480]; negative regulation of viral genome replication [GO:0045071]; response to oxidative stress [GO:0006979]","GO:0000785; GO:0000793; GO:0003677; GO:0003690; GO:0005634; GO:0005635; GO:0005654; GO:0005829; GO:0006325; GO:0006979; GO:0007084; GO:0010836; GO:0015074; GO:0032480; GO:0042802; GO:0042803; GO:0045071; GO:0045824; GO:0051276; GO:0075713; GO:0160049"
"1606","Pocillopora_acuta_HIv2___TS.g3024.t4",5769.89334618293,-1.34441955271646,0.561093952067508,0.00523099628394152,0.0241574489945499,"Q62770",1.1e-08,"Protein unc-13 homolog C (Munc13-3)","chemical synaptic transmission [GO:0007268]; dense core granule priming [GO:0061789]; negative regulation of synaptic plasticity [GO:0031914]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of neurotransmitter secretion [GO:0046928]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]","GO:0005509; GO:0005516; GO:0005543; GO:0005886; GO:0007268; GO:0016079; GO:0016081; GO:0016082; GO:0017075; GO:0019905; GO:0019992; GO:0030672; GO:0031594; GO:0031914; GO:0035249; GO:0042734; GO:0043195; GO:0044305; GO:0046928; GO:0061789; GO:0098688; GO:0098793; GO:0098831; GO:0099525"
"1607","Pocillopora_acuta_HIv2___RNAseq.g9049.t1",14251.4373068824,1.35739533979412,0.5726587440202,0.00526359400567891,0.0242847284523572,"P55008",8.21e-51,"Allograft inflammatory factor 1 (AIF-1) (Ionized calcium-binding adapter molecule 1) (Protein G1)","actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cellular response to oxidative stress [GO:0034599]; cellular response to type II interferon [GO:0071346]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parallel actin filament bundle assembly [GO:0030046]; phagocytosis, engulfment [GO:0006911]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of chemotaxis [GO:0050921]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; Rac protein signal transduction [GO:0016601]; regulation of gene expression [GO:0010468]; ruffle assembly [GO:0097178]","GO:0001726; GO:0001774; GO:0001891; GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0005884; GO:0006911; GO:0006954; GO:0008284; GO:0010468; GO:0016601; GO:0030027; GO:0030041; GO:0030046; GO:0030335; GO:0032587; GO:0032722; GO:0032755; GO:0034599; GO:0042102; GO:0048471; GO:0048661; GO:0048662; GO:0050921; GO:0051015; GO:0051017; GO:0051764; GO:0071346; GO:0071672; GO:0071673; GO:0071677; GO:0090026; GO:0090271; GO:0097178; GO:0097386; GO:1900087; GO:2000406"
"1608","Pocillopora_acuta_HIv2___RNAseq.g25228.t1",276.991026192191,-1.05983214138289,1.69087156325894,0.0052842905270002,0.0243646726753366,"Q8BUV3",3.5e-161,"Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E)]","establishment of protein localization [GO:0045184]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; maintenance of postsynaptic specialization structure [GO:0098880]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]","GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0006777; GO:0007529; GO:0008092; GO:0009898; GO:0014069; GO:0019897; GO:0030425; GO:0032324; GO:0042802; GO:0043025; GO:0045184; GO:0045211; GO:0046872; GO:0060077; GO:0060090; GO:0061598; GO:0061599; GO:0072579; GO:0097060; GO:0097112; GO:0098690; GO:0098794; GO:0098879; GO:0098880; GO:0098970; GO:0098982; GO:0099091; GO:0099572; GO:0099634; GO:0099645"
"1609","Pocillopora_acuta_HIv2___RNAseq.g6852.t1",194.644238443925,-1.03668296219373,1.57092397398068,0.0053110973920733,0.0244726704934528,"Q54TD7",1.82e-43,"ATP-dependent RNA helicase ddx24 (EC 3.6.4.13) (DEAD box protein 24)","","GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016887"
"1610","Pocillopora_acuta_HIv2___RNAseq.g20170.t1",65.8639879659293,-1.18884364938917,1.70034088348525,0.00532419928025491,0.0245174206907377,"P42688",5.12e-24,"Tyrosine-protein kinase SRK2 (EC 2.7.10.2)","cell differentiation [GO:0030154]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; innate immune response [GO:0045087]","GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0007169; GO:0030154; GO:0031234; GO:0045087"
"1611","Pocillopora_acuta_HIv2___RNAseq.g17386.t1",205.307743912488,1.19137247363626,1.8213749648867,0.00539338537968296,0.0247886641664234,NA,NA,NA,NA,NA
"1612","Pocillopora_acuta_HIv2___RNAseq.g10504.t1",1931.38047756694,1.84207203793967,1.0205477342321,0.00543278353641378,0.0249301335884166,NA,NA,NA,NA,NA
"1613","Pocillopora_acuta_HIv2___TS.g29319.t1",869.443334045035,-2.09851635195196,1.79221430991992,0.00548656640797148,0.0251594567046097,"Q8CFV2",9.75e-39,"Protein FAM149A","",""
"1614","Pocillopora_acuta_HIv2___RNAseq.g25274.t1",793.466349354076,1.65968497644801,2.18303615844658,0.00551631402889511,0.0252428482892095,"Q8BX37",1.74e-164,"Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form)","","GO:0003993; GO:0005576; GO:0046872"
"1615","Pocillopora_acuta_HIv2___RNAseq.g29813.t1",87.0149157465166,2.6166125557401,1.9090932001604,0.00563632010191432,0.0257335018794472,"Q01456",9.87e-13,"Ovarian abundant message protein (Protein OAM)","",""
"1616","Pocillopora_acuta_HIv2___RNAseq.g14663.t1b",1001.55205396497,-2.03643671708944,1.68079868276287,0.0056387443896744,0.0257364464664722,NA,NA,NA,NA,NA
"1617","Pocillopora_acuta_HIv2___TS.g5347.t1",849.577819501918,-1.09462587101561,1.62246287215834,0.00567377286837503,0.0258718318941288,"O09012",0,"Peroxisomal targeting signal 1 receptor (PTS1 receptor) (PTS1R) (PTS1-BP) (PXR1P) (Peroxin-5) (Peroxisomal C-terminal targeting signal import receptor) (Peroxisome receptor 1)","cell development [GO:0048468]; cellular lipid metabolic process [GO:0044255]; cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; cerebral cortex neuron differentiation [GO:0021895]; endoplasmic reticulum organization [GO:0007029]; fatty acid beta-oxidation [GO:0006635]; mitochondrial membrane organization [GO:0007006]; mitochondrion organization [GO:0007005]; negative regulation of protein-containing complex assembly [GO:0031333]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; pexophagy [GO:0000425]; positive regulation of multicellular organism growth [GO:0040018]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0000268; GO:0000425; GO:0001764; GO:0005052; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005794; GO:0005829; GO:0006625; GO:0006635; GO:0007005; GO:0007006; GO:0007029; GO:0007031; GO:0016558; GO:0016560; GO:0016562; GO:0021795; GO:0021895; GO:0031267; GO:0031333; GO:0032991; GO:0033328; GO:0034614; GO:0040018; GO:0044255; GO:0044721; GO:0045046; GO:0048468; GO:0050905; GO:0140597"
"1618","Pocillopora_acuta_HIv2___RNAseq.g13643.t1",516.181601699315,-1.82430462715855,1.107112404547,0.00570357325104159,0.025974963319605,"Q9JJ93",6.18e-21,"Uncharacterized protein C14orf119 homolog","","GO:0005739; GO:0005829"
"1619","Pocillopora_acuta_HIv2___RNAseq.g12231.t1",629.626738790545,-1.54152648784908,0.725189204639338,0.00573989272703739,0.0261156994035448,NA,NA,NA,NA,NA
"1620","Pocillopora_acuta_HIv2___TS.g25022.t1b",326.131313736852,-1.91489887239136,4.10216561071888,0.00574940034599766,0.0261507316366384,NA,NA,NA,NA,NA
"1621","Pocillopora_acuta_HIv2___RNAseq.g14750.t1",399.540143125754,1.82961941035372,1.96474030361038,0.00584255711203313,0.0265327303197636,"Q9Y2Y9",6.76e-44,"Krueppel-like factor 13 (Basic transcription element-binding protein 3) (BTE-binding protein 3) (Novel Sp1-like zinc finger transcription factor 1) (RANTES factor of late activated T-lymphocytes 1) (RFLAT-1) (Transcription factor BTEB3) (Transcription factor NSLP1)","negative regulation of cell population proliferation [GO:0008285]; negative regulation of erythrocyte differentiation [GO:0045647]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]","GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006366; GO:0008285; GO:0045647; GO:0046872; GO:1990837"
"1622","Pocillopora_acuta_HIv2___RNAseq.g29819.t1",656.270291485275,1.96353079512252,1.84104319906455,0.00586650310379683,0.0266247571049003,NA,NA,NA,NA,NA
"1623","Pocillopora_acuta_HIv2___RNAseq.g27031.t1",1984.42921036949,1.7308250051893,1.00618504728307,0.00588893593777006,0.0267181836273231,"Q91ZU6",3.4e-10,"Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060]","GO:0001725; GO:0003779; GO:0005198; GO:0005509; GO:0005634; GO:0005635; GO:0005737; GO:0005789; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007409; GO:0008017; GO:0008090; GO:0009898; GO:0014069; GO:0014704; GO:0015629; GO:0015630; GO:0016020; GO:0030018; GO:0030056; GO:0030424; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042383; GO:0042803; GO:0045098; GO:0045104; GO:0046907; GO:0048471; GO:0051010; GO:0097038; GO:1904115"
"1624","Pocillopora_acuta_HIv2___RNAseq.g19230.t1",924.708573679374,-1.02098772444924,1.44272711872049,0.00595230988001198,0.0269701030978756,"Q7SYJ9",4.88e-77,"Sperm-associated antigen 7 homolog","","GO:0003676"
"1625","Pocillopora_acuta_HIv2___RNAseq.g15698.t1",842.378649324237,1.7190670354026,0.893757816791005,0.00598901864180375,0.0271042445666613,"P54357",8.01e-10,"Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain)","actin filament-based movement [GO:0030048]","GO:0005509; GO:0005829; GO:0016460; GO:0017022; GO:0030048; GO:0031475; GO:0031476; GO:0031477; GO:0032036"
"1626","Pocillopora_acuta_HIv2___TS.g3644.t2",2525.75513754071,1.34807869492155,0.576646724258784,0.00600818262793042,0.0271824690429733,"P97379",4.85e-46,"Ras GTPase-activating protein-binding protein 2 (G3BP-2) (GAP SH3 domain-binding protein 2)","innate immune response [GO:0045087]; mRNA transport [GO:0051028]; positive regulation of stress granule assembly [GO:0062029]; protein homooligomerization [GO:0051260]; small GTPase-mediated signal transduction [GO:0007264]; stress granule assembly [GO:0034063]","GO:0003729; GO:0005829; GO:0007264; GO:0010494; GO:0034063; GO:0045087; GO:0051028; GO:0051260; GO:0062029; GO:0140693; GO:1990904"
"1627","Pocillopora_acuta_HIv2___RNAseq.g626.t1",825.478450901913,-1.72411650826137,1.95716554225192,0.00611687178254395,0.0276482604570987,"Q9VXE5",2.68e-145,"Serine/threonine-protein kinase PAK mbt (EC 2.7.11.1) (Protein mushroom bodies tiny) (p21-activated kinase-related protein)","compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; positive regulation of compound eye photoreceptor development [GO:0045315]; positive regulation of developmental growth [GO:0048639]; protein phosphorylation [GO:0006468]; regulation of cell-cell adhesion mediated by cadherin [GO:2000047]; regulation of MAPK cascade [GO:0043408]","GO:0001751; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0005912; GO:0006468; GO:0007010; GO:0007030; GO:0016319; GO:0031267; GO:0035556; GO:0043408; GO:0045315; GO:0045792; GO:0048639; GO:0048749; GO:0106310; GO:2000047"
"1628","Pocillopora_acuta_HIv2___RNAseq.g12290.t1",272.61928918956,-1.35223950790187,1.82375902696548,0.00612461532530966,0.0276659700391252,"Q7SIC1",1.31e-14,"Fucolectin","regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]","GO:0001868; GO:0005509; GO:0005576; GO:0010185; GO:0030246; GO:0042806; GO:0045088"
"1629","Pocillopora_acuta_HIv2___RNAseq.g29674.t1",113.266429183346,1.70743394368756,0.89556825524346,0.00616586650766274,0.0278175586920879,"E2JA28",5.73e-07,"Dapdiamide synthesis protein DdaC (EC 1.-.-.-)","antibiotic biosynthetic process [GO:0017000]","GO:0016491; GO:0017000"
"1630","Pocillopora_acuta_HIv2___RNAseq.g2565.t1",1916.73678394501,1.78432775914643,2.18221254068206,0.00619079321367964,0.0279213074657507,"Q9XSC1",1.1e-27,"Secreted frizzled-related protein 5 (sFRP-5)","canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; negative regulation of Wnt signaling pathway [GO:0030178]; non-canonical Wnt signaling pathway [GO:0035567]","GO:0005615; GO:0017147; GO:0030154; GO:0030178; GO:0035567; GO:0060070"
"1631","Pocillopora_acuta_HIv2___RNAseq.6832_t",2401.02573552091,1.33101184436965,1.87250879512518,0.00622576866256432,0.0280440728543539,"Q9UPX0",2.77e-78,"Protein turtle homolog B (Immunoglobulin superfamily member 9B) (IgSF9B)","cell adhesion [GO:0007155]; nervous system development [GO:0007399]","GO:0007155; GO:0007399; GO:0014069; GO:0043005; GO:0045211"
"1632","Pocillopora_acuta_HIv2___RNAseq.g28871.t1",1051.68497089319,-1.53675659096371,0.735419739894942,0.00629583323440403,0.0283155882781156,NA,NA,NA,NA,NA
"1633","Pocillopora_acuta_HIv2___RNAseq.g26299.t1",441.621586848928,-1.6704988561029,0.900729133006683,0.00633205989918798,0.028434310581141,"Q6P4K6",1.03e-40,"Serine/threonine-protein kinase 11-interacting protein","","GO:0005737"
"1634","Pocillopora_acuta_HIv2___RNAseq.g29898.t1",1879.11610484277,-2.03454850146396,1.85923422864969,0.00634835777103607,0.0284986489138007,"P16068",5.26e-167,"Guanylate cyclase soluble subunit beta-1 (GCS-beta-1) (EC 4.6.1.2) (Guanylate cyclase soluble subunit beta-3) (GCS-beta-3) (Soluble guanylate cyclase small subunit)","cellular response to nitric oxide [GO:0071732]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling [GO:0038060]; response to oxygen levels [GO:0070482]","GO:0004383; GO:0005525; GO:0005737; GO:0006182; GO:0008074; GO:0019934; GO:0020037; GO:0038060; GO:0046872; GO:0070482; GO:0071732"
"1635","Pocillopora_acuta_HIv2___TS.g24807.t1",6598.60729910285,-1.31902030609539,0.567959202937405,0.0064308239826761,0.0288151914762786,"Q96RW7",1.03e-15,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711"
"1636","Pocillopora_acuta_HIv2___RNAseq.g5096.t1",550.227807764451,1.70170151178681,1.77065583706347,0.00644807561652128,0.0288746023892767,NA,NA,NA,NA,NA
"1637","Pocillopora_acuta_HIv2___TS.g2830.t1",177.100315907635,-1.50481685138241,0.700277746912767,0.0064749357268662,0.02894112186446,"Q5F4A1",2.4e-18,"G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase)","apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]","GO:0004842; GO:0005634; GO:0005730; GO:0005737; GO:0006915; GO:0016567; GO:0046872"
"1638","Pocillopora_acuta_HIv2___RNAseq.g3532.t1",2305.54393704525,-1.81849863414643,1.15645760699089,0.00649370077314835,0.0290070685555336,"Q5E9E2",1.04e-88,"Myosin regulatory light polypeptide 9 (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9)","actomyosin structure organization [GO:0031032]","GO:0005509; GO:0005737; GO:0005938; GO:0016460; GO:0031032; GO:0042641; GO:0097513"
"1639","Pocillopora_acuta_HIv2___RNAseq.g21831.t1",1714.44668418446,-1.70036763237441,1.08299069549563,0.00652747886182248,0.0291309639794509,"O35066",1.36e-32,"Kinesin-like protein KIF3C","microtubule-based movement [GO:0007018]; positive regulation of neuron projection development [GO:0010976]","GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0008021; GO:0010976; GO:0015630; GO:0016887; GO:0019894; GO:0030424; GO:0030425; GO:0030426; GO:0035371; GO:0043025; GO:0071598"
"1640","Pocillopora_acuta_HIv2___RNAseq.g24929.t1",669.400544451373,-1.06428640670929,1.5882724259342,0.00665305178399549,0.0296547738069987,NA,NA,NA,NA,NA
"1641","Pocillopora_acuta_HIv2___TS.g29912.t2",1245.44592349205,1.38573706311438,1.52895180141379,0.00672647302760166,0.0299635681771575,"E7FDW2",1.57e-61,"E3 ubiquitin-protein ligase PDZRN3-B (EC 2.3.2.27) (PDZ domain-containing RING finger protein 3-B)","neuromuscular junction development [GO:0007528]; protein ubiquitination [GO:0016567]","GO:0005737; GO:0007528; GO:0016567; GO:0045202; GO:0046872; GO:0061630"
"1642","Pocillopora_acuta_HIv2___TS.g3256.t1",295.295562269589,-1.07198050204221,1.6003151530471,0.0067554270337028,0.0300740217345267,"Q9I929",3.19e-13,"Fucolectin-3","regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]","GO:0001868; GO:0005509; GO:0005615; GO:0010185; GO:0030246; GO:0042806; GO:0045088"
"1643","Pocillopora_acuta_HIv2___RNAseq.g14772.t1",631.815407480776,1.70338724522683,1.09555987057222,0.00676678477569628,0.0301153153832834,NA,NA,NA,NA,NA
"1644","Pocillopora_acuta_HIv2___RNAseq.g12054.t1",845.453698293954,-1.62095471902178,1.59426304060626,0.00680172937354143,0.0302429184318792,"Q5EAJ7",0,"Major vault protein (MVP)","","GO:0005634; GO:0005737; GO:1990904"
"1645","Pocillopora_acuta_HIv2___RNAseq.g16254.t1",374.33469469375,-1.42026747769945,1.65583085345887,0.00681982060148277,0.0303140396987851,"Q3KP44",3.99e-26,"Ankyrin repeat domain-containing protein 55","",""
"1646","Pocillopora_acuta_HIv2___RNAseq.g22674.t1",265.737790158686,2.21536160788402,1.85773687633943,0.00683355112118792,0.0303634759374094,NA,NA,NA,NA,NA
"1647","Pocillopora_acuta_HIv2___RNAseq.g12336.t1",233.822229841872,-1.02841246758771,1.53332807935732,0.00687703622553868,0.0305363087825343,NA,NA,NA,NA,NA
"1648","Pocillopora_acuta_HIv2___RNAseq.g6273.t1",715.748271921282,-1.61798922082397,0.891548399636149,0.00695840087753314,0.030863633944385,"Q5F4A1",1.91e-75,"G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase)","apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]","GO:0004842; GO:0005634; GO:0005730; GO:0005737; GO:0006915; GO:0016567; GO:0046872"
"1649","Pocillopora_acuta_HIv2___RNAseq.g18209.t1",614.583780373003,-1.1852594433375,1.698170620226,0.00701884806775031,0.031103130653168,"P49695",2.93e-30,"Probable serine/threonine-protein kinase PkwA (EC 2.7.11.1)","","GO:0004674; GO:0005524; GO:0106310"
"1650","Pocillopora_acuta_HIv2___RNAseq.g23661.t1",164.099075007577,-1.26534697071038,1.58287045418269,0.00703142232532567,0.031149308579942,NA,NA,NA,NA,NA
"1651","Pocillopora_acuta_HIv2___RNAseq.g11318.t1",3151.41830680575,1.67092536915961,0.971473137337822,0.0070398604369687,0.0311771406492086,NA,NA,NA,NA,NA
"1652","Pocillopora_acuta_HIv2___TS.g11857.t2",566.943042861022,-1.93293397682948,1.68543849721903,0.00707063871308244,0.031282971036469,"Q6NTV6",1.9e-82,"Inverted formin-2","actin cytoskeleton organization [GO:0030036]","GO:0003779; GO:0030036; GO:0031267"
"1653","Pocillopora_acuta_HIv2___TS.g5728.t1",48.5930896482267,-1.89511716310803,1.76931667010895,0.00709661363485588,0.0313612647768272,NA,NA,NA,NA,NA
"1654","Pocillopora_acuta_HIv2___TS.g31609.t2",1410.38041752249,1.45884350265525,0.687000986496015,0.00711743661590973,0.0314340773167995,"Q9DAN9",4.14e-25,"Sperm axonemal maintenance protein CFAP97D1 (CFAP97 domain-containing protein 1)","sperm axoneme assembly [GO:0007288]","GO:0007288"
"1655","Pocillopora_acuta_HIv2___RNAseq.g25999.t1",2200.92623455925,-1.56233268860172,0.808314801082161,0.00715318445898903,0.03155341872974,"Q2HJ23",1.37e-50,"Microtubule-associated proteins 1A/1B light chain 3A (Autophagy-related protein LC3 A) (Autophagy-related ubiquitin-like modifier LC3 A) (MAP1 light chain 3-like protein 1) (MAP1A/MAP1B light chain 3 A) (MAP1A/MAP1B LC3 A) (Microtubule-associated protein 1 light chain 3 alpha)","autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]","GO:0000045; GO:0000421; GO:0000422; GO:0005543; GO:0005776; GO:0005829; GO:0005874; GO:0006995; GO:0008017; GO:0008429; GO:0012505; GO:0031090; GO:0031410; GO:0031625; GO:0097352"
"1656","Pocillopora_acuta_HIv2___RNAseq.g1720.t1",926.303232608277,-1.64249900807517,0.921543685108192,0.00718168228456867,0.0316694672451223,"Q8BH18",1.07e-163,"Transmembrane protein 117","intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]","GO:0005783; GO:0005886; GO:0070059"
"1657","Pocillopora_acuta_HIv2___RNAseq.g3051.t1",4957.84105687557,-1.42172534154964,0.666141207194398,0.00719342319658989,0.0317115736408035,"P02640",0,"Villin-1","actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]","GO:0001726; GO:0005509; GO:0005546; GO:0005737; GO:0005902; GO:0007173; GO:0008154; GO:0008360; GO:0009617; GO:0010634; GO:0015629; GO:0030027; GO:0030041; GO:0030042; GO:0030175; GO:0030335; GO:0032233; GO:0032432; GO:0032433; GO:0035727; GO:0035729; GO:0042803; GO:0043027; GO:0051014; GO:0051015; GO:0051016; GO:0051125; GO:0051693; GO:0060327; GO:0061041; GO:0071364; GO:2000392"
"1658","Pocillopora_acuta_HIv2___RNAseq.g30726.t1",3698.97198668318,2.09110270062339,1.96345526404879,0.0072091950191464,0.0317530280117478,"O76082",1.84e-83,"Organic cation/carnitine transporter 2 (High-affinity sodium-dependent carnitine cotransporter) (Solute carrier family 22 member 5)","(R)-carnitine transmembrane transport [GO:1902270]; (R)-carnitine transport [GO:1900749]; carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; response to symbiotic bacterium [GO:0009609]; response to tumor necrosis factor [GO:0034612]; response to type II interferon [GO:0034341]; sodium ion transport [GO:0006814]; sodium-dependent organic cation transport [GO:0070715]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]","GO:0005524; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006814; GO:0009609; GO:0009925; GO:0015199; GO:0015226; GO:0015293; GO:0015651; GO:0015697; GO:0015879; GO:0016324; GO:0030165; GO:0031526; GO:0034341; GO:0034612; GO:0042910; GO:0060731; GO:0070062; GO:0070715; GO:0150104; GO:1900749; GO:1901235; GO:1902270; GO:1902603; GO:1990961"
"1659","Pocillopora_acuta_HIv2___RNAseq.g3839.t1",1229.59562668963,1.61128249375239,0.875189221468121,0.00726670595510279,0.0319761590917575,NA,NA,NA,NA,NA
"1660","Pocillopora_acuta_HIv2___RNAseq.g18779.t1",1389.65760866196,-1.37544551232233,0.623630901771889,0.0073295856720147,0.0322332402432413,"Q32P51",2.27e-39,"Heterogeneous nuclear ribonucleoprotein A1-like 2 (hnRNP A1-like 2) (hnRNP core protein A1-like 2)","mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]","GO:0000398; GO:0003730; GO:0005737; GO:0051028; GO:0071013"
"1661","Pocillopora_acuta_HIv2___RNAseq.g8406.t1",1412.21776731526,-1.26443913605251,1.57491243413195,0.00734006870834403,0.0322695300296316,"Q9JHS4",0,"ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial","ATP metabolic process [GO:0046034]; proteolysis involved in protein catabolic process [GO:0051603]","GO:0004176; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0008270; GO:0009368; GO:0009841; GO:0016504; GO:0016887; GO:0042645; GO:0046034; GO:0046983; GO:0051082; GO:0051603; GO:0140662"
"1662","Pocillopora_acuta_HIv2___RNAseq.g14084.t2",1622.62014090379,1.62695958537251,0.852945550278073,0.00740280035906495,0.0325156709363849,NA,NA,NA,NA,NA
"1663","Pocillopora_acuta_HIv2___TS.g13497.t1c",2223.1297318709,-1.72648639660654,1.17711292542036,0.00740991848898814,0.032527180887625,"Q94738",0,"97 kDa heat shock protein (Heat shock protein 110)","","GO:0005524; GO:0005634; GO:0005829; GO:0140662"
"1664","Pocillopora_acuta_HIv2___RNAseq.g24196.t1",123.563319715981,1.73598837097231,1.19592008366187,0.00742802782890195,0.0325770147111091,"P70115",2.37e-13,"Adrenocorticotropic hormone receptor (ACTH receptor) (ACTH-R) (Adrenocorticotropin receptor) (Melanocortin receptor 2) (MC2-R)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; regulation of metabolic process [GO:0019222]","GO:0004978; GO:0005737; GO:0005886; GO:0007189; GO:0019222"
"1665","Pocillopora_acuta_HIv2___RNAseq.g3266.t1",498.749949263909,-1.39430356668408,1.79497170954481,0.0075254323899111,0.0329044298934928,"Q4R6V2",0,"T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon)","","GO:0005524; GO:0005813; GO:0005832; GO:0016887; GO:0031681; GO:0051082; GO:0140662"
"1666","Pocillopora_acuta_HIv2___RNAseq.g10899.t1",537.611459652144,-1.42065641831999,1.67388327976026,0.00756449171549954,0.0330352681681719,"O35972",2.96e-31,"Large ribosomal subunit protein uL23m (39S ribosomal protein L23, mitochondrial) (L23mt) (MRP-L23) (L23 mitochondrial-related protein)","mitochondrial translation [GO:0032543]; translation [GO:0006412]","GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0032543"
"1667","Pocillopora_acuta_HIv2___RNAseq.g22366.t1",2478.84737977224,-1.69451721593276,1.48554185652275,0.00763620621521491,0.0333162191687377,"O43602",8.56e-46,"Neuronal migration protein doublecortin (Doublin) (Lissencephalin-X) (Lis-X)","axoneme assembly [GO:0035082]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; retina development in camera-type eye [GO:0060041]","GO:0001764; GO:0005829; GO:0005856; GO:0005874; GO:0005875; GO:0007399; GO:0007417; GO:0008017; GO:0019901; GO:0035082; GO:0035556; GO:0043005; GO:0060041"
"1668","Pocillopora_acuta_HIv2___TS.g6579.t1",663.596942693354,-1.39421501031114,0.645004886620601,0.00767912475426408,0.033485336281482,"Q969N2",0,"GPI transamidase component PIG-T (Phosphatidylinositol-glycan biosynthesis class T protein)","attachment of GPI anchor to protein [GO:0016255]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]","GO:0005789; GO:0016020; GO:0016255; GO:0030182; GO:0031410; GO:0042765; GO:0051402"
"1669","Pocillopora_acuta_HIv2___TS.g26021.t1",2935.17911250005,-1.90922073365235,1.90838893625173,0.00768894230725631,0.033507942612882,"Q795M8",9.5e-11,"Putative potassium channel protein YugO","","GO:0005267; GO:0005886"
"1670","Pocillopora_acuta_HIv2___RNAseq.g26319.t1",4443.85252487756,1.37285740661053,0.626969453109739,0.00769430730921613,0.0335212231688259,"Q9UJA9",4.2e-89,"Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (E-NPP 5) (NPP-5) (EC 3.1.-.-)","cell communication [GO:0007154]","GO:0000210; GO:0005576; GO:0005886; GO:0007154; GO:0008270"
"1671","Pocillopora_acuta_HIv2___RNAseq.g13683.t1",3735.23922183156,1.39873900406938,0.648530775017865,0.00771746752439087,0.0336119994799126,"Q9BXW4",4.18e-61,"Microtubule-associated proteins 1A/1B light chain 3C (Autophagy-related protein LC3 C) (Autophagy-related ubiquitin-like modifier LC3 C) (MAP1 light chain 3-like protein 3) (MAP1A/MAP1B light chain 3 C) (MAP1A/MAP1B LC3 C) (Microtubule-associated protein 1 light chain 3 gamma)","aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; protein exit from endoplasmic reticulum [GO:0032527]","GO:0000045; GO:0000421; GO:0000422; GO:0005776; GO:0005829; GO:0005874; GO:0006995; GO:0008429; GO:0009267; GO:0012505; GO:0016236; GO:0031090; GO:0031410; GO:0031625; GO:0032527; GO:0035973; GO:0036464; GO:0097352"
"1672","Pocillopora_acuta_HIv2___RNAseq.g10408.t1",1143.39865747466,-1.60936169039605,1.01321022569047,0.00784727922390552,0.0341362546449833,"P23511",7.2e-32,"Nuclear transcription factor Y subunit alpha (CAAT box DNA-binding protein subunit A) (Nuclear transcription factor Y subunit A) (NF-YA)","positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; transcription by RNA polymerase II [GO:0006366]","GO:0000785; GO:0000978; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0006366; GO:0016602; GO:0032993; GO:0045893; GO:0045944; GO:0048511; GO:0090575"
"1673","Pocillopora_acuta_HIv2___RNAseq.g8093.t1",2555.99530538479,-1.43620120714765,0.687633563344887,0.00786945006520041,0.0342121207523471,"Q06A37",0,"Chromodomain-helicase-DNA-binding protein 7 (CHD-7) (EC 3.6.4.12) (ATP-dependent helicase CHD7)","adult heart development [GO:0007512]; adult walking behavior [GO:0007628]; aorta morphogenesis [GO:0035909]; atrioventricular canal development [GO:0036302]; blood circulation [GO:0008015]; blood vessel remodeling [GO:0001974]; cardiac septum morphogenesis [GO:0060411]; central nervous system development [GO:0007417]; chordate embryonic development [GO:0043009]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; cranial nerve development [GO:0021545]; embryonic hindlimb morphogenesis [GO:0035116]; epithelium development [GO:0060429]; face development [GO:0060324]; female genitalia development [GO:0030540]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; innervation [GO:0060384]; nose development [GO:0043584]; olfactory behavior [GO:0042048]; olfactory bulb development [GO:0021772]; olfactory nerve development [GO:0021553]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of growth hormone secretion [GO:0060123]; regulation of neurogenesis [GO:0050767]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; response to bacterium [GO:0009617]; retina development in camera-type eye [GO:0060041]; right ventricular compact myocardium morphogenesis [GO:0003226]; rRNA processing [GO:0006364]; secondary palate development [GO:0062009]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; T cell differentiation [GO:0030217]; transcription by RNA polymerase II [GO:0006366]; ventricular trabecula myocardium morphogenesis [GO:0003222]","GO:0000785; GO:0000978; GO:0001501; GO:0001974; GO:0003007; GO:0003222; GO:0003226; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0006364; GO:0006366; GO:0007417; GO:0007512; GO:0007605; GO:0007628; GO:0008015; GO:0009617; GO:0010468; GO:0010880; GO:0016887; GO:0021545; GO:0021553; GO:0021772; GO:0030217; GO:0030540; GO:0035116; GO:0035909; GO:0036302; GO:0040018; GO:0042048; GO:0042393; GO:0042472; GO:0043009; GO:0043584; GO:0045944; GO:0048752; GO:0050767; GO:0050890; GO:0060041; GO:0060123; GO:0060324; GO:0060384; GO:0060411; GO:0060429; GO:0062009; GO:0140658; GO:1990841"
"1674","Pocillopora_acuta_HIv2___RNAseq.g16055.t1",521.287148657092,-1.01994775602328,1.48466761273124,0.00789886756016362,0.0343090751922542,NA,NA,NA,NA,NA
"1675","Pocillopora_acuta_HIv2___RNAseq.g17534.t1",547.211464427983,-1.60925019684577,1.62921973011713,0.00790519461658103,0.0343262488544665,"Q8JFV8",7.59e-39,"Synaptic vesicle membrane protein VAT-1 homolog (EC 1.-.-.-)","negative regulation of mitochondrial fusion [GO:0010637]","GO:0005741; GO:0008270; GO:0010637; GO:0016491"
"1676","Pocillopora_acuta_HIv2___RNAseq.g2716.t1",3466.38289277091,1.73401999096258,1.0683149350344,0.00807361704085409,0.0349421893713086,"O88818",0,"Plastin-3 (T-plastin)","actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]","GO:0005509; GO:0005737; GO:0005884; GO:0032432; GO:0051015; GO:0051017; GO:0051639"
"1677","Pocillopora_acuta_HIv2___RNAseq.g4679.t1",670.394943168705,1.46279748809099,0.710243177741627,0.00807921705847327,0.0349559663576899,"P57729",1.11e-23,"Ras-related protein Rab-38 (Melanoma antigen NY-MEL-1)","endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; phagosome acidification [GO:0090383]; platelet dense granule organization [GO:0060155]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of protein localization to cell periphery [GO:1904377]; protein localization to membrane [GO:0072657]; protein transport [GO:0015031]; small GTPase-mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]","GO:0003924; GO:0005525; GO:0005739; GO:0005764; GO:0005769; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0007005; GO:0007264; GO:0012505; GO:0015031; GO:0016020; GO:0016192; GO:0030670; GO:0030742; GO:0032438; GO:0033162; GO:0035646; GO:0035650; GO:0035651; GO:0036461; GO:0042470; GO:0044233; GO:0044297; GO:0045335; GO:0048023; GO:0048471; GO:0060155; GO:0072657; GO:0090383; GO:1903232; GO:1904377; GO:2001247"
"1678","Pocillopora_acuta_HIv2___RNAseq.g16101.t1",346.323567582662,-1.09768766741766,1.49771865585761,0.00808822859886228,0.0349844911644569,"Q8CG45",1.38e-112,"Aflatoxin B1 aldehyde reductase member 2 (rAFAR2) (EC 1.1.1.n11) (Succinic semialdehyde reductase) (SSA reductase)","daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; lipid metabolic process [GO:0006629]","GO:0004032; GO:0004033; GO:0005635; GO:0005737; GO:0005739; GO:0005795; GO:0006629; GO:0019119; GO:0044597; GO:0044598"
"1679","Pocillopora_acuta_HIv2___RNAseq.g7454.t2",22.4460646048048,-1.20190268797013,1.7452914087835,0.00810365711441764,0.0350407463386956,"P0CI65",3.24e-37,"Nephrocystin-3","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"1680","Pocillopora_acuta_HIv2___TS.g22622.t1",5425.1406131193,-1.3337266064777,0.61135345912121,0.00822868877988345,0.0354864413034817,"P14105",6.83e-36,"Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA)","actin cytoskeleton organization [GO:0030036]; actin filament-based movement [GO:0030048]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myosin filament assembly [GO:0031034]; platelet formation [GO:0030220]; protein transport [GO:0015031]; regulation of cell shape [GO:0008360]","GO:0000146; GO:0001525; GO:0001725; GO:0001726; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005826; GO:0005829; GO:0005886; GO:0005938; GO:0006509; GO:0008360; GO:0015031; GO:0015629; GO:0016460; GO:0030036; GO:0030048; GO:0030220; GO:0030224; GO:0031034; GO:0031252; GO:0032154; GO:0032506; GO:0032982; GO:0032991; GO:0042803; GO:0043495; GO:0043534; GO:0051015; GO:0060471; GO:0060473"
"1681","Pocillopora_acuta_HIv2___RNAseq.g26590.t1",238.771899532041,1.67881909602071,1.12141974790204,0.00824180611552338,0.0355213002547468,"Q3YBN2",8.89e-07,"Tear acid lipase-like protein (TALLP)","sterol metabolic process [GO:0016125]","GO:0004771; GO:0005615; GO:0008289; GO:0016125; GO:0043231"
"1682","Pocillopora_acuta_HIv2___RNAseq.g21021.t1",4513.05543217475,-1.57964700123708,0.923159080710455,0.00829782429793404,0.0357201579301541,"Q66KI8",2.81e-79,"Protein APCDD1 (Adenomatosis polyposis coli down-regulated 1 protein homolog) (Protein primglo) (xPgo)","negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]","GO:0005886; GO:0016055; GO:0017147; GO:0030178"
"1683","Pocillopora_acuta_HIv2___RNAseq.g26052.t1",970.461569766474,1.76725323574612,1.12960285900381,0.00830731707112168,0.0357440416058696,NA,NA,NA,NA,NA
"1684","Pocillopora_acuta_HIv2___RNAseq.g7660.t2",598.410608282049,-1.73755352363929,1.19751697448476,0.00830831498056787,0.0357440416058696,"Q91WC9",6.84e-117,"Diacylglycerol lipase-beta (DAGL-beta) (DAGLbeta) (DGL-beta) (EC 3.1.1.116) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta)","arachidonic acid metabolic process [GO:0019369]; cannabinoid biosynthetic process [GO:1901696]; diacylglycerol catabolic process [GO:0046340]; icosanoid metabolic process [GO:0006690]; monoacylglycerol biosynthetic process [GO:0006640]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727]","GO:0001516; GO:0004806; GO:0005654; GO:0005886; GO:0006640; GO:0006690; GO:0007405; GO:0010898; GO:0016298; GO:0019369; GO:0022008; GO:0046340; GO:0046872; GO:0047372; GO:0050727; GO:1901696"
"1685","Pocillopora_acuta_HIv2___RNAseq.g14581.t1",79.5838713103448,-1.13803900228524,1.58481272484935,0.00834609522318957,0.0358852322557116,NA,NA,NA,NA,NA
"1686","Pocillopora_acuta_HIv2___RNAseq.g15837.t1",4778.99036055545,1.67414794378555,1.01970897728927,0.00837022957691063,0.0359569351352644,"Q9U5M4",4.16e-14,"Tropomyosin-2","actin filament organization [GO:0007015]; muscle contraction [GO:0006936]","GO:0005884; GO:0006936; GO:0007015; GO:0051015"
"1687","Pocillopora_acuta_HIv2___RNAseq.g19470.t1",4616.90231220607,1.41753186648247,0.679814040596309,0.00841688834986582,0.036103758331097,"A0A481NSZ4",3.75e-90,"Bactericidal permeability-increasing protein (BPI) (Lipopolysaccharide-binding protein) (LBP)","defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]","GO:0005615; GO:0008289; GO:0042742; GO:0045087"
"1688","Pocillopora_acuta_HIv2___TS.g17199.t1",3983.64133206497,1.5934652965107,0.885390282508917,0.00843116143724736,0.036132835267658,"P19137",9.77e-10,"Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha)","animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; branching involved in salivary gland morphogenesis [GO:0060445]; camera-type eye development [GO:0043010]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; morphogenesis of an epithelial sheet [GO:0002011]; neuron projection development [GO:0031175]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein phosphorylation [GO:0006468]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retina development in camera-type eye [GO:0060041]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888]","GO:0002011; GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005608; GO:0005615; GO:0005911; GO:0006468; GO:0007155; GO:0007166; GO:0007411; GO:0009887; GO:0009888; GO:0016020; GO:0030334; GO:0031012; GO:0031175; GO:0043010; GO:0043208; GO:0043256; GO:0045198; GO:0045785; GO:0045995; GO:0048514; GO:0051149; GO:0060041; GO:0060441; GO:0060445; GO:0061304; GO:0062023; GO:0098637; GO:0110011; GO:2001046"
"1689","Pocillopora_acuta_HIv2___RNAseq.g22909.t1",33.6916398391469,2.2260706372007,1.29987704031077,0.00848318080114054,0.0362968102604489,NA,NA,NA,NA,NA
"1690","Pocillopora_acuta_HIv2___RNAseq.g16928.t3",5447.65606021035,1.8262702741519,1.26901918317798,0.00851650480399188,0.0364122747516815,"O70521",4.34e-40,"Regulator of G-protein signaling 19 (RGS19) (G-alpha-interacting protein) (GAIP)","negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to ethanol [GO:0045471]","GO:0000139; GO:0001965; GO:0005096; GO:0005903; GO:0008277; GO:0009968; GO:0030136; GO:0045471"
"1691","Pocillopora_acuta_HIv2___RNAseq.g3094.t1",661.57875312293,1.71827327384264,1.29951671421085,0.00864889283637657,0.0369085871478721,"P49288",2.49e-29,"Melatonin receptor type 1C (Mel-1C-R) (Mel1c receptor) (CKB)","G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of glucose import [GO:0046325]; negative regulation of glycolytic process [GO:0045820]","GO:0004930; GO:0005654; GO:0005886; GO:0007186; GO:0008502; GO:0045820; GO:0046325; GO:1904408"
"1692","Pocillopora_acuta_HIv2___RNAseq.g3482.t1",140.225661148268,-1.60834212356705,0.92667015263801,0.00865045011278252,0.0369085871478721,"Q8JIR0",1.62e-57,"Polycomb complex protein BMI-1-A (Polycomb group RING finger protein 4-A)","cerebellum development [GO:0021549]; chromatin remodeling [GO:0006338]; hematopoietic stem cell migration [GO:0035701]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; primitive hemopoiesis [GO:0060215]","GO:0000122; GO:0006338; GO:0021549; GO:0031519; GO:0035102; GO:0035701; GO:0045814; GO:0046872; GO:0060215; GO:1990841"
"1693","Pocillopora_acuta_HIv2___RNAseq.g8644.t1",1640.57207405207,-1.60800766691099,0.955870310212178,0.00867641888853799,0.0369757580447299,"Q95NR9",4.08e-102,"Calmodulin (CaM)","","GO:0005509; GO:0030234"
"1694","Pocillopora_acuta_HIv2___TS.g11523.t1b",1097.73965747704,-1.26479680635251,1.74238544364069,0.00870541530094519,0.0370825029586311,"A0A1B0GVH7",1.51e-21,"IQ domain-containing protein M","",""
"1695","Pocillopora_acuta_HIv2___RNAseq.g15953.t1",211.507091715162,1.63300135414802,0.99962997703141,0.00872595902169485,0.037154039237502,"Q923Y9",2.14e-06,"Trace amine-associated receptor 1 (TaR-1) (Trace amine receptor 1)","G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cAMP-mediated signaling [GO:0043950]","GO:0001594; GO:0004930; GO:0005886; GO:0007186; GO:0008227; GO:0043950"
"1696","Pocillopora_acuta_HIv2___RNAseq.g29446.t1",1041.78086355631,1.66606414761767,1.25213329223308,0.00873429177765833,0.0371785745356239,"Q13613",1.47e-67,"Phosphatidylinositol-3-phosphate phosphatase MTMR1 (EC 3.1.3.-) (Myotubularin-related protein 1) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95)","phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]","GO:0004438; GO:0005737; GO:0005829; GO:0005886; GO:0006661; GO:0016020; GO:0042803; GO:0046856; GO:0052629; GO:0060304"
"1697","Pocillopora_acuta_HIv2___TS.g10282.t1",19189.455270053,1.34732097228227,0.632891556624233,0.00884901313667493,0.0376226119955515,"Q9I954",3.83e-08,"Thymosin beta-b","actin filament organization [GO:0007015]; regulation of cell migration [GO:0030334]; sequestering of actin monomers [GO:0042989]","GO:0003785; GO:0005737; GO:0005856; GO:0007015; GO:0030334; GO:0042989"
"1698","Pocillopora_acuta_HIv2___RNAseq.g5348.t1a",913.41216561374,1.6492255255766,1.51184639701482,0.00889667507516244,0.0377586585349617,"Q5XJN2",3.63e-60,"Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (Gamma-interferon-inducible protein IP-30)","cell redox homeostasis [GO:0045454]; hematopoietic stem cell proliferation [GO:0071425]; immune system process [GO:0002376]","GO:0002376; GO:0005576; GO:0005764; GO:0016667; GO:0016671; GO:0045454; GO:0047134; GO:0071425"
"1699","Pocillopora_acuta_HIv2___TS.g7298.t1",19.503064510069,1.83762077371276,1.53317304975299,0.00894286639135003,0.0379213191100812,NA,NA,NA,NA,NA
"1700","Pocillopora_acuta_HIv2___RNAseq.g20144.t1",1237.88897709302,1.71881049337652,1.83878016312999,0.00897815189547468,0.0380272452194042,"Q6HA10",1.11e-57,"Growth/differentiation factor 6 (GDF-6) (Bone morphogenetic protein 13) (BMP-13) (Growth/differentiation factor 16)","activin receptor signaling pathway [GO:0032924]; apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cell migration involved in metanephros development [GO:0035788]; epithelial cell migration [GO:0010631]; fat cell differentiation [GO:0045444]; metanephros development [GO:0001656]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of SMAD protein signal transduction [GO:0060391]; retinal cell apoptotic process [GO:1990009]; SMAD protein signal transduction [GO:0060395]","GO:0001656; GO:0005125; GO:0005615; GO:0006915; GO:0008083; GO:0010631; GO:0030509; GO:0032332; GO:0032924; GO:0035788; GO:0042802; GO:0045444; GO:0045666; GO:0045893; GO:0060391; GO:0060395; GO:1900745; GO:1990009"
"1701","Pocillopora_acuta_HIv2___TS.g201.t2",806.722490334943,-1.44723147039158,0.730793968336179,0.00898099209551194,0.0380272452194042,"Q8TE73",0,"Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5)","cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158]","GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097728; GO:0097729"
"1702","Pocillopora_acuta_HIv2___RNAseq.g26540.t1",3285.50603487383,-1.64006603689864,0.995386587177001,0.0089872507447925,0.0380426089472282,"Q9U6Y6",5.86e-13,"GFP-like fluorescent chromoprotein amFP486","bioluminescence [GO:0008218]; generation of precursor metabolites and energy [GO:0006091]","GO:0006091; GO:0008218"
"1703","Pocillopora_acuta_HIv2___RNAseq.g9027.t1",2280.97939329074,-1.55097283832256,1.88200088834192,0.00899332966798891,0.0380558584870349,"P22004",2.5e-42,"Bone morphogenetic protein 6 (BMP-6) (VG-1-related protein) (VG-1-R) (VGR-1)","BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; cartilage development [GO:0051216]; cellular response to BMP stimulus [GO:0071773]; cellular response to iron ion [GO:0071281]; cellular response to mechanical stimulus [GO:0071260]; endochondral ossification [GO:0001958]; eye development [GO:0001654]; immune response [GO:0006955]; inflammatory response [GO:0006954]; intracellular iron ion homeostasis [GO:0006879]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; osteoblast differentiation [GO:0001649]; positive regulation of aldosterone biosynthetic process [GO:0032349]; positive regulation of aldosterone secretion [GO:2000860]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein secretion [GO:0050714]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular permeability [GO:0043117]; response to activity [GO:0014823]; response to glucocorticoid [GO:0051384]; response to magnesium ion [GO:0032026]; response to retinoic acid [GO:0032526]; skeletal system development [GO:0001501]; type B pancreatic cell development [GO:0003323]","GO:0000122; GO:0001501; GO:0001649; GO:0001654; GO:0001822; GO:0001938; GO:0001958; GO:0003323; GO:0005125; GO:0005615; GO:0006879; GO:0006954; GO:0006955; GO:0008083; GO:0008284; GO:0010628; GO:0014823; GO:0030182; GO:0030501; GO:0030509; GO:0030539; GO:0031666; GO:0031982; GO:0032026; GO:0032332; GO:0032349; GO:0032526; GO:0043117; GO:0045603; GO:0045666; GO:0045669; GO:0045944; GO:0046982; GO:0050679; GO:0050714; GO:0050731; GO:0051216; GO:0051384; GO:0060348; GO:0060391; GO:0060586; GO:0070700; GO:0071260; GO:0071281; GO:0071773; GO:1903392; GO:2000048; GO:2000860"
"1704","Pocillopora_acuta_HIv2___RNAseq.g23178.t1",407.628301957371,1.64722785066152,1.18097952469688,0.00899564298722154,0.0380558584870349,"A2AJ76",1.99e-12,"Hemicentin-2","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808]","GO:0005509; GO:0005576; GO:0005604; GO:0005886; GO:0005938; GO:0007156; GO:0008046; GO:0030054; GO:0030424; GO:0032154; GO:0043025; GO:0050808; GO:0062023"
"1705","Pocillopora_acuta_HIv2___TS.g7543.t1",290.825295473673,1.62181125042837,0.998781716763303,0.00904072988867669,0.0382316119336685,"A1ZAY1",1.88e-42,"SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains)","establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization involved in establishment of planar polarity [GO:0090251]","GO:0001736; GO:0005737; GO:0005929; GO:0016327; GO:0032436; GO:0035331; GO:0045179; GO:0045296; GO:0090163; GO:0090251; GO:0120219"
"1706","Pocillopora_acuta_HIv2___TS.g1110.t1",348.885701825709,-1.23828927181612,1.71274429155494,0.00912489837944559,0.0385276201241868,"Q5U5A6",5.57e-24,"Notch-regulated ankyrin repeat-containing protein","Notch signaling pathway [GO:0007219]","GO:0004857; GO:0005737; GO:0007219; GO:0019208"
"1707","Pocillopora_acuta_HIv2___RNAseq.g11922.t1",219.469499058424,-1.01291031982528,1.57351348005008,0.00912580382642865,0.0385276201241868,"Q5EBP3",8.97e-37,"Armadillo repeat-containing protein 5","adrenal cortex development [GO:0035801]; anatomical structure morphogenesis [GO:0009653]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; defense response to virus [GO:0051607]; gastrulation [GO:0007369]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; mesoderm formation [GO:0001707]; regulation of steroid biosynthetic process [GO:0050810]; T cell proliferation [GO:0042098]","GO:0001701; GO:0001707; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0007369; GO:0009653; GO:0016020; GO:0030097; GO:0035801; GO:0042098; GO:0043367; GO:0050810; GO:0051607"
"1708","Pocillopora_acuta_HIv2___RNAseq.g19906.t1",359.704646920077,-1.68354181715433,1.49252060863236,0.00913252747153722,0.0385335114785048,NA,NA,NA,NA,NA
"1709","Pocillopora_acuta_HIv2___RNAseq.g3743.t1",1180.333072061,-1.69864978033702,1.71197786420788,0.00917057697133789,0.0386602230584177,"Q08E39",9.08e-18,"Protein sprouty homolog 2 (Spry-2)","animal organ development [GO:0048513]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of lens fiber cell differentiation [GO:1902747]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]","GO:0005829; GO:0005874; GO:0010719; GO:0030512; GO:0031397; GO:0032587; GO:0040037; GO:0046580; GO:0048513; GO:0070373; GO:1902747"
"1710","Pocillopora_acuta_HIv2___RNAseq.g16303.t1",204.667465233608,-1.8027921610794,1.46993364852937,0.00918253096641396,0.0386993379656794,"P54797",1.6e-64,"Transport and Golgi organization 2 homolog (Ser/Thr-rich protein T10 in DGCR region)","Golgi organization [GO:0007030]; protein secretion [GO:0009306]","GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0007030; GO:0009306"
"1711","Pocillopora_acuta_HIv2___RNAseq.g25724.t1",651.359024047346,1.59262119631688,0.968423051887841,0.00923844091675911,0.0389009634410491,NA,NA,NA,NA,NA
"1712","Pocillopora_acuta_HIv2___TS.g6241.t1e",2993.3977054003,-1.42547377263579,0.719421528458083,0.00932350162870368,0.0392134712293021,"P94598",0,"Glutamate dehydrogenase (GDH) (EC 1.4.1.3) (NAD(P)H-utilizing glutamate dehydrogenase)","glutamate biosynthetic process [GO:0006537]","GO:0004352; GO:0004354; GO:0005829; GO:0006537"
"1713","Pocillopora_acuta_HIv2___RNAseq.g5138.t1",10953.8344849687,1.41574067207943,0.705028151398732,0.00937401433483359,0.0394144602729747,"Q90XW6",8.82e-46,"Iroquois-class homeodomain protein irx-4-A (Iroquois homeobox protein 4-A)","brain development [GO:0007420]; cell differentiation [GO:0030154]; dorsal/ventral pattern formation [GO:0009953]; heart development [GO:0007507]; proximal/distal pattern formation [GO:0009954]","GO:0000981; GO:0003677; GO:0005634; GO:0007420; GO:0007507; GO:0009953; GO:0009954; GO:0030154"
"1714","Pocillopora_acuta_HIv2___RNAseq.g1221.t1",1344.58561338708,1.98219242355108,1.68920860128473,0.009438740108556,0.0396405159495221,NA,NA,NA,NA,NA
"1715","Pocillopora_acuta_HIv2___RNAseq.g18123.t1",2002.50661812281,-1.60750694436502,0.95045983247449,0.00944376945948723,0.0396501252429676,"Q9R0R1",1.38e-24,"Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228)","iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756]","GO:0005506; GO:0005615; GO:0005769; GO:0005886; GO:0006826; GO:0009986; GO:0010756; GO:0055037; GO:0090091; GO:0098552; GO:1900025"
"1716","Pocillopora_acuta_HIv2___RNAseq.g25968.t1",976.044804729979,1.60635866950797,1.05087815475234,0.00958458162821909,0.0401946618354772,NA,NA,NA,NA,NA
"1717","Pocillopora_acuta_HIv2___RNAseq.g26887.t1",51.7649026085977,1.65126176548543,0.956799833466589,0.00962618586966845,0.0403457410660343,NA,NA,NA,NA,NA
"1718","Pocillopora_acuta_HIv2___TS.g2574.t2",153.207809911563,-1.46330401824898,1.53340102609853,0.00967856428142125,0.0405300387279899,"Q0VAA2",2.05e-22,"Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74)","",""
"1719","Pocillopora_acuta_HIv2___RNAseq.g18121.t1",6819.87418322837,-1.78321988369458,1.95411077773256,0.0097818710416597,0.0408889554964821,"Q6K3R5",3.79e-66,"Sodium/calcium exchanger NCL2 (Na(+)/Ca(2+)-exchange protein NCL2) (OsEFCAX2) (Protein NCX-like 2) (OsNCL2)","calcium ion transmembrane transport [GO:0070588]; intracellular calcium ion homeostasis [GO:0006874]; sodium ion transport [GO:0006814]","GO:0005509; GO:0005774; GO:0005886; GO:0006814; GO:0006874; GO:0015369; GO:0070588"
"1720","Pocillopora_acuta_HIv2___RNAseq.g20930.t1",68.1766318227456,1.68056809810961,1.17376747618067,0.00978406215246989,0.0408889554964821,NA,NA,NA,NA,NA
"1721","Pocillopora_acuta_HIv2___TS.g20846.t1",2193.74330397519,1.61037482107718,1.1313606771316,0.00987314484163071,0.0411898376086953,NA,NA,NA,NA,NA
"1722","Pocillopora_acuta_HIv2___TS.g7062.t1",144.731161654044,1.86271194635417,1.4357707735226,0.01004551651431,0.0418486033591533,"P97821",9.42e-34,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; T cell mediated cytotoxicity [GO:0001913]","GO:0001913; GO:0004197; GO:0004252; GO:0005615; GO:0005654; GO:0005737; GO:0005764; GO:0005813; GO:0006508; GO:0008234; GO:0008239; GO:0016505; GO:0019902; GO:0031404; GO:0031642; GO:0042802; GO:0051087; GO:0051603; GO:0062023; GO:1903052; GO:1903980; GO:2001235"
"1723","Pocillopora_acuta_HIv2___RNAseq.g28251.t1",2338.02487402005,-1.50063398404034,0.85957323484288,0.0100488990860404,0.0418506410539844,"P23978",1.73e-167,"Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1)","amino acid transport [GO:0006865]; associative learning [GO:0008306]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid import [GO:0051939]; inorganic anion import across plasma membrane [GO:0098658]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to organic cyclic compound [GO:0014070]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]","GO:0005283; GO:0005332; GO:0005886; GO:0006865; GO:0007612; GO:0007613; GO:0008306; GO:0009636; GO:0009744; GO:0009986; GO:0010288; GO:0014054; GO:0014070; GO:0014074; GO:0015185; GO:0015378; GO:0030424; GO:0032229; GO:0032355; GO:0035725; GO:0042220; GO:0042734; GO:0042802; GO:0043025; GO:0045211; GO:0046872; GO:0050808; GO:0051592; GO:0051939; GO:0098658; GO:0098719; GO:0098793; GO:0098810; GO:0098982; GO:1902476"
"1724","Pocillopora_acuta_HIv2___RNAseq.g18045.t1",1760.60580652435,1.42345786097607,1.83230364782535,0.0100745315795714,0.0419332445372436,"Q6GL62",5.25e-12,"DNA-binding protein inhibitor ID-4 (Inhibitor of DNA binding 4) (Inhibitor of differentiation 4)","negative regulation of transcription by RNA polymerase II [GO:0000122]","GO:0000122; GO:0005634; GO:0005737; GO:0043425; GO:0046983"
"1725","Pocillopora_acuta_HIv2___RNAseq.g30657.t1",881.370342871197,1.33668311503062,0.651731941855339,0.0100970059164109,0.0419784689781452,"Q5ZK62",0,"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2)","cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]","GO:0005096; GO:0010008; GO:0032456; GO:0046872; GO:1990090"
"1726","Pocillopora_acuta_HIv2___RNAseq.g8902.t1",4224.05660317593,-1.53058231918094,0.875611239614678,0.0101194295314268,0.0420475233388557,NA,NA,NA,NA,NA
"1727","Pocillopora_acuta_HIv2___RNAseq.g16474.t1",150.768359591201,-1.56084865025406,1.8336417358548,0.0101264878027566,0.0420647672541846,"P55013",0,"Solute carrier family 12 member 2 (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (NKCC1) (Na-K-CL symporter)","cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; inorganic cation import across plasma membrane [GO:0098659]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; sodium ion homeostasis [GO:0055078]","GO:0006884; GO:0008511; GO:0008519; GO:0016323; GO:0016324; GO:0046873; GO:0055064; GO:0055075; GO:0055078; GO:0071944; GO:0098659; GO:1990573"
"1728","Pocillopora_acuta_HIv2___RNAseq.g2501.t1",11.9190115551043,-1.38666841304546,2.03706904622395,0.0101433173494112,0.0421225788521054,"Q8N8K9",8.71e-07,"Uncharacterized protein KIAA1958","",""
"1729","Pocillopora_acuta_HIv2___RNAseq.g30525.t1",23.2499278764302,-1.72130889407492,2.00815677686074,0.0101688786165894,0.0422044936328116,"Q09575",1.09e-26,"Uncharacterized protein K02A2.6","DNA integration [GO:0015074]","GO:0003676; GO:0005737; GO:0008270; GO:0015074; GO:0019899; GO:0042575"
"1730","Pocillopora_acuta_HIv2___RNAseq.g12417.t1",170.56934460637,-1.02917994295767,1.48802016889124,0.0101983208638307,0.042290284683041,"Q60HG7",0,"Cystathionine gamma-lyase (CGL) (CSE) (EC 4.4.1.1) (Cysteine desulfhydrase) (Cysteine-protein sulfhydrase) (Gamma-cystathionase) (Homocysteine desulfhydrase) (EC 4.4.1.2)","cysteine biosynthetic process [GO:0019344]; hydrogen sulfide biosynthetic process [GO:0070814]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein sulfhydration [GO:0044524]; protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine [GO:0018272]; transsulfuration [GO:0019346]","GO:0004123; GO:0005516; GO:0005737; GO:0006629; GO:0018272; GO:0019344; GO:0019346; GO:0030170; GO:0043066; GO:0043123; GO:0044524; GO:0044540; GO:0047982; GO:0051092; GO:0070814; GO:0080146; GO:0098606"
"1731","Pocillopora_acuta_HIv2___RNAseq.g26013.t1",218.412116806322,-1.08845877368485,1.52439477138503,0.0102320493547053,0.0424058343456897,NA,NA,NA,NA,NA
"1732","Pocillopora_acuta_HIv2___TS.g11002.t4",167.397861014845,1.68587051150424,1.37835400276426,0.0102494231834308,0.0424656708465032,"P07207",6.79e-80,"Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]","actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]","GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048"
"1733","Pocillopora_acuta_HIv2___RNAseq.g30139.t1",821.795906152358,-1.47165100581324,1.32836698973554,0.0102729451630841,0.0425387571826078,"Q921G7",0,"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)","electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979]","GO:0004174; GO:0005739; GO:0005743; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0022900; GO:0031966; GO:0033539; GO:0046872; GO:0048039; GO:0051536; GO:0051539"
"1734","Pocillopora_acuta_HIv2___TS.g2709.t1",2877.74011371784,-1.58465342215955,0.939997161350656,0.0103538526952677,0.0428369923868285,"G8HTB6",1.65e-39,"ZP domain-containing protein","","GO:0016020"
"1735","Pocillopora_acuta_HIv2___RNAseq.g19685.t1",27.801113165429,1.6526250840119,1.64460649664116,0.0104037021602779,0.0430309259497452,NA,NA,NA,NA,NA
"1736","Pocillopora_acuta_HIv2___RNAseq.g29836.t1",906.661444393449,-1.54692220933555,1.11175597921446,0.0104321523450184,0.0431239358440541,"Q8QGQ6",3.28e-60,"Circadian locomoter output cycles protein kaput","circadian regulation of gene expression [GO:0032922]; DNA damage response [GO:0006974]; protein acetylation [GO:0006473]; regulation of transcription by RNA polymerase II [GO:0006357]; response to redox state [GO:0051775]","GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005829; GO:0006357; GO:0006473; GO:0006974; GO:0032922; GO:0046983; GO:0051775; GO:0070888; GO:1990513"
"1737","Pocillopora_acuta_HIv2___RNAseq.g866.t1",88.6705691286377,-1.70110728959845,1.60224266958141,0.010446391463056,0.0431704588918977,NA,NA,NA,NA,NA
"1738","Pocillopora_acuta_HIv2___RNAseq.g20576.t1",429.999734686616,1.31616159160012,1.61582886659656,0.0105482587661171,0.0435168325137243,"A1KZ92",9.84e-23,"Probable oxidoreductase PXDNL (EC 1.-.-.-) (Cardiac peroxidase) (Inactive peroxidasin-like protein) (Polysomal ribonuclease 1) (PRM1) (Vascular peroxidase 2)","hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]","GO:0004519; GO:0004601; GO:0005615; GO:0005783; GO:0005886; GO:0006979; GO:0020037; GO:0042744; GO:0046872; GO:0140825"
"1739","Pocillopora_acuta_HIv2___TS.g8264.t1",1804.33726633526,1.57688226461301,1.22063343012517,0.0107195298423322,0.0441227318268334,NA,NA,NA,NA,NA
"1740","Pocillopora_acuta_HIv2___RNAseq.g28196.t1",129.232933922407,1.6072874674631,1.45710147458055,0.0107531840900027,0.0442235014722205,"P16112",8.16e-20,"Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2]","cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; glial cell differentiation [GO:0010001]; positive regulation of neuroblast proliferation [GO:0002052]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]","GO:0001501; GO:0002052; GO:0005201; GO:0005540; GO:0005576; GO:0005615; GO:0005796; GO:0006508; GO:0007155; GO:0007417; GO:0010001; GO:0030246; GO:0043202; GO:0045202; GO:0046872; GO:0062023; GO:0072534"
"1741","Pocillopora_acuta_HIv2___RNAseq.g30596.t1",3380.50433137246,1.42316486421614,0.762133229862632,0.0107811687730595,0.0443259878151032,"Q6AZG8",1.31e-48,"Prostamide/prostaglandin F synthase (Prostamide/PG F synthase) (Prostamide/PGF synthase) (EC 1.11.1.20) (Peroxiredoxin-like 2B)","prostaglandin biosynthetic process [GO:0001516]","GO:0001516; GO:0005829; GO:0016616"
"1742","Pocillopora_acuta_HIv2___TS.g28867.t2",1865.24976729371,-1.46163652080028,0.79200837130963,0.0108065024948896,0.0444175197743915,"Q8VHT6",2.29e-104,"Arsenite methyltransferase (EC 2.1.1.137) (Methylarsonite methyltransferase) (S-adenosyl-L-methionine:arsenic(III) methyltransferase)","arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; response to arsenic-containing substance [GO:0046685]; toxin metabolic process [GO:0009404]","GO:0005829; GO:0008276; GO:0008757; GO:0009404; GO:0018872; GO:0030791; GO:0032259; GO:0046685"
"1743","Pocillopora_acuta_HIv2___RNAseq.g14240.t1",913.107922433722,1.07938935105972,1.49348810932228,0.0108134916856553,0.0444336203810562,"Q58CQ9",5.33e-148,"Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Vascular non-inflammatory molecule 1) (Vanin-1)","pantothenate metabolic process [GO:0015939]","GO:0005886; GO:0015939; GO:0017159; GO:0098552"
"1744","Pocillopora_acuta_HIv2___RNAseq.g14613.t1",5362.45358858501,-1.26070577776904,0.595029428457047,0.0108426223347484,0.0445153816207212,NA,NA,NA,NA,NA
"1745","Pocillopora_acuta_HIv2___RNAseq.g26272.t1",715.231439450758,-1.14043728169918,1.51555437592574,0.010848764252394,0.0445279586114152,"Q5TJF5",7.19e-91,"(3R)-3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12) (17-beta-hydroxysteroid dehydrogenase 8) (17-beta-HSD 8) (3-ketoacyl-[acyl-carrier-protein] reductase alpha subunit) (KAR alpha subunit) (3-oxoacyl-[acyl-carrier-protein] reductase) (Estradiol 17-beta-dehydrogenase 8) (EC 1.1.1.62) (Testosterone 17-beta-dehydrogenase 8) (EC 1.1.1.239)","estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; protein heterotetramerization [GO:0051290]","GO:0004303; GO:0005759; GO:0006633; GO:0006703; GO:0047035; GO:0051290; GO:0070404; GO:0106386"
"1746","Pocillopora_acuta_HIv2___TS.g25068.t1",467.082718224001,1.7444614696865,1.60854074084603,0.0109108508052492,0.0447446969229158,"Q9H3S4",1.68e-78,"Thiamine pyrophosphokinase 1 (hTPK1) (Placental protein 20) (PP20) (Thiamin pyrophosphokinase 1)","regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772]","GO:0004788; GO:0005524; GO:0005829; GO:0006772; GO:0009229; GO:0010510; GO:0016301; GO:0030975; GO:0042802; GO:0141200"
"1747","Pocillopora_acuta_HIv2___RNAseq.g16934.t1",360.232186009988,-1.19224312712914,1.48841292898244,0.0109246002771367,0.0447883839026377,"Q8IV20",1.43e-77,"Purine nucleoside phosphorylase LACC1 (EC 2.4.2.1) (Adenosine deaminase LACC1) (EC 3.5.4.4) (Fatty acid metabolism-immunity nexus) (Guanosine phosphorylase LACC1) (Laccase domain-containing protein 1) (S-methyl-5'-thioadenosine phosphorylase LACC1) (EC 2.4.2.28)","inflammatory response [GO:0006954]; innate immune response [GO:0045087]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine production involved in immune response [GO:0002720]; regulation of cellular pH [GO:0030641]; regulation of inflammatory response [GO:0050727]; regulation of purine nucleotide metabolic process [GO:1900542]","GO:0002221; GO:0002720; GO:0004000; GO:0004731; GO:0005507; GO:0005634; GO:0005777; GO:0005783; GO:0006954; GO:0017061; GO:0030641; GO:0045087; GO:0046936; GO:0047975; GO:0050727; GO:0070431; GO:1900542"
"1748","Pocillopora_acuta_HIv2___RNAseq.g5400.t1",480.60962427782,-1.22431077061885,1.60328879771694,0.0109634100779188,0.0448965921197672,NA,NA,NA,NA,NA
"1749","Pocillopora_acuta_HIv2___RNAseq.g3624.t1",4031.25327898199,-1.49969620384845,0.878380729764007,0.011234048085791,0.0458361837836055,"Q1LW01",3.56e-39,"Hatching enzyme 1.2 (EC 3.4.24.67) (Choriolysin H homolog 1) (High choriolytic enzyme 1 homolog) (zHCE-1)","hatching [GO:0035188]; proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008237; GO:0008270; GO:0035188"
"1750","Pocillopora_acuta_HIv2___RNAseq.g3166.t1",575.39470804944,-1.53505011896707,1.6409596727602,0.01127371891163,0.0459721089195984,"P09241",1.16e-26,"Rhodopsin","cellular response to light stimulus [GO:0071482]; phototransduction [GO:0007602]; visual perception [GO:0007601]","GO:0005886; GO:0007601; GO:0007602; GO:0008020; GO:0016020; GO:0016918; GO:0033583; GO:0071482"
"1751","Pocillopora_acuta_HIv2___RNAseq.g17728.t1",107.924740577755,-1.08931113453181,1.42478613538809,0.0112910914318359,0.0460040412591759,"Q7RTR2",3.38e-73,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223"
"1752","Pocillopora_acuta_HIv2___TS.g20153.t1a",2002.14050558377,-1.57319282335498,0.978522142126902,0.0113692617547603,0.0462704001184167,"P14733",3.96e-89,"Lamin-B1","cellular response to L-glutamate [GO:1905232]; heterochromatin formation [GO:0031507]; nuclear envelope organization [GO:0006998]; nuclear migration [GO:0007097]; nuclear pore localization [GO:0051664]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of JNK cascade [GO:0046330]; protein localization to nuclear envelope [GO:0090435]","GO:0003690; GO:0005200; GO:0005634; GO:0005635; GO:0005637; GO:0005638; GO:0005652; GO:0005654; GO:0006998; GO:0007097; GO:0008432; GO:0010971; GO:0016363; GO:0031507; GO:0031965; GO:0034399; GO:0043274; GO:0046330; GO:0051664; GO:0090435; GO:0160123; GO:1905232; GO:1990837"
"1753","Pocillopora_acuta_HIv2___RNAseq.g5145.t1",726.791347380608,1.05533326367433,1.59432418794089,0.0114401411641767,0.0465457670319696,"Q0V7M1",8.77e-150,"Serine/threonine-protein kinase H1 (EC 2.7.11.1) (Protein serine kinase H1) (PSK-H1)","determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]","GO:0004674; GO:0005524; GO:0005789; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0007368; GO:0007507; GO:0016607; GO:0106310"
"1754","Pocillopora_acuta_HIv2___RNAseq.g26503.t1",559.871419353052,-1.06201084521784,1.55406245987569,0.0114763739743211,0.0466669308868655,"Q99L13",1.87e-139,"3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH) (EC 1.1.1.31)","valine catabolic process [GO:0006574]","GO:0005739; GO:0006574; GO:0008442; GO:0050661; GO:0051287"
"1755","Pocillopora_acuta_HIv2___RNAseq.g2915.t1",1410.82770154705,-1.47060090041988,0.84529019677414,0.0115174104513789,0.0468206365285959,"Q9NYQ6",5.7e-42,"Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2)","apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lateral sprouting involved in lung morphogenesis [GO:0060490]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001736; GO:0001764; GO:0001843; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0007156; GO:0007266; GO:0007417; GO:0016020; GO:0032956; GO:0042249; GO:0045176; GO:0048105; GO:0060071; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0098609"
"1756","Pocillopora_acuta_HIv2___RNAseq.17885_t",1565.4831661472,-1.52251649198073,0.923219313028571,0.0115549098960642,0.0469335065253223,NA,NA,NA,NA,NA
"1757","Pocillopora_acuta_HIv2___RNAseq.g15510.t1",230.215674423879,1.68572942064615,1.95872519213557,0.0115678245140846,0.0469727719740932,"O42097",9.12e-81,"Hepatocyte nuclear factor 3-beta (HNF-3-beta) (HNF-3B) (Forkhead box protein A2) (Me-HNF3B)","anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009653; GO:0019904; GO:0030154"
"1758","Pocillopora_acuta_HIv2___RNAseq.g24790.t1",397.68046846859,-1.29553204423506,1.59535793470999,0.0115829073269399,0.0470208171700416,"A0A1X7TVA9",6.63e-12,"Death domain-containing ATP nucleosidase (DDAN) (EC 3.5.99.-)","nucleoside metabolic process [GO:0009116]","GO:0009116; GO:0016787"
"1759","Pocillopora_acuta_HIv2___RNAseq.g24051.t1",302.817257977235,-1.41043034888526,1.57046095701045,0.0116446099475153,0.0472447793214196,"A4IF63",1.6e-06,"Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2)","negative regulation of translation [GO:0017148]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523]","GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0017148; GO:0030371; GO:0043161; GO:0043523; GO:0061630"
"1760","Pocillopora_acuta_HIv2___RNAseq.g30473.t1",13.3243030004102,-1.34415259762016,1.90171908051364,0.0116777684885167,0.0473492302106327,"Q8N8K9",7.8e-06,"Uncharacterized protein KIAA1958","",""
"1761","Pocillopora_acuta_HIv2___RNAseq.g1075.t1",2897.25249885627,1.46015473308441,0.842013769234541,0.0117057272433553,0.0474011340885834,"Q9H3U7",4.25e-21,"SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2)","extracellular matrix organization [GO:0030198]; positive regulation of angiogenesis [GO:0045766]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; positive regulation of vascular wound healing [GO:0035470]","GO:0005509; GO:0005604; GO:0005615; GO:0008201; GO:0010595; GO:0030198; GO:0035470; GO:0045743; GO:0045766; GO:0045931; GO:0050840; GO:0071944; GO:1900748; GO:2000573; GO:2001028"
"1762","Pocillopora_acuta_HIv2___RNAseq.g25890.t1",3245.87267948305,1.4720704391473,0.8302478168261,0.0117121343110786,0.0474011340885834,"B3EWZ5",2.83e-80,"MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1)","","GO:0005576; GO:0016020"
"1763","Pocillopora_acuta_HIv2___TS.g18294.t2",481.562996550435,-1.50017877207491,0.906959438480115,0.0117161918754991,0.0474011340885834,"A8JF70",3.39e-82,"Outer dynein arm protein 1 (Docking complex component 2)","cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158]","GO:0036157; GO:0036158; GO:0060294"
"1764","Pocillopora_acuta_HIv2___RNAseq.g26135.t1",108.182951888324,-1.14024891899736,1.55365028945587,0.0117220451255053,0.0474011340885834,NA,NA,NA,NA,NA
"1765","Pocillopora_acuta_HIv2___RNAseq.g17945.t2",1248.0805225734,-1.06195371543828,1.41109255810166,0.01172247349522,0.0474011340885834,NA,NA,NA,NA,NA
"1766","Pocillopora_acuta_HIv2___RNAseq.g21706.t1",18.4887026819451,-1.90985274607781,4.22019694488102,0.0117963904901674,0.0476467444986824,NA,NA,NA,NA,NA
"1767","Pocillopora_acuta_HIv2___TS.g11671.t1",525.269075381019,-1.35085225653949,0.685954719247566,0.0118344755296704,0.0477872289394621,NA,NA,NA,NA,NA
"1768","Pocillopora_acuta_HIv2___RNAseq.g28353.t1",47.0974867061529,1.63912373565985,1.23637995208008,0.0118740800393443,0.0479337688219581,NA,NA,NA,NA,NA
"1769","Pocillopora_acuta_HIv2___RNAseq.g9149.t1",7807.41741925036,1.68586128122411,1.36028897398367,0.0119037094225243,0.0480399701694732,NA,NA,NA,NA,NA
"1770","Pocillopora_acuta_HIv2___RNAseq.g9330.t1",101.073997493127,-1.44085894393194,1.5830888950211,0.011983150849949,0.0483201265385174,NA,NA,NA,NA,NA
"1771","Pocillopora_acuta_HIv2___TS.g30330.t1",702.806760936339,-1.56254166020492,1.2133925532037,0.0120386420854986,0.0485303565007391,"P42638",1.54e-13,"Tropomyosin-2 (Tropomyosin II) (SmTMII) (TMII)","actin filament organization [GO:0007015]; muscle contraction [GO:0006936]","GO:0005884; GO:0006936; GO:0007015; GO:0051015"
"1772","Pocillopora_acuta_HIv2___TS.g15134.t1",4469.94208328515,-1.40303230644268,0.755191343303694,0.012125612471926,0.0488401166232074,"Q27433",1.32e-128,"Mechanosensory protein 2","detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612]","GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792"
"1773","Pocillopora_acuta_HIv2___RNAseq.g12166.t1",309.814925036758,-1.37517944034117,1.51512160103955,0.0123183116895809,0.0494784949397662,"Q9D119",1.81e-12,"Protein phosphatase 1 regulatory subunit 27 (Dysferlin-interacting protein 1)","","GO:0004864; GO:0019902"
"1774","Pocillopora_acuta_HIv2___RNAseq.g14039.t2",3338.8077280388,1.4284482686767,0.784660747282386,0.0124623028384994,0.0499874509861494,"Q7M329",8.8e-35,"Ribonuclease T2 (EC 4.6.1.19)","innate immune response [GO:0045087]; RNA catabolic process [GO:0006401]","GO:0003723; GO:0004521; GO:0004540; GO:0005576; GO:0005615; GO:0005758; GO:0005764; GO:0005788; GO:0006401; GO:0033897; GO:0043202; GO:0045087"
